<SUBMISSION>
<ACCESSION-NUMBER>0001144204-05-007249
<TYPE>6-K
<PUBLIC-DOCUMENT-COUNT>5
<PERIOD>20050310
<FILING-DATE>20050311
<DATE-OF-FILING-DATE-CHANGE>20050310
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>pSivida LTD
<CIK>0001314102
<ASSIGNED-SIC>3826
<IRS-NUMBER>000000000
<STATE-OF-INCORPORATION>C3
<FISCAL-YEAR-END>0630
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>6-K
<ACT>34
<FILE-NUMBER>000-51122
<FILM-NUMBER>05673714
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>LEVEL 12 BGC CENTRE
<STREET2>28 THE ESPLANADE
<CITY>PERTH
<STATE>C3
<ZIP>6000
<PHONE>61 8 9226 5099
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>LEVEL 12 BGC CENTRE
<STREET2>28 THE ESPLANADE
<CITY>PERTH
<STATE>C3
<ZIP>6000
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>v014148_6k.htm
<TEXT>
<HTML><HEAD>
<TITLE>
</TITLE>
</HEAD><BODY id=38 bgColor=#ffffff>
<DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><STRONG>SECURITIES
AND EXCHANGE COMMISSION</STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Washington,
D.C. 20549</STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman"><STRONG>FORM
6-K</STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">REPORT OF
FOREIGN ISSUER<BR></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
to Rule 13a-16 or 15d-16 of<BR></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
Securities Exchange Act of 1934</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>For
the month of March 2005</STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Commission
File Number 000-5112</STRONG></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><STRONG>pSivida
Limited<BR></STRONG></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Translation
of registrant&#146;s name into English) </FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Level 12
BGC Centre<BR></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">28 The
Esplanade<BR></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Perth WA
6000<BR></FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Address
of principal executive offices)</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Indicate
by check mark whether the registrant files or will file annual reports under
cover Form&nbsp;20-F or Form&nbsp;40-F). </FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT size=2></FONT>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Form 20-F
</FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">&#253;</FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form
40-F </FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">o</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(1):</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(7):</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate
by check mark whether the registrant by furnishing the information contained in
this Form is also thereby furnishing the information to the Commission pursuant
to Rule&nbsp;12g3-2(b) under the Securities Exchange Act of 1934.</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Yes
</FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">o</FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
</FONT><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">&#253;</FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If &#147;Yes&#148;
is marked, indicate below the file number assigned to the registrant in
connection with Rule&nbsp;12g3-2(b): 82- ___. </FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>SIGNATURE
</STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant,
pSivida Limited, has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized. </FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center>
<TABLE cellSpacing=0 cellPadding=0 width="100%" bgColor=#ffffff border=0>
  <TR vAlign=top bgColor=#ffffff>
    <TD width="50%"><FONT face="Times New Roman" size=2>&nbsp;</FONT></TD>
    <TD width="1%"><FONT face="Times New Roman" size=2>&nbsp;</FONT></TD>
    <TD width="49%"><FONT face="Times New Roman" size=2>&nbsp;</FONT></TD></TR>
  <TR vAlign=top bgColor=#ffffff>
    <TD><FONT face="Times New Roman" size=2>&nbsp;</FONT></TD>
    <TD colSpan=2><FONT face="Times New Roman" size=2>pSivida
  Limited</FONT></TD></TR>
  <TR vAlign=top bgColor=#ffffff>
    <TD><FONT face="Times New Roman" size=2>&nbsp;<BR>&nbsp;</FONT></TD>
    <TD><FONT face="Times New Roman" size=2>&nbsp;<BR>&nbsp;</FONT></TD>
    <TD><FONT face="Times New Roman" size=2>&nbsp;<BR>&nbsp;</FONT></TD></TR>
  <TR vAlign=top bgColor=#ffffff>
    <TD><FONT face="Times New Roman" size=2>Date: March 11, 2005</FONT></TD>
    <TD><FONT face="Times New Roman" size=2>By:&nbsp;&nbsp;</FONT></TD>
    <TD><FONT face="Times New Roman" size=2>/s/ Aaron Finlay</FONT></TD></TR>
  <TR vAlign=top bgColor=#ffffff>
    <TD colSpan=2><FONT face="Times New Roman" size=1>&nbsp;</FONT></TD>
    <TD align=left>
      <HR align=left width="80%" color=#000000 noShade SIZE=2>
    </TD></TR>
  <TR vAlign=top bgColor=#ffffff>
    <TD colSpan=2><FONT face="Times New Roman" size=2>&nbsp;</FONT></TD>
    <TD><FONT face="Times New Roman" size=2>Aaron Finlay<BR><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><EM>Chief
      Financial Officer and Company
Secretary</EM></FONT></FONT></TD></TR></TABLE></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 207pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV>
<DIV id=PGBRK style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<DIV id=FTR>
<DIV id=GLFTR style="WIDTH: 100%" align=left><FONT
style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV>
<DIV id=PN style="PAGE-BREAK-AFTER: always">
<DIV style="WIDTH: 100%; TEXT-ALIGN: center"><FONT
style="DISPLAY: inline; FONT-SIZE: 8pt" face="Times New Roman"></FONT></DIV>
<DIV style="WIDTH: 100%; TEXT-ALIGN: center">
<HR color=#000000 noShade SIZE=2>
</DIV></DIV>
<DIV id=HDR>
<DIV id=GLHDR style="WIDTH: 100%" align=right><FONT
style="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV></DIV>
<DIV>&nbsp;</DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=center><FONT
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG><EM><U>EXHIBIT
INDEX</U></EM></STRONG></FONT></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=justify>&nbsp;</DIV></DIV>
<DIV>
<TABLE cellSpacing=0 cellPadding=0 width="100%">
  <TR>
    <TD vAlign=top align=left width="15%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>EXHIBIT
      99.1:</STRONG></FONT></DIV></TD>
    <TD vAlign=top align=left width="62%">
      <DIV
      style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
      align=left><FONT
      style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shareholder
      Update March 2005</FONT></DIV></TD></TR></TABLE></DIV>
<DIV
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
align=left></DIV>
<DIV></DIV></DIV></BODY></HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v014148_ex99-1.htm
<TEXT>
<HTML>
  <HEAD>
         <TITLE> </TITLE>
  </HEAD>
  <BODY ID="38" BGCOLOR="#ffffff">
         <DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="center"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG></STRONG></FONT>&nbsp;</DIV>

                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="center"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG></STRONG></FONT>

                  <DIV ALIGN="center">
                         <TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BGCOLOR="#ffffff"
                          BORDER="0">
                                <TR BGCOLOR="#ffffff">
                                  <TD WIDTH="100%">
                                         <DIV
                                          STYLE="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"
                                          ALIGN="center"><IMG SRC="v014148_psivida-logo.jpg" WIDTH="428"
                                                HEIGHT="120"></DIV></TD>
                                </TR>
                         </TABLE></DIV></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="center"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><STRONG>SHAREHOLDER
                  UPDATE</STRONG></FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="center"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><STRONG>March
                  2005</STRONG></FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="left"><BR></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dear
                  Shareholder,</FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The past
                  six months has been a busy and exciting period for pSivida with a number of
                  significant events occurring throughout this period.</FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"> &nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><IMG SRC="v014148_psivida-photo.jpg" ALIGN="LEFT" WIDTH="208"
                  HEIGHT="300" BORDER="0"></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In
                  January your Company became truly global with pSivida listing on NASDAQ&#146;s
                  National Market joining only eleven other Australian companies listed on one of
                  the world&#146;s premier capital markets. With its NASDAQ listing completed
                  your Company is actively seeking to increase its presence and capabilities in
                  the US, the world&#146;s most important pharmaceutical and capital market.
                  pSivida is looking to appoint a US based CEO and Business Development executive
                  to assist with accelerating the commercialization efforts for BioSilicon<FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.
                  </FONT></FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                  </FONT>awareness of pSivida in the US has been steadily growing with increasing
                  coverage in US-based investor newsletters and industry publications such as
                  NanoBiotech News and the Forbes/Global Nanotech Report. pSivida has also been
                  asked to present at upcoming investor based conferences in March and April
                  following a successful presentation at the Brean Murray &amp; Co Annual
                  Institutional Investor Conference in New York in early February. Your Company
                  is currently in the US conducting a series of investor seminars for both retail
                  and institutional investors in an effort to increase US-based investment in
                  your Company.</FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Importantly
                  your Company also continues to make excellent progress with the development of
                  its lead product BrachySil</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">, for
                  the treatment of inoperable primary liver cancer by effectively delivering
                  radiation directly to the tumor. Further interim data released in February from
                  the current Phase IIa clinical trial showed that BrachySil</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> led to
                  significant regression of tumors. The results revealed an average reduction in
                  tumor size of 80% with some small tumors disappearing completely. These results
                  are particularly pleasing given the significant level of tumor regression
                  achieved despite the low dose being administered in the trial. As one of the
                  few available technologies that deliver a radioisotope directly to tumours,
                  BrachySil</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> has
                  also shown to be safe, a problem associated with some other tumour-targeted
                  treatments. Importantly no treatment related adverse events were reported in
                  these patients.</FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">These
                  studies represent a critical milestone in pSivida&#146;s product development
                  plans and lay the foundations for the process leading to registration of
                  BrachySil&#153;, our lead product. Following the completion of the Phase IIa
                  trial your Company expects to commence a dose profiling study and pivotal
                  registration trials for the product during 2005. BrachySil</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> is
                  expected to be registered as an approved treatment for liver cancer potentially
                  as early as 2007. </FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV ID="PGBRK"
                 STYLE="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                  <DIV ID="FTR">
                         <DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="left"><FONT
                                STYLE="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV>

                  <DIV ID="PN" STYLE="PAGE-BREAK-AFTER: always">
                         <DIV STYLE="WIDTH: 100%; TEXT-ALIGN: center"><FONT
                                STYLE="DISPLAY: inline; FONT-SIZE: 8pt" FACE="Times New Roman"></FONT></DIV>
                         <DIV STYLE="WIDTH: 100%; TEXT-ALIGN: center">
                                <HR COLOR="#000000" NOSHADE="NOSHADE" SIZE="2"> </DIV></DIV>
                  <DIV ID="HDR">
                         <DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="right"><FONT
                                STYLE="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV></DIV>

                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In line
                  with the broader strategy for the development of BrachySil</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> your
                  Company is looking to significantly expand the use of BrachySil</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> for
                  other solid tumour cancers, ultimately producing a pipeline of
                  BioSilicon</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> based
                  oncology products. This strategy will substantially broaden the market
                  potential of the product well beyond the possibilities for current
                  brachytherapy and embolisation approaches. The selection of these indications
                  has resulted from considerable consultation with the Company&#146;s Oncology
                  Advisory Panel and significant research into the potential market size and
                  competitive landscapes that exist for cancer treatment in these
                  areas.</FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As a
                  first step in this process and in parallel to the development of
                  BrachySil</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> for
                  primary liver cancer, your Company aims to commence a human clinical trial for
                  a second cancer indication such as pancreatic cancer, within the next year.
                  Importantly a manufacturing and supply chain compliant to worldwide regulatory
                  guidelines has already been established for BrachySil</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                  eliminating a costly and time-consuming component in the development of future
                  BrachySil</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                  products. </FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Your
                  Company is currently seeking and is in discussions with development and
                  marketing partners in an effort to maximise the future return to shareholders
                  for BrachySil</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">. Your
                  Company is seeking to share some of the risks and costs associated with taking
                  this product through to registration and ultimately to market, although we have
                  the expertise and financial capacity to take BrachySil</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> to
                  product registration alone should we choose to do so. </FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other
                  recent milestones for pSivida include:</FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV>
                  <TABLE ID="list" CELLSPACING="0" CELLPADDING="0" WIDTH="100%">
                         <TR STYLE="LINE-HEIGHT: 1.25" VALIGN="top">
                                <TD STYLE="WIDTH: 36pt" ALIGN="right"><FONT
                                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&middot;&nbsp;&nbsp;</FONT></TD>

                                <TD>
                                  <DIV
                                        STYLE="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                                         signing of a deal with a top five global pharmaceutical company to evaluate
                                         pSivida&#146;s BioSilicon</FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                                         technology for drug delivery. The undisclosed pharmaceutical company will fund
                                         the evaluation of BioSilicon</FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> in the
                                         controlled release of a number of compounds. It is expected that this deal is
                                         the first of a number of potential similar deals to be signed with other
                                         pharmaceutical companies during the year.</FONT></DIV></TD>
                         </TR>
                  </TABLE></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV>
                  <TABLE ID="list" CELLSPACING="0" CELLPADDING="0" WIDTH="100%">
                         <TR STYLE="LINE-HEIGHT: 1.25" VALIGN="top">
                                <TD STYLE="WIDTH: 36pt" ALIGN="right"><FONT
                                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&middot;&nbsp;&nbsp;</FONT></TD>

                                <TD>
                                  <DIV
                                        STYLE="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                                         signing of an agreement with ITOCHU Corporation of Japan, to develop and
                                         commercialise BioSilicon</FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                                         products in Japan and Asia. The Agreement is an important one as ITOCHU is one
                                         of Japan&#146;s largest companies and the deal covers opportunities for
                                         production, distribution, direct investment, licensing and co-operative
                                         development programmes as well as the development of entirely new applications
                                         for BioSilicon</FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</FONT></DIV></TD>
                         </TR>
                  </TABLE></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV>
                  <TABLE ID="list" CELLSPACING="0" CELLPADDING="0" WIDTH="100%">
                         <TR STYLE="LINE-HEIGHT: 1.25" VALIGN="top">
                                <TD STYLE="WIDTH: 36pt" ALIGN="right"><FONT
                                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&middot;&nbsp;&nbsp;</FONT></TD>

                                <TD>
                                  <DIV
                                        STYLE="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                                         creation of Australian based subsidiary AION Diagnostics Limited for a planned
                                         future spin off, which will develop diagnostic applications for
                                         BioSilicon</FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">. Your
                                         Company appointed Dr Anna Kluczewska as MD of AION.</FONT></DIV></TD>
                         </TR>
                  </TABLE></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In other
                  news, pSivida appointed a new R&amp;D Director. Dr Mark Parry-Billings is a
                  former Director of R&amp;D at Innovata Biomed and has held senior roles at
                  Schering Healthcare (UK). The appointment allows Chief Scientific Officer, Dr
                  Leigh Canham to concentrate on strategic developments associated with
                  BioSilicon</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                  including new manufacturing methods, &#145;smart devices&#146; and general
                  technical support for your Company&#146;s drug delivery program. </FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV ID="PGBRK"
                 STYLE="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                  <DIV ID="FTR">
                         <DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="left"><FONT
                                STYLE="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV>

                  <DIV ID="PN" STYLE="PAGE-BREAK-AFTER: always">
                         <DIV STYLE="WIDTH: 100%; TEXT-ALIGN: center"><FONT
                                STYLE="DISPLAY: inline; FONT-SIZE: 8pt" FACE="Times New Roman"></FONT></DIV>
                         <DIV STYLE="WIDTH: 100%; TEXT-ALIGN: center">
                                <HR COLOR="#000000" NOSHADE="NOSHADE" SIZE="2"> </DIV></DIV>
                  <DIV ID="HDR">
                         <DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="right"><FONT
                                STYLE="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV></DIV>

                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Your
                  Company&#146;s UK based operations have grown substantially over the last 12
                  months with a current staff of 22 including some 15 PhDs. This has been
                  necessary to meet the increasing commitments involving the later stage
                  development projects we are currently working on, to expand our
                  BioSilicon</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                  technology platform especially in drug delivery, including the work for the
                  undisclosed top five global pharmaceutical company and also to support some of
                  our other collaborative programmes. </FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
                  has also strengthened its patent positions with a new European patent granted
                  for &#146;Biomirrors&#146;, a novel form of BioSilicon</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> that
                  can be used in the blocking of light as a means to protect the skin from
                  harmful UV rays. In addition a European patent was granted for the oral
                  delivery of BioSilicon</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> and, in
                  the US, a patent was granted for silicon fabricated products which overcomes
                  the problems normally associated with the damage to circuits caused by high
                  temperature welding. </FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Importantly
                  your Company&#146;s focus remains the application of BioSilicon</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> in
                  controlled release in drug delivery, exploiting this truly unique
                  biomaterial&#146;s many wonderful and exciting properties. We have been using a
                  similar consultative process to that which we employed with
                  BrachySil</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,
                  consulting clinicians and market researchers to explore other potential drug
                  delivery applications for our technology. We are planning and progressing the
                  necessary pre-clinical studies which will enable us to embark on these with a
                  minimum of delay. </FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Updates
                  on the progress of the top five global pharmaceutical company&#146;s evaluation
                  of BioSilicon</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> for
                  drug delivery are expected throughout the year. It remains the Company&#146;s
                  expectation that on the basis of successful outcomes from this, and other
                  similar evaluations that we expect to be carrying out, it will be in a position
                  to secure licensing agreements for the use of BioSilicon</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> in
                  delivering drugs for partner companies in the pharmaceutical and biotechnology
                  sectors.</FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
                  has had an excellent start to 2005. We at pSivida thank you for your continued
                  support and look forward to achieving milestones such as the completion of the
                  Phase IIa trial and the commencement of pivotal registration trials for
                  BrachySil</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> as well
                  as further strengthening of the Company&#146;s patent position, a growing
                  international profile and the maturation of your Company&#146;s planned spin
                  out, the newly created AION Diagnostics.</FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV ALIGN="center">
                  <TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BGCOLOR="#ffffff">
                         <TR BGCOLOR="#ffffff">
                                <TD WIDTH="100%"><FONT SIZE="2">Yours Sincerely,</FONT></TD>
                         </TR>
                         <TR BGCOLOR="#ffffff">
                                <TD WIDTH="100%"><IMG SRC="v014148_psivida-sig.jpg" WIDTH="203"
                                  HEIGHT="90"></TD>
                         </TR>
                         <TR BGCOLOR="#ffffff">
                                <TD WIDTH="100%"><FONT SIZE="2">Gavin Rezos,<BR><FONT
                                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Managing
                                  Director<BR></FONT><FONT
                                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>pSivida
                                  Limited</STRONG></FONT></FONT></TD>
                         </TR>
                  </TABLE></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV><BR>
                <DIV ID="PGBRK"
                 STYLE="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                  <DIV ID="FTR">
                         <DIV STYLE="WIDTH: 100%" ALIGN="center"><FONT
                                STYLE="DISPLAY: inline; FONT-SIZE: 10pt; COLOR: #000000; FONT-FAMILY: Times New Roman"><STRONG>-ENDS-</STRONG></FONT></DIV>

                         <DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="left"><FONT
                                STYLE="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV>

                  <DIV ID="PN" STYLE="PAGE-BREAK-AFTER: always">
                         <DIV STYLE="WIDTH: 100%; TEXT-ALIGN: center"><FONT
                                STYLE="DISPLAY: inline; FONT-SIZE: 8pt" FACE="Times New Roman"></FONT></DIV>
                         <DIV STYLE="WIDTH: 100%; TEXT-ALIGN: center">
                                <HR COLOR="#000000" NOSHADE="NOSHADE" SIZE="2"> </DIV></DIV>
                  <DIV ID="HDR">
                         <DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="right"><FONT
                                STYLE="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV></DIV><BR>

                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Released
                  by:</STRONG></FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV ALIGN="left">
                  <TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0">
                         <TR>
                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" WIDTH="36%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>In
                                         Australia:</STRONG></FONT></DIV></TD>
                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" WIDTH="38%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>In
                                         US:</STRONG></FONT></DIV></TD>
                         </TR>
                         <TR>
                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" ALIGN="left"
                                 WIDTH="36%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="left"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Josh
                                         Mann</FONT></DIV></TD>
                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" ALIGN="left"
                                 WIDTH="38%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="left"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Beverly
                                         Jedynak</FONT></DIV></TD>
                         </TR>
                         <TR>
                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" ALIGN="left"
                                 WIDTH="36%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="left"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Investor
                                         Relations</FONT></DIV></TD>
                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" ALIGN="left"
                                 WIDTH="38%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="left"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">President</FONT></DIV></TD>
                         </TR>
                         <TR>
                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" ALIGN="left"
                                 WIDTH="36%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="left"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
                                         Limited</FONT></DIV></TD>
                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" ALIGN="left"
                                 WIDTH="38%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="left"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Martin
                                         E. Janis &amp; Company, Inc.</FONT></DIV></TD>
                         </TR>
                         <TR>
                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" ALIGN="left"
                                 WIDTH="36%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="left"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Tel: +
                                         61 8 9226 5099</FONT></DIV></TD>
                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" ALIGN="left"
                                 WIDTH="38%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="left"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Tel:
                                         312-943-1100 ext. 12</FONT></DIV></TD>
                         </TR>
                         <TR>
                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" WIDTH="36%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">joshuamann@psivida.com</FONT></DIV></TD>

                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" WIDTH="38%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">bjedynak@janispr.com</FONT></DIV></TD>
                         </TR>
                  </TABLE></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>NOTES
                  TO EDITORS:</STRONG></FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Ticker
                  Symbols</STRONG></FONT></DIV>
                <DIV ALIGN="left">
                  <TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0">
                         <TR>
                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" WIDTH="36%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Australian
                                         Stock Exchange</FONT></DIV></TD>
                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" WIDTH="38%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">:
                                         PSD</FONT></DIV></TD>
                         </TR>
                         <TR>
                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" WIDTH="36%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NASDAQ</FONT></DIV></TD>

                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" WIDTH="38%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">:
                                         PSDV</FONT></DIV></TD>
                         </TR>
                         <TR>
                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" WIDTH="36%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Frankfurt
                                         Stock Exchange (Xetra)</FONT></DIV></TD>
                                <TD STYLE="BORDER-BOTTOM: medium none" VALIGN="top" WIDTH="38%">
                                  <DIV
                                        STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">:
                                         PSI</FONT></DIV></TD>
                         </TR>
                  </TABLE></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="left"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>pSivida
                  Limited</STRONG></FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
                  is a global nanotechnology company committed to the biomedical sector and the
                  development of products in healthcare. The company&#146;s focus is the
                  development and commercialisation of a modified form of silicon (porosified or
                  nano-structured silicon) known as BioSilicon&#153;. As a new and exciting
                  biocompatible material, BioSilicon&#153; offers multiple potential applications
                  across the high growth healthcare sector, including controlled release drug
                  delivery, targeted cancer therapies (including brachytherapy and localized
                  chemotherapy), tissue engineering and orthopedics. Potential diagnostics
                  applications are being developed through its subsidiary AION Diagnostics
                  Limited. </FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
                  owns the intellectual property rights to BioSilicon&#153; for use in or on
                  humans and animals. The IP portfolio consists of 24 patent families, 26 granted
                  patents and over 80 patent applications. The core patent, which recognises
                  BioSilicon&#153; as a biomaterial was granted in the UK in 2000 and in the US
                  in 2001. </FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
                  is listed on NASDAQ (</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>PSDV</STRONG></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">), the
                  Australian Stock Exchange (</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>PSD</STRONG></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">) and in
                  Germany on the Frankfurt Stock Exchange on the XETRA system (</FONT><FONT STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>German</STRONG></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Symbol:
                  PSI. Securities Code (WKN) 358705</STRONG></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">).
                  pSivida&#146;s shares also trade in the United Kingdom on the OFEX
                  International Market Service (IMS) under the ticker symbol </FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>PSD</STRONG></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</FONT></DIV>

                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                  Company&#146;s strategic partner and largest shareholder is the QinetiQ group,
                  the largest science and technology company in Europe. QinetiQ is the former UK
                  government Defence Evaluation Research Agency and was instrumental in
                  discovering BioSilicon&#153;. pSivida enjoys a strong relationship with QinetiQ
                  having access to its cutting edge research and development facilities. For more
                  information on QinetiQ visit www.qinetiq.com.</FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</DIV>

                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
                  has a strong management team with a powerful blend of international experience
                  in biotechnology commercialization, the pharmaceutical industry, licensing and
                  capital markets:</FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV>
                  <TABLE ID="list" CELLSPACING="0" CELLPADDING="0" WIDTH="100%">
                         <TR STYLE="LINE-HEIGHT: 1.25" VALIGN="top">
                                <TD STYLE="WIDTH: 18pt" ALIGN="right"><FONT
                                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&middot;&nbsp;&nbsp;</FONT></TD>

                                <TD>
                                  <DIV
                                        STYLE="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Mr
                                         Gavin Rezos,</STRONG></FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Managing
                                         Director -</STRONG></FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> a
                                         former Investment Banking Director of the HSBC Group.</FONT></DIV></TD>
                         </TR>
                  </TABLE></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV>
                  <TABLE ID="list" CELLSPACING="0" CELLPADDING="0" WIDTH="100%">
                         <TR STYLE="LINE-HEIGHT: 1.25" VALIGN="top">
                                <TD STYLE="WIDTH: 18pt" ALIGN="right"><FONT
                                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&middot;&nbsp;&nbsp;</FONT></TD>

                                <TD>
                                  <DIV
                                        STYLE="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Dr
                                         Roger Brimblecombe,</STRONG></FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&nbsp;</FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Non
                                         Executive Chairman </STRONG></FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">- former
                                         Chairman of SmithKline &amp; French Research and Chairman of MVM
                                         Ventures.</FONT></DIV></TD>
                         </TR>
                  </TABLE></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV>
                  <TABLE ID="list" CELLSPACING="0" CELLPADDING="0" WIDTH="100%">
                         <TR STYLE="LINE-HEIGHT: 1.25" VALIGN="top">
                                <TD STYLE="WIDTH: 18pt" ALIGN="right"><FONT
                                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&middot;&nbsp;&nbsp;</FONT></TD>

                                <TD>
                                  <DIV
                                        STYLE="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Dr
                                         Roger Aston, Director Strategy</STRONG></FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> -
                                         former CEO PepTech Ltd and Director of Cambridge Antibody Technology Ltd
                                         (UK).</FONT></DIV></TD>
                         </TR>
                  </TABLE></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV>
                  <TABLE ID="list" CELLSPACING="0" CELLPADDING="0" WIDTH="100%">
                         <TR STYLE="LINE-HEIGHT: 1.25" VALIGN="top">
                                <TD STYLE="WIDTH: 18pt" ALIGN="right"><FONT
                                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&middot;&nbsp;&nbsp;</FONT></TD>

                                <TD>
                                  <DIV
                                        STYLE="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Professor
                                         Leigh Canham, Chief Scientific Officer </STRONG></FONT><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">- a DERA
                                         fellow and the world&#146;s foremost authority on porous silicon and the
                                         inventor of BioSilicon&#153;. </FONT></DIV></TD>
                         </TR>
                  </TABLE></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV>
                  <TABLE ID="list" CELLSPACING="0" CELLPADDING="0" WIDTH="100%">
                         <TR STYLE="LINE-HEIGHT: 1.25" VALIGN="top">
                                <TD STYLE="WIDTH: 18pt" ALIGN="right"><FONT
                                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif">&middot;&nbsp;&nbsp;</FONT></TD>

                                <TD>
                                  <DIV
                                        STYLE="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"
                                        ALIGN="justify"><FONT
                                         STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><STRONG>Dr
                                         Anna Kluczewska, Managing Director, AION Diagnostics</STRONG></FONT><FONT STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                                         - a former Global Product Manager with Baxter Healthcare Inc, based in Munich
                                         and Vienna.</FONT></DIV></TD>
                         </TR>
                  </TABLE></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify">&nbsp;</DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR>&nbsp;</DIV>
                <DIV ID="PGBRK"
                 STYLE="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                  <DIV ID="FTR">
                         <DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="left"><FONT
                                STYLE="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV>

                  <DIV ID="PN" STYLE="PAGE-BREAK-AFTER: always">
                         <DIV STYLE="WIDTH: 100%; TEXT-ALIGN: center"><FONT
                                STYLE="DISPLAY: inline; FONT-SIZE: 8pt" FACE="Times New Roman"></FONT></DIV>
                         <DIV STYLE="WIDTH: 100%; TEXT-ALIGN: center">
                                <HR COLOR="#000000" NOSHADE="NOSHADE" SIZE="2"> </DIV></DIV>
                  <DIV ID="HDR">
                         <DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="right"><FONT
                                STYLE="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV></DIV>

                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"></FONT>&nbsp;</DIV>

                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For more
                  information visit www.psivida.com</FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
                  document contains forward-looking statements that involve risks and
                  uncertainties. Although we believe that the expectations reflected in such
                  forward-looking statements are reasonable at this time, we can give no
                  assurance that such expectations will prove to be correct. Given these
                  uncertainties, readers are cautioned not to place undue reliance on such
                  forward-looking statements. Actual results could differ materially from those
                  anticipated in these forward-looking statements due to many important factors
                  including: the inability to attract the required staff in the US; the inability
                  to reach agreement with prospective development and marketing partners; and our
                  failure to develop applications for BioSilicon</FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 7pt; FONT-FAMILY: Arial, sans-serif"><SUP>TM</SUP></FONT><FONT
                  STYLE="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"> due to
                  regulatory, scientific or other issues. Other reasons are contained in
                  cautionary statements in the Registration Statement on Form 20-F filed with the
                  U.S. Securities and Exchange Commission, including, without limitation, under
                  Item&nbsp;3.D, "Risk Factors" therein. We do not undertake to update any oral
                  or written forward-looking statements that may be made by or on behalf of
                  pSivida.</FONT></DIV>
                <DIV
                 STYLE="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"
                 ALIGN="justify"><BR></DIV>
                <DIV ID="PGBRK"
                 STYLE="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
                  <DIV ID="FTR">
                         <DIV ID="GLFTR" STYLE="WIDTH: 100%" ALIGN="left"><FONT
                                STYLE="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV>

                  <DIV ID="PN">
                         <DIV STYLE="WIDTH: 100%; TEXT-ALIGN: center"><FONT
                                STYLE="DISPLAY: inline; FONT-SIZE: 8pt" FACE="Times New Roman"></FONT></DIV>
                         <DIV STYLE="WIDTH: 100%; TEXT-ALIGN: center">
                                <HR COLOR="#000000" NOSHADE="NOSHADE" SIZE="2"> </DIV></DIV>
                  <DIV ID="HDR">
                         <DIV ID="GLHDR" STYLE="WIDTH: 100%" ALIGN="right"><FONT
                                STYLE="DISPLAY: inline; FONT-SIZE: 8pt; COLOR: #000000; FONT-FAMILY: Times New Roman"></FONT></DIV></DIV></DIV></DIV>
         </BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>v014148_psivida-logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 v014148_psivida-logo.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`>`&L`P$1``(1`0,1`?_$`.X``0`"`@(#`0$`````
M```````)"@<(!@L#!`4!`@$!``$$`P$!``````````````8%!P@)`0,$`@H0
M```&`@$"`P0$"`@("0T```$"`P0%!@`'"!$2(1,),2(4"D$5-[=1,B,6MG<X
M>&%Q0C.U=A@Y<[-T128V%R>!D:%2-'75EE=B<M)#TR14E"676!D:$0`!`P,!
M!`4$"0\&"`T%```!``(#$00%!B$Q$@=!46$3"'&!L2*1H<$RLB,S%`GPT>%"
M4G)SLS05-746-C=B@L)3=+22TI.%M788./%#@],D1%34)565)AFB8T56%__:
M``P#`0`"$0,1`#\`O\81,(F$3")A$PB81,(F$3")A$PB81,(OY.<B9#J*'*F
MFF4QSG.8"D(0H"8QSF,(%*4I0ZB(^`!A<$@"IW*+'E%ZS/`3BLM)0EDV\CLR
M]1@@FXH&EFR%_FT%Q*!OAY&:;O6-'A%T^X.])[+-UB?\P1\,J-OBKVXVAO"S
MK=L'U_:5J=5<ZN7VDW.M[F\^=9!NSN;8=Z^HW@N!$32*[6ND#NQ17V+YDFVR
MRSA_I[T_=FVFFDZ*L[/8;;+MU'C0IE2*+KL:GK6SQ#$@F*'0Q91P4!`P#XAE
M3;@&-/#-.`[J`^N1Z%:>Y\3%[..]P>G;F>SWA[YBVH[6LA>`0=]'D=JW6].W
MUR=,<XMDMM&V[74OH;<DPA)N*?%2%E96ZG7<8AL=Z_B(>RA&5N096I)@@LX+
M'N8\I%4D%/*<**%\L?)?X::R9WS'<<(WFE"/*-HIY_,IMRUY\X/7N2&!N[9^
M/SC@3&QSQ)')P@DM:_AC<'T!<&EE"!L<3L4Y6497Y3")A$PB81,(F$3")A$P
MB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3
M")A$PB81,(F$3")A$PB81,(F$4/_`#M]:?B1PJ":IS2:_P!N.\H])9$NKM=R
M#-9E`R(`H5)+8=Y,#B!J)$UT^U=JG\=,)]0$67:;O"J6>)NKNCB."$_;'J[!
MT^T.U6;U]SNT?H?CLFR?/\\*@00D$-=U2R;6Q[=A:`^0=,=#50YP=`]8;UH7
M2<UL:U.^'_#R;<"JVBVC&:JD3/0)E5P($14"/8Z_;<5.B(`+J9>,(!<0[T.W
MIY>55S\5B1PQCO;H>?;Y=S?-MZZJR\&-YS\[7]]DY3A=&//O0',:]AXO>Q@B
M2XJ"-LCA$=['-(X5-+Q/]%?@=Q4:QDBWU<TW/L-FC^7V#NA!C<7`.56I$'1X
M6H+M4Z17VXG`YD?*8'=H@?H+E00[LI-SEKRXV<7!'U-V>WO]SL5[M)<D-`Z4
M:V46HOLD!MFN:2$FFTMC([IO3PGA+Q]V=ZE>9LVD>U;L6#5LQ9-$4V[1FS02
M;-6K=(H$20;MT2D1112(``4I0`I0#H`932234[U=QC&1L$<8#8VB@`%``.@`
M;@J+NEM8M]_?,+V@VIP8H4Z@<J;QMN7DJVJW3B6<!JEYY\X[:JM!*@9O8KFV
M39F!+J5120'VE$1R8S2&WP8$U>-S`T5[1[@V^98%X+$-U!XD)CA^%MG:Y.6=
M[HS1H;`\N=NWA\@##382_JVJ]7D-6>R81,(F$3")A$PB81,(F$3")A$PB81,
M(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(F$3"+2KF'Z@G%O@W61F=Z[%8L+(]8JO*QK"O>7/;,MPD*MY/U/56JH
M.6L<NN@*7UD_,SBTE?=4<E,(`/KM;&YO'<,+26]).X>?W!4]B@^L^8FD]!VI
MGU!<M;<EM60,HZ>3JX8Z[`2*<;RU@.PN!5<"Q\PO5-]9J?EM;\.Z1(\:^+YY
M!>(L6Q/K:0@$G48*KA!5.[[=:M0>O7BC%<HKU^I(*+E'W5CK)?E,KXM<;B6B
M2Z/>7/5]8>Z?9!V+&FXUIS9YTW+\=HJ!V+TKQEKYBXMJ*GY2>E2:4K%"TD5H
MYKV^LI8>"_H8\4N)8Q-XV,R1Y(;O;&1?GN%^B&QJ96Y?WU%5J50'"DA'-UTE
MU1$K^34D'_>0JJ9VYA$H4R\S%S<^I'\7#U#?YS];SU5W=`\A])Z/+;_(C\Y9
MX4)EE:.[8[_[<1J-G0YY<X$5;P;E-D`````````=``/```/8`!]`!E(5\5^X
M11*>L+Z@$=P<XR2S>J2K4>06Y&TE2M/0J2RWUI%BZ0*TL>QQ0:_ER-*4R>E.
MV,(D\Z56:I%[@%3MJ>+LC>7'K?(,VN/H'G]%5:'G+S"BT)I9[;1P.HKT&*V9
M7UA78^6@VTC!]4[N\+!NK3`OH2^GO.\3=&3.\=PQ"K'?G(EM'2;V-EV[@ECH
M>N$3GD(*K3)W@_$(6&Q/EAEY9,0`Y%3-D5>JK8W3NS-\VYF$,7R,?MGK\V[V
M3TJ@<A.7,^CL"_-YEE-19(!S@0>.*+>V-W%M#G'UWB@(]1KO68IY<HROZF$3
M")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81
M,(F$3")A$PB81,(F$3"+CUN6FVU5LKBM)"M8D(&75@42II+"K,)L'!XU,$5A
M!%43O`(':<0*/L'PR'<P[G4]GH'-W>B6&7646)NWV+`UKRZ\;!(;9H8_U'5F
M#!PO]4[CL7HM!"ZZC;<FEN7MXOO:BOM*/-+9?-]KW*+TR1=E3`3'(M28X0Z)
M]1.!/@5$%#B8`_DB(C_)\<T\V_.WZ46PXY;G35W<L94D/PL%*-VFG<-C<ZM/
MM22?M=I"G[L=HIU`)FCR2'W:KGNI^:#&<E4*WM*):55\LJ5FE8&0NB1`/P4%
M$6\LQ=^:[AQ,K[OF"HHD0W7S/+#QR['A]^DRQ6J]01:'Y\8^WT_F9'B%M_#W
MK;3O^+@,=U!+QRV=7;.\,DD;'5[WN6`N'@RNCGP0FYQCS+'2O":<5.MI&QWD
MH#U56]Y3%,4#%$#%,`&*8H@)3%$.H"`AX"`AFUUKFO:'L(+"*@C:"#N(/2"H
M.M0M[\GI'3ER:U5K36T^DX@6<R+Y:7<,!(=T[?M1;^4G'.R"!`9`/=W`(]WL
M\,US^+#QUYGPV<RH-!6&F8<O;S8F&\,[[Q\!!EEGC,?`VWE!#>Y!XN($\5*;
M*F78+3,>8LS=/F,9$A;3A!W`&M:CK6%/[?$O_P"&D;_WF<_]C9C!_P#+EJ$;
M]#6?_J<G_<E6OV#A_P"TN_P!_C)_;XE__#2-_P"\SG_L;./_`)<M0_\`Z/9_
M^IR?]R3]@XO^TN_P!_C)_;XE_#_=I&^/L#\YG/4?XO\`Z-XYS_\`+EJ$[M#6
M?_J<G_<D_8.+_M+O\`?XRPE1.+G!KF)LV[6#:G#'54A<'C4;5-W&47FI:>L$
MBYD46ZII)\<[!=QU\SJ'<<Y0*':!0+X9F+X/_'+J+Q,ZNRFE;W`Q86'&XQMT
MV1EVZX+ZSLAX.%UO$&CURX.!.T$4Z5:;5_(_E_&[\Z7UE!=7D\Q+W.:X.+J5
M+B1)4G93R;-RETKM;JE!K,96:I!P-.I]9CBLHF"@H]A`UZ"BF9#&*W8Q[))K
M'QS)N0!'M(4A"^(C].9X75W#;PR7M](V.WC8Y\DCW!K6M:"YSWN<0&M:`2YQ
M(``))HO59V=M901V-A$R*V8`UD;&AK6CH:UK0`!U`!:2;,YI@VF%*SJ*!;V9
MS\0#!&P/R/%VCY^HH5$B4'#-/(>2115$2D4,H0JIN@D(<H@8VI#GC])LVRU*
M_0OAUQ,.=R)E[AE_.V:2&:=S@QK+*SAX);D%QX8Y'2-$KJ&..1A:YUPL;HWB
MA^=9:0Q,I7A%*@?RG'8.T4V=)JN'K;'YQN#=4:=(M1,`@0B5*B@3ZF_%[C/#
MKF+V]?I,`!].6]GYS_2D7LK>XTY>6X=049AK:FWI)F;(1YR`.E>L8_131MF:
M[_E'>Y1;?[@WM0>.&CK'O'>-A;5.I46JH3=K?N0("YWXMD4TX:,9)FZOIR8E
ME2M&;5+J99RJ0A?;US=#I<9B]P>/_.[:9V2SA,[:!M)S$TS`@>JVC^*H&P4V
M;%:;4><Q6FL=<YK)2"/&6X+B=Y(K1K6C>Y[R0UK1M<X@*#+A)Q%V=S]Y*K^J
M/SJJ;V(K0+,U.'''.S@FY:5.CQRZSNJ7"T1+A!,"I-%51?QZ"R*:DC*KJ2:I
M`1!D4\QNKIEE;_F^S/K_`&[AOKT@?5L&S?6E@M$Z/R7,#4QYI:[B<VV!'YNL
MW[6QQM-62N:>KWS*@%[R9:!O!6QWE"62"81,(F$3")A$PB81>N[>-(]LN]?N
MF[)FV3,LY=NUTFS9ND7Q,JNNL8B2290]IC"`!GCR.1Q^(L9<GEIX;7&P,+Y)
M9GMCBC8-[GR/+6L:.ESB`.M?3&/D<&1@N>=P`J3Y`L!S7*?1<&Z49JWAO(+)
M"8J@PD?*3#8#%\.A7S%FJQ5ZC[!(H8,Q(U3X]O"II._?C;O5,-W=,)#OF5O=
M7D=1U3P0O@?7H+)'#M5>ATOG)V\;8"T'[HM:?8)K[2^4SY>Z'=JD2/:GC+O.
M!/->UZ=31+UZ]#'438+`0G\(^SZ<H&-^D7\)N1N&V[]07-L7.IQ38^_:T=I<
MVW>`.T[NFFU=C])9UC>+N@?(]OUUGNNVFMVZ/)*U>=BI^//T#XJ*>H/4B',7
MN!);R3F,@L`#XD.!3A](!F6VC=>:+YAXAN>T+E;#+8=Q`[VUGCF:UQ%>!_`X
MF-X&^-X:]O2T*A7%K<VDG=7+'1R=3@1[%=X[0OO9+%T)A%I5MKEXIK#8$]1R
MT$LT$*$;TDAL@L!<_6$4RD_^B?4KORO*%YV?SANO;U\.O3-8?B%^D7EY$\WL
MMRL;I)N3;C/FW_2?SD8.\^<6D%U\E\RFX>#ON#Y1U>'BV5H)GB=)#)V$=]W_
M``<==G!6E'%N_B'5U+E>AN2RFZ[+,U\].+7`B8/ZY!V$X,H*X_'M67P_D_53
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M`ZK)^U43,)#F((E'H(AXY[VXR^>T.;&2TBN\?75M+GG#RVL[F2SN<K"RYB>Y
MCVEDVQS26N&R.FP@C82.I;(\<^7?&_EM&6B9XY[5@]IQE*D8^)M#N#9SK-.'
MD95HJ^CVK@LY$Q2BAW35`YRBF!R@!1`1`?#///;3VQ`G;PD[MH/H)4FTWJ_3
M>KHI9].73+J*%P:\M:]O"7`D>_:VM:'=4;%LAG0I*F$3")A$PB81,(F$3")A
M$PBUYY$LXDM<A9N9VQ:M2,HZ6%F:8K(RZOUDI)-SBC'O6<2H510"F9^8FJ8H
M@GT,'4.[,//&1CL`S1>-U1J/7^?Y?8ZRO^Y-WC#>O^<.N&$M@F@LGM<ZAA+X
MY'-<(Z/&SCJI!I]\OSA\$-K%=O<VO"_AV4.\%P[:$=.SJ46&V(BB,Y!G)4W:
M#S9KB9.^7L+N5B)6-E&[T#)&3<N%I%$H/RORJ&[C=YE`.3WO`0'-!WB&T]RI
MQV7ML_RVUW=:WO\`(OG?D)KJSO+6ZCF!86R/?=,'SCOPY]7A[GM>PEX]<%70
MQ,M\]ABO+5MLQ@'"&N:YI'50;J>PI%^&NQG=RUPYKDLY^)E*&\;Q2*JAQ,X5
M@';<588RPF\3"V%%9N!O'W$2]?'V[G_HU^=.1YF<E9M'Z@G[[/Z5N([5KB:R
M.L)6%UF7])[LLFMVG^KA97;4FWFL,<RRR(GB%(IP7=G$#ZWLU!\I*VX5;MUO
MYY!%7J'0?-2(IU#\'O%'P\<V&3V=G=?E,4<FRGK-:[9YP5$PYPW$A1><Z(2(
MC+E27\=',V+J4@),)%5HW2;B]%B^;$:J.?*(0%E44US%`YNINWH'7H`=-$7T
MK>F-/87F-IC+8BRMK7(7^*N!</BC;&9NXF8(G2<('&YK7N:'.J[AX6UHT`7.
MT/-+):3,D<YS6O%*FM*@UI["T:S5*IPI!>"$%#/W>QI9]&,GDC'IUIFQ=.FR
M3A5FW>_7:CPC8RI#"C\29JGWB7H)@(`#X!FXCZ)K2NF\K?:SS^4L;6YS-HS&
MQ02RQMD?#'/\]=,V,N!X.],4?&6T+@QH)H**W^NIYF-MXF.<(W<9(!I4CAI7
MR5-%)(F@@C_,HI)>'3\FF0GA^#W0#PS=A!:6ML*6T4<8I3U6ANSJV`*W)<X[
MR2M*N;&R'-;I<518IT9N_NRS@\L9(P%5+6XT$_B6PCT[B$E'JZ:8B`AW))J$
M'P,.:R/I/N==[H?EA8\K<!.8LOJ>20W1::.&.M^'O(STM%S,^-A((XXXYHS5
MKB%,M&8UMU>NO916.$"GWYW'S`'SD%:(ZCBJ`JN[F[;MV1U=,1+MN%>4A8:7
MD)17O05^*?D?1R0@P*EW@F3H<%#")A\``.NIWPZ:>Y0S3W&J^8/,.]T-J6PN
M&#'NLK*]N+IU6/[V<3VK?B`VK8V<,@D<2^H#0"Z=9::_%(+2T;<PN'K\3FAO
M8*.W]>ZBE+T&6#:T:1G8_:=BV?%NY1\NK:;6K*-_@48Q%-!=D@WF%!.T:,S)
MG4.I[I3B<1$>@!TWY^#^RP'_`/-+C.:<UOG-?8^^R4M,ADS>->SN6LB-M##>
M.=)'&QP<\N:`)72$[0&TM;J%\C;L,N+>*T+&;6LX:4-3Q$MV;NO<`M;+/QR<
M\S=L5397(-@L?C=J29)8-&<>Y9LJDRV-=D$C();PWE".RBG(-XPISA4:XX3`
M&:"AWT@7XEP#-KEZ)FVD1C@VW#AZSON?Y+?=/7NW55HKG3LNL,M'D-0-_P#;
M5J[BMK0@_'2;C<733O`W00D;&DNDVO,;9#RE*4H%*`%*4`*4I0`"E*`=```#
MP``#V!G@5PE^X1,(F$3")A$PB81?R<Y$B'44.5--,ICJ*',!2$(0!,8YS&$`
M*4I0ZB(^`!GQ++'!$Z:9S60L:7.<X@!H`J22=@`&TD[`%R`2:#>5"SR!WI.;
M<LSYHV>.6M#BGJJ$!"IJ"1N^*W.9(LW)IICVNWCSM$Z0'[BMTS`4GB)C&_,E
MXP_%AJGQ!ZXNL7C;J:#E187+F6-HQU(YQ&XM%[<!NR666G'&'%S8&.#(]ID>
M^\FG\'!BK9LCV@WSVU<[I%?M1U`=/6?,L'0T%-V)\2,K\/)SDBH0QR,(A@ZD
M79DR=.]0&[1)54$R=0ZFZ=H?2.8H:9TEJG6N4;@]'XV^RN9<TN$%I!+<2EK:
M<3N[B:]W"*BKJ4%=I5=FN(+9G>7#VQQUI5Q`'LE?8L="N]/(DK:JC8Z\BN<$
MT7$O$/63954Q>\$DW*R)6YU1+X]H&$W\&236O*'FGRWBCN-?:=S.'M)7<+)+
MNTGAB>XCBX6RO8(W.IMX0XN`WA=-MD+&[);:S1R.'0UP)]BM5Y*-?;5KB>;V
M.HRJ\8_1,4'"13"9C)M@,!CLI1F(^2\:J?@,'<0?>()3``AZ>4_.#7_)35D.
ML>7M_+99*,@2,!)@N8P:F&YAKP31.^Y<*M-'L+)&M</F_P`?:Y&`V]TT.8=W
M6#U@]!^H[%-CJ/9<7MFC15OCB%;++^8SF(SS/,/$S+3M*]8G/T*)R>\51(W3
MWT5"&]HB`?J$\/7.W`^('E;C^8N$#89Y@8KNW#BXVMY%030$D`D;6R1.('%#
M)&XT)(%ELKCI<5>NM)=H&UIZVG<?</:"LF9>Y4Y1Y[QXJ;&V1M"S7.!DJFWB
MI@(CX5*3D)-%Z7X"$CHY;SDF\0Y2+U7:F$O0YNI>@^`^&:<?%1X`N='.SGOG
M.9>D[W3\.`R7S3NFW-Q<LF'<6-M;/XV1V<K!62%Q;21U6D$T-0+@X35..QV,
MBLYVRF5G%6@!&UQ/2X=!ZES;C/QWO.GK?/SMH?5QTRE*V,2W+#/7[EP5U]9L
MGG<J1W&LB%1\IN;Q`PCW=/#Z<NEX'?!MS3\-_,/+:IUW=86?&WV&-K&+.>>6
M02FY@EJYLMK``SAB=M#B:D#AIM7AU+J&RR]K'!:MD#FR<1X@!LH1T$]:W6S9
MXH8F$3")A$PB815K?6"](7D[SVY-5'<6F;-IV&JT#IJO:_>-;_9;3#S)YN*M
MUWG7"[=K"TNQ-#QQF=C0*0YERG%0IP$@``",BQ.5MK&W,4P>7%Y.P`[P.T=2
MQ=YT\E]4\Q-4PYK"RV4=I'9,A(FDD:[B;)*\T#8GBE)!0\5:UV+%WI=>BGRS
MX7\RZ!R!VK:](2U)K%;V#$2+*E6JW2EB.ZM-2D8*-.U92]#@F*B*;QV45A,Y
M()4P$2@8?#.S)Y>UO+0PQ!_&2-X%-X/6>I4KE-R*U?H76MOJ'+2V#[&)DK7"
M*21SZOB>P4:Z%@(JX5]84'6K4>1E9;IA$PB81=5[RL_:CY*_O`;D^\6QY<RT
M_)H_O!Z%J,UE^]V4_6-S^.>K4GRNGV2\NOUG:U_1":R+ZD^6C\A]Q9@>%#]!
MY;^T0_!E5I[(VLLTPB81,(F$3")A$PB81,(F$6*-RM+*\IHI5.AUC8TN66CU
M"URW)L5(H6X"L5=^`2+IFV*[:%,'8/>!NAAZ`.6!\2>/UIDN6Q@T%I3!ZSU`
M+^W<,=EF0/M3&.,/GI<S01"6($<![SB`<[A:X[%5,.^W9>5NIY;>+A/KQU#N
MP;`30^11][JKFUST%^\LF@=9Z_AHM['/GEDJ):^C+-P%R5BDW$&$RZ<JM'2[
MTI5"@F8`\##TZ=0T_P#B=T7S]DY1WF1UGRAT/I'3=A<V\\V2Q3<?'=Q@R"!D
M?_1[V:5\4LDS6O:(W"O"XT#>(3[#7.+%^UEO?W,\S@0&2<9:=E:[6@5`&Q>Q
MP5E5&VRK3$=1\B5IQW1B]?`7$5+,`1-T_"",@K_QYZ/HHM0S67.K/::_ZK?Z
M<=*?PEK=VX8?,RXE]GM7&N8@['13?;-FIYG--?0%NGR8Y/Z5XBZIG-R;UN+2
MI5"&+Y+9+H#N?L\RJ0QF-9J,&0Y7E@L4D8@@DW1#H4H&55,FBFHH3?[;V\MU
M*(815Y]H=9^KVU8[4VJ,)I#$R9G/3-ALV;MW$]U"0R-M1Q/-#0#<`22&@D1D
M;)W['\I=.<8N0D57G54C-KZZF;4PKCY\C)OHAHXG2-D&;UZV1;MUWA$VP"KV
M%["J")0$P!W#HV^EWA^;Z[T?#6O#C+W;_P`O"KE<F<_'JG2S=00QF**Z#7AA
M-2T5<*$T&W9M[>O>L$9J!5W5(WP%_F=I?X:H?XNQ9NG^B+_)=>?A,1Z,BK=:
M]]]:^23^@I$\W,JWJB6YOR/Q>X(]D`F[8FEQ*':(B)04=R,N].8H>PHF35(`
M_AZ!GYZ/I3<T[(>(JRQ0)[K'Z:M64KLXY;B[F<0.@ELC`>N@5U]$Q<&)=)TO
MF<?8#1[A7W]2UK;J&OZ^I`\=]67>(?).9)A9K0%=<34DW>NUE2&<F>S3=RFF
MC_-ID,0G:F4/#QZC,_#WH?Q#V7*'$/TQR:T'J?`74<EQ!DLFW&R7ERR:9[@9
M#-?QRM:SY.-CHV<,;6[-M3YLK<XDW\@FR%U#*T@%C"\-:0.BC2-N\FIVK?O4
MK&=;T9HVM='K-#E5'<D+NK5A%B6%024=*`BL4C%R\:'5>H`"B@@<>IC>(`/A
MFW/P[V&KL;ROM;?7&F,+I#49N;ATF-Q3(66D0,KN"1HMY9HN.9E))"V0DN.V
MAJ!`LLZWDO'&WFDN(>$#CDJ7'9M&T`T&[<LGY?%4Y,(F$3"*&?U%O60H7IW;
MBJ6H+3H^Z;,?6S7++8B$W6[3`0;-FU>V.Q5PL8LUE6JZZKE-6O'5%0H@02JE
M#IU`<JUABI+^(RL<&@.INKT`]8ZU9/F5SJQO+;,PX>]LI;F2:V;,'->&@!SY
M&4H6N_JR:UZ=R^%P%];+5W.W;EMU8PTY:-/MZ;JRQ[7FKI=;K6'E?:0=8EZ[
M%R)'AVB#,&":2=@!P=RJH5%))`PFZ=>H<WV(ELHQ(7<57`4`Z37M/4O/R\YZ
M8?F!F)L3#:26@AM'SNDDD:6AD;F-=7U6T'KU))H`#5:[\HOF1>-&J+'(U#CU
MKJP\D7<:+ALZNQ)U+7VMSODC)E($')OH6<G[.S*(G[G"3!LV4[0\E94AN\/1
M:Z?N9F\4[A&.JE3Z0/3VT4:U?XF]*X2Y?9:>MY,G,RH,G'W,50:>J2Q[W`;=
MO`T'9PEP-5B+1?S.FLK%9XJ#Y"<<Y_6-?D'@-GM]H5S)L)E!)*^ZB]DZH\K=
M;FE6""@A\0=FNZ7(GU,1!00[![I].2,:702!Q'013VZGT4[51M.>*G$7MVRV
MU'CGVD+G4[V*7O@VO2YAC8Z@Z>%SG4W-)V&SI3+G5-BU*N7RBV&*ME-M\,PL
M-9LL&\2?Q$W"RC<CMA(Q[M`QDUF[E!0#`/M#V"`"`AD<>QS'%CQ1P-"%E197
MMIDK2*_L)&2V4S`]CVFK7-<*@@]1"XONE\YC=2;(>M!$KE&F6#RCEZ]Q!4C5
MTA4+V^(&3*H(@/T"&6,\366O,'X>=:Y3'GAO8M,Y#@=TM+K:1G$.UH<2#T$!
M5S#,;)EK9CO>F9GP@H'@````#V```'\6?DP5]5*IP:C*ZEKB=EF0-E+*[LKI
MI.J]""];M&K=L:(9F'^<(T.DH=8G\DQU#_24>F__`.BMP>C;?DIE-08ON7ZS
MN<U)%?/H.^CBBCC-K"33B$1:Z25GVKGODWEII:O6TMP[),B?46[8P6CH))/$
M?+N'D`6X%CKL-;(22KM@8(241*M5&CQHX3*<ATU"]`.3N`?+71-T.F<.ADSE
M`Q1`0`<V-ZQT?IO7^F;S1^KK2*]T]?P.BFBD:'`M<-CA4'A>PT?&\4=&]K7M
M(<`5$K>XFM9FSP.+96FH(^KV5%`;AKMQS:)F)CF<<WKS&5<M8ZS34FW;H2,<
M503-7I&3,'DD8YFYB]X>24/,`0`>GCGY^)OHT/$+>Z\R6!PL%C#HZVOY([?)
M7ES'&RXMPZL<HAA$MQQ&,CC'<!HDXFAU!574&L<4VU9+(7&X+02QH)(/2*F@
MW]NY;T\=M%RNDH^PMI&UH3XV%=@Z.R9QIV;*/<,4W")ED5UW*SAP=TBL4I^I
M$P`$R^`YM;\&_A6SOA?PF7QV8S\67&7F@E[F*V,,-N^%LC"]DCY'/D=*U[0^
MK(P!&V@.]0?4&;BS4D;V1&,Q@BI-20:=%-E/*=ZV1S-)1U:@[0Y<P>L;S-TA
MY2YB6<0OU?YD@UDV#=!?ZPC&<D7L162,H3RR.P(/4?$2B/LS73SU^D1TGR,Y
MIY/E=D]-Y"_O<9\WXIXKF&-C_G%K#<BC'1EPX1,&FI-2TG<5+L9I.?)V++UD
MS6-?786DTHXMWU[%R?2?)2)W389:OQ]5DX%2*AAF#N7S]F[36)\:V9>01-NF
M0Y3]SD#=1\.@9.?##XV=.>)O5U_I+#8*]Q<]ACC=NDFGBE:]HFBAX`UC&D&L
MH=6I%`11>7-:<EPT#)Y)6O#G\-`".@GK[%]#E?OI7B]QXVER`+0Y?93755>_
M.J6I\#)LHB7D()H_9I3KQF^D$5V9!A(E=9\H4Y??2;&*4>X0S.2VA^<3MAK0
MN-*[U;C5N?.EM.W6H>X=<LM(^-S&N#26`@//$01ZC27G9M#2J]P_-%:=Z"(<
M2=J"/3P#_:'3`ZC]`=?J[PZY7?V<F_K!['V5CC_M78#_`,JN?\JW_FU8LXW[
MSK')C0^I]^TUL[8US:])A+C'QK\Q%'T0:3;`9]"O54BE16>0TB19JJ<@>6<Z
M(F+[HAE`GA=!,Z%V]II]GSK)C3N:M]1X*TSMJTL@NH&2!IWMXA4M)Z2TU:3T
MT7K<F]\0'&#C_MKD#:(MY.0>J*9*6YY"1[EJR?S1V)2)LH=D[>_^ZMW4H_62
M03.?J`'4#P'V#S;PNN)FPMWN-/L^9=>IL[!IC`7>?N6E\-I`Z0M!`+J;F@G8
M"XT`[2J[G_\`45ISIU'B5M0/#J/^\*F>'X?\W?1E>_9R;^L'L?96-?\`M78#
M=^:KG_*M_P";5B+C'NEQR,T#JG>KBBS.M2[5J,?=6%+L+YK(S,1#30JN8([Y
MXR20;*GE884'A>TH=J;@I1\0'*#<0]Q,Z&M>$TKZ>OR+)33&:=J/`6F==`ZW
M%W")6QN/$0UVUA)H/?-HX;!L<`=JC2]1#UFZ#Z>F[:]I6T:,NVRI"P:WB-C)
M3U<M5?A&+9K+V&SU].+4:2K5=P=RBK63J&4`0()52@`=0'*A88F2^B,K'!H#
MB-U=U.T=:M;S)YW8SEOG(\)>V4MQ+);-FXFO#0`Y\C*4+7;1W9-:]*X+P9]=
M+7/.'DA4N.=<X^7V@2MKAK=,HVB=N%;EXUDG4J^\GUD%F$:S1=JG>I,Q2()3
M`!3&`1ZAGW>X:2R@,[G@@4V4ZR!U]J\&@>?F*U[J2+3EI83032M>[C=('`<#
M'/W!@K4-IO4[N497^6#N1G(W4/%+4EFW9N^UMZE0ZPFB1=T9([R3EY1Z84HN
MNUV)0ZO)NPRZX=C=JB`F-T,<PE3(H<O=!!+<RB&$5>?JVJAZCU'B-*8B7-YR
M40V$0VGI<3N8P;W/=T`=I-`"16=OOS14<A/J(:OXB/92KH/5R)RE[VLA!3DF
MP(N8K=<(6!IL^SAW#AN`'$AGKL$S&[>H].HR*+3;BVLLM'=C:CTCT!8KY/Q8
MP1W7!B,.9+0'WTL_`YPKL]5L3PTT_E/\^\R1\)?76XB\N)N,U]:_K'CIMN9>
M$80E4V+)L7E6M#Q<Y2-&-7V&T18Q+F4=''M(T?H1SA4_0J)53"`93KS#75J.
M-OKQ]8WCRCZU>VBNIH/GWH[6LS<?.3CLNXT;',X%CR:;&2T:.*IH&O:PN-`S
MB*HV\K/VH^2O[P&Y/O%L>36T_)H_O&^@+7[K+][LI^L;G\<]6I/E=/LEY=?K
M.UK^B$UD7U)\M'Y#[BR_\*'Z#RW]HA^#*K3V1M99K1SF5ZBG%7@G#Q[O?%].
MWL\XV.[K6M*BQ_.;8UB:)J^0H_9UY%PV3CHDJH&+\=(KLF1CD,0JICE$N>RT
ML;F\=2%OJC>3N^KR54$UKS(TEH&`2:@N.&Y>*LA8..9XV[0VH#02"`Y[FM)%
M`:[%`C>?FC(M-RHCK/A])O&A7"H)2%\VTSBW"S4JA@14/#UZF32;9=5+H8Q?
MCE`(81#J;IU&N1Z:<1\;+0]C?=K[BQVR/BRMVNX<3AG/;7?+<<)I]ZV)VW^>
M?/O7O:^^:*K+AVT;[5XBV")9*.T"/9?7VTHVPKMF1U`!PX0@;'5*P5RNW3ZF
M*F,@F"@^'<3VXETT\?(RU/:*>V"?0NS%^+&S>\-S.(?&RNUT,X>:=C'QL!/E
M>`>L*PIQ(YL<<^;U"<7_`(^WI*R-8M=%G::S)M5(2[4N0<@J9LRM59=F%Y'&
M>)H',W7(*K1T4AA164[3=*!<VD]I)W<[:'HZCY/JJLD](:WTWKG'G(Z=N!*Q
MIH]A'#)&36@>SHK0T<"6NH>%QH5M?GF4M3")A$PB81,(L0;WAZ[,:NLH6IY8
MF$'&)-IIZ\JGEC.H)Q;I)P8[,BH"DH'8`^8!O#R^X?:&8Z^*S3>CM2\B\W'K
MVYR]GI>R9'>S38O@-[&VVE;(70B0%A%`>\#M@CXS4$`JK8.:XAR<9M1&Z=Q+
M0'UX3Q"FVFWR=JBQMJFA#UR5"K7+<DA8/ARC%LK(@P^HW#@JR0B20%+\H"7E
M`80$/8<`'-"_,1WA*DT3D&Z%U1S%O=7=R#:P9".V^9R2![#PS\#0\-X>(@@B
MC@T[MBN?:?GX7+/G4%HV"OK%I/$!3HJN4\.98(S<A42D25>2M3L;"-;K./A4
MW4@BFVE$6HN!35!+SR1QP[NPW:'4>@^P9Y]&/G+/$^)^&RNWM8_)8.^MHJFG
M%(.ZNN$=O=VTA`Z:+R:UC>_!N?&*N9(UU-W6-^VFTC;100:MXQ\UO71Y+SNX
M>4,M-:GXR:LN,[421L>FZ9P\&,-+*,IS66F(J1(=O*6D5&@(SMG<IK`DH0"J
M"HHFBR2_3)+<6F&MQ':@.N'BM?=/4.H>QTE:P\7I/7//G5$F9U<^2STI:S.C
M#6[&MX74=#`T['/!%))7`^L!Q5X6QJ>KDWJBA:,K6A=0:N@$*OK[7U$DJY58
M%NLY<DCXQF^8]I5'3Q5=V[<KJG.JLLJ<ZBRQS',(F,(YH,^ESD?-KC1TLAJ]
MV,OJ_P"7A6QOE;B;#!81V(Q<8BQ]OP,8VI-``=Y))))J2222225J5FH17.4C
M?`7^9VE_AJA_B[%FZ?Z(O\EUY^$Q'HR*MUKWWUKY)/Z"D3S<RK>J&/EM+-Y;
M>UL^&4*J2+:P<.<Q1Z@#EI%-U727_G(N')B&_`8!S\SOTB.H;3/^*S/LLGA\
M5A!96A(W=Y%:1.E;Y62/<QW4YI'0KQZ3B=%@XN+87%SO,7&GM!>"O*\>R0,0
M$_=MULIHL>V&6:PB$>$.V?\`E@+I&-\SW_@TU!$""/B(!U^G/C1;O!]'I'&M
MU9JOF5:ZG^9Q?.X;..U^:1W!:#*RWXQQ=TU]0PN))`J=Z7'[0&=Y@@LW0<1X
M2XGB(Z*TZ5*WJ&'AX+6M/8U]Q-NH8\0E)1[FR=H3J[>944ER*292`!$W(_&^
M)0#H4.@?1F_WP[Z;TYI3DIIW%:1FR=QIMV/;<V\N0X1>R1WCG78=<!H#6R'O
MO>@`-%&]"M;EII9\C+).&";BH0SWM6^KL[-BR1EZ%3DPB81,(J._S-/[;&FO
MW9('[SMF9,].?DC_`,(?0U8$>*K]^++]5Q_C[A0N<4=5[LY!;@B>-NB)@(JV
M;_9.J#,).II6!@I2HQYT+W.M;4_;HN'*E9CR4\D@Y;IIJG<BR(0$U#"4@U>\
MDA@A,\XJUFWKV[MG;MHK&Z)Q6>U%G&:9T]+W=YD&F)WK<#71BDS@\C;P#N@\
M@`UX10$T!LV#\KW4B:P<%_M56EQN<L$NLU<EH\*UU>>R@D*K9BK&'=N;66",
ML'D'<@^^(`H^<"/AY`QO]I)>^J(P(*[J[?9W>;VUE=_LH8L8@L.4F.=X-CN[
M:(.+J+*E].CBXQ]UP?:JI3>*79=;W6WZ\N<8K"V^B6:=I]HB%^HJQM@K<FYB
M)=F8W0O>"#YH<I3`'0Y>A@\!R61O;*P2,VM<*CR%88Y/'76)R,^+O6EEW;RO
MC>#T.8XM</,00KHGRTG(";OO&?;VAK#-K29M#WZ+D::S=F.=:'HNS64C))Q3
M14YS`:.:V^!EEDTP#\@+H2A[@D`L-U#;B*Y;,T4#QM\HI[A'L+.SPO:DN,II
M.[P5U(7OQ\[3&#O;%,'$-!Z0)&/=V<5%8^FHEG/0\K!R)!4CYF.>Q;U,!`#'
M:2#95JX*41`>TPI*CT'Z!R":FT_C=6Z<O]+9EG>8C)64UK.WI=%<1NBD`-#0
MECS0TV':LH897P3-GCV2,<'#R@U"@BV7KJ>U;;I.I3Z!RG:*G4C'P%-\+,1)
MSF^"DFBH@!5"K)``*%_&25`Q#``AGY/.>O);5G(;F-?:!U7"X&&1SK6>GQ=W
M:N<>YN(G4`(>T4>T;8Y`^-P#FD*^>,R4&4M&W4!%2/6'2UW2#Y/;&U?FO-EW
M'5TX$]3I4S%PH5-)^R6(#B+EFR9A,#629'$"+IE$QNPY1(JD)A$ARB(CG7R9
MYY\R.0NJ/VKY<7QM;EX:V>%X[RVNHVDD17,)/"]HJ>%X+98^)QBD8XDID<99
MY2#N+MM1T'I:>L'Z@>D*2G5W,JAV[X6+NR7YBSRO8E\2X5%Q67BP@`=49,2@
MI&^8?KT(Z*!"AX>:8<W>\A_I*>4O,<08/F8S]E=6/`;WDCN/&ROW59<&CK?B
M-3PW+0Q@H/G#RK;Y31]]9DR6?Q\'4-CQY1T^;:>I;AH.$'2*3EJLDY;KIE50
M<(*$6162.`&(HDJF)B*)G*/4!`1`0S8[:7=K?VT=[8RQS6<K`YDD;@]CVN%6
MN:YI+7-(V@@D$;0HBYKFN+7`APW@[UY<]"X3"*%SEC]OM[_BK?Z+0N?F/^D(
M_P![K5?^;?\`15BKRZ4_0,'\_P"&Y95X(_:1</ZD#_3L7F0/T3O\9M1?ZL._
MOUHJ7KK]'0_AOZ+E)%?:=$;$HURH$^BFX@KQ5;#4)E!5%-PFK%62)=P\@F=!
M8!26*9J\.`E-[IO8.;\6/,;P]OOFD$>96CR%E#DK"?'7(#K>>)\;@14%KVEI
M%.G85U5>U=;SVG-G[%U):4CHV/6-XM-"FR'342$TC5)IY"KKD35`%`1="S\U
M,1]J9P'Q`>N7-@D;-"V5OO7-!'D*U$YW%W.$S-UB+P4NK:>2-VRGK,<6F@ZJ
M@T[%>,^71WJ?9_`]?6,B].YFN/>RK)2TDE"#W(U&U"G?*P/F].BA".YR1;$#
MJ(D(U`/`.F0O/P]W>]X*4>T'SC9Z*+/[PU9U^5Y=C'RDF6PNI(Q7[A])6^;B
M>\"NZE-U%\7YD/<ZU`X-US5L>Y(B_P![;<K<#()`X%-=:J49!S>I<4T2AW+I
M!/1<2FH(B!2E5\>HF#.=/Q=Y>]X=S&GV3L]%5YO$WFW8WE^S&1GU[^\8QVVG
MQ<8,I/;\8V('RJE!I'5$WO;<FJ]+5PHFF]K;!J=!8&`P$!N>SS3.*7>G.;P3
M2CVKA1<YA]A4Q')E<RMA@?*[<UI*P0TUA[C4&?L\+:U^<7-Q'&#U%[@WB-=E
M!6I[`5VI=0J\31ZG5Z5`(F;P50KL)5X5N<XJ'0B:_&MHF-1,<?$YDF;0A1'Z
M1#+9O<7N+W;R:^RMN5G:PV-I%96XI!#&UC1U-8T-`]@!4@/F7/V\-;?NPTK[
MR-K9,]._D3OPA]#5@3XI_P"(%K^JHOQUPL`^@#_>>Z>_J/N7[N)O.[/?H]WE
M'P@H]X<?XIV?X*X_N\J[!_((MD"I8?,R\@;%8>0.F^-#5XJA2M<Z^1VE*1Z:
MI/*E+Q>I&:A6+QXD0.XQX"LP(D:]X^[]9+B`!W=1E^G+=HA?<D>N74'D%/=/
MM+!OQ4ZDN9\[8Z5C<196]N)W#H=)*YS144WL8SU=NP2.ZU!+Q!XPW;F1R)UO
MQVH+MM%3-]DW17UA?-E'D?5:U#,',Q9;,^:)+-E':,1$,U#D0*HF9PN*:(&*
M*@"%<O+IEG`Z=^T`;NL]`]E8\Z'TC?:XU-;:<L#P23N/$\BHC8T%SWD;*\+0
M2!4<1HT&I"LH[J^6%C&6OGS_`(_<DI^;V9&M3.FM?VK7(1C4[2N@W`YHU"9K
M)4Y"J.73@@^0NLE(HD$Q2J```*P1N'4;S)2X8.Z)Z-X^O[2RJSOA5LX\:9-,
MY&4Y=C:\,[6ADC@-P<S;%4[B1)U$C:Y5.;9`V&JVJSU>W-G#.UUJPS5>L[-V
MY3>NFEAA9)S&S39P\26<I.UT))LH0RI%%"J"'<!C`/496QS7L#F>](V+#._M
MKFRO9K2]!%Y%*YCP2"0]KB'`D$@D.!K0E7`/E=/LEY=?K.UK^B$UD1U)\M'Y
M#[BS9\*'Z#RW]HA^#*K'G(7<$3Q^T5M_>$XW%[%ZHUS;[ZXCRJE0/*'K4(\D
MVL2DL<2D37EG;=-L01'H!U0R@01&:9L(WN<![)636HLQ#I[`WF=N!6*TMI)2
M/NN!I<&^5Q`:.TKJ^=X;MV-R-VO=]U[9L+NR7R_S;J:F'KEPNL@R264,,?`0
MR2ZBGU=7:\R$C1@T(()MVR12%#VB-R;>".VB$48HT#ZOJ\ZU/ZEU#E-4YJXS
M>6D=)>3R%Q)K0`[FM!)HUHHUK:^JT`#8`I?N`'H3[NYL:EB][6?9T#HG6=I4
M=#0S2%4?72VW"-9N%6:UC0A$INM,8JO+O4#IM55GAEW0)F4*D5(4U%*1?9R&
MTE,+&E[QOVT`\]#Z/.KT\O/#SG=;X9F>O;IF/Q\Q/=<4;I)'M!(+N#BC`:2/
M5)?5VTAO#0G5OU(/3#VWZ<5HI#:XVR`V3K_9:<R%*V!78U_">9)U[X(\O7[%
M`OEWPPTPBUD45T?+=ND72!CF(<#)*D+ZL=DX\@'<(+7M.X]O_`HCS1Y2Y?EE
M<0&ZF9=8ZY#N"5C2WUF4XFN82>$^L"/6<"#L)(('Q/2HY-V+BQSGT5<(V7=L
M:G=KG!ZIV;%IN')(Z;I&P)1K7ES23-%9))Z>N2KYM*M/,`WEN6A1`/$0'ZRM
MLVYLW@@<8%0>T;?;W>==7)O5MUI+7MC<1O<+*XF;!,T;G1RN#22.G@)$@_E,
M!794Y;Q;0TPB81,(F$3"+QJIE6242,`"50ATS`8I#EZ'*)1ZD.!B'#H/L$!`
M?ISJGA9<0/MY*%CVEIJ`X4(IM:X%I\A!!W$$+D$@U&\+12YPG)5LI+PCV>TA
M]1299-@S6F&L5"/).'6!1L*IFRK?N07,U6#S`(<P$./@/LS55S+TOXU+&?(Z
M7R&5Y8?LK?-N;>%]Y':64US:/#HR\QNAJQYC>.,,>[NWF@<=A,WLY]..#)FL
MO>_;0GA+G`.W[Z[=OLK2"2JUYT1;:U8SJPCIS%R#.3B96#F6DW#NG#8PJ+1K
ME9FH5PB*R!3IK)J$3$Z1Q$HB`]<U8YK0/-3PE\P\'KF67%W%Y97D5S;75A>1
M7EI(^,\3[>1T+@]G&P.CECD;&7QN=P%S3Q*:Q7=CG;62U`>&N:00YI:X5Z=N
MSM!V[5*7J+?>I[Q!LVT/(0M0E$DC*OJ>].SAE&+Q=0SE\+`IBM6<DV5>+G4\
MY#J)Q,)E"D.(@&_KD;XR>2?._!P7%KEK3%:M,+3<8Z]F9!-%(`.,0NE+&740
M<?4DA)/#0R,B=5@M7?Z;OL2\Q-B)M@31S&^KM).T#WI)VFO37:=ZU(YWN&[F
MQZZ4;KHN$Q@IT0.@J14@@,@QZ"!DS&+X],UN?2R7EG?:PT9-92QS0G%WOK,<
MUX^7AZ6DA3/0K7-M[@.!!XV[_(5H7FI!3M2)\#';5HWVDHZ<MVQ/-J(][A9-
M$G0$[%U'N4,4.@=?'-SGT2^0L,=8Z\ER$\,$7'B3Q2/:P;!D:[7$#9TJWFNF
M.>ZU#`2:2;A7[A;*;7Y*:ZUK%/`;3,=9K4*!PC*]#NTWXBZ,0WD'EG30ZB$8
MR(?H*G><%3%_$(8<S>\0'C9Y,\DL!<_-,G9YO7G=$6V/LY6SDREIX'74L3G1
MVT+30R<;Q,YA^*C>3LC>*TYD<E*.)CH[6NU[A39T\(.TGJZ.LJ+6N4.\;GG)
MZQD<U]!5_)O927F+)-,8.-7DWK@7:S1`BRAG*YS"MX$33,0A`Z&,7PZZ%]%<
MIN:GB:U5EM<1SXB&XNKZ:YNKO)7D-C;/N9I.]?%&'N,CR2\D-B8YD;!1SF>K
M6YUS?V&%@CM2'D-:`UK&EQH!2IZ/9WK?2F17).6E(IHO.:5-6FCM@WFEZ^QB
M)=VQBB"7S$FS=%KV?$J-4A(B!S%`!Z"/@`YMNY9X#QHZ@SUA87N3Y9NT3;7$
M$=X_'PV=Y-!:BE6QQMAIWCHFEL0>YHK0G8"H)>2Z=BB<YC+SYR02WC+F@GM-
M=U=ZW<*4I"E*4H%*4`*4I0`"E*`=`*4`Z````>`9L^8QD;!'&`UC0``!0`#<
M`.@#H"AF_:=Z_<^D3")A$PBH[_,T_ML::_=D@?O.V9DSTY^2/_"'T-6!'BJ_
M?BR_5<?X^X6EWH;_`-Z/Q?\`\HVI]R^P\]F:_1TGD'PFJ!\@?XL8G[Z?^ZSK
ML6<@"V9KK1/5:;)M/4AYF(I%(0AMVSCKM3(!"][Z,AWJYA*'0!.HX<',8WM,
M8PB/MRX>))-A'7[D>A:NN=38V\SLL(F\+?G3B1UN.UQ\YJ5,C\KNZ6)N+ELQ
M`X_#KZUUB[.3KX"LUM%H12.(>P1*1V</^'*3J7Y./[X^C["O3X37$9;+MZ#;
M0^T]U/A%7*LB2S<6/MC:PINTX08.WQ9'B28G4CWZ(@A*Q#DY0*+F,?`4QVZA
MNT.\H@9)4``#E,'AEH><W(SEOSZTL=*<Q;%MS;M+G03L(9=6DA`'>6TP!+'&
M@XF$.BE#0V6-[0`O?C\E=XR?O[1W"[I&]KAU$=/I'00HT-I<.]@4PSB2IW??
M*^01.!&:)4;*S2\/!Q%`822`$Z_CM1,8W01%(N:/N?7T;/-OEM)-F^69=JK2
M+:N#(FAF1A;OI):@D3TW<=L7N=M<8(PKDXO6%C>4BO/B;CM]X?/T>?V2M1%4
ME4%5$%TE$5DC"FL@LF=)9(Y?`R:J2A2J)G+](&`!#-<MU:W-E</M+R-\5U&X
MM>Q[2U[7#86N:X`@@[""*A2X.#@'-(+3TA9VTYR$N^H'B+9FX4G*@=8#/JI(
M+G%J4AA_*K0RY@4/$/.@B/N!Y*AOYPAO`0RT\-7C)YH^'7)16-K/)E>73I`9
M\7.\F,-)]9]F\\3K2;:3ZGQ4COEHGD-+:#F-/666:7D<%W38\;_(X?;#R[1T
M$*8JD72`V#6(JVUIU\5%2J'F)]X%(Y:K$,*;EB]1`Q_(>M%BB10G4>@AU`1*
M("/Z1^6/,O27-[0]AS!T3<?.-/Y"+B:3021O:2V2&9@)X)HG@LD94@$5:7-+
M7&T-Y9SV%RZUN!25I\QZB.P]"Y7D^7E4+G+'[?;W_%6_T6A<_,?](1_O=:K_
M`,V_Z*L5>72GZ!@_G_#<LJ\$?M(N']2!_IV+S('Z)W^,VHO]6'?WZT5+UU^C
MH?PW]%RE.S?>K7*@!\P-H%33?J"V6\,T%"5SD/3J]M)@H8Q#)DL+!`M*N+),
M2CW@8K^OH/3`8`$`D``.H>R<8"X$MEW1IQ,)'FWU]NGF6NOQ):;?AN83\FP'
MYKD863`]`>!W;VCMJSC/WX6S/RS>\7%4Y.;GT(\=&+#;>U@WN<6U,)>S\[M7
M2I$P\H#&`Q3NJQ;7IC]H")@:DZ^!0Z>?4<(=`R8;VNIYC]D!2KPJYYUMJ2_T
M^]U(;JU$C02/E(7;`.TLDD)IT-[%Q_YEG<Z]QY?:NTNV<I'B-,:C0EW;=)<5
M#I6S:,JK)2`.4@`"H*%K-=B#$#Q,)%>X?`Q<^M.0\-LZ8[W.]H;O;JO)XI\V
MZ[U?9X-I!AL[,..T[))G%S@1N]XV(CRK#_R\^@&FX.?#38,PW1<P?':@SNQT
MT7")E4EK=-F3I-1*'AV$78#-/)!(PCU*JQ*(!U#J';GY^ZL^Z'OGD#S;SZ*>
M=4;PTZ;;F-??G68`V^.@=+M_K'4C8*=G&7BNXL'FOS9"%L.5%[YES]O#6W[L
M-*^\C:V373OY$[\(?0U8`>*?^(%K^JHOQUPL`^@#_>>Z>_J/N7[N)O.[/?H]
MWE'P@H]X<?XIV?X*X_N\J[!_((MD"Z^CY@5TNY]3K:J2QQ.1AKW3;-J4?_5-
MS45@_,F'\`NGRIOXS9.L"!^;VGM/I*UQ^)&1S^:%TQQ]5L$`'8##&?22L[?+
M30,=)\[-C3#QNFL\K7&RWNHA0Y0$S1U)W[7$4Y<)&'Q(H:/752$0]I5!#.G4
M;B+-HZY!Z'*O>%B".37MU,\5?'C)2WL)E@;7V'$><J]#D+6?RZKWE9^U'R5_
M>`W)]XMCRYEI^2Q_>#T+49K+][LI^L;G\<]6I/E=/LEY=?K.UK^B$UD7U)\M
M'Y#[BS`\*'Z#RW]HA^#*K-]^H%*VG3;#KS8M9B+E1[9'J1-EJT^T3?PTW&*G
M(HHQD6:O5-RV4.F41(;P'ID=8]T;@]AHX;BLI[_'V64LY,?D8F364K>%['"K
M7#J(ZEIU_P#JX].W_P##70'_`-OH?_V6>S\Y7_\`6O\`94*__E'+;_R3'?Y)
MJ\^XN:7!'@/4(&A7_;&M=4QE1@VL'4]2U8!FK/&PT.U3;QT5%:^J#:5G8]BB
M@0J:1UFZ+<!\!4#Q'.(K2]O7E[&N<7':X[O9.Q?69UOH#E[8LQ]_=VUI#!&&
MLMX_6>UC11K6PQASVCH!(#>U5*O6:]5[2'J!535^L])T7849#ZUO4G<7%WOC
M:&A#30/*\X@B1\37(^1F7R"!CNA5,LY60/T3*'D^]U+*,/BY[)[I)BVKAN%?
ML?5TK#KGGS@T_P`P[*VQ&!@N!';3EYEE#6\56\-&M:7&E=M20=GO5"EI'[;-
M,_K<UE^G$%E8NOR=_P!ZK$Z8_>*R_M,?P@NUORV2V])A$PB81,(F$4;GJ5>H
M]K'T\].GLDQ\%;-R7)L^8:?U61X1-Y8)5)/RU;)8"IJ%=1M#KBRI#OG)0`ZQ
MQ*V0_+*@8E0Q^/DOY>%NR,>^/N#M*MGS/YEXGEOA#>7/#+F)@1;P5VO</MG4
MVMB9LXCTFC1M-1&CZ-S[G-S/INV=I\SI1C<N-^P)Z8L6JG5PA'3&^EO,@^*G
M+2.EI!FX:(UC3T,FBHU*V62=-EG:94V@`FFZ%2W'/+DGRIYTZ;_8_7^-COK=
M@)BE!X)[9[FT[VWF;\9%)N)H2R0`"9DC/5,/\/&IN:E^+O4FH)P,#<R.?"V1
MIXW/+MO=C8T6X%12A'%01<)#U([<.!\ZT76<4"W1DBT,<QDH^RH*1K]),3>X
ME]8QR+IH\.4O\H4&X#^#-.7,SZ)_5EK<R7?*74=G>X\N)9;Y-K[>=C:[&_.+
M=DT4SJ;W&&V!^Y"S%LM<P%H;?PN:_P"Z90@^8T(]DK!,WQ6WI#"('HRLJEU$
M`5A92(DBFZ#X"")7J;LH#^$R9<Q-U+X`O%9IJ7A=IA]]!6@DL[JUN`>W@;,)
M@.UT;578=4X.8?+<)ZG-</<I[:Q-:Z+<**NS:7"NR==</DE5V*,DD5(SE%`Y
M4UE$.U10IB)G.`#T'VCF/7,/E1S)Y4W=MC^9&'OL1=W4;GPMN6\)D8PAKG,V
MD$!Q`-#O*JMI?V=\"ZTD;(&T!IT+BF6Z7L7,:GKZ[WSXXM.K$M8_JT6X2/U8
MD50K070+"U!P)U$RE\\$%.WK[>T<N=RZY.<T^;/SIO+;"7^8;9F,7'S=G$(N
M]X^Z[PD@-X^[?PU.WA*\5YD+&QI\\D9&75I7IIOI[(65X/BEO29[>VE?4Z(B
M`"M-RT3'@3J/B)FY7:[T0#^!(<R#TQ]'YXK-3OJ=-_F^WK0R7MU:P`=IC[U\
MY`[(CV55*FU5@X!LFXSU-:X^W2GMK/=+X'R:ZR#K8=N8M6Q3$,M%59N=V\53
M`>IT33$DB@@U,(?25LM[?`<RYY8?1/YR:XBO>;^I+>WL@07VN+8Z61XZ6F[N
M61LB/:VVG'53>J#>ZYC`+;"$EWW3]@_P16O^$%OW1Z#4M<P:%=IT,UAXU(04
M4!$!.Y>N>T"G>2#M03.'KM0"^)U#"(!X!T*``&W+EARHT!R<TO%I#EWCH<?A
MHZ%W#5TLTE`#-<3.K)-*X`5>]QH`&MX6-:T0.]OKK(3FXNWE\A]@#J`W`+F&
M7$7D3")A$PB814=_F:?VV--?NR0/WG;,R9Z<_)'_`(0^AJP(\57[\67ZKC_'
MW"TN]#?^]'XO_P"4;4^Y?8>>S-?HZ3R#X35`^0/\6,3]]/\`W6==BSD`6S-=
M:;ZLG]Y-S*]@_P"^1_[/'_,,!_RY</$_D$?WH]`6KOG5_$[+?VIRE_\`E>OM
MMY8?JKUS^EL]E)U)\G']][BO/X3OTQEO[-%\,JYD(@`"(B```=1$?```/:(C
M]`!D1)#07.-`%FZN`6#:^M*J50;!>ZM&'2Z@=NM,LE'@"4.X2@Q055>&-T^@
M$Q'+1ZNY^\D]!L<[5NJL#92,)!C=>0NFJ!6@@C>^8GL$9*]T&,R-R0(()75Z
M>$T]D[/;7,HR3834:PEXMTF]C91FVD(]XCU\ITS>(D<-ET^X"F`JJ*@&#J`"
M'7Q`!RY.#S>*U+A;346"G9<X6^MH[B"9E>&6&9@DCD;4`T<QP<*@$5V@'8O)
M)&^&1T4@I(TD$=1&PA8,W3QYINW(UVZ%FWA;JF@88RT,T2IKJKD)^1:S2:?8
M648*=H%'OZJI%\4S%\0'%?Q-^#OEKXB<)<7DEO#C.9;8B;;)PL#9'/:WU([Q
MK:"Z@-`P\=98F[87M%6NK>&S]YB9`T.+[.NUA.RG6W[D^38>D*&&4C'T+)R4
M-)HBVD8E^[C'[<1ZBB\8N%&SE+N#P,!%DA`!^D/'/S)ZAP.4TMG[[3.;C,.9
MQUW-;3L.W@F@D=%(VO31[2*C8=X5Y8963Q-FC-8WM#@>PBH6^O`ZUNR3-WHZ
MAS'8.(UM:6:9C&$&[MJY0BG_`)9>O87XM%X@)O#Q%$,VX_1-<PLBS/ZGY63O
M+L5)9QY.%I)^+EBECM9^$5H.];-!Q;`?B6J!ZZLV]W#?#WX=P'M!!</8H?94
ME6;MU;A0N<L?M]O?\5;_`$6A<_,?](1_O=:K_P`V_P"BK%7ETI^@8/Y_PW+*
MO!'[2+A_4@?Z=B\R!^B=_C-J+_5AW]^M%2]=?HZ'\-_1<I3LWWJURK5?,OZ#
M;6_C%J?D*P;$&=TML@E5EW!$SBJI2=I-TV"H*G(4Q138VZ%B^SOZ`4'*G0>I
MN@R#3T_!=.A-:/;[8^P3["Q@\4>FVY#25KJ*,-^<6%QP.)W]U,`//21C``?N
MC15>?34W6OQ]YX<7=E@^,PC&^UJ_4K.OYB::7YH[$5/0K,+@RQTT00;Q5B47
M$3F`I3)`;J`@`A)LG#W]C(SIX21Y1M'M@+$OE/G':>YAXK(AW#%\[9&\UH.[
ME/=2$UV4#'N.WJKT+X?J$[A4WUS?Y1[2^.3D8^=W+<8NNO$#BH@M4*=(&I5/
M.@<3&`R9ZS7FINH#VB)A$ON],YQT7<V4<9W\(KY3M/MU71S0S7[0:_RV4#N*
M)]Y(UAZXXSW<9WG_`(MK?L*U_P#+5:*2H_$38V\7\<X;3F\]I.V,<[<H$3!W
M1M8-!@8A5@H)`5.U4M<G.`8>[L,=,.@>[U&+:@G,EV(?M6-]L_8`68GA@T\W
M&Z*GSDC:7&0N30TWQ0CA;Y?C'2@^0#H5CC*"LEE1>^9<_;PUM^[#2OO(VMDU
MT[^1._"'T-6`'BG_`(@6OZJB_'7"P#Z`/]Y[I[^H^Y?NXF\[L]^CW>4?""CW
MAQ_BG9_@KC^[RKL'\@BV0+KX/7^_O/MP_P!1M,_=S"Y.\#^CV^4^DK7!XC_X
MI7GX*W_$1+9?Y9;]M?<O[LL[]YVM,\^H_P`D9^$'H<I/X5?WXO?U7)^/MU>(
MR&+/A=5[RL_:CY*_O`;D^\6QY<RT_)H_O!Z%J,UE^]V4_6-S^.>K4GRNGV2\
MNOUG:U_1":R+ZD^6C\A]Q9@>%#]!Y;^T0_!E5GZUVJN46L6&Z7":CZY4ZG"R
M=CLL_+."-(R%@H9FM(2LH_<J="(M&+)N=10P^PI1R.M:Y[@QHJXF@"RKN[JV
ML;62]O'MCM(F.>][C1K6M%7.)Z``"2J._J->O3O'D'/V367%"<FM(:%;.7L2
MG<H@RD7MG9S$H+-%95Q-%Z/:#7I$AN]LR8"C)>7T,Y<@)S-DIEC\'#"T2W0#
MYM]/M1]?RGS#I6!7,_Q#YW/W$N(T>]]C@@2WO6U;<3#:.(NWQ-.]K64>/MWF
MI8V.?AGZ<O+'U!;1)/=45DP55.75)=MX;%?/X^D,)155-:03<SRB$A,6^S='
M(*JM&"3QT`G`RXI%-WY4+O(6E@VCSZ]-C1O_`.#RJVFB.6&L^95RZ;',(L@\
M]Y<S%S8@X[3ZU'%[S6I:QKG;07``\2W2]4/TDJ1Z<?'G2UT1VS:-J[/V%LU_
M5+.^6AXNKT=C$MZB]FTV]?KB9I>;*\2D6G:9VYE%2K)"'1ND/7/'C<K)?W#F
M%H;&&U'2=_7L'M>=3?FSR:QO+/3%E?-NY;O+7%T6//"UD0:&<5&L]9U:[W%]
M"/M&J'[2/VV:9_6YK+]-X+*K=?D[_O59;3'[Q67]IC^$%VM^6R6WI,(F$3")
MA%I_S@YHZIX*:'L6Z]GN@=KH@,30Z,R=-T;#L2Z.DS#%UJ$36$1(F`@*[YV)
M3)L&*:BQP,)2D/ZK.TEO9A#%YSU#K^MUJ&Z[UOB-`Z?ESF5<"1ZL40(#YI#N
M8WTN=0\+030F@-3S@IQ$W=ZT_*BV\RN8#V1/H2OV))I)M&IY",C+<ZB1%Q#:
M3UF103_5E$K")R?7;I%0%C>:).\SUTLNA)KVZAQ%L+2TIWY'L=9/:>CZPHL1
MM`:.SW._5DNN=:%_[.QR4#=K6R%NUL$0V\,3!3C(-0#L)D>YXNW04%"U>%B:
MW6XF-@*_`QS.(A(2'9-XZ*B(J/;IM6$=&L&B:35DR9MDBII))E*0A"@```!D
M0<XN)<XDN/2LYH((+6!EM;,;';QM#6M:`&M:!0-:!L``V`#8`OJYPNU,(HR^
M>W^LVNO^HI[^D&&:-_I;OWTT;^J[W\?"KE:#_)KC[]OH*T%S4.IZI&^`O\SM
M+_#5#_%V+-T_T1?Y+KS\)B/1D5;K7OOK7R2?T%(0L_8MW+1DN[;(O'PJ@R:*
M+)D<N_()YJXMT!,"BP(IAW'$H"!0]O3-S5#OZ%;HR,:X,<0'NK0=)IM-/(O;
MSA?:81,(F$3")A$PBH[_`#-/[;&FOW9('[SMF9,].?DC_P`(?0U8$>*K]^++
M]5Q_C[A:">C5>*?KOU*>,5HOEEAJC6TIN\0ZT]8'R$9$-I*RZQNE=@6KN0='
M3:M!E)R4;M4C*&*05EB@(AUSWY=CY,?(V,$NH-@['`GV@K<<CK^RQO-'%7>0
MECAM1)*TO>0UH+X)6-!)V#B>YK17I(78^K.$&Z"KI==%!J@B=PLY65(F@B@F
M05%%U5CF*FFBFF43&,(@4"AU$>F6]6STN:UI<X@-`K7HHNK_`.?.TJSNWFOR
MDVM2W17]1NNZ+E(UF23$YDI6#9/0A(R80$_O?#R[.+(Y3#P]Q4/`,N/CH3!9
MQQNKQ<(K7KIM'F*U2\SLW;ZBUYD\M:$.M)+J0,<-SF-<6L=L^Z:`>O;MVJP7
M\KG39`]DY@[",W4+$H0VI*4@Z,7HDO).'EUGGK9(_P#*4:-$&YE`#\4%R?A#
M*'J5[:11_;5)]'UUD9X3;&;OLQD7-^(X((P>MQ=*YP'D#6U\H5HOD52']]U+
M9XF',["98H$G(I%FNJBH]=1?<LK''*D8HN"2#(RJ0)CU`RABCTZ@&89>,CE?
MEN;/A\SNG=/.N!J2VA%[:LA<YKII+6KW6Y#2.\$\)EB:P[#(YAH2T+.G3]['
M8Y6*:6G<D\+J]`=T]E#0UZJJ$#M`!'W>T?$#`)>TP"'@(&`0`0$!]H#GY8WM
M<QQ9("'@T(.\$;P>U7M!!%1N4E/%+D76FM98:SO<NWA'T,)V]9F)1<B$;(1J
MJIU48M=ZH!$63R/,<2)><<I%4>TI3=Q>T=WOT?WC-T1::&M.2/-7(PXO+XSB
MCQUW=/$=M<6SG.>RV?,X-9!+;EQ9'WKFLDB[MC7<;.%UMM4Z>N#<NR5BPOC?
MM>T"I!ZP-Y!Z:;0:G<MO+AM[7-(A7$W.6V$*BD@99NT9R+5])21^T12;QS!H
MJLY=*+F```2E["]>IC%*`B&Q;F)XB.3/+#3,VJ-4:AQ8M8XB^.*&YBGN+@T]
M5EO!$]\DKGF@!:W@;7B>YK`7")6F)R%Y,(88G\1.\@@#M).P?53:H/+;8%K9
M:;):'"0(+6*=E)I1N!@,#<9)ZLZ*@!@``-Y!5`)U^GIUS\KW,?6-QS#Y@9O7
M=U&(I\QE;J\,8-1'\XF?*&`T%>`.#:T%:55[K.W%I:QVK341L:VO704JMU>!
MU>=K6J\6L4Q!A'P+2OE5$>@'>R;]&1.F0.GO"BWBRB;\'F%_#FS_`.B9T7?W
M&N=4<PG,(Q5IBH\>UQW.FNIX[@AO7P,M07=7>,ZU"M=7#1;PVGV[G\?F:"/2
M[VE)QF\U6U4+G+'[?;W_`!5O]%H7/S'_`$A'^]UJO_-O^BK%7ETI^@8/Y_PW
M+*O!'[2+A_4@?Z=B\R!^B=_C-J+_`%8=_?K14O77Z.A_#?T7*4[-]ZM<M5><
M.BV7)7B-R$TD[;?%.+QK"S-H`I4"N54+?%,C3M,>-TC&)W.&5JBV:I.ABFZE
MZ`(>W/39S?-[IDO0'"ODW'VE%-=8%FI](9'!.`+[BU>&;`:2-'%$:'?21K2N
MKM+YZ)@\PJK9TB?HH0>Y)=LX2-T.0?Q3IK(JE$/H$I@_#ERAM&U:F'AT,Q:*
MAS7>0[#[2\K=L[D'3=DQ14=R#]R@S9-DP$ZSM\\6(W:MTP\1.JX<*E*4/:)C
M8<0UI.X!(8GSS-B8"Z1S@`!M))ZNU=I-P]TFVXX\6M!:/09I,7&M]65&OS2*
M)Q43/:2Q2#RWO`4$3=YI"TNWC@P]>@F5'IX9;2ZE[^Y?+T.<:>3H]I;;='81
MFF]*X_!M;PNMK6-KAO\`C.$&0U[9"X^=;(YYU)51>^9<_;PUM^[#2OO(VMDU
MT[^1._"'T-6`'BG_`(@6OZJB_'7"P#Z`/]Y[I[^H^Y?NXF\[L]^CW>4?""CW
MAQ_BG9_@KC^[RKL'\@BV0*@;\Q#658+U)+'+GZ^7==.:HL2/7K[&+*7J*G3J
M`>[WUG^'QZY.-/NXK`#J<1[=?=6NWQ,VAMN93YC7X^SAD'D#3%Z8BOE?+];I
MA-1^HE5X.Q2#6,CMVZ\N.HF;IX<4T365\YA+?6&)3]!*5S,2E0!D@`].]=R0
M@#U.`#]9Z(R6!<-['!WN>@U\RZ?#;FX,1S(CM[AP:R^MI+<5W<;BV1@KT%SH
M@P=9<!TJ_C/3T'5H65LEFF(NO5Z#8.92:G)M^UBXB)C621EWDA)2+U5!HR9-
M42"=150Y2$*`B(@&09K7.(:T$N/0MB<\\%K"^YN7LCMV-+G.<0UK0-I+B:``
M#>3L75<\B+%"V_D%O:V5N01EJ[:-S;1L4!*MN_X:4A)J\3DE%2+?S")J?#O6
M+E-4G<4!$I@Z@&7-MFEMNQKMC@T>A:C-57$-WJ;(W5LX/MY+Z=[7#<YKI7.:
M1Y005:^^5T^R7EU^L[6OZ(36174GRT?D/N+,7PH?H/+?VB'X,JVU^8OVQ9]<
M>GXWK-;>.6"6Y]TTK6=G<M5U&ZJE52@;C?Y".,9/H<S>6=T9NW7)U`JB"AR&
M`2F$,\F"C9)?CC%>%I(\NP>ZIMXDLG>8[EH]EH[A;<WD4,E"03&0]]!3K=&V
MHW%M0=ZH:,DVBSUDC(.3LX]9XU2?O$B>8JS8J.$R/'2:8`(J*-FQC'*7H/<)
M>F3IQ(:2-ZUUV[8WSL;*:1EPJ:5H/)TKM4N/NOM6:LTCJVAZ39Q#355?H]<;
MT92$!J9A*0"T8V=,K!\4S(FC)N[$FO\`'.'GB=XNX.L83&.(C;&>2265SY:]
MX2:_6\RV\:>QV*Q.#M<?@VL;B8X&"+AI1S2T$/J-CB^O&YWVQ)<=I583YF/D
M-IVT5S1W'>LWB(L.VZ/L.5O-WJ\*L$B>FPCFJ/(:/1LKQMWLXJ:DW4@4Z+`Y
M_B_AR"L=,B9DC*2/3L$HD?.X$1$4!Z_(L4_%/J3"W-C8Z<MIV29B&X=))&TU
M,;2SA'&1L:XDU#??`;2`"VM6W2/VV:9_6YK+]-X+)+=?D[_O5B5IC]XK+^TQ
M_""[6_+9+;TF$3")A%PO8VPZ7J6AV[9NQ;#'52C46`DK-:+#*KE08Q</%-SN
M72ZAC#W**F*3L22(!E5U3%33*8YBE'[8Q\KQ'&*O)H`O%DLC8XBPFRF2D;#8
M01E[WNW-:T5)[>H`5)-``20%1LD7^]?F`?4+0C69YVD\=-?"H=N7M(X9Z=TN
M5ZDDZE%DSB1F[VIM1VP*`%$5#?$F*0.YE'&$LQ`AP=C4T-R[VS]8?5M.W`Z5
M^>\17,;NF=Y!I2T/1M;#`#O/VIFF([:N('K1Q[+P.H]3:^T5K:G:CU76F%1U
M_0H5M`UJ`CB=J#-DW[CJ*K*&$5GD@_=*J.'3E43+.7*JBJAC'.8PPZ21\SS)
M(:O)VK.W$8G'X+&0XC%1MBQ]NP,8T=`'7UDFI<3M<XDG:5D;/A5%,(F$49?/
M;_6;77_44]_2##-&WTMW[ZZ-_5=[^/A5RM!_DUQ]^WT%1]2$@PB6#V5E7S.+
MBXULJ\D9.1=(,8]@S0(91=T]>NE$FS5NDF41,<YBE``]N:D["PO\K?0XO%P3
M7.3N)&QQ0PL=)++(XT:R.-@<][W$T#6@DG<%.+BXM[2W?=W<C(K6)I<][W!C
M&-&TN<YQ#6@=))`61^$O(#;FYW%[KW#BF,)BFR<O%1-IY9;%8OT=*U`\&,VV
ME&6MZZDO%S^];JD=T7RD6:["":G`!>2!>I$5OT.?1P^&[F9R)TGG\_S9M&XN
M\U"^Q=;6!>'7D<=LVY+GW;&AS+8O^<-#8G.,PX7=XQAH%C'JOF7^W>0CQO+1
M@N;"`O;-DIFN%FPD@%MLVK9+R0<)][W<(JTF4@@&:+6VK8[7K9=VZG;!>[M+
M)D_.C8MS=-WMGL"I5#*@@5-BU80E<@FRANC:*BFC*.;@'4J(JF44/L=DD+SL
M`:SH`W#W3Y34KNQN*CQS2]TDD]\\>O-(07O]@!K&CH9&UK!U5J3E#.M51,(F
M$3")A$PB814=_F:?VV--?NR0/WG;,R9Z<_)'_A#Z&K`CQ5?OQ9?JN/\`'W"A
M8XE\9[7S"WY2N.U&G("NV[8#6W#`2EI!^%?*_JU,G[@1G**QC5\^:MY-.!,V
M!9-!843J@<4S``AE8N[EMI`9W@EC:5\Y`]U6*T5I6[UIJ2WTW82,BO+@2<#G
MUX>)D3Y`'%H)`/!PU`-*UHL\\AK%ZE?$F*DN+'(#8O)/6M(704BDJ/+[$M+O
M6UGA`(5,[:J3S.7>5NR55=$0*=LQ=J->G5-9(IP,0/-`W&W1^<PB,OZZ"H/;
MLJ#Y=JE.I9^:^CXGZ3S]QE(+&A`C,LIA>P#<PM<8WQT(J&$LZ#MJ%H]1:3<-
MFVJ&HFMZM/7JYV!VBP@ZK4HMU.3DDZ6.5)--M'QZ:RWEE,8.]0P%22+U,<Q2
M@(A[I)HHF&1[@&!6]QV(RF7O8[#'02S7LKJ-:UKG.<>P`$GK/9M78I^D;P7D
M>!_$N&HET*U'<.P9EQLC;OP3M)^SBK)*,64?'5)B^;G4:/&U2@H]NU461$R2
M[SXA1,QDSD'(!E+T7MT9&_)@4'DZ_.?:HMF/)[0+^7VCX\9=T.6G>9IZ&H:]
MP`#`02#P-:`2"07\1&PA2B93E=11R<C.)TH[E9&^:L8D>%D%57L[36_8BX3>
M*=5',C7RF,5)P1VH(G5:=2F*H(BEW`;L+I@\:/T?.;RN=O.;'(:U;<&\D=-?
M8B.C9!*[UI+BQ!(;()7<3Y+4<+VO)-N)`\11W#T[JN..)MCE'$<(HV0[J=`=
MU4Z#NZZ;S'M(,'T4Z582K)W&/43"1=E(MEF3I(P>TJC=R1)4HA_"&:<LQ@\U
MI[(28G/VEU8Y6$T?#<1/AE8>IT<C6O:>P@*X,<L4S!)$YKF'<001[(7I`*1?
M8*8#[`Z"4!_B#*90GK7VLTZST+LC:3Q`L+!N8Z$.<GQ5GFD%F,.V1$W0ZC<Z
MQ"K2BQ0#W4VQ5!$>G<)"^\&3G([PB\[.>^3ACTYBI[+3#G-[W)7C'P6<<9.U
MT;G-#KIX&Z.W;(ZM.,QL)>*+DL_C<9&3*\.FZ&--7$]O5Y33LJIA=7ZU@-4T
M^/J,`!U4FW<XD)%<A"NYB47`OQ<D[`G4I3JB0"D(`B"212D`1`O4?TA\C.2N
MDN07+NSY>Z1:YUO!62>X>`);NY>!WMQ+2H!=0-8P$B.)K(P2&U-HLGD9\I=N
MNY]YV`=#6]`'N]9J5D/+P*GJ%[E@0YM^WL2D4,'2M^)2&,'^JT+](`(9^93Z
M0:&9_BXU6YC'%I_-VX$__BK%7DTHX#`P5(^W^&Y95X)%.79%P[B'+_H2/XQ#
M%_S[%_A`,O\`_1/Q2,YS:BXVN'_MD[P1_P!>M%2]<D''0T_KOZ+E*9F^Q6O3
M"+K2?5*X_ON///KDO0&T,X9P$CL&0V+3B-FJQF9JELWI=8M-F8A#$,WC5I==
MCX#[JC0Y?`2B`7$QDXGL8WG?PT/E&P^BOG6KCG!IMVGN8N3L(F%ML^<S1]7!
M-\8*?R6\18.HM(Z%]_TDN/S[D#ZA'&^HNXH7%>JER2VU;BR+!52/&NZM)^=@
MMW::J(I'3E9MDR8@!O=$[H.OAGQEIQ#82.!VD4'GV?9\R]7)73<NH.9&-MW,
M!MX)A<25W<$/K[1TAS@UG55PJNR7RWRV>IA%1C^98;N%>=^MS(MW"Q?[,5+`
M3)(*JE`0V/M81`3)D,`"`"'ADTTZ0+-WX0^AJP#\4L;WZ_M2T5_\*B_'7"P%
MZ`C=REZGFGC*MG*1?S'W+[RK=9,OV<S0>)CD*4/$<[LZ:X]U.L?""CWASC>W
MFE9EPI\3<?B)%V#.05;'57A]?;T[+SRJUK2>0>CJPYMNW='L):(LE1B$A7L-
MVU7(JC*K(U]BFB=Q,V"GS15';9DF8%7+9X[*B51?RDCUW!W[;64P2FD3^GJ/
MV>OL"QO\0_+2]UAB(=08*)TN;L00Z-HJ^6`U=1H`JY\;JEK!M(<^@+N%IHU*
MF?P$J=%<7T%.PC\`516^)B)F&E&"X&`%$U/AG\9(L7*0#X@FJDH7Z!#)KQ,<
M*5!!"P"[J\LYZ\,D=Q&_J(+7-/M$$>8A2?:+H_J<>J9(0&FX?9F]-KZSBW#)
MI,V?9M\N+G2=(8M3I!]96B6?.%XN;D8Y-,#HM$R2$NL)0!)(?$Q:9/)C<:#+
MPL;(=P`%3V"G1[765=[3V-YL\UY(\,VZR%QBF$-?)/+*;>,"FV0N):7`;A1T
MA'O6FA6M'-SCI'<6>5&X>/E9DYVV0^K)F$KR-EE(XK=[..E:C7I:4DE&K$BC
M5DBYE9%8R*!3J^0CV$%10Q14-ZK*Y-U;,G>`"X5IYU#=?Z6BTEJZ]T[9.?+!
M:/:SC<`"X]VQSC0;JN)(%304%3O-G+Y7A)5+4W+H%45D1'9VM>@*I*)"/^B$
MS[`4*41]N1K4GRT?D/N+*_PHM+<)E@=_SB'X,I]T*77U7^&LQSBX:7K4U.!H
M.S:[)Q6S=6)/E4&K:1NM12?D2KZKYR=)O'A:H*3?1A%U#D105=D44$$R&'*5
MC;L6=VV5WR9V'R'ZQ`*O-S;T3+KW15QAK2GYR8X305I0R,#APU)`'&USF`D@
M`N!.P+KCKU2+EJ^US%%V159^AW2ONUF,W5K9%NH.<C72"ADE$W#!^FBL*8G(
M/8J0#)*%Z&(8Q1`1N"R:*5@D8X%AW&N]:QLEA\GB+R3'Y*"6&\B=1S'M<UP/
M:"`17>*[QM6PFJ>4O-=K6V6@M([WY'#7),?@8C5.LKM?'8*%7'H:/@*[6W:\
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MOHH+IT.@SMG-*"(VW$9)_G!=KD`@(`(#U`?$!#Q`0'V"`Y;);>4PB81,(JCG
MS&7,ZSSMJH/I\:G6F'2\F-;N6X8N$254>6V:GWK?_9/K5)!-O\2^`SDI959!
M,YDW#A=@`@)DA`)/@+1H#KZ6G"*@5]L^Y[/6L/?$KK6\GNK7EQAB_O9BR2<-
MWO+C\3%0"II\H0-Y,?2U3F>F#P6K7`SB_5M>%:,7.UK<W97'=EJ10(#J;N[Y
MMYGU,FYZ"J>!I35?ZM8$$>T2I*+]I5'"O6CY&\=>W)D/R8V-'9]<[RK]<K-`
MVG+[2L.+:UIRLH$ES(-[I3MX0=E61@\#-@K0NH'.<I%\\"N0F$3"((@`"(CT
M`/$1'V`'X1PBKD>IWZC>C8G:M)U#HTSWD_OI%&6K3?5^FP5M)F]G>/&IFT++
M34(WE$32A!1,*S!@1X^2[#`J1'\8-?\`XOO!=KSQ3\Q],7./O;3"Z&Q>/N6W
MM]/\9*TRS1.;';6K2UTLCF-<[BD?%"T4)D)]4PJ^\1&D-"1SX;$1RYS6$TH;
M%:6OK-XP'?*S-#@*$4+(VR2UV%K=XP'4^!NRKXG!;=]4ZY%:P:IRSU#X!ZIF
M#1\8[$!$S%7<EEA9!559LW,4AE$".G2G41(+HIO-9CX,I_LA?1MZ6%[@K,9/
MFS<6](IIW,GS%X?>E['%O=XVS<:A[XHXF$`M`N96@&DXW0_,_G5>,R7-:Z-O
MIMKP]F*MB8[>.AJT7#V.+IGC80"][P=O'&.)BG,X66U:Q-KQ%LH>"J-/JC6H
M0U(H-1C&D'4*9!E+8#$BX&(8HH-FY#"0HJ*=O>J8.H]```"E^`KQ#\Q?$=JC
M7NK=>W`[B&3%ML[2.HM[.)_YP+F1`U<Y[^%IEFD+I)"T5(8UC&WRSNGL5IJP
MLL9B(F0VS&/`#0&B@X*``4``Z```/+5;SYLC483")A$PB81,(F$3"*CO\S3^
MVQIK]V2!^\[9F3/3GY(_\(?0U8$>*K]^++]5Q_C[A:7>AO\`WH_%_P#RC:GW
M+[#SV9K]'2>0?":H'R!_BQB?OI_[K.NPQMM(I=_B30-[J-8NL&94JYH:VP$5
M8XDRY"G(18T=,-'C,52$4,`&[.H`80Z^(Y`F/?&>)A(=U@T6RF\L;+(PFVR$
M,4]N=[9&->T_S7`CVEQVCZ9T_K%99QK;5.MM>N'"`MG"]'HU8J:R[8QRJF;K
M*P,6P451%0H&$AA$HF`!Z=<^GS32[)7N<.TD^E>:PPF&Q53B[2VMB=_=1,C^
M`T=062LZU4TPB81?(DZ_`S7;]<PD1+=A1(3ZSC63_L(80$Q2_%(J]I1$/$`\
M,CN<TCI/4_#^TN+QV0X6T'SFVAGH#M('>L?0$[:#8NV*XGA^1>]GWI(]!7RV
MM#HS$X*,J95&BA3`<#MJ[$('`Q1ZE,!DF9#`8HAU`?HRA6'*?E9BI!-B]-8"
MVF!!#HL?:1D$;0:LA!J#M!ZUVOOKV04?-*1VO<?=7*P``#H'@`>``'L`,GP`
M`H-@"\J9RB81?P*:9AZF3(81]HB0HC_QB'7.IT,+SQ.8TNZR`N:E"ID(/4I"
M%'V=2E`!Z?@\`#.6111FK&M![``E2=Z_O.Q<)A%ZZC1JL;O6;-U3]`#O4134
M-T#V!W&*(]`SFI&Y?)8QQJX`GR(DT:H&[T6S=$_3IW)(IIFZ#[0[B%`>@],5
M)WH&,::@`'R+V,X7TF$7@5:M5S`=9L@L8`[0,JBFH8"@(B``)RB/3J.<U(W+
MY+&.-7`$^1?RFS:(G!1)JV2.'4`.F@D0X=0Z#T,4H"'4,5*!C`:@`'R+V<X7
MTF$6(;5Q]T)>Y=2?N^D=17&>55(NK-VK6U-L,NJNF4A"+*24M"NWAU2$3*`&
M$XB`%`/H#.UD\\8X6/>UO82%1KS3FGLA-\XO["RGN/NI((GN_P`)S2?;61X*
MOP-6BFD%682(KD''D%-A#04:SB(IDF8YE#)M(Z/1;M&Q#*'$P@0A0$1$<ZW.
M<\\3B2X])53@MX+6(06S&1P-W-:`UH\@``"]X[)FH83J-&RAS#U,<Z"1C&'V
M=1,8@B(XJ5V%C":D"OD7D2000`00121`P]3`DF1,#"'@`B!`#J(!G&]<AK6^
M]`"\N%RL<7?3NH]FJ(K;(U9KC8*S=#X5NK=Z16;6J@V[S*`W14GHQ^=)`%#B
M;L*(%[A$>G7.QDTL7R;G-\A(]"IE_A</E2#E+2VN2!0=[$R2@ZAQM/6O)2M1
M:HUJ=9776L->4%1P@#5=2E4JMU4Z[8#@J#=8\%&L#*(`H'=V&ZE[O'IUP^66
M7Y1SG>4D^E<V&&Q&+K^;+6VMZBGQ43(]G5ZC0N?JHI+%[%DDUB=0-V*D*H7J
M'L'M.`AU#KG6JB6APHX`A>O]7L/_`(%G_P#+(_\`H9S4]97SW<?W+?8"]S.%
M]IA$PB^3*3D9#*Q"$@Y*BO/2R4'$(CXJ/I-5H]D?AD2_RC)QT:X7/_S4D3F^
MC.0TFI'0*E=,UQ%`6-E-'2/X&CK=0NH/YK7'R`JK.VX=7Y_\Q6OL#=<'-/-=
M3"4SOK3MK>1KE:JVQS1]<5R"KM582[ALI'_7&NYA8%UF8'!PD$>DL!035(<9
M'\[9^8N[B/KCU2.D5._S[?9[%BFW1-\_Q)'*YICW8][3<V[RT\$ACA:UC`2.
M'BA=PU`-1W;7&G&VMJ[(VLLDPB\2RR+9%5PX520;H)*++KK*%21112*)U555
M3B4B:29"B)C"(``!U'"X)#14[`%#9S(]<OA3Q1&4K5>LI^1&U&'G(FI.I)"/
M?P46^04*FHWMFQU#+U:$%(W>"B349)\D).AFP=0'*K:X>\N?6<."/K/N#?[-
M!VJRVM.?&AM(\5M!-^<<L*CNK<AS0ZI%'R[6-VBA#>-[3O8HAX";]7;ULE5C
MJ2YN'G"F2$4I:1AVT[6H"T5Y0B8O$(U=51G>]WKN6A1$P?$,JMYQ1`PHG`2#
M49Y,/@(G3S$/FC:7$G[4`$DGH:`!7K\JL_:3<Y.>3MCOS-HB0T):',;(P["!
M_P`9<D](+FPD[^`[%)QH/C3HGT_ZRO5>(FEK59-F/6!8RX<E+]3G\M<9PW0G
MQ:4!YT2BWC(=1P3N3:-$&L>7P$R;D_Y4=4_B?\=?,F%L^D_#YI?/WE_M8[+2
MXJ\^;1$$@FRMY(*W#AT37#1#TLBE:0X9><KN1^B]"6XE88C>N'KR/>UT\FZH
M<^M(VF@]2.E:#B)=M/QI>L[/GY)Y,S=:O<M+2"HKO9&0@IUR[<JB`!W*K*,Q
M,(%*``4`Z%*4``````,TGZDT1SXUCG+C4NJL)JO(9^[D+YKB>QOI)9''95SW
M1$[``UHW-:`UH#0`,AH;G%V\8A@D@9$T4`#F@#VUDC4]IW=IR1D7U4IDZLA,
M)MDI6,EJA.NF+T&0KBT4$4$6KM!9N+I3M,FH7J!A`P"'3I>SP]Z_\47AKR][
MDM`Z8RLMIDF1-NK:[Q-]+!-W)>8G>HR*5CX^]DX71R-KQ$/#A0"FY6TPF88U
MMU,P/97A<V1H(KO&VH(-!O"W^T#NC9NS+!.15YHB5491T,G(,WB<18(X73LS
MY%N9N)YA51$X`BH)NTGO>'X,V]^$7Q,\\.>&K<G@N:>E&8#&V>-$\4S;2_MN
M]E,T<?=\5V][#ZCG.X6^MZM:TJH%GL-C<;`R6QG[U[GT(XFF@H37U5M7F?:B
MR81,(F$3")A$PBIE_,7Z)WAM#F)J2<UGIK:NQ81EQSA(MY,477MLML6TDT]C
M[%=*1SJ0@8E^T0?D:NDE!1.<%`34*;IT,`C+M/SPQ6KFR/:T]X=Y`Z&]96#_
M`(FM/9[+ZSLY\597=S"W&L:710R2-#A-.2"6-<`:$&E:T(ZUJ%Z,7&[D31/4
MHXW6J\:#W33*O%+[-&4LEKU==J]`1H.]0WUBU%_,2T(TCV8.7KE-%/S%"]ZJ
MA2!U,8`'UYBYMWX^1K'L+B!L#@3[YO:H5R-TMJ;'<T,9>7^.OH+1CIN)\EO,
MQC:VTP%7.8&BI(`J=I("OXY!EL53")A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB@N]9WF-;>$=NX!;EAF+V?
MJL'OB^OK[3VKQ-D%M@#:R?U=[&IKK$,@G+-X2X2#A@=3\D1VD03AV]1"L8FT
M;>-FA)H\M`!\]?2!YE8KG5K.YT+-@<\R-\MG#?R.E:#0.:8C$0=A%>"5Y97[
M8`]"VYT/ZK_I]\B(5A+53DCKJJRYV2;UW3]LS,?J^X0:JHF159NF%Q<1K-XZ
M1$1*<\<Y>H&*/<14Q!ZYYIL;?0.X71N/WHJ/:W>>BEF!YN<N]16[;BUREK%(
M1[RX>V![3TBDA:'$=)8YPZB0O?VEZK?IVZ?*Z+;>6FHWKUJT4=_55%G3;+E5
MP)T`&Z#/7S>RF%VH8P`"9A*(=>H]"@(AQ'C+Z0@-B<*]?J^FB[,IS:Y<8B-\
MEUE[-_!O$+^_=MW"D(?M]'310[<C/F;M10#=[%<7-'VK84J9LF#*Y[;<I42I
M-WIU1`XEJT2O*VN:;)H].A5%XDYSCTZ@``8U6M].RNHZY>&MZAO]D[O8*LOJ
M;Q2X2U#K?2EC-=7`W23$,CKUAC"Y[QY71E1XIQWK9>L<JW))*VFA<?+"MW&6
M<)/-(<?PA'3H5`4(P2_TLVZU9D/T2$Q9XP]H`*A/$0]Q.'Q/O:.G'\YWV/\`
MZ5;81<]>=1'>F6UTY(>FMM:\)/5[Z<"NP_'.%-X4VO"'T`^*W&E2%NV[13Y+
M[7C_`"'B7YU1*+/4]=D4^U0IX+7JAWB,RHV5#JFXF57OO`!TT4#>`4>\S=U<
M>I%\7%V;_9Z/-M[2KZZ$\/.D=+N9?YO_`,4S`VUE'Q#3_)B->.G7(7"H#@QI
M4\R""+9%%LV12;MVZ2:""""9$D4$4B`FDBBDF!2)I)D*!2E*```!T#**L@&M
M:UH:T`-`H`-P'4%Y<+E,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%J
M?S.X:Z=YS:3EM);D9/RQB[UM.U>U02K=M::+;&":Z,?9JX[=(.FI72;=TL@L
M@NDJW=-5E$E""!@$OIM+N:SF$T)V](Z".HJ(ZUT5A=>8-^"S;7=R7!S'MH'Q
M/`(#V$@BM"00006D@CI%9N:^5RV!]:2)8#EY35X('2HQ!YS4TRE+"R$1%`LD
MFQN*[('9"B!3F2'L,(=P%+U[0D0U(PCUHC7R@^X%BS-X3KYLSC:YF+N.(TXH
M'!U*[*TE(K3?MVE9DU)\KYK]@9)SO+E);[(4%DCJ0NJJ3#4QN*!#=5D33MI?
M71PJ9<O@!B,D!3_\KZ.J74<A^0C`\IKZ*>E5S#^%'%1GCS^5GF/$*""-L>RN
MXND=+6OW@IVJ:+CGZ5'`KB\LTE-:\>ZC(6MFLDZ;WK8J:VRKBU=I$[".XN6N
M)Y4E?7`.H]8U)F'4PCTRD7&3O;G9)(0VE*#8//3?YZJ^.FN4O+[2A$N+QL+K
MH&HEFK-(".EIDX@P_@PP*0TI0*`%*`%*4`*4I0``*`!T```/```,\"N.OW")
MA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
BF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$7__V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>v014148_psivida-photo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 v014148_psivida-photo.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@!+`#0`P$1``(1`0,1`?_$`,$```$$`P$!`0$`````
M``````<%!@@)`P0*`@`!"P$``@(#`0$!`0``````````!`4#!@$"!P`("0H0
M``$$`0,#`@4"!0($`P<$`P,!`@0%!A$2!P`3""$4,4$B%0DC%E%A<3(DD1>!
M,R4*H4)2\,'A0S0F&+'Q8G)31$41``(!`P,"!`0#!@0$!00!!0$"$2$#!``Q
M$D$%42(3!F%Q,A2!0@?PD:$C%0BQP=%2\6(S).%R@D,)DJ(E%A=3HS0U5?_:
M``P#`0`"$0,1`#\`[Z437^UOK\?AU.2!OI8J$F-]9>TOQUT]$U]-?]/AUIZG
MB-3FQ`TT\WRBEP?$<FRS)+:)1TV.4%S>V-G,*P08<*IKSS94I=R.<_L##NVM
M:YRKHB(JJB=%8=JYEY-O'L*7N.ZJ`.I)``_'2[N%RUA8ES(OL$148R2.@,1.
MYF`!6NJ,_'&BS_((>2\R<P5LM_+7/F78;<6I+:$./D5-ADS(=,,Q0@@E(.I!
M!PK#@27QPJP:/ED<1JO71/H*VMG%QK>'C!;>/8MM`$D<@/,U=_,Q(DGIUU\_
M9^9EW;O!RS.SH;@)J;C$LQ)D`@!0%C901&TG(-D27)K;0QE&;[!RYGK'L<1!
MAAR+V)7QK%B,15W'@G:".BZ;6$=HU?BC2T$M+P42`Z)'B0"0M?#ZV^.E2W6_
M]XDNMMW)^9W'&L'85%(H=]<DOY&_*',/,CG[CWQNX-29F.&<57,#C?C^IHRE
M6'ROSP>*RDR:_=*&]>[AN'D$<`I3W=D(`2Y;OBURZW%&3>&/:`X(\GIR:E?_
M`$C_`#BFK7VNQ]O9%V^W"_<LF&D_R[$>9SX%X\I-8\2VK2N)\.PCPA\?*6^U
MMLZ!AUI)H>.J*"1Y;GR,\G\]=!K+W*JB,\7?."SNXQ:7&UU[<&@C'DJFQS")
M9D6S@X_I$0S$<C0EIJ!/B>HH`!40-*;^8^9DAL<1S7C84D^5(,L_A,<F,40?
M&-1SY=\9,:/%!1>1EE7Y5S5RK5$Y,Y3R1"67VNGS*:Q68WAF#6`71I-/78#3
MUZ5U6V(<$HFPLGZE.].O7`;&&<E['JBY=`?BJSRCB"&^I552`&H!4DUC2ON6
M=?Q<^TO;,D6+5BV0[L#QN<^7.XRU^N``""%4*L"I,41P/(SQHAXL:>S)N:^*
MYM/%NXI01VR>6<:@K1Q45DZ(R1$@\CU]2">B.4?MK]C$5'-.C?4[$S_0#*0V
M190\3)!O+6?*0`MY20>-`VVA<M<'NEB`5QNY-$-46+AF008E"PB%?R@FG'1/
MH<MP+G'&,5R/$LA]U*!GT^+`M:.WD0+S&+"=#R`DM8DL\<%ECEJ[V(QS:^9&
M[9T<C9,0K/56UF[@9!:YB/ZF/Z=")!#"`P*[BI-#`I4:K.38[EV/)>WFCB@M
M`\2#P?:!$F(WY@^'$@G3R3*Y]!4VF'<Q5,+-^,[2TD`MILRO<N/$%':V&U<L
MQ^*^4?$)H^TBK9UKBTB.:TK_`+;M1O0.1CV63BRI)$2H$P:P1$;R28BGY3J#
M'R;CW%R>WNUO-!#\2[>8[R#(!^0/+H0X&HC<W>"DZXH)^4\*2)?+&"6MG<B-
MQO*L'2N0<5B@-82X,C#KU)+6YI`!7PD().XVP5J)V2RD5&=<^[EVNW8+>EY;
M@@\=YF(9>O7::`;R)UUCVW[KNW,>VO<U4/<9[9H#$`E0XV!8"9V.WE--!_QZ
M\^^3O'E*K!^8Y.2\M<,5-Y'B0<G*&9*YBXP%7V$995+<0ICXLO+,?A)'<Q\*
M<@[&)K]#U1$%TZ[)[IR^V_\`:]T#7\0*`'@<[:CIM+"E3]0_?H'OGL['[DR9
M7MZX+&8I+>C/DN$F9MU$$[A"0I)I.YN1QKGC`^3\&M+'&;^JY%PV]KYJX=?X
MO8OE,,D.(]JB`DOV,ZFR*E60U)U/.8.2#57L5XEUZZ=AY=C+QUOX]VW<PW_.
M#-.O(@'BWS@TI-=<RS?5[1EG![FEW[+DK.64<[3"`.(8@4^I8#5!DU`)XO13
M8--9@I;K[MC,J`P['-[K/MJ,?(]W[E&JTE=/>HT^IK5&55UVMU1>CL1$"AV4
M&P9DTY`Q(CX3\HTIL"ZMU<1'5^V7&0O,*$')I\WU2T;@,>1J`-)F=3!T^$Y+
MD/NEM\0JFU<B_B3D(TU:$)32)$MX-VX<@K1.[)0HK'JW5R([ZE%=ELJUJZ%?
M&,R*2I)@K/AX@UK37L<759%PF6]CLUL<#Y0&'-9;P8DFJ@"@8F/,:2.,)YJ?
MF#CRYP?*(USB4CE_&:B'=;R2PK-;DM7*F8Q^VC#=/EA#3,<2WDOVP6QU)VR;
M]JK7<GNKY.,R8BJ,:T&:21((843B*EJ\9,P=CN+YVZWBXR^F7(SFA6+2&8D<
MH4"`.`)+,WU_2%!C7?\`<`L,#A+BJ*=#,)`P>@K>W(?W#@95PF5PHYB*KMYH
MPHK1N=\55NO7S%[BM):[]F6T`"#)>!X2TT^%=7/";U,.R]:VQX]*;FNBZJ(Y
M5^7\_P"/\/7I."1J4J2).L&U?_5HNBKHNNGS]/Y];2/#43(=I.L.G\W+_+7^
MO\].MX&AR":DG7A4U7155-/AZJG_`,->O5%1OK1N72=8G#1?_P"2Z(OQ^I=-
M=%]5U]-?_'J1;@&^^HR[`Q4?CK3<!VJJKM$15^G3X_Z?TZ(%SPUL+SQ$ZUGB
M5==%=Z*BJCO@FJ>B?Z=2K<'6-:^HX&^M?VZZHJZ^JII\_1%]/77U5=>I?5$4
MUM;8L\_FG4B$:U/@G_P_IUS+7T_`&PUZZ]K.H*>=W&:<GX9QS`DWJU%)BW("
M9YDT$8I+CY)38EC]O:`H6GC2HZQPR\C'7J;>TPRB:HU8JO14N_L2ZUKN-UE&
M]J)\"S`4_`M\MYU0_?MVS8[?:=X-WD_$$")XT-32&XG8UC;<`^?*2LG@$JE%
M#I+#*)IW]ON&%`XSXY@4!C,57,(I_NMOVFN8CFN,A/@J]=-QB'4D59N`GH3<
M<M^ZDD?[0-</NP"2W$(H8]-E4+X@F?IKM),"FJ:ORP>7YO&?C"+PMQ_=DJN:
M^8N+L<Q6)9Q7D&_`^.49;/SW-1$=O]M,[:CJX+U57-DF>;XQNF[78Q#=7ZV=
MN(W($^9R/CTZS$==;]OPE;(BZ0<*T%#;@EORH(J03$P8"@S$@F''XNO#X6+8
M:O,&;0Q8WD/(&'39=86[`V";B3QB,V0D_*5F2GL-3YISZ.`9!E(YA8.,@4RH
MBE57/NVXUNS;%U__`$[;_P"XR#&]?W30Z:]ZRC__`*_E!J^0PB`!#)8W^D"I
M'C(Z`:FIB]I%Y(N2>7MUCDTG%N#1+7CKP2XG#%'")DJ74>30FY>;42U`.+;<
M@/C+!QPA=B5F,H^6JM;)<YC&R/NKRWBW\L"9-#_S,/&1'$'H*BN@V?[>SS0_
M]_D`"&IZ:;K;VFM'N^``7H9J&_)MF%KPOS`L0&0FL^9\APBEL\[G4\Y6+"-<
MOOY4+'/M]PLG'[SC>CHUCQ@0)4=#H1OO1F%),3>/WCO^+VY;>-8Y?=W68`*1
MR"$!5:XLPR\N1@B=^)$5QVSLK=VR;@R'48%E/,[*PY7-SP9:J[`4$D``*1$G
M4K.&,^G\7<$\3#YVK+C(W6^,,/!S^Z>>93I"NTK#2:#)$NZ>ER/C]]82.(,9
MUT*35E5J=FV5'C;UR;VAE=R[O[BR;=F\4P;9(*<F**R^47`1R0\B#40""2:Z
MM7OGLW;^W=@Q"N*ES.N@?S&!%PJU6ME&',D&"(#_``"S0=9OXZ81R9+POD#@
M6XL^+.:;>7:/M;ZJ2N*'(Q!J;N]CDRC'96VHS:DEB`(;/>,[O:<BQ9RIHJ=-
MMY'=<7NN19[RI`"!K=ZV(\DJ@1]U<#Y\Q.P!U0'OXK]JL6S:]?B!:N6+AD!@
MLF[:N"#9$CB5(XEBI@R0&1CG.]_QS;1L!\EL>AX1:NS"3!K.2H9)1^*LBG/F
M6,8H17,LBS^/[R24K=E?<$'O540,HB?3T[.4R<%R!Q5@"MQ:VW+"1YC!0G>'
MZT5FIJLY?9+60K7.SEF(52UEO^M;B"?**7%K]:`J8((71[IL:M<0LAY%PO<1
MF#!EF02FXV5I&8G:#*^XE.-7!A`EFP^PM!D<YQX`#0S[E=)@G<JG2?N%BS>M
MI9RA!=5ZU!*\C6)4]9$`QMTT#C=TNV+RM=!-ZRO`LR^;PJ&D,I$^4^8"@8:&
MW)W&'#7E%-BQ,DK9G"_.\/&\CDSL@#6PG3K<D):Y]9^ZJ\!GU/(&*#>=XFV,
M203L[MK9<<B*%$&=V9G+%:U`Y#<#:2.HBL@Q)VW&K3VGW%>[?CHL<^W*K#YM
M1E"]5;Z@R$4WJ(.JF<OXQ\C/![D)MYCI4PJSR..A0/C(^_X7Y=JI\0T=@9P^
MVD>):'BG*Q&$2+;P][E$KFZD5#:'=>PWQW#M3<9'F7_VWC<,I_-&W6IW&NA6
M.X]E]SXOI=RA[JQ#$`W;?*LMN&0D1)Y(8`:=A;EXT><W%_D'4V>%R&%XBYK%
MC<P=SQKD-FCH.7.B@,^59<>9#(:&-E%<Y5:4<`FRRBHU41",17]=/]L^[.W=
MYOKCL1C]QV:PU%(@B;1/U=9`K6H&N1=[]A-[;S4SD)?M-QPS75Y$,"_G#Q(`
M10&"MQ%"J;QJ3WDE6!R;QZSXN+VWV;)(N+U,F56GL'50K*OCVT5TLE'/?(".
M,!X"JLF*;5LA'JU%:JH[IIW6T&Q<A;(AX:G1B-N=#(GJ/,!,5C5?[7>Q'[^C
M!T$W>(6'"`2P#())MJ0_)MR29,1JA7C?(L9M.2J*#)JY]7861X<"UJ:&%%Q^
M;<5<6V<@J;!G!G0_8P;(C(_N)Y>V=ZN<CW;'J]U0Q[N,V-<>U96WS44XL593
M/X`@R3,@!MQ$"\A,L9("A'M=792:;08'E6!(,4^HR-?T4O$<=I%\?L!I+:18
M3I>+1K'&16EL=DJPN*JHLY0J"VF2&.<X\J=0/BO*]_ZCR[G.^I5ZX)[RMKB^
MY,E%)*,58>/F13!^1IJX]JBY@*2&7S-ON?,32>E8'RU)#3JM!P17?1IMSMK[
M5?EUOJ)EGYZ\*Q'+K\%UUU1/C_7UZR&(U$UD3RB=87,5$75-/CIJOS1/1$_G
MUOR\*G0Y0Q,:3P`*A"2#:(4GT-&U=6B$W^UNNNCG*JZJO4MQD*A$^D?O)T-Z
M;'S.-];>W5/J1%T3_P!M/Z+U%MMK5K9%1MK"X+7:JGTJJIN^6NW7T5/CIULK
M%3\-1P1OK"L;YZ)_'1%_I\$^'PZF%X1$]-;)(8$>(T<NJ#KZDU]U[7M16\B2
MK93*3'%<C1''4B+OVH)R7>74PCM)NUW(E52R]6IZKN3J^>SD]-+N4!+3'[D/
M^;#7)/U+NFY=QL,$$1R(/Q<3_P#:A^>VVH`<X\J81Q-Q!R9R[G<U:W$L0XIO
MLGN#M4"3Y+N0<ZDF@5E>,BB;(O;*'6,!&"U^Z3+DM9HJZ+UT7'+H0I)`%ROR
MMI!/S+&`/``==<M].]=_E6D'KW``.A+.Y8BL&0O\=<J?#F#YO^2ORSSKR&YL
MI)5A@D'(**5D^(#-+'`GQ"[5X=\6L6F-*T47[B`+9V1F'KVZIDV21$=*9TZP
M,9\S*%QB4L6NE>GC6L3R\"Q'AJSDV>P=M6YQ%[)F+<@$O=8`,Y4_E0&)W`"B
M175XG(=&WEG*+7Q:A6@P8#C8ZG/_`#?Y!K2>PII%<^*.7C_CICTIA$96Q<@J
MHX66,5JC^U8E'&)6M?.;U8RAO*+*GRMN*D\?]I_\WSVG_=6OV,=+:'+R"C\'
M\YV]2Z!))$SQMF"9F6(7HVO/+/,7'?"O&-QY9\IBBTG&V!XZM-X_<?QQ#K3S
M:Z5!KHM?*JJ@Q8T05_FL6/V:]BC&E91>JJSOR6HQNWEQK1L@>:0#QCS$T5!&
M\D@1,=>FH_4O@\[D>M=:`"0"-]S4B:L_A`&XUQ-^4?EKEG-/.V<\JSLB@YC.
MSAT&58(6NFP,;QMJU(01L4QD<@S+*TI\4&3V;#F$$<L@GR!HQ"HJ"97MON=Z
M^,FZ<>T"(;U"2]OP],*`\[4)4$RQ(.GMONG;\3!&/;2Y<NAN2D&`S34D&5"T
M\OY@/`F-/?D'\GGE9R2VG!:Y]4X_!HJQ:JJAX?B%53^TBI'AQ',?82G6EO,4
ML:$-CT,9[2-UW(Y.F?M;V3[4]JK<?%O76R+S2[3!,$GCL8%30$3\3I'[E[SW
MWW-<M/G6[?#'8FV`6@<HDD`B305,D13<ZCY6^7/.&,K5NH.5\EHATIYLBD#6
M2X]4VE-9M.EBE.(3>S719;3N1P`L8%K5TV^O3Q^W>W+J+8OM?:UR#<6NLH8S
M/TA@`!(@10P5X[:5"SW1V:["^LP\S!9D;0U-Z;DDG3R'YC\[609L>]Y&LLHA
MVLDQ+:NR9E9=UD]);GDE,G0K2#.CSPS"$<KQE8HW*]7:(OKT\Q>R=FMH?3:Z
MZ05XO>-Q0IB%'/E18(4$-0D3/FTFR;7<5<74%M+B+`9;?%C!I+*4(CH09&PT
M3>!O._E+@P(JZJ;!N\9CV1YU?C5B2?)I:1\LAV.C4+UF$G44$8Y"I[(2N@CU
M51B:J(J*K'M7'MAK7KLT)*R"P0\B(!'F6!%`""I/$""#MW/+O]P=;N18M&\%
M')AY78@5)!4JQ)GS2',^8UG5BV%?D7X`YH/047-F*W'$MG`#=/AYI6S76V-Q
M;JR-`9$M(U[2$A91C,K4;Q^]00GHQ^TQ"C<K%6'MW<,*Z]JXG*XC"2LLOP*/
M\:&@,@C8"JI[;6^383!U8C^4R\+G4D$,?3N".@)\:D")MSYZFX^/#SRLI>=.
M&\CQ>$.)DM3$KK^,R`1[CBD7E35.+7S5K&B>CK.F8PH'HKSP(ZHZ1T.<>WF'
MT*!6/FFH,T,KN5V)('C3KJ/#NBS?^XPB,;.1Z*9%2)6"6'%ZD<')!-.3&FJ_
M>;OQZGNHO[Z\?SSL]Q0,E]W7XG$M$/R#CH(D8<T-CQYE,:0\F61XZ,>X0GF^
MX,0>P1)2IVTI?>O;J#E=Q"_)3(`/T_%6!J-N)W_YCKH/MSWUZK'MW=E"6V6#
MR$HYCS"Y;/T,*DD2H`-%`)T&X?FCF4CCV^XAY[DSLBB@H;;#L1YG<`@L@HP2
M),$9\5YIHA!0EQ3QUA-1;`01V<*2,9'M]'+U[!]Z96-BG!]Q6_55%95N,OF6
M($74_.L?FD%8$TD%SF>PL#)S;?=^P\%,<VM4(ACR#(:ET@L>%5\S5$C0FX^R
M>5'S"._-0NG$2QAS<5M89:HE7D,04]J!2TM0Z#=CCZTCR]N,I_<M:H5:F]'M
MLUK.&2+=]`7OW5E8*A@`I15Y@F;8BB@C<$`F%U6?Z>?NV5'N+=Y$LI)2I-./
M(U!%`)H=AOK^BW^.;DRPY6\3..KG(*R)59;2Q(]!E,2J<\E/)G-JZJYK+O'C
M'7W4C'<DQRWA3XCS(AD$?8[ZF+UPKW[:NVO<CM?'%KEJVV\B>/%H,"?,I@P/
MEJT]CM'^F58W&6X0#$$@P08@1UD2:@P=3E5BKHNB-^>U$_FO_#1>J9&FYLD@
M137EPU;_`#_HGHNG\U7K8,1J,VXH=8E:[5%3T3^G^O\`IU(K@TZZ@:V2?+`'
M7_PU^*BJNNNJ::::)_KK\>M]1-:8.2?HB(UYV)\$]-51=/Y_#7^6J=9Y'?6A
MM#C`UB4:Z>GU(BK_`%TT7^/6X;0Y29(VUC<Q431$]?CZIZJBZI_PZR"#J)K<
M4UY375-/X_#3Y:_STTZQ`UH+8)!ZZ,W5)U].Z^Z]KVH1<WV)3YG+.-7*&@6V
MF*Y%=LWXSQ[82(S'HC%51!NLS$YR(OU/1NGJW3KI?MFUP[:@I-QOX-<`/XD6
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MTY`A,<"+1*_]*T")<S]37"9I$T'TDG7W+>9\+>$_CIF4WD3+)Y.(N*9QLPYY
MY`(L8N9>1G/N4E'-_8L:.QZDLLBS3)$$:PCIH")6MCP=S`,-VR5R+>)9.3?:
M"%))/0>/Q)/E`'4@;"DSSG7A@8*<[:_RU0&)?Z@.5!">9[K&1),CH>(7SH_(
M]SUYY<G'RS-SR,?X^I7R(W&G#F/R2_MW#ZEC6-&62-KT9=7YH06NF3C-_P"9
MN0>P2-;TKQ?=J8MU\FXA&.O_`$E4<GY$;L>K&O@JB@&Y-RP?::(`^4ZW,]OK
M<T11_M0'Z5GXEVW-::@)(RH\+9WSB:IA]U@OU#'V]YZ(A'L_N>JM]431.E>=
M[]O<C>OJMJZTE5+$L0/$``2:U!I^\Z='VO9N$(@9P`)8`!?P!\(TD_O>4B*J
M*XY%>]S":*'1CD5-GJY[E8S_`,RIHO\`3I#=_44SZ@1[D&8HH`CYEB/XG1__
M`.HVBPY$(M*``_CT_#P^.K]O&D_X_8?BIA=_RTGC?_O`?C7-9]D[)Y&.'S!^
M3O!DSJ`5K&E$/-6Q:=L5HD*/>OZ>B;=%Z<Y-WV[G^TKO<XQ5[W>:;@9P;GU5
MX@MR^D4*`&!0SJAMD>[</WO]A8;/'MFV`@XKRM3Z8J0%^GF3L9!B3`.J$09_
M/9O[L83AHXFU&E5':[W*COJ;MVZ*FB?Z+TKQOU3OV;:V[N)50-KE#$#8K^.^
MKM>]D85VHN'U&,DD?C_C.C'PB-.6<U#A<BVL,:9(K[*>RU@"CD+'=`:TC&H*
M1W@2-ZNT>CFIJB^BIU;>P^]']R92]G[=>O\`;\ZX9#PCR%!D0?*2?")W\TZK
MO?/;6)V##?N619MY=E5C@699+4%5@BNT3^(T\^4X!N*,K=BBY9'S."8(BBN0
M53:HZ%8"*Z;#G0V3[$+3QBR]J*Q[=R)N5C==J/\``]Y=TQ\_)['W:[8O-8X\
M;BJ;8?D#(*EB`R[,5,5I\:V_M?M7=>WVN[=JMW+/,-RMW#/$B**1$B>I$_'1
M3X+\S>5/'J7+-Q_D[DQBT]NS(\!N#EEX;DT,&O<"6&17/J;%$U05A"44N.]=
MR.<FK5MK9/:,^V;ZH+6<@'$[J>,T(%?--29VG5>N>U\AV]&\&);=@/,"2"#6
M01_RL(/2-]=)/C1S'QQY6XP7E[QPNVX1FHLA"F?\07$EDKV=^6G<1"W-=!:%
MQ0V2A?[2_K$%*DL:U)0I+VNCMK]G*5CZ5\JQ4P3O$B0#$&HD@C>9/+;52[SV
MWN';L@8&<"(CT+@^H!=BC%0#!D,CDU^@H"&TG\D<`\2>1)Q0,IKR<1<W_:H:
M`R8D$4I,@A0C.$\UN`"QJKDC&Q*5J..%PK:"-$1_LW:A47O/9+'<PS.H.01(
M*BLU`K^8`^%128T?V;W/W+V_>'&X+O9F:O(,%4TY,(DV&G9:AH8J&CD*C\]X
M#Y:\:\X-1Y-0!C8<Z]ES$0\,^1\87H(\Y\8F38=(1\5]>K"-;WX9$&1KB-=(
MC.U81:1C6<[L.8F"S!L>^3Z=J?+==?-`,C@X^HF:14&D])S/=/8.[=O3)M!6
M[LMTJ:>92"020>ACRN/*W62"-=\'X8+NMR3PJP.QK;^1DR)5T$2192^Q[UDR
MGI@X[85%K[=Y1BLZ2TII`.RY>Y'B)'$[^Q%6G?J0UR]G8>5=97-S$'F4R"0[
M21%.HF`),TU)[3M2N3;^GC=^B9"R)\!4U:E(:@&K9U'HJHOQ^7PTZYS45&K4
M]@C?6%6)HJ::_#7T_P!/EU(MSHVVA'L#ZHDZPO8C4143U1=-%71'*O\`%51?
MAU("K;:$O6N(Y[5\8UC5G^B:ZKK_`#__`$ZV!*@QJ)D(Z4UA>Q'M>S541S5:
MJM54<W<BIJUR?!43X+\EZV6Y$%JUU"R(X*]8UX$)`B8)'/>@V(U'$=O(Y$33
M5[__`#.7J8OS8O2IZ;:C%HHL3(`WUDT1=/3YZ_U7K%=1LD2.NO",35JK\E^'
MR77^/].LR8UH+7F!IHM]4S7T=K[KVO:YT_RY^:`_'/C;(Z'%IVWE_G#'\MQC
MCE@I`T?C%/=9;V,GY&DN]'1H^.8]C(112:HCY\^,W^T9-.O]D1</!LY-VENR
MR3,06X4!_P#5<IT)IUU\Y=Y1N\^X\FTOFL,6-PDD!;7+QJ)(4*!O4GI&JP?Q
MD^)])Q9A&4^6'.Y4HH]W@<G(V75[W766'<$SWELIMRZR:\LI<W\@B@:P@'(D
MYF-#VJG<M6M6X]HL7K5O[K(C^H7S`_VI%8K/E0>9FFMSDU(XB+OV=9],=HQE
M/HPOJ`02WT^G8(@>:*N(B.*=-678-29E=9)+YKR:G+1\X\VXXW%N*L-LVQR"
M\:?'6(6%/KPV-8TC`1,AO)`PV=VYK4?)N9$2N5.S#5S7^,JW+GJD>5)`W/.I
MD_-AYB/R@(NZR4&;>%EOZ9::V<FX9N-%%XB($".*2%38,Y)CCKD)_P"X=\F9
M68<_87XI8-,./ACQXJY5O+5DAY69YS/E$F:/.,RM93-HKB51/82M:9[5>E@Z
MP=KJ]42M^YL^Z&&*#"T)$^`I(CHNWS,:Z#[0[8MO$_J3K_-=`B=>*")`/B[*
M"6Z@#7//19$E)+G37Q$E]RMM:V,U7(WMFL`>U26JJU=J#$Y^FB:[E33Y]4L]
MX;'N&AX1'A)CC7P$36NKRV!ZED*K%'E3/2C`E8ZS_P"/331FRC39"%?IN:Q@
MVL:N@F#:K]K41-RHJ;U^/Q=ZKU7,K)N9-]K]TJ'8@4V%($?/_/3FVB6;96:_
MY_MOOI^8QQ?FV60,WNJ:J0U=QOCR95F9I%C`B/J,>D3H=:"8Z)*DCE3E/.F"
M$U@!O>G<:JHC5UZEQ^Q]TS+&1?L6F-BPA>XW(#B@,3#$$^!@'Y;:%R.Y86)<
MM8V1<1;U]RMM8)+,%+$4V/$$U(VTP#M&KD1&*CMK]%T:Q=&-1535OJJJGI\?
METJ3C,C>-^O[?M71BSQAJC^'[?ZZS1H,B<:/#!HLB5(!%`Q5VM)(D'$*.UR:
MZ(TI'^NJZ)_37K=>=U@B?4S17;PWZ?MTU@W`BEF^@`DGX16L=-2%S[QM\H_'
M%&Y9FO&/(?'D:`1@AYE$"]:81)K%0#!9-2RI5<U)C7(UK7%3N)Z;5^'5ARNR
M^X_;K#,OV;^/P8<;B@B#TAQ(!ZBM?#2.QW;V[W]3AVLC%RE8'R<@28,&4,&A
MZQ.@#?Y-?WZPWW-F>>2`224$LFU)7=FD$240\AK!ED$>\+5W.5SEV_ZCY/<L
MW/N_<9%QGR`!Y]F/S(B?QTYQ.W86'::S8MJMAORQ(H(_#Y:UXU^>.U6R-I1M
M:Y$=MT-MVJY4?M30C=?DJ(OQ7I_VSW3GX`".S%-I!@@?+8[GH#I=E]DQ[K![
M/E<F8Z'Y>'\=2OX1YOY'\0.8L;Y-Q6;(B,[?9F!E-)]ORC%[&*(D@%C6@D.<
M]T!)(I0&.7<TK&/8JH_U<6/<&3VWN%K*N<2A`!GEQ=#M-94@#80012AU4>Z^
MV^V^Y.WMA72>'*A$<[;J>DB".AI!$@U&NL+'_*?BC/L3Q^A\@:.1Q]DD[&*K
M)<8ESV&FU691!OBS:G*>+\NI8@DS"2*++[@F0O:9!$8_Z@CT55[#AY#*Q0@6
MW8<PI)96$`\K3@UH9,0Z]4WU\Y=Q[-EXU\ICOZV&KFTSV^)-L&CKD62I*``,
M"'FV9@N:#49?R6#SS#N+^+)Y<FD9/BT'D')$J66L9X[FP=,H_NT&IRX;V1JR
MY$,<-LEQG,CS-R=L@#D13J)WR[C#'%PADO2(8$<D-/@9'("0"!%#337V5CX=
MSN5^R&47_2.P(MJ!<^M"Q+<BK+`::&0P%-=*W_;J$L[#P^C9$1TH<7)AR4R2
M'-*\AOW[B>99=0'R,*O8/]')L-?4C_MT<E8Q^KE>JKR#]2%0V,#)!/KMZO(0
M``)4Q`IR!F2-Y!UUWL5T7.ZYUL+"1;*GQ4`A3$^69:`!0`5B-=";AZ_#U]?3
M7KEPN#KJT%>HU@<S5-431?AHO_CJG\>I*?AJ)K<C:NL3P[D5%35/Y+IK_P"]
M-.O"E1OH:YBJZ\6`*ZP;$1$1/AI\%^/IZ>NOSZW%PC?09QPJP/I'C_#6)X=W
M_F<GKKZ+Z?!4^&GK\?AU(KAMM]#7,<'J0)Z:\=I43T]=-?[E1%_EZ]9C4)LL
MH`63\_\`76-6.375NFGQ77X?S^'6ZL5$:B8.`0P$=:_^&O"::IZ^GQ^*?R7U
M_AHB]9]0QMK0!>0FBC]JZ+'52U]!Z9G(N>8MQ=@68\CYM<1L?Q'!\:N,HR.Y
MF/:P%=4TL$TZ9(=N_P"81H@JC&)JXCU1K45RHBSXN.^5DV\:W5W<*/Q/^'CH
M/N&7;P,&[F7?^G;MEOB8%`/B3``ZDC7#U@.-9O\`E*\R+WF#DBILF<38L3'J
M^OPU3'[`<7BE[W&O!T&>[LQXUYFYPR+W*"-_5#5,G%T^L'7><.S8L@<H..!(
M!F@K+E3U:!"]!Q^,\"4-A6'XUS+S<F)%"\>4'KPM"K^+4W8$74WL.EY%RF91
M23)9\!^/>8U\O/9-;"%'%Y`^45?)@_8L`J:L3D!(Q3BFS?$WPA[XIKE(4!$[
M=>9.F]JXS$(`/7=3()GTK8V4TW80S&>D$26`3%;.+@?=N6NY3/\`R@)#/<#'
MG>,""UQI"3(`EB8XD(/,V2<@,N@\+\:6,>-Y6<^UI+K+\N")MI7>.7"T(I8=
MCDYM4:$[:1LIT#'XI%8EOD9GR53M,*K&]MP+2L*8RTM@@>8R.3'8QXD=2%VT
MLLX98MD9I/,%7O<6:"8A;2?&-Z"@+U)`UQ-_FBG<+\4<HYEXH<>8W-?F.`9I
MQ_*OLUG&^Y3)6(5/'%U;PZBPO9CCVMKD>09[RI;7%F5RL:\^U[D>KA[*E[FR
M\<_]G;K<D$DR6,`PI/4>8P!\C776O;!R\FU;RW`3&:V?Y8(@-(`I`^E%@>$D
M#;59?D=X>\G>*V+<-7/+4BF@WW-=%=9?1X?62BV,_'\7@MH75<R]L&C97K.N
MEN7*V,!2^V0'U$5SMK:KW[V_G]EQ<?(SW1GR0Q5%JR@!3YH@`^:($\8J9TR[
M)[H[=WWN69VW`6\&P75'=TX(S,7$6PU6`X&6(7E((I!+:XB\0O(KG6;@L?CG
MBO++&LY%F9Q$Q;+9]3+J\*M6<64;LIY1D@RJ9';628_'V,L6;;=EQ21AJB;'
M%<T;JDBAW"6B3<6)!%=R14TGY]*FFKDMB^55[BE;+\H)Z\=X`EC6@`!)/E`)
MU8AQSX8\I,XGYYL<$R'C7.\RY5X4RC*,9X[HKO,297D'%>*>2M;X]7F38O)D
M8"+&;:67DE0`@U<B?"L94-[9`QZM[2WO$[E?Q^U]PP;-I&3-LJI(82H5I;8F
M1LN^]:B=5S.[`,_N6'=:X4NXETW.!ML.1<<8+$J485,%=C!@TTH\[?AHRCQH
MRC.I7+?/-`O#?'_%G%F>W/*.!<=Y)D$^XRKD_F:RX!7C?%L'O+;&)%A8X?R3
M1V+)]B:=&AEK8K)$9"ND@$ZKV>S70S&ZZI:Z02?S$".(/(DQ3\H-:B-6$-A\
M?41KS6Z``(`Q:8/U,`%%2"3)H($T\^/WX:>7^8O(OR;X&Q_F#BJLSSPXYVP+
M!L]F9$#)(6%6.#W4O+Y-ER\[)`Q32,?Q+%FX>!+".>*2:UUH-K45PGHN<7MM
MQ<MF5!<>S<^@'ZC0\?DVW+0UY\94=+]UK=KC(?B"`HD,Q$S(,>62#6M*S@_*
M%9\Q3?'['^!<EX!Y!H\TS.ZQ.9$M<9<;,^/*D\?DG,.,*2HS#+F5U"##KK+[
MO%W3JJ+/"UQ:J5&DD<+NM:G7_=OO/$[Q[?O=N^WOVLZ^4"!@I4$.I)G>*%10
M$^.N5^T_8'=.R>X[O>VNX^1@.KCDH8%2[JZR'6)XB25)`GPUS"9OB.2<?9=E
MN`9C5R*#,,(R6ZQ'+*.6\+IE+D>-SY%3=U,I8Y3QGFKK.(4+E&1XU5JJU531
M5XBI:VWIO0AB(C;_`(:["A'TR#3I7^.^OJ3!\DR2DM+>EK2S(]3(%&GH+12,
M62/N`&-NOZA"+JU&>BK\O7TZ-M8F3?LMD6`'2V88#ZMB9`V-!_X0-"W,S#LY
M"8;N%NW%)4$Q,>'X_P"FMB]S.^R6OQRGND`9V*1I-;!D,BBC22Q'.9L!.4+!
M^[EQGM5J%=^HYGHY5TU7:YEWK]NW;9IX'<;D>#?'H(BFHK>!CXSW'LT]3S$=
M)ZQ\_GJ^'Q&\H^(\G\?L`XN\I*&URNOPG%K[$N-BS^RF/B9$E2),.02S"R-:
M4-C508PHR31DDR0A8W8X+6[7=H]O=[M9';[&#F)RNH"%+3!`\OEI1E$#F""/
MAKA/N;VUG6N_WNX=E=4:\P9R`20Q_*R[.CM#$-",9D2-3<RKA/G[G/CWCO",
M?F-S_CJZY=/;\:)GL^R'E^/CA8/-FP;1^9V(ALSC!)M.TQ02[`0K,`HK6O)(
M:YSF-.XY+6>W-F6OYF*KK!N!O50<M@2//R/E$\!,$EA4UWM-G`P^]/C8PMV.
MZWK8#BVTV6DJ2>%3:921SCE;@495`UT<_P#;W\EV).,\UX@N5]_75DFQM./,
MM`(<:JOZ['Y%-7Y;0U\1C6>UA8U)O*^37+HGN*VR;JUKXY-><?J-D7.X=MQ<
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M/40%^_9`1WT1Q1PJ31H3)UTKV?V46\<]XRBH+2$4CZE&_P#]9$?^4'>=<R]W
M]W7(R1@VG`QK#2_@;@$R8,A;(JVPY&-UTG6]+6^%_CIA?`O#]T"-S1R35V,B
MNSAC!P)='C\L]>3ESR6R%I1.[![V3';58R,R(0<(<".U6M%)5++W/NWVEHY#
M`&](H!/*X:`14%4F30CD0#(.JGVGM-SON4UQF]/"022>B#S!3N.5T@LY$\5)
MWX@:@!Q/^5&NX=KJRCRGC.3?81Q7'O:3B>FJ)X$B6^6"VI+R6TR8C1CM)+I%
MBCWV,@4AW^5*E=YY"-5AUKN+60;5V76Z0685N5`/&E".1*]"2)@TT+F]EMYC
M_<6'1,A$E%G^2HVY"8XCB04`J%H0IG4^N`.4<$N*5U;CW*5%E'E7Y,2!YAR_
MG2L&%,1@3JT(Z&%C5=8$4$C$\1JB#J\5@L*YL^0Y\HK55TQ6V?!S\3)969D]
M)0.%N8)@D$+->,S!$R9(J=5[O&%=QKAP@I&/9(+L9J3#%O+^=Q)F?(HV@0>`
M_P#)%F=;E/G_`.4V15,A]]CT+F_(:FJD299I9;2DPV1$QB(I[(ZO),?-B4>C
MCNW*15WK\=.N>>X,I1W6Y<8<K:O4`^$3!Z5^=9UUCVSCVK78\=$'E:W(_P#5
M+#^!`G]]=3*X4_(GQ#S9Y$W',_Y"L/QN_P")<$XOH.+N).,<1Q<5M?\`'4>Z
MSS$9DG..,@V#7?>\XQ"LQ<DF3)L3-:0$IXPH%',8E=]T]]S?<SVYBS8M2$$D
MP-@&,<GD5)VD3`TV]J=DQ/:6->-DM=R;SKS+`2:EO(#2WQ@*"/,1NQJ=(')G
MY2#2\4Q/BO"O'_&Y/'_%675W*_#.2YMEO).&Y_1YU<0N1KSDS+K`'#V?8R/V
M?(>3\CRI@X,6?#CMAU\,<M)2[T;#A>MB*76VQ45Y<BOQH!)($Q2)&F=]VR'9
M9M05`"NOJD!0.L@<N4F2"%)V-28TY+^53SER?)G9@O-(L:RTUX._=E&%8#QS
MB^32SAY#N.6ZRLFY#7XLE]98Y3\BWQK>)6RI)H(IS`&<-Y`"<W%SOV?ZO,"V
MIJ!"BM9(V.])\>LG6JX]R/1N7;S(3)!8_5$3(BL3%:2?AIR>%_/GEAS!Y!>/
M/CG`\J>6\'QW*\WL,+KK%9D+,&XM%Y'RVKS;*IJ5&6#F5]\V1FM#"N4#/>0<
M>QC-D`4!-7JMS._=QQ,*]?5@S):9N)`()6H!GI/PIT`VT5@X&->SK5H<K:DQ
M*,R$"()'$B)'AOUG5JOY._&;F?\`'IAW*_DQQIYW9AR7EWFUDMIP?Y+CI.,>
M/^.ZSD.GL:\M_?NM9&(>ZJ26%E90%)-)7QXD@LHYS$-W#$1]/]L>_<OW!G76
M6S:M<%!)0AHN"4B(!$RP8_@1X/N^^W<3`Q+9+W;KL8!:!*"*-QB:@1(BDF3J
MM27^9OS@R9F6LY0S>EY3F9E98O9RK>YH1XS;U1<;Q:CP0\>J=@),7II%5E.$
MX\"OM8MA"G1COW2VL9+53+T:WWN\>*7T5B*TD`U.\R*G]QVC51.#64=N43YI
M->A!!6('EZ@K0@FNB-+\SO"/RES@4SR1X69Q=!LPYJ&<M9B\7*L7QJ]Y`YR#
MR5F7+;\YXX@XOS=DV=S^/;NZH846T!:U$"S'73D&H^^(<M[*PLM`2GI7`(F.
MLU)<23(K!6)IUU*MS.M!$8<[:30>;?<*C<>))^I@Y:#($C36E>&L2HQJ%G'@
M_P`J.\C,1N_L$W*>/+06,U>;1WPL+Q#*+^WCW5?/3'X\7')F2RH,ROL$@28I
M:V1H^0K/I#P>^WNS<A=X7,=U^J(*G;D!X@?X]-8RNTXG>KENY''(M&`K$1#1
M(Y2O$SL32A\QVU3Y;Q)M==7%980)-98P;*RASZV<$T6?6S8\HH9$&9%*UI02
MXI4<Q['HBHYJ]1B];NISLF;32008)K\M,V#(.%Q2KBA!Z'PKOMJT7Q5N>'<A
MXZQG!N0H%U(FUU]D4BL]@^$X"V[JSW5'[R$0:'G5<JV<Y);6O<]K7_2X:(G5
MV]O^H_<L<(Y^U8VRRO/$!3#`3`4MO"F3O$U'/._/>LC(<RI*$*R1(!$>!J&K
M!H1^,V=<A\B9.:OE\)-)'G461Y+5WL-D^Z:Z%#E-I#/@DKLF'"0;H\R>Q\**
MR4@I@9!MI9,Q":,Z]E=SQ^]*>T7`PN2#;]1I<`"1)%"&Z3R(\IY$1KCV#VS#
ML=P_J=M5-^[C1,0+BPP$@F599)`#,DP0%`.NCO\`[>V:V?'MAR'S9[*8Y(SA
MEHHU3!Q[*IF&QXAY-#)`@RSZ;):2G<.8U[58*QA#</1'N:RA^_URK?M'[:_Q
MY6<I%)%`5EH`$M!65D4/F)(KJW>TK@O>Y<=^1:W]M<4'C&P-#!(Y4()$=#%=
M=4GHOQZX1777VQP?IUC>C%<T:ZJK]=/1?_+ZK]7R^'6P)`G0=VT`XMO]1V_X
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MMBY$[+>RT");1K=NS:M*`:*JA%A[A/@GT\OS-\0=<7RC=[IEVL##0W<FX$0\
M15VA>"T($D@O=;Q^KKJ+_E#F&1SL=Y!SCD<P87('($<%IR^:+*21!X^P\$>6
M/!>!\;>11("!'K5:DQ!J(A92RI>Y'2(_5$L7;G>^X#N)!7`LH194B>2A@6NQ
ML2=CO+4$\==*RK.+V+M/]'L$-DM/J-!'*ZRQ%&V%8FH4;#D=47YC88A>,;-L
M9=_C->6':#P?'*B+(+32B%8"N2UL1&E2)L)N0/BN$CD0[(L>,C.VYJZ-N=L%
M;BW;3+Z,EB9,D`@`B2H!(@!6!XHL-,'5$R&M-?NV+G*XZJ&;A"A9W6.)H0O-
MCR)JHJ"#I+QB)R=6YAD<+!<OE2+^YQN+'R/,*:7+;/I7N&9PZ''8AA1ATF0V
M4^*./''(8\P(S'D?]*[7SXF([Y3VL<,K(2SL26/0#>?-$!8H""0`)UF[<LW%
MN/PY8>ZH0?,:<IBL;"!(($%3-**+CBKDS-L?YIYFK\=L[#C[C'):V%R!F\H[
M!P*W(<WR*148W3K+*]%M<@NY0RG[$?ND;'$0ST:Q$<J+N.)?OK?SFY''ML2S
M'H284&@J?A_`:NF-?Q\<6;)*(URB+_N@20LUA1XQH"_J)HQ5<Y%W*FCW>KOD
MW1R(FO\`)5^'5;"`BOU$S7\!OMX:;J03\>OX=?\`74Y^$/%O+?);%.9.5*G(
MJ7CWA;Q\PW!#\H<K9O4YU<U&/'RN-*QW$*6OQOC'$<\S2\GY/9T,]`O#7-@1
M`1B'F28XF[G.KEQ;]KTK<JY@$MY:['Q,'X5(Z:"MV6+'(<D'D8"J79N1)H%&
MP%2S$*!UFFI`V7XB_*FTIN-\NXRX_P`AM,!RSB>KY!RW/.2[/B_CO&<2L!</
M+SWF:LGQN1\HTXXI>,"@GUM]8?;R7"D[;(HS*T*KF[>!>558LK-$09!VBL4.
MX-!71H56)$JJJ))9U)@"9A`U#^45;Q$ZFOP_^,7-."/)'GGE@.1Y%P90>,W"
MGD;S'X\_O//>&\UY<SKEOQPXMPO*+)_[>IJZ?B^3\85>6YL"/:SXX`I'"5@&
MO=(#(>SU[M&'D)<L75=L>Y;XGH(,2*$U@TJ17?4UMAC/]US'J@DH`2Q!$#D3
MZ<0-BI`).TP3IN><&0_E$\@[+PJ\6_.'(>,TX\\@>5J-W"?(?'E'@UG56%W9
MY;5\69)=&M\*D1)MB3%9>2L=)KY+(O=W,>)RM>A.JWVWVMVGL]XGM]LVA<F3
MR8BE1NS1.]/X;:GR<O-R(&7>:\H)/@1\@40_*D?/?5:N:>"V?45%S_-QF3F'
M(M[P=Y67WBW'H<*XDS3(8N=66-@S:QM<HAY+0K;5^-38M5A$B:VCG"25)A(4
MT<I6Q9",?C"?B74S_F!%13:M:_/<:!XEFXVE=FD@?3_'S<@3TA2-Y(C44,6X
MWY`NK;-JJFPS+I]E@.'WN89M!AX];$M,/Q3'#PVY%DF45[8J3*2FI"G&DR3(
M&P47?J56)KT5V^4R#Z\A.!J03\JU$'QG4=_E=M%0/.3L:;>`W^<?Y:VL=Y#R
M_B6_PK/>,[^?C&210$LW6=:;05@>+96440KB`[N5=U7EAF>)P)(RB>%[D5OU
M*O6G<<3&/D1!Z;+4#K76,-GO(2QBXI@'J*3UDDC8:5>=^<I7.UQA>46M"^KS
M&@P&#B.47+[R==@R^UK+J]L860"CV873:-K:JUCPEBODS=OM>XA=K]C1L>SZ
M:F3Y0P/28'3]U/\`'3',O7<M5-WZT4+N22!M]4Q\A0=`-M6`\9?[`9]=<G3J
M"G^T8=<<LI;8)#BD=4V=4RZQ.*ZNII`Y,P((5/6719#B*&2"4QR(@".:J(G0
ML.Y9O9BIC%3@-?4@PQ*K21QE(B0)#+M4@1KF/><B_AV`,D,V4,=I$<IBFT%6
MKYH\I,1,FA7O>/\`D3$I88>33)/(/'^1K2R12/<3(EI#APCL]F$DV5$$I(D6
M4P;2&7MN*%%?O?KOZO>1AY';>XVWNW.2LY)=&\Z@J5`=H"D<0`O*IJL^4:YS
M8O=LR%MWK-DV<]4>$/E1B1L0?^G#02-AT\M==.'X$+G**KR`M($/(2&)1,QZ
MBSGCRD(R;BP<<S9N6UL2VB(TYHT:^PW(*NM,4XGD<Z)+EM<\B$8K4OO/%0^V
M<RVSJ+ML6GA5'$A2H4EHY>HPY!P3``4U+2'G8;HM^X>VO>MA<DNR,5%(*L!,
M&)68D"(0'_=KM![+==?3^/PU_P#VZ^>N;:[<4CIK$H?1%1=?Z)I_Q7K<7.AU
MJ;:_$:Q.9M5$=ZIKKK\_3K<-R$C?0MRT&%1MKSM1?7T_XIUF2-!O9@\14ZPJ
M+^B_P54]?3X>NOKUN'T&UCQ_PUC<)/E\U]=/EZ?_`*=;!M0O8ZZQ*U?7XZ(G
MQT7U3^7\?AUGK/70[6VW&VO",3Y-]/\`CUGDQZZU"F=M+&1^X6AMQQ(4:RDG
MKY,8$&:HT@R2R1.CL%.[OT+!52:F1455$CD1%71%68X7UTYF$Y`GQ@5I\?#7
M0>X,ZX-[TH%STV`)V!(@$SX;ZYR^?N2&\LYU#=C4B/D/&W&69Y#6X`CY:^QY
M@YQ:RTJLMY=FC"$RLQ'`154ROI',WB8C"G$[UB*MR[D;N;':E0HI"G(V(2W`
M-NU,$`SYGD5:ICB=4_VQVU.QV6[B[A\Z_*8Y@T0U>Z10CE,S0E8'YQJEGS7R
MH-K26>&UQ'R<(Q?*I$KDS,S$;$CYOR()D1Y*ICQO'%EP:0LA$EZZC"=!QFHG
MMGM5YVW$1+@Q69%QT7BL`R%)Y`""8-1,^7\QF:"=UR'M6N3+ZGJ"C,2PE3YK
MG&O('8#?<+19U5B^3;YW=U-@(]7)M&VD&IQFB.%PJN'3UDEUO,G60P/C2/80
M2*`1Q,=N,XXX['.>[1;%8L7;E\X&-;=;S5)(J`0.55H5`ZCC^6O0(5LM?O$V
M6%RRA\Y$GB5WD`21,2.A%:2=(V+\F`O>7Z_`L&>*PX\XJ+E7(7-.9.EN4V;9
MOBF-6F5@Q]DL`MMP*!:P0RK`NKA.?&9%:G:$B/*&3BVLL=JLLIL6@7N.84NR
MJ>*+$$F5'E795_VC3+(LW+.*<UIB1;LTY-)@<NL0)XG83S,T&JJ`^6;*CP8R
M;P^IL2WR^2^?ZGG3D'.YDM53V6(8]&J,,Q2DKQ)O=(?8R)<NPE&>K48@1"8J
MJ1[:AE=Z0=I;M=M?YUR[R=ID0(A8\0>O^.G*=I]7NUCN3/"6+3(JQ4LQJ?P`
M&VYK0;@SQWQ^%F?D#P5AUH*#)K<NYJXIQNSCV4H,6O-5W>>8]6V09\J4K(T>
M"^!*(TI"JT;!ZJ[1J+U75Y<E78S^[P/SZB/#5D``XF(`))G8?.==$_/7YF\(
MX3\N<MS3@L/+>99+P?C')/`.$76)Y5A_!7CQRO4/YFYWR>KJ.8^$L/QC(@\G
M\-<6U>?U51BM2RQK_>Q:0ARF$R;L:SNY6%8N<%0O$$K`XS`FIDB"`0P$F2`1
MOI2@S,A/68$W6'E=G8LDBK`+0\IHI;BH"T)D"OJ3^7?ROS'B+E?QFQJ!QEBV
M">1O&?CCP1E8Z^DL_N=;CG!&"U/%U4;%;0UI[?&B<C44%K,CV12L*%SA1VB&
MB(H#]RN,P*VU#@4/)B9.Y@0),D`$'CT\=%6K5SGY[IXEO-028VDP3`ZQOUIJ
M8W+'G5^2KAZIY:R'D"9X;VUW/3D"6:^B8'79;R)@>-<\OP65FN-\864\87T^
M$91-QJEGFAF22HW$5'JC#/"HN#[C'<;9R$M$*"5#,&''B)XD!F$0"5Y;C8:Q
M<NX]J\<6UD3<HS*J<9DJ0>3J/]P,*1^^=0*YN_*KY!<^\F^.G*F<XEQ!$O\`
MQGYJR7GC"@XSC^5PHF0Y[FO(F.<GY:[,S7&97]K95=OE>-"(V/&D11PXY7@C
MH(+1,')]X#'%/Y8)W8R0>E9B!X?+4J*XY*2O/X(HDU))X@<B34D[UU(GA+\O
MB<599S+E.%^+<7'[#F?EO(/(3,UP7EK,YEC6\FW?"/DOP_/O,:DY176]G3U)
M+7R,2W;&9*<L)]3VPO\`\G<$RW>MY(%RTMPE*P"#2DT"C8@:#R;;,!Z[6@(`
M)@KRK],LS5-9Z'8#4J;'\FGAUY.EQ^=SE3.KLNQ'%^7J^@3FO#4LG`KH?B_X
MH8EQIBK<YQ][[*3"R7GOBC+K)T(LH;%'<E?->J3Y`W'VKV";P4$)*CD#*F2T
MDD[3Q:(DD\8\-"LF3:!]/F;`CCLX!`@<=^(``^D``U&D?RQ_$9PKROSE+Y)X
M/YSX\X]Q7DOD'-N6<^H[*W!(XMI.*+OE?,H4V1P'D6$8OD-),EXC5QZD):@D
MJ8@#9%",5($$;VI'W+MSXZ&YC$$<>7&1`I0B"*3T^7CH_"SER4+,K!>1\]2&
MB:&`>!'Q8TDP-4,QN(<8J/(_D[A*^L)AZO$LKY>P*JLS+'K[:58X/9WU903I
M`6$?'%93"4C7/!JX;B/5B:IIUGV]C6NZY:8N489[;%8,><+(`V$G:IBO6DC^
MY<W+[=@#*P0"ZW[8/*H"%PIF!M!^H1I_>-]G%@TM_7S8UD5@\FIYC;*O')<2
M%VZVPAR@(V$\!P%EQOJ1>YVU02H\;VZITY[(EP6;GI2[!MH@@S"^>&X1X<""
M=Z#5:]TVG=>:NB@(^Y$F(,A3N/B`"/&NK>[RCO*3"?89!&GVN*Y;QX=[9<-!
M#GGJ*AXB(M8Y7CK91@-1P7)&'"DLWHTD4NFJ]Q+O>[3>MV&1K)L#F8`*00PY
M&@8`@FD$"H4UUQ;"[@;>99NBX$/KP%;S*Q8^8#=D-)`>0*$'PM^_[<G,Z[#_
M`"A#B%ED=#45>9X`.MX\Q:1VHE[<65/>OM;!TQK!,C'O04THY',0KC.C#W-:
MYC5<G/?<B.WMW-Q[PM"\<4..)ARJD$N0:E7A8/7B6Z4NZN+?N'MN7<\MQLL`
M@20>155)DR!Q/E.S`GJ-=X"A1?Y?'X>G_P"_7SIR:-]=^:PI,C;6-1JGP7T3
M^.B?S7UZV%SQ%=0-:ZBNL/T/37T77YIIHOR^*>B]2R1H7@K#DL$'P_UUA<#5
M55%T]?A_[>G6XN0*BNHFM@U&^L+FJW7YZ+Z__#1?7J0,#J)K8`!I&L+R"$FX
MQ!A;Z_41[!M]/CJYZHGIUM7I70=VU;`Y2`/CUUK1IE?-<9D*=$F.CO:R0V+)
M#(]N16[D87LO>@WJU==%T7K<K<0`NK`':01/RG?0X6V[%;;(Q&\$'_#6PHD5
M?35%1?YZ?'^&OSZQSU$;0)H*@Z$?DY$M[+AS*JJOR8.%55E%?%S3+U.\%C0X
M,@#GR@N/O8FYF0V=>%8,0J*UT4DKW#=SQ-8Z7L!"]UM/P%RXIE5.Q;\L_`&I
M\8C3/W<_#LK@DBV73E`DE0P)6*?4!Q,5@F*ZYJ,ULI,&T#@7&D2OQ/)LMK&4
M];V@B96<(\-PY+X,Z]+#&U'1\DDC&($44ES%-/VD5SAQ'JMRQK:XEMU<?]P]
MPL31BQ)DM!@0M(!H)`BL:6W+PS+GW.2Q"):Y44;`2J*#0&1+`369$`:I4\Q9
MB&ETN*X>2=%XWQ^5%IL-J`L9++EMWVGNF63"O,0EJ:=.&24Z:97*8J'([<Q&
MO>[LVN2BQC\ES8`!^HN7B0RCR*(B2PWWC8UJ_DWLW,-VT%NW;CGB)*BTFS/-
M)8$@10+R``H8KLS_`".XJC2."^-+F,+D2_@0I_)^>A>-7<=8J4$A'550C!C_
M`.NS$7M16:#D#5_N2[7E;VVO=<]>Q8K8>.`W<2C>L;>UM25XHAI))/$&8DB2
M":,L+!M/:-Z\3]ICI#$D`O\`3!)6`3_OW$4J1H<UDW'./^.^?J3`V3!U/'/C
MEG;)MD4B^S=F67R8F)CC-F#<A9=ZX=NUQ"HJJ-41%T:5$0#"R#;Q+SJBB]:Q
MVY%&!8\V*KRE94E29W/(0I%8QFX[O>L<V):[D""TCB!4A$,@H``O(!9#!C6I
MI:+VT;M&JHNFS<YZ(UWHKD1$U7T]?X:IU02H9RRF!)I_H9)U<;:GG+4$?,[]
M=+,RO!`B5AMK7FL:DLP[7KKVWN?($FSUU1"":B_U1>C%M6UBX0W)K;&6VDBD
M>-*@Z@-]KE\V08"D"/']_P#AIM*BL1J;VB'VT<S14:Q$;\%]'(B(C4^7IZZ?
M#I?0+.S"D:-9T!"D"FBGQ>DNNS7',@;CEYD];AEQ5Y9DM510SR)C<=QVQ@S[
MDA7"CF'61_:?0Z49&@`KVN>Y$^,!ND$M;HPFO@Q!B9B8F:&NM?3=[A'$LHJ1
M\)$S_AX=-6*^77EG.\A..PVT7A;D3%<6MHX,*QWDK(:R**HO_LEBDSV%AD];
M51Z*^R6!6P/:/;&*A4$%.XU=BN0#M>(O:L1[8=KK7!YAQX*I/@.1,#X@$R#X
MR/>Q<S(OV\J_:BU;E48]0?$A`"0!`@QTZ#5<0<-S`XK0\;$LGD1Z.ACY1=DC
MX]<F#38K,/$BPLHMS#@O95X[,DV`!BGGV12O.-K2*I&(L_!I+;*)ZGQH*_QT
M2+-\"2C<@M?*?IZ':@\#45WTK<<W=90WDB3;E)&C&J)45#"&8CD.0XW#:O81
MQ6#51*F[1?YIU9O:O<,;![CZN:XMV2A'*"0"3_"G\-)>ZXK9F'Z-I"WF!_=U
MK2GAUUL<O6=59+CA*B;'FL"RS:=8AD<]JN=`V/DB>O>%OVO5K7:Z_)5Z:>Z<
MK!RKUI\*Y;N)Q,E2"=Z3%9$==0^W;5['QVM9"E&Y$P=XH/D)@;1\M>N$?)3F
MKQTR>CR?B?.+&E;26LNX%BEH$&3\<6TFSK#4]NS)N.,@'889D8+>I.^/);+A
M/<02MT<CF,<VM+>N("BDP.A,@G_R[?COI\V+9<^JM+H`AA`-/C%?QZ$C8Z8_
M(N5Y;G><Y-RKE@/:9#RCE63<C2YT"$:LJIMQD=]86MO+HAHYZ1XH+HYF,&Q[
MNPK4;KJFJRI:NVEMN5*!@&4[3!Z'K'SW&I"+=Q6M$AF6C?/>H^(K\NFBCPG8
M93#_`'+:4!)!VU\&+.NHHW-(*;$+(<-C3P2-,&8GN%]%>-W;>J?QT5MVVSG7
M+5RYB%^`:79?J`-)`J&KN#0BL$@:J??KG;UO6<;-*(URX1;+;2!)AA4$C8#<
M=-]6N<5<_'NN,X^'WU$+)<5IL1R7&JV;0/G2;K$R6AQ%/+OZ,.^_BC:1%WS!
M)90W;WJJ!5'(WK?:.ZN.WDV%Y<48MZ56CB0/40@LHDR&606(!%"-<L[CV<X.
M<+EMD%UKH<+="BE5`MN"JDB?I)#0`8;?5D'X4\;JXGD7AM'*6%05<R-.=@F9
MV)X_W\?)E5D%%D>+6D"6!@^RD2YJ(\,I$=V"`EJ!WT'<U<W`F3V?(N+8YV1:
MN<F;ER=&1N2B:?RS_M@&3(H-3=QR,NV+-]%47+=]2Y`8B>5OTS6@"F0($R1)
MD#7](IBN5C%>B->K6J]J+JC7*B;D1?FB+U\L:^CM?JHB_'U^/I\EU]/5/GZ=
M>UB`=]8T"-J(UC4:U-?I1/3U]?\`A\>LDDGD=]1K8M(@MHH5!T&O#@Z)Z+_%
M?_;UZR'(WKJ*YCR973*S;+:3"Z659W=W5T0F`D%9-M2L'%CL"$AC2I&][&CC
M1QC57D>K1-73<J:]'8F/>RV/HHS!=X\/GTG2_*>SC+SONB+$RVP'4_(#\-4?
M<A^66=?=N4%R63`Y!RG"#5WLL$QP4B%3T=0_DMF!SK:7-<=DVV/#AY!639T0
M(HL9&)HR2K7[^NB8F'96W9.-;%G&<D<F/F=N#,.DP2I537QBFJCD7O5NWE<B
MX+:\I_*(901)@<N+`\13C!DSHL\/<\YW7AX3S"\K8L.)D>,TTS.Z7!1!-"#<
M%DR*[)",@PBS`VL`<T<=!$$1Q0N5[4>9%TZWO8V-EX]_%+#RL0A?ZA(E?D1U
M%)\-`O?%H6<M`OI1):V0`64D-$?4K;'H#)FFK?84H=A#BSX^]8\V.&4'N,<(
MJ".QI&(43T0@BM1VCFJB.:Y%1?5.N>7%-JX;3T=20?F-7&SQO6UO(OE82/Q_
M:NH?^?\`FL7!>%F6L[O6+#W+(=-A\%1):9QF)8IUQ/'X;2O8TC4LV>Y*BJT8
MF`4Q'(,3D<Z]G6/7[BX(,!*MOQ!-2!XF@$D>'72_WC>(.'C)_P!6Y?/&L>91
M1NOTR36@W/37-]<B)C]7ELS+KD++B\%+ROG3/&RO:0H5>*$9\+!J2<J#D0JN
MJKA>T`J(A(]>CBJB2);%ZOEM+#7&>G-Z+`#$!('*(`@?F_W7#,D2-(>XY>/C
M6&%EN.+9!Y;DLQ$TB3$G8"8@`5U0?Y5\_P!E.R!9&%0$/F-\*PI.,J%D'LUV
M%U$4`1/S3)1!:7V4Z="C(K`/VJH59':C&MDHZU960O8L5/5AN\7R/2!%41C#
M7'K6)H:F8GE77NT]H.'BMFYMH'N3J+CQ+^0R2.DLS&@V]2.@!U"(58?'2AX^
MPFW?*RG*.\?E'D62LJ=*9,.:'-FVQY#&&,2]FRWH.OC-3L`8-A'KM:JNH#Y8
M]!D<,<U2[,)!8!OS$R/"0"2TDP)C1BFR2;UZ5P@$"I!!I!(@B&Y$\BW@5)W`
MT55Q/&H?C)S+B+RNHPY:;C?$4EA?%=82Z$O)&%SK(@Y$ESI%G-D-B3C2)#FM
M1IAHQ7[VN:UC=MOB8.781"UF;:!I`+5!8JI@@#Z2:@`$S)T*,PW[V%D,T,06
M98)@"VW`&#%14^+;P32B&6X)99VA&Y@E*?LMU:Y!B:]ZB8XB)HYPQJB*JZJN
MG5&+$AG40LF!X?N/[>&KK:Y"V&G?_'K`/372/X@?A,Q[.^&_"SRRYFS:SS7B
MCG6^H,NSO#:RQI^/ZK!N+<!%S?GG+^*Y3G%S:QVULFXXIXCKC0+9#U,>"7(D
M5[G(P95W>VWI&X[-]("@[$L!%*F`212/IUY[MJPTL!]'-I\H@*3Q'7_;YB8@
MZM3P;P1\;_&OE3/<9K<"K_&RMX&\T\@S_!>0>>L,XBR#C'S/XOSF"_-?&WBG
MAWR&Y2M9.7XM><#PHP%LH\$B4=S&8>3:S3*8>P4W@"&6""@V!)4]?P:")W`&
MVB4=K:>H["V1R@!E\S08+"C#C2#/$3XG2IPEYP^!G"]EC5QY2>2?$N8^1_._
MCSXW_CS\O\^XI9A'(\7]NR>/.4<F\@LYY%R7'9D&@3%Z6RY`Q'&Y^6TBVSI]
MEB91@#*")YF"7T+%@%XVPS$`T!(BG^<'_/1*Y5H'R$NC!02.6R+4R9+2Q\L5
M(%*:@]Y"\S>.F=>#GF;1<->37%')/'%)^/[\?'#/#_C`N6LQC+<%Y"\=N4ZJ
M/SIRW2\?9E%HJAUH^V]]/#,QXL^[R.-E;Y"C<)).R2TL%>:PO-I8PPB*4!,5
MGX;3.O7LBT[L4/\`,N%1600JKXF`=A"B:UIIA6F3^*.7YE-RG,^<.#,_P'-_
MQB?C]\>ZC$L?\C['B[,K+E+B&^\2\3Y>XMSB3#F4H<)IIV+NR<<LE_'G5",K
M'V&C70FDZD3UEM0H,^HQ-%-#,&.L&"=1N]NX68\&N*00&Y@4IO&V]1.IH5WX
MT?QO^0F"<X\:\;R.+QU'&WDAD7)N&3?&;E&)FW,TK$\G\9^*;W&^`%L76/DG
MDF?&Q>WNL@D3A8L/):Z9<8]*6"X??>L>-KUY$'KKY&0`@K2C&32(FD=30:&^
MXMM:9%*%PU`OE)-)Z^:*U6ACH9U5KY9?BZ\>?&;PQM,QQ_D3*.8^1\K\E_%F
M+AW+<OCW*N-<:I.#N;$\FZ0>/U<.]NWCR/,#FXHA2LBC6%77S\>MHSH344;R
M*L]F+A6VH"&#-9-"N\]*F(DGQUN515(0-`@R1\Y`WJ(@S\]`KR[_``@>0O`<
MN??<:W<#D3!++DY.(.-\>SI*KBGR$SW.SYCFN&5F.X_Q!/N;4=\;(%PHMG22
MX=DK,@J)(I$(3WCE`CE?;W>8*`NI%(H>A(KO'7?^&HFOV+,!F`D_2:D5W+`%
M`#TY$>$3JN?/)2T7#\7AS,::\Q'E;BG-+:NR+#\KI9='D%45;.R29#-#L``E
MQ3PR2=APD8PK')JK5:J.Z>7,S$O=CLXA)&58NL2I$4::CQ%1X>$:5V[%U.[W
M,B!Z5Q`!!,2(W@[SL!0B3/36?QBS*GP[++1;<1TC7&.'K8\D0ARTC2FSH<L:
M2H!W#BV$.8C%$83U:NU=1KW$;TY]EY^+A9]W[L-Z=RTR*0?*&)!(9=F4[%3&
M\@R!JL>^NR9'>>W!<4H;ENYS`)X[`B5:I5EW0BD[T)U+R]J<DQC(_P#<WCR@
M3$PDK16,^B+;QY@[JNEB&*;,AUXWJV12G>Y6%$KW%`JZ$VO:UR7//Q<S#RAW
MCM=M+!=06M.X=;JN(A08+*?]I@*1N"*4CLO?>WY.)_0.]7AE70_%7-HA496\
MJ7&8"'BJ,``8E9DC5BWX?>2<`XX\AL3R[(+.>^C`?((66E,R=*+B53?X]*J`
MV4BGB=QQJREF''(E6+!Z`C,>1S!H!SNM.U=QL=P_E7+5V_F"P9:?+9+\0542
M2>=%(J(ANDZ8]]P[ESMMZR+8#!EXM20`:L-J0)@1-(DQ']0FC.DJEJ)+9;)[
M9%77G2<)[2"F(:((B2QD8JL>R0CMZ*GHJ+Z=?-]]0E]U`X@.1'A!V_#7<<)V
MN8=JX[<G:TI)\25$G\=]*G46B=?=>U[7W7M>U4[^6OCY,WXEXO>^<M?$@\JT
M\>[*DBQC+(H+FLML>M((GUC7RG2Y42[(V.FB(AU8_5JL1R6_VCG7,3(N>F%9
M^/)>0Y!668;B2`2/C-)H=M5OW%9MFTEZZ";8\I''EN0!3YG>@&Y,3J!;6P'Y
M3;OA5L.E-G_&@)YYMA%::[?;R\)QVS#8?8"!-6U[XV08,YD];<DIQRL;M<B*
MYJO'N76L!9)6W=H>4+'.:/\`50/06P"HK&JM;-L7A;N`3>Q_I(EY-J)X5MIY
MK<$W.2DQ#`>71%X-S2TL;C$*ND/67M&EURWBLRW#'#D,FL<:-49?0CDW]C%&
MR!`*R:C4B@58CMX1IJ@M4P_H8EZ;RQ==;;5\@,$HP5:EI(^IN+2)(KK&->R,
MY@MEE;&%R\KPP>"ZK<MEG(`41(X)*CD%DP3JR3Q1Y-25*N.+[D\\UT(MGD%8
MDZ0^0Z-`8RL?/JW,.\DF%[:38HX8E>46F]!$<QFC0?=&`@MKW&R1Q$*PBLF2
M#.Q'38=-,.RY7#*."P(Y@L*]5`Y".A,S&VA%^0^OAC?CEV^T99YFZ!(Q_CJ@
M/'UKL,!:OW9KF\S0CFGDV$".&$CGHQ[A-]O'5'F*Y<^RWN6C<<"+)(Y'Q/1?
M$Q,P.L3H?W8&O]XQ[%ICZP0FGY!,\C4"K`'<3Q`-)UQY><?E!B]57I@V'MG7
M]377YH-5$CS6LNN9>6'S)+Q.>UA&G=C./6`M99E10/-N<F@P!1>GXW/M>,>[
MYO&Y)BS:85:L`'<$Q!F*1R,2)%M8PNW+&8ML>M)"*XHS1!NM2`2&/#_Z@!*:
MJ#R.?EU0RMK4L077*F82K7)[JST5]?1GN358FF$R,I(Y:'&8CDCQ0N)O?(&X
M:)MW.5!F7[N8]L9Q/W[BXY>H!4$J5@CDJK:7BD>5I(H15C?R[=O!%Q#<-I47
MF8DEBW!1,P#0```P(,T.GU2XG5X5"#''/&T0(Y;/+,FGVKX2W,^,])V3S+JW
M(U4@U54]1.FRT9I%8,0@H\Q0C55A(+F.;UZMAJ*OY>+$'D7$_EJ8-.42::49
M9%QA:1_(#+<3-:`)&VX)@58@5%8`OE+F?O/%29/I:T];`S'G#&L=J[J0!\"R
MR''\5Q'*K8D\=>(NN,T9I\]HZ^MW.>.`U"&7OG*Y?9^7ZO9C=LEN-W)X\B#+
M!58FK>8*)`59@+-22=$=OQH[Y;M.Q`M678J#16)50&&S-Q)DQ"GR@3M4K#IK
M:T24ZK@R#!C!,264;/\`'C""USRO<9R;&M:)OP]57Y?'JM)C7KR,,9';B),"
M@`$U.PI.KI<R,>QQ&0Z*[$``F"W@`.L_#4R,@_(QY=WW!\+QLA\OW&(<"AQ7
M'\.F<88:@:3'[ZGH^.Z?C"2V_D;9%W/3)\5I1,MHZRFP)9G/>H&H]4Z@>[<N
M4.W$#YA9CY?A77CC^I=]9V8L"8%0!L!3Q'$>.@'C-E:YM=V5EF4NTSD]=2,>
M/]TVMAD1T[18-7"&T]K(F&5L>-L$%NJ-8-K6-3:C40WM%NS<RU&0OJH8\IZF
M8'^/^&@.Y%\;#9L<^G<8@2*'XF?&@DZGI^1O#L%P5/&.HP7':/'!VW"[,FNO
MLM?#KELK"VDU[D/9L@AC]R0%C7,8KDU1NNG\[E^IF/@XM_"QL/&MV`,<\@B!
M>4<0"Q`\S$`R6DS7KJA?ISG]R[A;[A=[G=N77MYG!>18A0%V4DFAW;XQXZK2
M57/8G<T=L=JQ7*J(Q6LT5ZZZZN1%5-4TZY<;=OC4>7^/_#X:Z<28(\!^'XZD
M9XD4U?E'D_P+CES&AV=-<<I8E`M*ZP"`]?85YK(22H<T$EA(\B+($Q6/:]JM
M<U51477I[[3LV6]SX2WT#6&O@,I$AAU!WD4V@:2>X<F_9[)DWL9B,I+#%2)D
M&-U^(Z$;&NKM/RW^.'`W#?!&.9]Q?Q/AF`9M)Y(@5*9)B5*"AGCKRUMG*-$8
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M,6Y<^B6*[[<B`.L3(I0^(,1H7*MN+99`IO$$2:3_`,I`\I!^(D&"#2I=_(=G
MGBYSEX=8SRC@7(=!RYR7PUEO!OB91YU;4%Q@7)>644+BLG)^8<E2<.O9C<F)
M1ON6'QM)=F.2KWQD<PB.(US\9JV[CI>LD;PT&=A,1N/W:WQV/IFV\]"JG\LF
MH`WBD=09IJD+!F--828R*NTU7+:XJ,(]D=&J%[CO:BZ(QC4^I7:MT]5Z([6%
M%\JR,0RTW(6OU1UX]1H#N;M;1+H($.#'B*T'S\/^.I&8CR/;U`XE!=VED:B!
M-+(0(Y.UX)!(Q8H)89)$(9D5%(U2-;]!AZM715W)=</NEU2,>^!P`H=R#XST
MV_-M2:#55[A[<[=W1'[AAV[:9K+Q-)!AI(*"`3OQ)$KN)VU-7!LCRO"<\Q;G
M7ANZ9C_(.)RJJTASDAQ74>0ZUG8L(;J@+S0)D*?%4D>PK3H[N1R.:[>U5<A6
M-DY:=Q:ZY3DHE+@-8Y"$=`%#+])7>345`U63E_\`:MVCNQ<677C$GDHFG)@)
MXDQQ)$+^\:_HL_AL_)?PMYT>.V(8+3F9A7/?"N#8SC')G$=Q/0EL*)0U\2AC
M9MB9)+FR;["+4D9B(5N\M:<B1I*[NT0W,/=7:LK&[A=[B0&Q,BZSAE'E!<EN
M)H`#O'B/`@@=7]L]RLW,.WVMX7*L6E4"9#JH@,IZT`E=U^(()N3ZJFK3K[KV
MO:^Z]KVJEOR%R,M7*:NH#,5V,2L`OLAC`L)SXE169!C3FV42:B)W'*<GV]R$
MV"*YH_71->KO[;N8Z83.4'K+>`Y!0SPU(K0BM`>H!Z3JC>Z!DME(BDFUZ;&&
M=D20I/F*UCRP8J%8T.J^:Z#!!8<5V9W?>C172*<S8LJ928Z@*[-KB"!JP&=V
M7.&M+FPG1SR"NA2.RB[$>1BM.+WKCW[BK$FM`S@>G!\Q(4>9)XCS5XS32BU;
MM):QQ<FX4,+!9+8BY*2@DO"7&7D1P)$M$C3\X\!:4I*J*>9'$F/Y9ATT-+7.
MBLC5\9LJRPZU=345>!AJ:)-0`6R2:J,AT5^[35.O9)L.HO";K.ER6DBI`<2S
M4)!FD=#!T3BV;Z<L<D6[2W%XIY0"J.RG@B_0"I$M4DQ,:F?Q=82,5Y[Q\R]L
MT$^4OJ>X\CW.A1,A'-KQ(!I%1ZC(2RCJYS%<!SD>Y6M>FY2,U!E]AN$&)M\@
M*;K#3/6:TWGQU*H^T[M;;C"K<`DB:$E3$;"&F=HZ5U6Y^;_S"Q#BR1E_'=/E
M4@>3LAU[.1[:%VGV6.XS+J(YZ7CS$R#&I29IF9[':,($<>'&*\ZJPTD3T/\`
M9>&%[:,O-4#"`+"03)DU(\:0/&D`P!I7W?GD^Y;SK)L)"L1L3``0@;B:';?C
MN3KCDM[N5$S*?EUM7-M\TLH"4N"8>P;HH,$J7UT9UP$.G=/%%5LDJZQEN1"J
M\:"16]QC49=_S+F;F+<S2R64("VI$\1LBJL1R-3<:!M"M$::9#/DW!P\P(DE
MJ".`@(1`XB3.W+I6!IPP<:DQ)$%DLKY5K6T<(<ZQ]N&'WRPV6%C:'4A1R@4U
M:%\WN2))6J*''8Q='$<`;\IBWW8Y-\O]JN.5<L0G)FXT4[PJS6./FYD25!$R
M52_@FY]#"\A^E3RXK)@U0GD1,5_'3?EW3<^P#)?M=37GQ>^R[CW%*"VL@D%)
MRB,EU'N)DY*.8FE=BH6B']OAG52&:A94MSSR%T69=_EA.UL#[=6"4(#,%,\5
M4[`D`"2($M5MLXEETR4+L/7",_&`8)$`$@QRV)%>-`(U%3SCS&HD\0<(8A`.
M,EI(R7.L[L([7N9)%7FJ\?H:.7)`U$`(=D9)Y![===CG)Z/Z7=U`Q^WXF*CJ
MS,[76XM*F0!5?R$57X@3N=%=G]6_W3)RKJLMN>(DRI\Q-`"5!``F!,,/#4&L
M9RRHQ[`[N`:6]UK<AMQ!A@&XQ=\H'M`*9Z;6A$S;N7<Y-45=$^'4G;>XXF%V
MK*MNY^YO+Q4`5-"))B`!)(,[=)G17<.W9&;W"Q=5?Y-E@9)B*R?GM0#0<8B*
MNBM5%1-K6HFOP3YJK55%5R^J?RZJY-:5&K.">NE:)(GPG.?%ERX;B"1AGQI9
M0=T;'HY!D4+V.>QKVH[1=41R:_+KRWGM>:T65P344.WPU#<1+B\;@4J#,$37
MQKX:42SYL\S36$V;/.K4'W+"9(F/[0]$8)II)2O1K6_!$5&IK\.M;UV]?/.\
M[._BQ+']Y/\`#4`1+5+:JJ[P``/Q@#7XW16.1J*KW*Y-&KJC6[5U<NGH]%7^
MOQZB,$_"=;@N)D$DC_#KK>B2Y4(P)L&3+@3HA&'BSX!RQ)48XW-<TD23'<,P
M"L<FK7L5KD7U1>M58JXN6F(N+L02"/EX:CN*K@JX!5@!6(^4;$?PT[[WDWDW
M+*`>-Y/R+G>2XX&4R:"CR++;Z\J030H0(I@8-E/DQARAB*YC2(B.1BJFOJO1
MUSN>?D6ACW\B[<L"L,Y*_N)_;;0EGMW;L>\<K&L6;>0P@LJ*"1-1(`_8:'A0
MIMV[-5T]=7:*NK5V[5:K=/77^J?\>A+=TF!``/Q_:/W:-#!2#45^'['62ID#
MA/D*14VG`@FJ1JN;N:B_20:)N3T75%_BG3CMV59LNS7/*./@3UVI/['4>4GJ
M!>`$@U^7[;Z^RLD<U],+%49AJ&#V#C5CVJB0(B&8TC%V[.\U=6IZ-5.M+@07
M/+6`*@TV'['4MH'T0+E7%#X_"?D-.O`S2::UAS#@D`CV=-<CA2'M=$'*CD#*
M@DDQ'R-D::`<N,0+O[F*]CF*N]%1)<!KUC)]8`^=&`!F#,R8V(!$'<:7=QMB
M_:*K!808-:BL?NVVU('$*FORJ[Q^LLH1(P9LT,(K*T+'$,+MO0LF`288;(DH
MFK7.AD5$>OH+UT7JYX^5VW*=&RH0<@IXK/(1Q+`\CL>G\:ZI^;]_AV+SX!)S
M%60&('39_%?!Q)%2U-%#"KFSXJNXAK&!)RG"2S_JB2_<PF/%&63$'*1&.4];
M8`8[5K=>]$)IN3T<UQHMKVVXGJ#UNWRQB"&6LQ\`"08/TE9$3&@LNW;[_CJY
M5;7<N'F@AH,3"G9@:Q2&U8QP5D.98MG?'?-WB=E%CA7.&'3Z4N&W6,L9!-D5
MO.>@'XGD<(VE7/;;KK#D1SH^#;C(K=JN78Y]>P<+.[2;G*W<QRIYJQ)0`(:"
MOEO+!A3'..:P94*^TW.Z6\D8MUHOHW)`"941$J[&0^[<6CBH(JK$#^@!^,K\
MG.*^<F)2\&Y"HV\0^6?'4",/E3AZU0L!;-K`B:_.^/&3B./=8;8E>CGM8\Q:
MXCT&5SQN"<W!N\]C;MX&9BMZO:W,*_53_LN#\K;QXBHUV#M/=_N8PLV$[D%F
M-N8KY@.AI+*)C<$K75KG5?T^U]U[7M5X>>./@G$XBLY02/B%R*QQR1(C]KW$
M%+N"L%LAKB_V"0<PBO5OJFU/EKU:/;3VYOVKG5`1OT^7X;B/EJL>Y+=XBRUJ
M8Y$$B`0-SOL")J"""!&JLR&DU&$CF6IOLXZS()+8Q%.`(6"D4M=:(CY)/JD2
M)$BC>]B(P:/^EK?J]%;W;S9.9*A.8$D=3#4"JO2&D#XDS`G2C&L#&QK@8D6)
MJ>1`-*EG<^*[@F`!3?2NM_\`?).?T\*IGS17>,9%=U%]$C$HJ1J-A5G(&/+]
MTA**VF_=9,T@&DBZ^U7=O5%5%6`)]L@NNZ<TNA>))=X#%&'$^4`3/%C43&M[
MCC+N^@%N<+MIB+BPEOSV^:D7`>3JQ''DDP=_J!T:YV83&V>,9C62(<D1:C&\
MA*V(])$190HZ#/*&]R)(9#!*HD1IH[GN[*JI1KNW=.>V6S<Q3CW"5N2R5_A\
M)@U!B3,'0><2+BW;?"613->.V^TA9`/(3`W&VN/3E_DIO+>69SY&<P65K=SG
M\@V./\)\=37NFY%FF<7!2DRCF;((01EWW$=92^Q`Y-E:$)":,4;&M?/DK=5,
M2V@M=LLD!00I+L3`'&:@*)53!$ACYMUYQ[]JZMFZ8R[Q=FN`2UOK))$`F""S
M#R[=2=1OQN@<%MWD<]_W/+<NO+>026QX^Z"B#:29,:-WG#)$K8C0C>^2<K.V
MYNIC;E].@K&#=[OWCD9';+(/)S<*DM#<5MF!)6A`+0%\[4@$VU;"\`K&W9MP
M6:!4U/DDB9)^%)C<2@!NK^>3E*PG.=%K\=P#+:Z8].S-F7UY:R(%<I1.1HEI
M<;H3V)6PXW_-E'5TL_U.&-C&YGW6Q;O:%`3%L6^-Q6$O<8L"9!E>*AIWDM+-
MY@`)LF[?Q\?&P6)4765B!`(\Q;SB?J))@;+$&LZ:?),R90<1\=46*"6;93\\
MG!$8RQPQ&/QBFM%+/L"M,TA(X'.0H(Z$:\[VL;HYI&M6LW<N[<L$`*2]]F7X
M*$'U-!#<2QXB"-C4QJ;&M,.Z,+A9"ED3!I,@\ECHT;4_#?5;GE93WF/99BE1
M>^_(>'@%`R'-M&L&:UA*!/<V(T$O;4*Y`L^.BMU:GME1KG)Z]+.YVA9S0DR%
M0*#''D!22)WF1)B8%*Z.[4Z7E>\"I+722%,P3'RB1'2H@ZB@FBZ.:U&HJO:/
MU5$T1'(KM/[5^6ORZ5L>)W_;PT_(()Z4!T_^/>.,FY$L9$.C'!CU]5&=;9+E
M5_/#2X?AM"-[!&R#+<ADM6+45@RO1K4^L\DJM$`12N:-9<;&O9CLED`!5ER3
MQ5%&Y9C0#^),!03353]W^\^Q^S,!<ONS7'RK[^ECXUA#>RLN^02MG&L+YKMP
M@$G9$4%[C(@+"5G&./<3X_G^-4I<+B9CB-:$.:<E<O\`-./Y'4XQ(XUKI#6Y
M#+X]X[695*ZOMB#?7TTN<:986EF8+!!BO51M+[5E=FO98MX;6,JQ:?\`G7'/
M)5"P646U8<3!A>9+LQ6`DQKB_O[_`/E+)]K7NZ=URLWL7>,U/1[9VKMC6CE-
MDW9%ALK/N6G#\(]7(3'2WC6;27.5V\%Y&*.5V./VV6Y1:8K1IC6,V.1W=AC>
M.K)?,6@Q^?92)%/3ODG*0IWUE<\8'.>YSG*S557X]+;S(UUWMJ4M,QA=^()H
MOB8$"OAKN'MW#[IV_L.!V_O>2<SO5K$M6\B^0%-Z\MM1<N\5`4<WEH``K0#;
M24-$1-K6)ZHK5T_]6GR]/X_+UZA8P?P_;]J:<R30D\MO]/\`@::>M%Q]G.1U
MEE?4.%YA>T52YS+:\I,9OK>HJBK]2#LK2M@2H%>Y&MUT*]BZ?'I+E]\[3B7U
MQ<K*Q[60_P!*/<1';KY5)#&GA,;Z*3!RW'K(EQD'4`D#??2$V*O;<[5NFGJJ
MJW1-7/35-5^.Y?\`7_CT;ZQ;^8M4`_QVDGK28U#Z#P2OU_$;?+_6=HG6F2,K
M6-(BHYC].T]%14<GJUJHK$T5RHNBZ+Z=$(_FZ1(WI/R_;;0Y0IY6$F?W]/V'
M7268/TN5J>JJC55%VJNUJJJIJBINT^2]$H3R/#Z1^Q_=K",:';?261J(KOGJ
MWT:K435JLT1RZIIJBK_'UZ*#^4``;[S_`(_YZG$L(7::_/4J,AS_`!/*^%?%
M;!($E_[PXKC\\4651"Q#Q.W7YAG#LYQ$X;#1`SHLH=I+:J-55C%&Y'-1'HJN
M3>Q[F/B6K+?]TC7.8\)/DBD&1/7<?#2(V[UG*R[Y`-ES;*F16%XD&NX(V@32
MLZ0<9MY=5/@F,`B-CO$:0'])5+%:4:O<%45K#-1B>BIJYB_#Z4VJQLW!R')5
M+6VWV(,UJ#/+:.HW'74-]+>4C!2HN;*34B1^;_"#0]?'4SL&N(F55LEI'5ZU
MLTFV>.5)?-<R.$[!BE7A!!$L60)9"*VV`)Y&[MD@2L3JSB\F6ROY@Q4<WKQ/
MY:L=ZB6`A@*DSKG^9;O=O<QR)'0`">HX+6:`^3]QJ-/WCJ;G7CMEK<XQB(/)
M,1AV(&7M!*'[RLDUY9#2,A&0:ECGB2W-7LR0ZB(1K"B<PK&HR=O72\]['#"T
M!#$?]-A)XGRT;Q0@\Q4`B2NB,++Q>^JF)=)5PV_E#-Q-8Y1503(-0"PC76W<
MUO&/F=P-QOYC^!?(Q,3YS\>PT!JK+95[&A<C<4G&425?#?+.A(K,OQJ^LC&A
M5M[-CI&L6.(&>QCW*X])PQE8G<GQ^Z<?^Z]103;Y6[_+ZBV_!@L3Q)9"5(G5
MNS[5I,-+^$&]#'`XDD\[`4`0K59E)J&W4ZNI_&?^3FC\QJZVX;Y@IP<3>8G%
MP"0^1N,+!PX`\MC5BMBRL^P",<JFETDDJ(Z5%;O?`(_T<\*M)U4^^=C;MY&5
MC$OV]^O5"9\C>.TJPD,.LR-6+L??#FJN'G0O<0LTHMP5,K0>:!++^*TGC;9U
M7=674,/.Z(5.##7L7NI+Q?)Z"Y"\#4<9&A.]"#:JHNC3*K6N]%U1=/GTZ["[
M+FE`2.2$37X=!O2::4=Z2VV*INB;8N":32HU2,Z4(Q.0*V<$;CQ)IK:'$'(3
M(K,U+"RTP:^3&K'/8R&^+6Y1M17/&4:C&U=R?&QW[)MLC6Y*LT%JHH)4B"VY
MV%%IJLV;GW+7;+<0_$GAY;CMQ93(0^4+YH'(AOAMK+77,HD_CB229%J6SZK'
M:>T%)*ZXR0@P.O\`$+(4>NCD;04J3PGC/=+"!I!C>C'_`$M3;H&0)>3B226(
M_(GFXM4GSN`5A5,RU10F<>BZK9NW"R75X@EIN7#P9E\J@^E:9@\<P`0"`\1`
M(]Q;6U!QMB.0A!/C2ZVWM:Z8`ZQK,04J;FNC]Y\-J/EN9)KVF<KHZ.<$6_<U
M4]4G[=EVVNOCN`5W$2O23$_':1!.I<C#,"ZJL+G(@\BKA8'U$@B#`_*216=<
M>$.GK:;%3\D9E,!+R[*IUJF(T\B8^/"Q3#O>S9A9U;)&P;8\FPL@(>QE%:(?
M8'M5WMPKI=L/$.2IS&K=Y$.QX@J`Q7RDPJW'F>4T84*JAT$A%]KN/;-SA:@-
M<XS]40K<HY3S8P)'+<<::&,@=9DA..VTY#2<4FCR>[M1FBO'6Y$+&;T4>B2%
MWBBLYN)'G0C2@#(T:V9.W(.Q6-&%NG<<^T+%C%Q&=<(NI(`,MP<1R*@ON"Q@
M'G'0!0"\/)MV_6Y*%6SQXC?B15>43#"@@5!KO`T/IV5%M.*>58./LB.MIF48
M=C^I6%E$BEOLHEV[TEQX[E0\H$)K3H%Z)ZJWN^JIHC+.]B]DJR\W<!C"C<\N
M2KX@J!YJ"D>&M+@-[+Q[1@(EMF++N9F0)%!+4WWTJ2,?JZNCX=H&V+'5;<9S
M7++>X)*?.ER39-95<.;8N.37VSSK,D,>4.QS%T4:-:C>E%]<RX;2+!@SN:,S
MJ&!``XD1(7J29@1J1;^-::_>:0@8!1QCE"L0(8223O0$["#34&O/_(8MUSX"
MJ@%[55A_%O&&+P5<QPABCFQL6422[5&IQM25DQ-=45_T*J_'3J/W#RMYW!_4
M9DLV_JW)X\B0#$<ID`[?+4WMU1]HUTB"]Y_RE8XGB-]P`M&%""`-JV-^*?X@
ML,E^<O@YP-Y'Y9<\S\)^;_'DKDCC/D/QCN#8M#;6TQK1N3LRV1R+B+\AJZK'
MTHWC,Z/`CR)#IT5PB"57M;\E>XOUM[EW'V?W3O'M2RG;NY]H[@,7)MYR^HPE
M^"FUZ+E"S$@J'8@`$$$QKI9[)A8&=;Q.Y7!<6_8#VBK<`6*\N#!O,3`,!8/R
MKJW;C7PG\2JG\UO-OC'@GCY@E1XP?C=X,F\[1\7*7*\OG\W<SEQ/BK]G6/D!
M:YAD&00\Y;C>:9H635USHL:`%(CAJ$J$,C^6^YO?WN_`_2#^M97=,R_W?ON<
MUGB61$M6;;7!_)1$3@3Y1<:I@D*1.O8'9^U7>]'N!Q,9<K$M&W;N^FIN(+A'
M*'8%_-!,`@2`2#`URV>=/D/R'SYY+\YY)EF<7V4U<ODO):VD993IAXL/%<:O
MK>'BF-U,`AWQ:G%\>$0SJZNC-%"B/DD(,37D<O7U/^E/M_!]M^Q.WX&'92P]
MS'MW+T`<KEUU!9[C"#<<T\S23XZJ'=;%K,[X>[Y7\W,0%+3/7TT)\P3?AS@<
MR-P`-M$SPU\1.,N?N%?)7F'DW-<UP^LX'JH-H$F'U=1:++":IL;6>LJMM6#+
M92XXH2-"$<B,U7/3>]$]>N[^V_;6%WOM'<>Y9=ZY97!MJWD`:00Q,@U)\M!*
MUW.OB_\`N3_N-][_`*0_J;[+_3SV5VOMG<L[W3DO:_[N[>M!&%RW:M\;EKD$
M4ER69K=P@`\5)T\_(3PZX8H?#?BWS!\=\HY)F8OEV5/PK(L>Y33'/O4><0MW
M6CM:]V.1@Q(A06M*X;A;Y(E&5CFO16N18_<?MOM./[4Q?=/8[M_[>]<]-DO\
M2>?FJ.(`CRF5K\]])OT4_N0_5#NO]R/>_P"W+]8>W]EM][PL'[S&R>V&_P"D
MUL"TYMO]PQ=I2X"K\;;!D8%8(([4,!YTYJY7\!/#K+_P195P%84?CYC&/`\F
M?#.YK,+KN1\O9#Q[&XUSA=P+(8[I%)?$L8EHLJ8Z37FO"S&2XL^0]K6$_)K/
M]OXN#[P[I9_5U<VW?R+A%C*4L56X78B^`/\`K6B(HO((OE*KLGZ:');(LH_;
M6MRGY2:<0*)(^EAT)B3_`!Y>\LY'L_*+\U?#F3<,>*F&>"_,MWSM@6.77$?)
MT&PS?!ZWFZ%=S(\W*^1./@8WA)@Q+EA8ZVE7#`,<@C'26%<\ZO=],=OQ_P#]
M>_1K.Q>Z]T;N_9FQG=+N/Y'%F%\EIW-SZ3)4OM/`J`(U6FR+F7WRV+%MK&67
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MK\1><-Z8`H33Z@#]4;#II+[I_4;&[3VWO0]JV5]P^]^S6%NW>SX=^S]\Y8!D
MM\&;^4]Q"6M&X%5Z`&HT)<JJ!4=]=T8K.MO(]/<6E:&\IC*>GN0P)9XP[FJD
M/1JDJ[$8D,!R^KA/1>H`#9N-:#*R*Q`85!$_4)Z'<2-M7[LG<G[GVC&[ED6+
MV+<R<>W<:S='&[9+J&-JZ!M<MD\'`V8&-;V%''&RB@?)-V1-FN:\[0I((%"1
MR,W.$JL[R:N]6?%6ZZ*B]%8=RVN6ANDK;Y5B/C6M(G]J:)SU%W%=8'&)B8GX
MST/@=&V.4:-2.L1DEA936A'O18RE<7>Q\1ZJ[VQ7:?4(NX:ZKZ?'JQ6+BHH)
M4NS&M`'`)B3T8#K)^6JO?]4!F0E"!!/YH@T/^X?$>;1&!2Y7A$GW]0.1'G#*
M=+*G(TH3`%VNZP,H;40/^9"(YS%8KVO$FJJYJZ*TR\;-[9<>[9!X*9X$;$CP
M%00(KUGJ"=+[69A=[QO3N%6M$0K+7:A8$UCE&]0?EJ9?#7)M5E8*^A`:36D@
MA+%E8J)X22HT69*59+<=!8R&1YSI)7N*^L.K0&^(2A-HWHOM7<K^5?6S?):P
M5CB"%*F-^BLY-2H!!B#!`.J[E=ES<7*%]75K)<09^HD0.9V!G_W!!!W!&N@G
MD/P/\@?'OC_#O.CPARJ@E1<QP;"L@Y$XAPR3)E<?\Q5AL>B3;@@\?[$8<6PK
MH\H[;>LG1TE5YWOWM5I$D'KR=T[7<SWP$LW!P=_+=^M1(D(:UK(FHZS&KP^-
MW#^GJV>R`7%263E!.YY`CRW%BI^EB)(!W4,(S3CGS_QW'.7>"\LD>-WFMX]H
M&TASHTR7#RG`,CK#&,Z/=L,S[EF'%IC@<!QS$(:J&;9)&>&KW@8_;!PP9E:R
MY@<@"=IX.OQ##C0!H)!#Z176OXEPR#Z8>0ZGS!J#F)^EH@M$].%"==(/XS_R
M:G\H3V_C;Y,X_7<.><?%E:UV:X'W$C8[RI10V""3D_B@IB/'85$M[D?-@!(9
M\)7H1CGQW(H^>>X.RCMN0;F*&^S8R`:E?@3U6H@[]&\V_2NS=X3N"&VY'JJ8
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MRFV,RKFP#PB,@.$1ID(G;<C'KU`V/;&9PO-R<A2.4O<)#%2(!5+9(/*&\L!8
M-1.RY=W+Q!=M2P]1I$K;M0UL-#-YF?BZU*PX),J0#+ZRN=8R,-SR/%LV'=7<
M@XYE801J0S5CQ,\J',LG+)B3@V3`U]A:C]Y)B[9(&ZLV/;JUTUAD6\A*$@JR
MU=3'!B!Y2"`:45N2L28^#+%1%O7`G`3>5U`0K5P*@BEQ]Y8`1U$`D\A.:V\R
MQ?>PFV$&5A0<6A53#0F^^?:FRB/&)5P8Y3QXQ15=3#(%7*,:NLBD0CD0`1"Z
MOG=<JU8P;V'B!?MDQ5;EY6#M<BC25"@5<G=F(8`)`T&C6Q?5+1"DWJKL6'(`
M\@`0`Z\N-`:'X`)&1Y4V-R2VAJ(#&UV#\9UTV3-.<D:)!C2*JVLH40".VK+G
MS9=S'>7Z4&!@U<OUN8J4W&OY`6R'/*[:LEGJ&!D$J6DCR@=`#6HFH,-VTC+D
MW5\MN[D%0%I00(X]=B23_"=(U36TU'QOA.(TM;:#2QY"LC3MD1[I&07]3A#B
M&DL&$:37$E691B7OJY4,BN=M8J(U:N1D7.WLR769FO<I42%`*B6H>4!CX0(,
M;0PN"PG<>;J%M6,:(Y0#+$C:*[?B*^&G7?V..%)4Y5[P>%TT>+!P.DN'E'-,
M^T]1Q<<X_KNV6/D.4+/E,:2W01H$!&:A:5['/$;;<I94YU"S'B:@NTB8%2@:
M`09`!,F22"ENL]Z[<1?-RN%XZ@;<F/P&]:B0/'56/F8*.#R1Y9IZX_OXV/VE
M5B()3"&D.DEQ?%,?Q^2_>9YCR#).KWHKG.>Y[T5=55>@>[W3>[C=N$N3($L9
M)XJ%K0>$4$=0(TX[*UO[!'4D)YF'([`LQ_!1T&P6.@UW'_B;Y%\4O(GGO\:E
M)2^01<*\IO$S@KEO`N0O$Y.-,AM['((D3&)9UFY!R<.%!Q3"TP^VOBS#UH3V
M*3I08C2=J2!6#_.'W+[?_4#V&GN3V]WCM_\`^`[OWFW?.4SJ`#;9KEM%4%G8
MGJI"\2LF:`7E7]I>_.X]K]_=NNOEG$[>Z8NXM)ZD6[E]4(`9V7R6[U9M.?3(
M#,6JI_*_^5_!>!?)#\C'!?AYP#-X\YDYQYBML-\F/++.L[L+W/<F=QP$.(Q\
M?X=QBA2HK,$PBHE5QG1%F'G$)(UDE`IFA>+I7Z>_I)?]X]J[5WKW9EF[[?L`
MW<;#5."^:X[,;QH+GJ-!92K$@*.8$@ZW^\K:>[B]MXA_5/-ID\HBAV4KTC8^
M!)UR>J1Q2.(I%<\BJ]7/<U7/>Y=5<]VJN7<JZKJFJJO]>OKRTB6K815`18`I
M```@`=*=-5MZM+06C?\`UU?9^-NLII7X]/R`ARC)(^#XU>^THK+.)%1,NH.-
M`/B3(TBQE5=4CK6=&BK8#[@P-4B#>KFHNFG77_9%FQ<]C]\&1<]"U<95-R"T
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MNF7BW/0XF6`-64;JW)O#K45D:2/+_P`O/$ORI_[C+P(S_P`;,EQK),8PG.^$
M\'Y.Y:I_;5F+9YFU-EV0R&S(=[(9';?P,;H9T&L;9+H$RQ^V%Y`B&]6GMGVW
M[D[)^B'??ZY;NV+>1;:Y:LN"KV[?!0[%#]`<@M!`,#D0"="W[UB]WO&NVB"4
M/$MN#(,`'K$Q/X:C/Y@<F5F(_P#<4>2./W,R,3".6\B3A[(T:43XLF)R)P[B
M$6M0I-S@O"Z]'$;\TU>OSZ^J_P"T3*MX?M7M>.U<3,MWK)(-"MQF6?CYH(U\
M._\`R$>T,KW+^AW=N[]I5C[D]O9&)W?%(F5;!='N%8K2R;L[;>&@WS35T'$'
MF1^+SPRI946\H.$)598Y-%*,,FMM+GD"SLPD^YPY+2@D$EU->][FD8NHY.W1
M471?J;N0M=L]T=A]HVX-G%*%IV9[K&9!G=0`00!YOC&OSY_3?/[K[_\`[<?U
MN_N2SUN8O>O<MNY;QG5F2[:LX%JW'INL,O"Z\`J?J29G0/X@\<O'9W*O*?(W
M(]-DGWV!^22#P-Q]5T+*B1A-97VUC;6Y*3)\8E1X]9:X[=!1\`BA1KX;7B<-
MBL:]KEO9/;_9CGY&;W-+@OKWQ;"*L&TH+$E62@*L/+$RLR)`(UU7]1/UF_6,
M>Q^Q>T/9F3A'M=[]'+G>\^[D&ZN;<N6K=JT+V-E*QN6[]HD7E#2+I#J[!F5A
M3UR!QME>'W#+B=B]M2XCE&9YQ6X/:R(^RON08GE4^AF@KI&JL>2LD`03VJC=
M=-416^O7,<C"O8V24*%$:X_IGH55RDK.X!I\=?H[[+][=@]S88[=B9]C(]Q8
M?;\*YFVE:;EELK&MWD+KN!=#<E-9ZF=/W$E=#!CDZ1&K"E@7)XUS!E@9)E74
M:'V[$1&1)3CI/*D>0X2C1HW.8QJ(BIJO3S#/IV4?ZCR(@[F""(FLUGP^4C5@
MS;'W"74$2Z^5B8XDT@'H/$S%8IMJ=U3QO>91]GS"LF2YEG>XY&N9T2&Y\L99
M-C#CQQ!CQ98YT:*HSR6@6$5R1F,74#F_2%''NGO^)VG$'=.YW"61T20/4+<C
MY%`%0T)YD-%Z4(U2NV6/O+[=MPK*->5FH!P4`$R000!&Y,@DTWKIHW_%EC:W
M*3J=L>CRP0A%KY]65D>KLY_;$8P!E.@TA2]KU8M<5&D1K=K=R)HBBQD87N##
ML=U[1=-W'O;-6*B@(HRN&HP,030134N)FM@7CVK,5VBX%96^I)/U'>4Z\Q((
M@P-=)?XVOR6XM5816>-WE%:9%X_\VVV)1<6P3E7+CVA^%N9\8C-:*#$R!60'
M6F+Y?6"C,C5V013&DP3O1%><*N@=*L^[E'N'_>"W=]-@W(0+D@>7SK*M3<&"
M:")U9K';\.WA/?P+CVGNHX`8E[3*6EPJFH800.BDRM-9>>/"N^R++`^2/B1D
M9N-/*/"K^/9S+`4J/54N9G["3*VARV-$<"LCSL@$((:ZQ`UU)D33M4213[HJ
M6;UQ><75@W^-)CB2)I(B5WD`@BI$&NJSCY*!/MLU3]L&@$@^7XS`$;0`:2-Y
M.A?6>75SS[F_CI4TN*3^#/R!^-_+PKIM)9Q6UM31LH6EL\EKZM0Q'74_C+.X
MQ9;)M,#<R"8A904>$BQG*<S(6[F+?S793Z;6[UMB2S^H85N4<;@V`8#D*!N)
M$Z?V+7<,'"O6,=FN$O;N6W#*(`^H`D`B35@##`4J*RO_`",?F=YJYYQSC6G\
M-\CMPXOD7C+*M/*2+AF2EJ,:P7++&PLJBSQLV3W6+5EO&FX^9KG++J+%&6<0
M@QN(UHR[L=B[-:PK+Y.7CK=R+=SFG+H@$\C$@B-E,&:B-]!]\]RMF9%JQ@Y3
M6[A0(4#<5=RX/$R`:J(Y*?I8U,1J@=?'/*K`-9GGD!RM74N(VT9V1YU&QFPC
M$R.JJ'W`H,)MP8<^XS;(Y5]HT8G;9.U#B73;JJ/;6(S7K63<!;!NGF_%BJV@
M$_EJ*\EE2H@4J0.I-?RN]!;V3;Q@!WBTW%4!+B^\GEQ<$'BJL3,R1,TU<5X;
MR,0X_P`"=PI@LI_["R;(Q9S@5OF5Q*Q^DIZR)56LFSL;UD[')-N:YM($J2R"
MKVB,^2%0HK44:*G]SX5W!R;&5B%GPKZ%(_-R:)01!9:*Y!Z4WKHGV9WK$R3>
MPNZ$6[[W^9GZ$:U-#)**2(`(,`P29WLSQQH9627^.6E=(6)*CRJN;:3+458.
M[M,1AP%QZQ@0XS5>Z)(>-KGR>Z11O&FY%1?1;92S;MLBLK7BQ<`;#E,J36"!
ML#,U-3KH(OWK^1]K81Q*\?48JI<H`RFV!$RK$EJ12=<>')Q4S?(<\HJI9E?6
MLY3A8FE]%$PZ.C4PR09T"G*\,8B65>.F&.1-"UWMWFVLU<U5Z9=]RQ<2[P(N
M,C*I,*`$/E$S6.-5"T$$3Q,&#MP:[=L^LSP5NWMB/,*@""2%-!#'Y$[Z\656
M)+/DY8\R#!C27#Q.F#/F-;%95XM3BI'S#SE:24D>*M:YK7,<_<3Z6M<5S.DE
MTWFR;I5(-E54D'U.,KQ3@8!D*3M`\T#RZW!%G&QFN$P;C7.($4FL@$ST'X[2
M*:>=9E68-$HJNYAVEK,EBFOQ3`A(ZMN<C%;6:.L+C+I*#0N(87'F'&-L5%=9
M6+-C3_2KHZ9NV[-I%M72_J*0@7HQ)`+%01#+-&:8,!0!,PV$O9V2UVR$1S5C
M4J@!D#_F)J2`/G.AU=1AY=Y-8O7R364D%!EN$T=1`?(2-6TT:!$'(G)4UH6I
M#K(IY&CC(,8W*C6HY531.I;/:WR.Z#$MMS(/%8!Z"8\T\0)$33D=2W7:QVM[
MEM?/<5BS$_4IY"GP^9&_PU#3)KR-)\@N=^7;(,"PAX1GF?YK!@S6M^W6.53<
MWFUN"02QE=^M'%?S!3C"558^-`*UVK57J&V>6;?S7`86F9XJ?-RXH#O/F()-
M9@^.J_[CMWLOLV'[5Q;ERW>[L5QRRR'MXXM^IE,/]K&PK6E.X>ZI4R-6C_A<
MYHX]\%?(VT\K_*'G*GX1!D/#V55=%'FT629OS7?47(EI3S++-\*PJEK)Y6W^
M3QJLP*:5;*&(K91;(B/"$#)?%?UE]N]P[E[>Q,?$PLC.[Q>R@]FTA1;:#BRF
M_E/<90EN+A-I`>=YANML%COVKW1<]P=XR/:'L:XF-[<[>!CYV?;JEDVX']/[
M?QE+F6@4+D7(-O!4J/-DD(E:'GGFG`7(OE5S)R5XUYGRSG7&/(^9Y'R!'N^:
M,;BXOFP+G+[^UN["C-%9E693[>KI0RP1P64Z6R?/<UY#`$JHWIU^GV)[@P?;
M=C"]RV,:QW&RHM\;+\U*J``QA556)DE5'$=#KH*XF#@_]MVSD,1``H-3\:DE
MB9J6:2Q))))U$-C_`*D:QS=55FKE<U7-:JN]%5$3U;_%?BO]>KVIGH=8:8D[
MZEAQYY;<M<:<`\J>-6*DQ@7'',%@ECFKIM&LK)2$2-6Q.S6VSIHQUX'@K!(J
M(![O[O7ZO1YA^X.X8/9<GL5CTAA99ER5ES0"C33Z1TIK@'O+^WOV![Y_5WL?
MZT=]^^;WA[<M\,,)>"8X$NW*Y:X$W&FXQ^L#;PU',)'L]7)JBKN<]$1-%=IH
MJZ>CG?QTZK3I`(`CQBG[HUW0%4((Z=>E/C_EI1<1%3<K&.57+ZD&UR-15VKM
M>K-4:J?%/@GQZ'*>:OE$[?']O'4C97!8$_O.WC7XZ](1P41W<>A4749$<C7:
MM<JZM<S3ZM%3355]?AUDXBE2+BAK;&)(!4_B:&>DZ#^[N`#@P((B/QW^<?AK
M9A75Q`LXM_&M)H+ROF0Y]=;`E&2R@SZX@SU\R-,:3W`),(H6.$]';AJQ-NFB
M=%]M_P#QK`X0%O@?+Q`$5!!$`16LCK72CNN)C=XQKO;^X6TOX-^VUNXC@,ER
MVRE71U:C*RDJP-"#!T4:CR.Y6C<[XEY%Y3DDWD7DW#,AQO(8]QFTD]BZW-BB
M`'50+4\=T22:&.)':+4;F/5J:[MVJJYM=][BG>4[[>N&]GVG4R_FY<(@$TVH
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M6Y,HP8KA,88M*NY+7!!937.(GN`SA$:QJ)KU7?<%C%M9%C)Q;ER[8R#>:?\`
MVU"W7"VT.X@'D1XN#`%==!_17W!WR[^I][VQWW%[9V[+[?V'"QWM):X=RR'3
MMO;KS968T_S+*W&N8]D!3P>RZECMJ*'WN"R-7OES%"L+*U]I(.)QRB3V<9XP
MO:,1H\MJG;JN]?J8GHKEUZT2X@L\6+\P?S#EQIM$UF!-28^6OK9+7E+(#Q(J
M!M^'4';_`#U;WX_7\S$[[C+$\FBVU1D<?$"QI=)8B;%CY)$JFQ[FDN:`J*^!
M<0)7LRB&]CG=@J(TJ,U72B_J;G9"=HQ<V^3<P,;N*7GM&48AK+HI4\89/4X@
M$5((F>BOV_V^VN=D&VW$7K9XN#*@!@8WE6KYEIRCR['12R_CJ@F9@X]5(8V-
M=JT:,M0-0$F6DB9"<EG7.&0$Z0JU[7L[CMX>^KQ&&B:=0_I5WS#R>YYW9+%T
MV^U!;5]+CRK6B49+ZQ!4IR2?-U,@`DS'[HQFOW;65=2<GF0`H$D`A4@K/'G(
M.Y\#KH#\6^`>,?.CP-HO'OF7&L8Y6C<1U%I1LI\6CTQ/*C@](,NSEXQ<\?21
M1X5OR#B4V1.[GMI&ZR;7!<,:3&-;'2^^X.V8V%W'@&>SW!PI6XXFS<)CS$BG
M$CPCPVT7V+)[DF,^/>2UD=JMNT6U`%Y;<4A:0Q;8B1`H0::K-Q3FWR'_`!D9
M(SBWR/$;G+Q5NI):O!>::A85W>8373"BA/%,D$CS)\NN&^.P%A4V?Z)WQG"(
M+5NT,N+=]#^7(%L^8Q!W!@BAF3,#<;TIH+.L#/M&]:$Y*`PI8@D`U#B:&0!R
M(`!GIK4_*-/JLHLO%GR>\=\TA#N[45C&Q+F?#9T4$QDG'OLD^K#.RZ'8ENA2
M((K9R'AV@3RJUC6C]W+B(PS'&8HR?3='2XJK(4CZH()#4@PT56)I(Z:5]OR[
MF%CW+.7:9<3F0>7.%Y*:**P#!D'>:#>`UQU@DOCZRI.-*WDJWJ>36YKDE]Y`
M\9!N(AK^X?%A1#Q\=+'L*VQ@W9"G@3.Q6#F-"\$\9";VHUR.;27+EP'&N@70
MWJ75FIM@15?RJTA5&QD&G2B9V58NI>?N>.\O;]/%=5(16]2"P@CB!38$2!`$
MD:9/C9BN/<A9CY#??,3QC!\1R6JNYT[)N2L[J,9)B];-O1V=;34[R53V9!DI
MI-A"5L6'8E(@(KF(%6HCE%P,_MJ6\F[F>7%<&KP``2"%:H8B28*D@1X0=6/N
M/:^\^KA+VNP#G8X0LJ0>1`"L[%B`.8)(6.4$DDR!HL<8YXK.#JFERW,\NSKD
MSM76,SJ:GQ'!08I4\>UHX/M!Q9^2,H&Y#>0RP6N:(,64R,UN_P!XQQ']"7^_
M]JR^T'MR6KV1>1?4!`AD*;%6G8"LB2P-&^F#D]E96)DMF-=&/AEX8,K/ZCDQ
M$54*6)`-:TI`F4/AQR/RP'E+"^-[+*L9F8ICEIEX\BF9/63PY4VSE9=%QD>.
M8M<*/[7&'"2^B0X\-JL1D,3'-<]S^VE*;NAO8A`<`W01`@!C!-0(B&&_B2#X
MZLG;.TW\')?%OVP+V/<#*6JRVRJB4ZJ"M`3)(),@0-4R%?-+)Q:V$CR-3(\M
MOT!$<LN9*L[:4Z<D*-!?VCGD2PR7J[N*P0F*AS/$%-RLLUK3VN-ZXH5G9RM1
M^6%$\1PD[,2.4T$B=,[5V\EQ[2AE)L);$$$+_NDGK2HF104-"+^2.11U,*0_
MC:716V6AR@]:8C8ZVM!C&09(])=A;UUD;MQLKS"EKDD.+,=NKX9%4,4:;7;L
M*SV[+9.+<%V]S500H4;3QC<\%59)W\W0QKV+9=@MF_R%HIY3)DA3'E`Z$G\>
MND$E?:'SSCK'K[(665M48EAT>XNI\69+?.O9<N;D5ALDJ$TD\NUE07":YS4`
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MQ-4]W>T/=ON?-PNW=J[G:[7[1%AUS'LVV/<W!*19P\DMZ>+;NHI3(O<'R`L"
MPUMOYBB#)LHR+,KZXRK*;FQR#);R:6?<7-H=9$ZPEEVHIC$T8QC6,:T8QL:P
M0AM:QC6L:C47WWO9-YLB\Y>^[22U22?VIT'01J_=C['V?VWVG'[%V''M8G9L
M6V$M6K:PB*.@'4DDLS$EF8EF)8DE&9HNW37=WG*B_!?Y[M$T5&?^_K0``S\-
M-"W0P?\`+]OPUMA8JHBN;Z;VKJOH[555VN[1$TW?+Y=9BLF1H9WMDQ(Y1O\`
MP&E88U38YJ_%7>FOU*GKI_\`V8B>NB>NO4;,!(.^AS>`,@08_;]OCI2CB)_\
MSU15=HU43Z41%5'.73T35%1/3XKUY<6_D0Z*2I)C;]_P^'_AH.[D;JI,09_T
MTH$:ST$T3G[6Z-71[6)ZN3U5J(Y$1RIKHOK_`$33II9[0A`YCRUW^/6M9C_7
M0_W'('D?+3?X?#64$<S]NT7U.35%[3D:B,<3^Y?7>K=/EIZ]&)VY%B3"C^/Q
M^'PT->R+2F.7FZ>/[?/6(H]45%1575$TTV*Y4UVHB+HGJG\OGUC([?QMP@)@
M4^&M%O<23T)_:=(Y&*QJZM3555$1S?1$TU5OHFJZ(OKTD>P;)BXL$;=1\9@;
M^-=%*X82":]?#6HJ[]R:JC5;M55T1$]/5%31-?AJOR7K#@M`/4?O^7[#1/+C
M\6W_`&C2N[*,@!CDO%67=FW&9L\%H>@?-,ZI=8Q%'VK(<![W18\Y&L1KC,:T
MCV(C7*J:(FRL[%9,H&)@DGH.FU1`/P&@?Z%V:YWI._MBV?ZY;M-:7("`71:;
M>V7`Y-;DR%8D`U`!)UMSY9$II+AJ11Q\OJ9FU1H5PS$KIS-S)*]S<K?:Z[?J
MUTUU]%Z+)#VV*1',1O(H0)_=^.FH`%V'B>)Z[BG04_';74]-\?W<M^/?&>31
MK!*S(ZZFQV\Q?*10F/F4EK'''/6SX*/1-2IVD60)7(TK7/:J:*K773N7;>V^
M[>R)VO.!]*]AVI<@<O-;7D2!,>;S*R_28F1,4[&RK/;6/IJUN\I`K5>1`+*Q
M(^94BHD3(,B/O(-#RU26-3DS:ZESJNCQ:V1DU3C]=-B9![F!((R5=4=!9V"P
MLCKI3%1DJ"&4"4-43MN>Y=.JWV']+<KVEBW;O;_^X%Y61W4AF`*D$J%(@D'D
M(,_5`B=-;EW/SKUK(L6O-9:@YJ9(,KY@?*>JAAYH/AIV\:<_VU/=P>4L%R6=
MC-IB:P^U<8C;SJW(HF7$;+L;<L^5+CAR*MFK'$Z,^!/#W>Z,3M%8J:%6NZ,+
MMS$S;8O=O4,Q5P?I)EF0F2KVX/E&ZDTD",X]BQEW>-B;/<28!$HZ`2U)(0>8
M!G,$$&`"3.K.L&YMPKE"5D@N:28W8.Y62#&SJXLZUMIBN;2PFM@`/R5CT!),
MFNOQ2IA5';0!K-&9-CTFC11-TLX]B]=];LSW;^!;#'CM<MA8!(5CYU@@!A(@
M[S30&58[A8NM(`R'0/ZFZ,@D'D5HK!R94$S0\=XJ,\W?&2?XJ7>17_`UT>PX
M-D6K[W_:+(+:ON9F#FF#@L=D>(6L:3[>[J&'<UO>@KN:QB.*P1![!O,GMG_9
MV.\8C&Y;N&6*TJI(-#*\:#E2NQILOL]TQ^Y7KG:,D<<GB`9V,@P*;0:B@F1$
M'9[`\MY679W?<M<;WL_#7Y'CN-58!5D*IQW*C`R>@9$R.[]S55!&(R)?XDL2
MS+6K3F<K6N"P37/W5K/R<\]V-C%8V[=X*&N)/EMJ`)<GDP93!(`,S`($`VSV
M_P!I[7:[7;MYAM>K9#.%N5F\6_)'TAI$'98$RQG4:Q9=!H`JYMO<6-E+Q+"9
MD>4E).--K<@^^V$[,*RQGS63)XH912'1D-(E*WL/5K58O5?09"8MS*NV;JY*
M7G"DRP(5N,J:`"Y;CR&2LUZJ+(B!\A+GD%GB\JHDAX/$[DR&J:P9%!`TEX;G
MDP66T$?#&U==-C3L]P^GLLOB`*V9^X8CBS(TN+4!0=G95L&4UJ2Y<PBGF*UK
MU=HB=;V<CGW"P,=55W!55+&H),EB>(4`T"[>6!4'6Z>JG;<G$=B^.UQ'8@E3
M;8#H5E@NQ.T*`"2:F>/#/+^/3<RS>[S+,H7'?.[[BOOZR3QZK*+#\V9'+56,
MQU77R6JJ2Y44Y`6<$A^VPBL(UKV:*&OW!F=MS@UA/5PD8RI/0MN"/PB>@(%8
MT-EI_4+2W794S!:'IN`2#`@JPGX3X$U@UU6M:YQ*LLMENQ.2V%AL?$;V[L9D
MFH'#N;:/%HK9E?1"K4<3[%C`),9AQPAJLF0]$=)*YR:.NPQ'S<@L.=NU<QN9
M,J66%80I$@S0$D&%`,S)TBMV+:6N-_RWU8*%%98M5FBLP8C::B=M!X=>*#18
M9CQPQ(BDEV9S@CM:)'3A1/L$:#*7Y;#S51B#]&-5K?5=>M067$L6K,IZEPL(
M$DBBS)J9D@B?X:8O#9-Q[A'E0`>"G>FY)`K&TZ4Y=G";SW81)9U:D.T?%C5A
M3-2QD!H,/"1$58VHZ^#'-)^ISB-=Z[&)N5>G2.B]Y9KD<`20:S*(%!/B-X/C
M^&E-]2G9S;A2#,DR!YF@?(ST^/2NA]P1:V3\FSK*9;HD6MH.)^8<I#3UK7/*
M&RDTUZ^)*FZ,*QTD)!L5&N^AC/J3:NJJO[6W!\G)@>7'<@FI'(17XGIXGX:D
M[M:%S&MVN/+E=0--!"$&@W.TB/"=]0=Q'C#DGD,5T;`./\RS6-B=%)O,GEXK
MC5Q?`Q^DKHWN9MM=2JV)(#5P(H!N<XAW,1&HJIKT%A]LS\U&;"LWKPMH6?@C
M.%43);B#``&YT/[@][^SO:-W%L>Z>Z]O[=?SKZ6<=<G(M66OWKC<4M65N,IN
M.Q@!4!,D:L`\//Q6\U>8G$F8<[8]G/&_'O%^(2\HKIESF$RXF7D^?B5!'O[H
M=5CM+7F[D4$.6-O?/)`U7[D:B[%ZO'M?]->^>ZNSW.^8EW'M=MM,X+/R))M@
M$PJC;:I8=:4U\H?W`_WQ_IG^@/O_`+?^F'>L#NW<_>G<;>,Z6L5+2VE3*OM9
MLE[]VX/,75OY:6V,1,<A#6_'#X-S/.OGT?&TF\L,2X[QO'9V8\DYI5PX\R93
M4PE'!IZZL;,:Z`EWD=O)&('=1S6@&<NQ_:VJ+^GOLFY[X[PV&6>W@VK?.XZ@
M%AT5!,B2?&8`8P8TZ_N]_NAPO[8?TM__`'+T+.9[JS<NWB=OQ+K%$NWB"]VY
M<X?S/1L6E9G"P2YMIR7G(LP_)9^''C/Q*\>J[F[@#*N2,R'BN1Q(/*\#.IU'
M9E!C5[L@U&24H:+':-L`%5?;!2VD<;44QK]6H)57H?O_`/2#$]N=C'=>S/?;
MTW`N^H0WE:`&'%5CBT`_`ST.OCG^SC_Y$/<WZ[_JM=_3?]2L3M&#D9V(S]M;
M#2\@:_9E[MBZUZ]>YFY:E[?'CYK94@\A#3_$+^,7ACS1Q7D_E/G>XS)<8PW+
M8>"XSB6&68:$EE<+31+VUN;BZ]G-E^UC@GA%'C`[6KU>\CU1&MZ#_3/],NU>
MY<*[W/NYN,B.$5%/&O$$DF"2*@`"*R2=6G^_;^]3WY_;M[C[-[%_3FSA)W?N
M&`V;D9659;(%NWZK6;=FU:#HO)BCL[N6A>*HLR=6&3/Q_P#X4ZN7*ICY;R=&
MG5<V5736ER?EMSP2XQWAE"4R8.^*YHC#<B.:KF+IJBJG70%]C?IU;FT[W^0)
MW:[N*&L`&-?*5O\`NM_^07N-JUFXG;^UW,2];5U/VW;O,K`$,%^[#"5.Q\PF
MH!U"CR\\1OQQXYF7C5AOC-G.0WEOR7S9CF&<CTL[+KNULJS`+B7!@GLHD.\Q
M^%*JY3Y<C8,^PB;UTVN^2'NWL[VC_4NU]L[/=;U\O,2W<_F<B;9^IA((#4@-
M,3/RU]"?HK_<!_=CW#L'O+W#^J_;<;'[=V;V[D9>!=^UMVDN9EI'<6W>U>9;
MB\5EDE3'YAJR>\_`OX;'CZ4G*O-6*D4J#`D^\PNVB)IN3LL'-Q&O(5Y=/F;=
MHGIU>LG]&_;P)%ELI9VEU8`^$%:Z^,>R_P#RF_KJQ6YW3M'MW,:"75+.9;8T
M%97(>`#\-C74.^?O^WQLL?P?)\NX5Y\%FEQ0TUA<P,*S+$!4DN^96Q32WUM?
MDM-<S8([&4`2M`A830D-HUSV-=JVJ]Y_1^]CXSW^TY#W+B*3Z;H!RBH`93O\
MUW\!KZ*_2K_Y4NV=V]P8?9_U"]O?T_"RLBW:;*Q<KUEM-<94#O8NVD?@"9<K
M<+!9(5B(-`_`7C'S9Y59]-XOX1PTF79E`HK;)IL!]G6T<:'3TA`!FR)5I=RX
M-;%*Z5+"`(RE8XQB(UO7%NW^U.X^Y<DXO9[9N92VRQ!8+Q60#)8A09,`$[Z_
M47]4?UL_3K]$_:]OWE^I'<!@>W;N1:QT?T[EYWNW064+;LJ]QQQ1G9E0A44D
MZ8?,?"G*'`6<VO&7,6%7.`9S2QX<JPQ^]9';+;#L`>YK[`$B$>3"F0+`/U#,
M$CQO371?142M=Z[-G=ASSA]Q1[5]=P0))(I!600169@^.K;^GWZA^S_U.]MV
M/=_L7N%CN7MS(9A;OV2Q4LAXLK!@K*ZM1E9583M4:%!$;V2.U16N;KNUU;\/
MDNBJC5T3X=)PP!I!$?\`CJ_K<,[4G;QTX`7<BHJ;]XM$='E5,H+6B8B%-)'8
M14[Q=KS=C^UVW=JNW;Z(Y>I[-VX++<2!)@[$[])UNR"\RF`&,UZ@#H/G^`VG
M;78]Q=R>;"O`7A3D.\P?(,DQ!W&U/99-?XLR+86F.3ZVJ$:!$G8ZYXY):JX8
M,@UL`E>.'([:2&#$12CM_;<ZU]U:N2!:.*I$`@&%K0U%1`GX08KJI=SQ;HQ[
MMFTJN3?!B0.)/$$28H!)D2U8`/5MXAF.$9C8U=IA5S"N<)SZ/)GUK$<T%KBF
M8!#'E6N-V,/N]ZL)=1RK*$-S$_R&&5JJU4TN&'?&1:Y8P'".4@P:FJLIJ".H
MCJ9VDJ(O6K0(A<NR/,)!Y),`_'@003&Q$@'=B<J^.N,Y-;'RZKEFPK,!0/;@
MRK'HPFV#Q@0Q10LEA&8:ORNB1J]M8<P3VL9_RWC=HO4.;VS"[HOI7U(SN0/J
M*8+"`(=:!O$DGD>A&FN!W9<RR,;+M>KD!_\`J!@&@P(Z=?,9)D].NHZ9UF>=
M<9WD*'R=V:./.'453.0*.#$FX3D(*Z/#+55;I,\:S,,9:CC,82OLW,B$*[NB
ME$*S1W.LKM>9V7)2]BFY;2J!T)F`QIM($B&7>)@LLD6(Y:G'%/5$$AX`/(DK
MYU'$\E$AB68$C>-?O/&>T6.</V]=<'KR1,NCU]3&E7LYM[2X_86#(,LMG2PS
M`,M18V4NJ"@7C$$FS5I4+%(@^K7B^Y[7=.VW.W-:`=>/F(50CF58E:E8'(#C
M]1),&1%3[M[>=>Z)W7#,7>7,K;$^40/K,\H!#<5D!MB"#J+7*'^VB<-FY)]W
M5<8V&,<><(0ZK#<ER4=,SEFSRBRR"HML]PO&Q6Q9!`QK+$WFLJ\:,[0I1YPV
M"8K6-IG=[=WMMQLO&8ETM@W+*`J7@_0A:*QQ,D==]]6SL5_&>X.TW`#;9;C)
M?JR*2T0]`\B>H\P!!Y")$\JSG2O9#H$@X^=T6YJ9;8V5Y:>86S<I<OAN>6/8
MABAE@J"^UCJ1'-4.UJ.5475'@]\6]VO[SMMW)*/;;B\QP*M#B-P=PR]:FI@Z
MN6'VYL;NR8'<+=GB;R)`)CBQ4K5"!#?[C`@]"!K:I76[,BA"GYGENM3.P:\)
M-DV`9D=:?)72"RB0!EKK"7!DU)6;%,,C2(FYRM75NC%.^=ZMX%G(/,V&="5W
ME'@,]30O')J$R>@##1+]L[:_<.X=ER+CV[(M72`7\I<&`&4TN`@00V_6174H
M\4AT-MR<M5CG)*9!"II0+6/]GBX;=92/(::P)&#,K5'04\FW<,+FD?$:5CW1
MVN(KGL1_;&[OW"[A8O/[>P]MA(9D"J"WE'T!>`^,!5/F(FIK^!C)D?\`;BZ_
M,DJ4Z\5-.'(0(!EN,3L#.HT9:>%4U7-,I11QMBCBX?%E%DCAAAQ9$J#5'>4C
MWO%&$8BF(C-ZGT<JKJU%<KU587LA%/$6L14D4X\H!"QO`,4WBL3H0W6XV68`
ME[Q8P9)"@F*B:1$;UT%QS9-CE7$5/5-C%!8!K;$L^PE.W+7V.0Q)BMJ8!F.V
M3I<*HW--(^I%+O<J*J=1VD5<C#LVXX`*9(@@S-8.]-MMJ;ZVORR7[U0%K`I7
MCXC8#PG>-)%`#N<J<K9<VOB%%(K.0+*1+D/8Y`.U?!@"9*,7NJZ/[5';6:HY
MZ?5\>L6<FZO=LAU4^CZ5TE]X)-`!'@)\::CNXZCM5FTS`7B]M0L@B"9))G<Q
M`)-))KI-XXD.I.+.>\H;`<.79<*FHG3E<R(D5,EDQ*1?:B1$?(9*':HU[T31
M6/75=%TZ'[;8^V[=ELK<FX*#.X+,)(/[Q'QGYP=XNM>S\:T_%%Y<AUY<1MT@
M[$321\-=!/X$:.IQ_P`,^5\OR"WKL6J<V\A@XR^SM9<>'!FECX[AE%3UQSR"
M>W?]PN[Q8@Q.30Q2H/1=^G7UI^@:XV#[-O9F4H3ULYXY0.0"VT`D[\F/$":D
MP-?S]_\`RL97=.^_W']@[%V:S=R\SMOM0Y'"TK.UH-D9=Z[>"H.0].S9%UF6
MJJI:1QU:)E?`W%?BKXG^4&.<51@8UB<O#^>N4I%'"*5857D61X1:2;:-4,$[
M6JIQ2H37`CHU6QT<K&:,1K6]#R.W87M_VKW).SV/0QFL9-T)^56="3Q!`A9'
ME6L;#7Q7VK]1/>7ZU_W`>Q^Y^^LH=Q[_`&<_LG;ER('.[8QLM!;:[,^I=AR+
MEPP;D!FK)(._#CXAB\7_``WIKC(*_P"U\N<[P8?).:V!HC23*"IEUVS`,?<.
M6QC$9144ALLP'Z)[Z8=':IU5?TT]K_\`ZW[8MT%O.R@+MPR)\P\@/Q53,=&+
M#78/[^OU]L?K7^O>7V[M[/D^R?;%Q\#$1>7&[<2X#G7U*[^O>4VE<&?1M6R/
MC.['N,,5M^%+?QYS7,;?G&JGXI?8CF]OE]GC]IF=Y29<2T&0E^.G[(8QXXIK
MAQ"]ABL2.-4U<S7JVIVS'O\`:F[+G9/W0-IDN,Y!=@TU:!$P8!@;2-?,G</?
MG>^V?J%8_57VQV8>W<BUG6<K#LXUN]:QK=W&%NE@WCR*L4#7%#&3<8$<6C5-
MGXL>`/,7QCY*\OO'S$[+BYN#\9\JX^\]1RKCV82I62LR>@+,Q7-L3N\6L8C(
M4:\PV!$66.0*4SW":-[;F/1W*O8/:O<G8<CN/:+=RQ]ACY``]0-R?DLK<ME2
M``R!>2D&M)!!G]&/[SOU+_0?]8_;?L+]4.]XG?']U]Y['>'+`O8@MV/M[H%_
M$RK62C<GM9-RX+36VMGA4E@5B[@3O+#W4?="\?1#[GZRC3E+N>W:YO>02/VB
M4G:UV[M&JO733_5B!-S&*2)^J8^'@?W_`!U^?UQOT<#'[?']SIE!&*$GMO$D
M#\T-0;;$DB8KJ)7Y(ZS$9%+XL6F24-)^\0^8WC["PJSDBB-O6_<,J<_(H5.9
M=9[HTRLBZR1:]I6L8KDW-8J*?=7V=INWWX1\O^IV$2?J')O,0?`"20*4D[:Z
MW_:_W'W*+_O;!PS?M=@N?I[WFYDI;)]!BMB++75$J'#,?3<PPD@&"1IU?D.\
M5,T\Q/'8G$&"9!2X-D;<\QO+1763!M'U?MZ%MF.3!>M*T\P1IB6#5&1&/:BM
M]4^'1_O+L65[C[0>WX60EJ_ZB,K,6`'&9^GS3!IJG?VF_K5[?_0']3%]^^YN
MUYG<.TGMM_%:WC^ES#73;*O%U@C`<"")!KOK5\!_&CD#Q6\7/]HN7\DILPRR
MNR?.+S[S2VE]:524=Y(":K`"7D$"!8A6)&"[>)!]H:ZHU535>B_:';,[L'9[
M';,^\MV];+\G4L0079OSUHI`K^&M?[HOU8]G?K7^L5W]0_8O;\KM_;+N'A65
MLW[5JS<%ZS1VXV6>V>3L(<,68"L'4._Q*^*\G@+@CEKGQ,=?<\J<ZV.6Y+AF
M,ODQ*:>[`*"PNW\:XTEA/=&%6MS:8_WY#%5H1BD1W/\`0>O55_3OV]D]A[-D
M]W:SRS\VXUQ5B/Y:EC:0$[<IY5,0RSMKN_\`?1^MF%^K7ZI]B_2R_G_:^Q_:
M]C&Q\J^O*XOW]]+(S\CTT)+_`&EO^2JJ&/-+P'U1IE?D+\44YMYV_&WY&<A<
M>"CER+D;`>&>?.-K5\"TC0?O1)&5X]2WMC6EFU]O6UN2@L:UY>Z2/*#($U%5
MI-.EON[L>+W/W#V+O'<,4"T^3;LY%MH80WG56B0P#\E/1@0-73^UO]:LS],_
MTF_5[]*_:W>CD-C=HSNZ]D[A:YHY]$#%O7;*W`K6W>R;&0HXA[;J[;B=5[?E
ME\6/#X5%S5EGCU0U7&_./CU9X2_FS`,7B3J+%"8_GH8DBIN'XZ2)]BBS),:Q
M"4$NJ<()',>,P^YHY*E^KWM3V6<'*[A[7%NQWOM[I]Q:640I=XE2$("B>8@V
MZ3((D:^F/["/UT_N,;NWMOV[^L>1D=X_3/W=CYA[-GY+)>R_7PN?JVON%;UG
M13;97M909U!5[;\9&N>$@HYX&1!E2'Q(BUU(<DK:28YCFV+1CV!85J.5[C[$
M57(C577KYE@*P4?3O)FE`?AUIO.OV67BSK<%:F%$29'Q(_;IKI_X7Y7;9?C/
MXTPR-+*DZOE86YA8D@D8BP@6)&L[SQ%&Q!=UK.X/56IJU%1>K?VW%R6Q\;N5
MLDLMLJ8Z<2P`IX`K_P"8ST!U7+Y6Y<OV'0.+CCRP"1!629Z`"0QZ`CH-5D\.
M<B9"7(?_`+XJ,VG7U?#JK^#>XW]OB9)C4;&T'*CRXM4?[<#*:P:G0BQ(\@#E
M"YZ#1=$:EHQNU]QR0!V_U+]Q;9NGB@#*JB6$B.:@-/DJ!,@Q2LY?=<&R4O7G
MMK:]86P2S<27!!)*AN+0-W'&:$B:W?\`'MU;76!8[G<WD.KY(IN0S)<8C*_;
M;\6FOKSB:KZQS&%V0)424$GZ)&/;N3MJY/CU(+CJY6Z5-]!):``(I`K-=I-=
M_@=%V<9?O3BVU*W0MQFZB$`)XPOF\LMR-3$":$)'*(8-Q&AQY,%IXEK3.CV%
M/;Q!''+0)3192/&;O0+>&1KFM<HW%8FGKZ.ZDQUQ\G%N8>0%9N9#"L0ZAH$]
M14RNWC31-RSE8PMW"O$*3Q::,"%*D;$=9&XI,2-4^^>>$VO%_'(KK#+:4#$Y
M-EC$*=C,IC+.HKQ&W-`"L6>XTJ#![C&M?!(Z1$1COTFA5J)U2\K!RNTX;([\
M[1N2I828Z2Q))),[DR*S33S"_G]Q2Y>#)?./R6#`(;KQ'610BLST.JV,BF$R
M?!73:W"*^5.II5')L<E#,ER+:*^14"1&BA]UC6U_M6;GC8Q6MT:YZNT1>N=]
M[S,M?<%I\G/6WBW;1"6"!R9H')Y()W@`EJ1"C?5N[-]O8P;C"R[9B723>/TJ
MO(PL3OXTKJ57&-U:3./:R52D.9(MW0ME5PWCGW\+[J&726-ZQSH93!KH`+)`
ML>T&A$>[N.1HTU3>V\AS:O=M>XG\K(N&0`"0Q!J-ZR0:P2)WII]W2Q8NW[6;
M;L,[7K5OI)D'C0C<*26&QZ131!F4-E`R"++F%C7F-`QV1/)591-?=K%R&IE,
M?7"L(6-*3V=+9@AO/VFMCHUA51WI]26%<G&3'(N+Z=X'CQJ0`21,@$B`>@H?
M'KN_8,Z[W$6?KLD!N8(4L8%%]7B7K((Z@4(VT9>4<&9CTO!N0N+VCJI\=U%D
M8WP5G@"9;B%6V320#G"%1BB%(8+1%:XPVM1KT7U5;)F7D^W2S3[6[;,'H5($
MJRFM=I-3N(C57.`WWV0EKF;EIUFG&#!^@DEJ%37Z:B#T$6LE;/L:+/HKI8K&
M5=<EPH4"G?#_`.CUX:R?D-VXS%1^DB8=D$1)1RZIV]C==->HKUYK^/F72`+;
MWU`@<20"2=JP/\CK2S;'K8BB2%1VG?\`*`#/45F:]-9L9C#?R]%#:$@G/B6.
M1F'<!6B@!-74TWNR)!6-1KXHI*C<W8B.?Z(U$9JJ%(BGNED@#^6!`!V`6=C&
M]*&D'2_(N-;[??\`,5]5C+3)WX]*TJ?D*QH>XR)X\+SRY4(91IE%;E8KR$2,
M$$Z80C5`%HU1T@AY'P<OQT3T7XQV1PP\F^_EN/`FDF8%=X$G8>'@=$W_`$_4
MQ[5N2%N**?\`*#N9^$GX'XC6<XX]9XQ<GOD!,*S='XQ@1GEW`$Z-8Y-"D-[*
MHC/>*1E.?<FBM'V5]=-$7RVC8[;=:^"&NWE`\I'+CN0=B`()I4&1J/('W&8C
M(4*J>!VY!N/(J"-C'&:BAT7H'G)QABWXO)7A104V>R.6<MY0D9_DN4A]G589
M01(F855]71HLI+)]Q;V,FOH8Z?I1A,"5R.[BJSUZ';]]=NQOTT'LW&6\.ZO?
M]1KG%0BD75<0Q)9CQ5=@(;K37Q'F_P!KWO;OG][Z?W(]TR.V+["P.Q+@8^*>
M=S+O.^-<LW"R>F+-NVCWG,M<=G61P`:=%6-^=?S"_P!E:?A>SI>'LJ2'C$C$
M+_.\SQ*UR/*\RIB`]DUN2A)D$.@FS'U:^WE&6*YTQ-2$^MSU<?\`_P`V>[!V
MQ.WM;QKET6^+77#,7BDLI8),1R)!Y&3%3JFC_P",;^W^S^I%_P#43`O]]P9S
MONK&%BW[5C&Q+Q/(FPPL-?5!<E[2"X!9)XKY0H$5O)7\E_EYY:4E3B_,?*C)
M.)44]]G68MA=!3X!2)-6(Z`PDT.,QX<NX;%BO>,(Y9C""CW;6HYVO5-[Y[_]
MU>X+2X_<,B,=6)"H`@F(\T?5UB3`DZ[_`/I)_:#^A?Z+=RO][]C]D`[YE6_2
MN9&5=N9=WASYD(;Y9;7)X+-;56:!)@:CAQ?Y`\N<+VEG>\2\HYQQE<WD`=7=
MV>%93;8_/M:T4GW(H-A*K9("R@"/^HQK]=CO5NFJ]).W]_[YVAWN]KRKUEK@
M`8HQ$@;`P:@?':NNK^\_TH_3S]0<3'[=[Z[)VSN^%B73=LIEX]N\EJX1Q-RV
M'4\6*^4D;BAG1$7S4\HRV<^W)Y/\XLMK-L4=M8LY7S04^P;`$45:R=)%<,)+
M97#,]`(]7()'JC=$54ZG;WA[J-PW6S<@L=_.WF`VD@S\O#IJN6O[??T4MX]O
M`3VE[>^RL\C;0X&,50N07X@VR`7(!:(Y$":QK,OFWY5K]2>5'.[=S=KG?[OY
MV_<K4W(NU;MFU-?CZ=1O[P]U,`GWN3Q)ZW+AK_\`4(_`ZC']O/Z(KM[0]M\@
M?_\`G8LC_P#M5_?ID9%Y'\RY?D6/95EG-/).4Y-A\X%IB5_D>=Y)<VV*V<20
M.3&L,=FS[*0:JG"D!8]"!V/W-1=?I3H>Y[G[_=R$RKN5=;(LM*$LY*$=5))(
M,CX:L7;OTE_37LO;,SLG9>P=IQ>S=PMFWDV;6)8MV\BVP*M;OJJ#U%()!5I$
M$TJ=2)I/R<^>E*QOV_R_YJ(C51[0V.6I>HKD?NU>V]B63EU5-%U]%3Y=63'_
M`%)][V8/WMY^)!J>4_`A@8'SD==<D[G_`&:_VP]S!^[]C^WQ(WMV#9^%/29`
M(\173_O_`,OWY`\FQ&QPFW\CKN91W$9T"T>/&L(AW$Z`5J,F0%OZS'(5S&C3
M`JHB]DPGN&]R(YNO3-_U9]ZW,<V&OKP.YX(&()DKR50?^4Q!C8ZJ?;_[!_[6
M.V][M=]PO:MA<^PP>V&R,Q[2.M4<6;E]K19".2\U8!@"0=&V9^=_S@7`JC"L
M<7B'!9=%)IW0,NQ#CT(+,=)3Q"1&8N2DNK&\Q1E-)%VD>@X(S#:%&L>U%7IW
M<_7#WA=Q5QN&/:N(P\R+7B)A>+%E`VV41$`ZY-A__%W_`&UVO=-_W'W-.^]T
MMY*WC<QLO.9K9O76#-D"[;2SD>H#RCE=927)928U,;@?\\&/Y1QC=83YM8==
M9'E]=E>-YI@F><2XM25T%\O#K.ER?'X61T3KV`Z):#R.G5/>PVN&Z/(V/$B-
M<KK/V#];<;(LBU[KMW&R4N*ZM;25\I5E!$B#(W%(,$;ZX5^IG_QA9G9?<]OO
M7]NF;C8/9LC`OXF9B=QR+SMZ>5;O8]]K5WTG#V_0N@^E<A@]ODKF0`3?,WDO
MPXYZ\4?-SR0\<\[K\ESOE_C3C2'RI32[2;!R:F3%,BH*S$/ON"6ZH>ALP#58
M*GBI[24K$5'$5$>MF][Y_LSOWLSN_N;VS>2YW#)L65R`7/)"CJ$FTU4)CB2(
M#$")W/*/[<_9W]QGZ5_KU^FGZ-?K#VN]A^T_;W>.YMVN^MI'Q[PR<:^^2+.=
M:E;UL_\`6].Y_-M29"B5'*VTSBU.1Z*JL+B\<I7*JZ*D2]HU;M<JZ-5-RKZ*
MJ_R]>OD:Z[<H!IUF!3>)W-?EK][HAT9B*/`_%3\^FK3.`^<(=!P!2X[:20)$
MB8]'GPH)Y*Q"R9F/%#:C''&5=3^Y=$1FK$5VTBN1J_!;KVNT]SL8R4O"U<7U
M`5)`6XJL'`XD@R*0XJ12H$"M9XO6>Z-]N@;D1RB9J(K!B"0)^/4FFHK\9<L"
MQC-6W,V/(F!)5W]<>.\9Q&/53ZZ57E`&<1Q$#.CQBJX1'`8)JCVJYFY'-?\`
M9_=;8'<<:]F6C=Q;5AK85"P+*P`+<@:L(#;#E4'>J7OWM(=W[5=QL6]Z5XL+
MB<H9.8)/$A1]-2#4GJ8ZWX>('*F.YGPWQWC0KB)$6A<)S'`)%F)5S9<M)]A4
M6%<U8Y(PVJ]'L>PS7L:9R^C>B7?'S>>5CW%N7Y<,D`$J1*L)D<S)D!0)6E::
MBQ_N<7(.,"1D<>)E2.0$51Z^;JFT,HF08T;N=0E;4X>808:I53+J*:P&KIP_
M8F]O9B.]1@1XHD(ZJY&R$:K5U[:NU57*KV1=L8>3D.MPNWIP$264B5!WY".L
M;DP0!46O$R+65D7FO6V2R;`50ZR0THO.6H`T$1),@S02((^;&.R<Q\3<N1DJ
M-<RJ^AH;F`XG9[X9=/D]>22]DQTA1*`\([WM4JIJKU:CFZ(U569>R\WMWIW5
M4\%0EA,^ILP),K])!@D-7?6]I0O<[%P6_2N*K@B3!0<44@<!^8@5--X(,BHK
MQNX<YZYHY@XHXEX4J%S#EN_DUD?!<,B6F&3G6EA4"+8&IIT7(Y[L76`2MJGF
M(.Q:0!6_00;VN5BU;*6^HLY=BU:?(MF`6B0L28#`@B0"W3Q-8U%WO![=G8.5
MVSN5Q[>%D(02I<2[2J^:V5<,.1@H0P(!4@@$6K^7>`>7_'7*,3&O)?Q,'XSW
M;,#</CB(M;2Y,"\IHV:Q)ZVI<GQX-OCF5R*>NE2:XY8[(Y(;7#1L<2-9L7YU
MJSF=_7NN5C6[..;"H2A4&XP8L.94"2H8B2L\0`*0-(_T<]JW?T^]I7^R87>,
MWN.1?R?5FZ[\+;%0C"RKEGMH>/(J7?S<F/F).HFW,F%'N;:"$[P"K,OSFLHH
M)ILFFK+U^65+85=4O%($U#%0$=YH[7"^!-JO'JJJOL6@JW[:!3:CZJ$E3R)H
M`=@9$[&2*Z[CW+)6[D]M[ID.W.VB=-W3RRS&%,GJL_@:Z/`+2'/X6XMM3C:X
MU>$=80Z[K"1$E5%Q-!#F/@JQC7/&T@1.$BE5$<C]435&W+&OID]GL(`6R%0#
MC1>(4W%D-,D$!3LI-9HLE!WFS]IWV[=(DW`6`K4!Q$R2IJ[-(BE`#4F,D@4A
MU+@$)HY<2+87.5W]LH6-CA?#)[.C<:<?4;R-D1YBL,]Z[4:KDTU5V@"67?%6
MW:GUFRF)WZ`"8K3<^$_AI2C^ADO>O56WBCRP!N6,#QI%*F@@:TJJ.M5:Y/EM
MO9UE76Y)"L8=.^S8K!ECS8\:$`T"&56V%G(4<;>(0F+Z.:J/1SG-Z=KCFW>N
M9-TA58%0#]73S`CJ1L`/F`=)+F<'QUP\4,^0K28`D03*L3Y161)/0Z9^(0I,
M#N`J(\.-41A#61?Y\QT.K&*.Q>W,CXVIHYI1G)&:U$EDCZO^I=4TZVQ\5K2W
MBH/VK$0USR@1,GC0UIYFXQIGW`NF,+EQ6-PGR\8Y<B((D2!1MP#^/1E\YYUC
M2\5'HZW+Y.6W.49QC,I\MPQLKW56$TF51K!:P42-$@0((+C)0C8UJ$(=6JJO
M=LUZ![G<MM9MBU<-P^HQ)Z`@`>6/*!4BGPJ8.A^UVKB'C=MFTZDDKRY<@T0S
M$F>1@D;'QC;4&%*Y7_2WT]&HOU:-W>OIZJ[=Z])BQ)D[?XZ='ZI.X_AK(L66
MYJN49%UW:.<U!)K\4T1^BKJB>G65WB3/^6M-Z';:/C^&MN!6&LID>!&3N3)9
MQ@"!JO=J<CVM8WT71'*Y4UTZU<J@+F2!\?\`(:W55/QKM_AKP2.R,=X2-<][
M#.CE3MZ*UPWD:OQ>WU3145.O#CQ`$1'CKP0<?A^_2_4T,:RD`"B&&Z3(9&8O
M;9_<][!J[ZR;OH<_TTZTNWS9MESQHLU_RUB!<O+;CSL:1_G\O#3AML&!3H)Y
M"F<*8:T8)SQ@$X@JR6^`0K6N5B?7($[:FJZ:>NJ^O0UG/.0650LIQ^-6`('[
MC/PG4U['-@+SDAN7@#"TZ_'2(2BA-5/K*J;/708'(CW:*BZ(1J_%=/15T3HB
MU=9U)90(/PGP_P`/CH9RMF&`8SXQ^ZG\*:3OM(MP6"852E,V,B.#HO<5^U%<
MYAM&HKE^'K\>I"\>$"N\?PC6J,C>9>7+H#!U@N*4M/92ZN65HIL&0L<XT<]V
MU[4^M$=]3537TU3773K9+B$5%3K;TBC%3)'^>M!(Q5<K`O5[_I14&JO5-6ZJ
MB(BIJK43^NJ=;"2>*DD^&^L.JJ/,?"O\/AKR4DR,CD?O]/1VY%:OHB:(C'?P
M_CK\.L.[H>)JH_`_CUU(51A(@_AHY</\_/XMP[GW##XV&_A\[<3DXUDS'3G0
M#XW)#D%3D=;>A%[>0*>@959VR!=VU5C]S7M5-%==F]PGM7;NX8/I\K7<,46B
M>4>F0ZNK1!Y5$08WD$:Y5^H?Z76???N/VG[C7+;$R/:W?OZBJA.:Y"MCW<:Y
M98\E-ODMWD''*J\2I!HPL7MUA@MAN;'8)^/29*R#08]D0:UI8Y%8&/($H'L,
MW<BM(U[=Z-=N337JOW+HML&85)$?.O38_+\>FNF7K(8HR$\@](IN.M.G0C18
MN+XTW`N-<C<*.\T3(H$KL=M&M1!R):LC.:UHP]J0L9&$5K&HNY=$ZL!NN_9;
M5P@DB[X12#`'0]9@0?#2ZS;%O.O6#)MFV#)/QV-/QU<I:>+.+7>1FI^3\/C`
MSF^CY995SJ8\J!62\,'<0YU'(;%VA%4Y)%9)`PHV-<TXA/<U[V*_K:T.X6+R
MGTUO8EP,#<1P%#(`T(H!!-1S0<"*3`V.S[-Z[CK=PUY6U<CF@^N@%5(F`*J?
MS3()IJ%.5I8>/.8Y%@F$GR7$JIYJ>V+=8^VM#D8A2ZX)Y8EM)##2F]HN]C')
M$>Y&.]'-^5@[4R9?:C?M\FQ[IY>K;4`<A$\E,7!43M(!'X55ULOE*^0TY22%
M#EH`/^X;33_<.E#&C^+S4RDE=9B:RKO*&MB53*L=3)G2\WG2P!9'LIER<E9"
MH"EDD;JT8W!VZ?4GKHTFS>OV;K&[>N/B!:`$LW(])(!%303L9.B+EA[B*K-4
M'=F)3>0`LS4;;`'QT7,@YQP+G#QXYNPN.@*G.F\79(=].LD+K*:UU0"PCSS4
M\0QA1Y`K.!V'M>-AMPD(CE$]NY5D7,:,K'"W/N&M@%@!YNJAU&Q7E/,`+`)F
M-&"]>QCCG)5H+0(81Q((@]2*@UF8%)@B"WXAN2('&7Y!_!7,R$EADU_D=@-?
M)1KAMKS55YDT>DFH3MHI1RGP;U[6HN@M%^/KU6[2(;(DMR9AUI,@4K,0?"NH
M_<5A[N'=9%DJO*`),B"*4Z@=:&OS[&_^Z;P`TVN\3\TBM0BV$WF_BV0-3'0;
MP9)B^.Y.^2L<4H+%2%`QV:1"N81&.<U%3ZDZERO3/;K=PB;J/$0#(8$`5^(\
M9I2=">T&?U+]E2.,#_.3\/G&WX:XTLMDV+8,+(GF?!J`U/&N9410AA2+.8Y$
M=B-;9L10PXX`PYA"^Y&YC-^]JHB:)JGQ7MB^[VEY\[8Y;;K`,^(,$CQ%"2==
M$S#<?M5@W'I9=U'EF@\PZ[R1^`H!MJ3>'1K,W`^05%=-BOO<*Y-N:DDKVPV@
MDME2:V>%S1%VJ$$_[21=$>B-543T=Z],?;M\K>NVW56#)-L'C/U5`F&B'-)8
MF2!(D:@[^0^18O"3:>TP!4QQFV"9Z_ED30DF*[`W(;05:9])(L*G%I:):5%+
M!G28N19O+81LIPQPJT;_`+51A(34A']N2YNB[GM7U2QK;MV[(Q4BT[S`,%F)
MF3&PZGKX=-4GUKF1>%^XERY9IR(/"V.)H22.30=B8F1UT,Z[D.L=59A;8M4?
M;[/%(,&+#RK+2-N;2RERYZP5:,!)!/8P8S(Q']D9&MTVZ#:B:*`.XV?3O/BJ
MQNV5`YMN23`^,345KX:.N]NO/>L6\EN5F\Q)5!`"B?,8F3Y@),$FI/30VO66
MEI@`9&0FFW4JZS!\R*>9L")(X02E:.-&8%(\>.TK7$:C4:B.1577Y`Y%[)RN
MRJ^60;MR^23(!A4H!&P$5\9T_"V[=Y5L^94$;>'$`$>(&T>.A[G$9K\)Q0;G
M=]Q'DEK[=%=#&I"61_TR-U[BO;(8KU1STW>GI\$CNGT.V8]LL3+'<1XF`?"N
M_7>!H<>K<OW+T021T@PHBO\`COU^.F9B--'D4N5VCQ(XM97.,$JM1W98I4`_
MMH]J(JJXS5^2Z)TMN7/3=1^5J?CO/\(_'4D7'6%I!K\9Z:'DQVXGU&>9S4W.
M<XC6ZMT75J-1SW)HWX:KZ:=20$!X#Q_XZW5G+\FB*2-S/[?#3^X/B#LN5L(C
M2.W[?[]`(1#/1@T$"2,KW$.YS6!&QC%]55$3^/4,-<7A$L?"OX;3_#6R7$1B
M]QN-M:DG]OVZ:9]H`Y+:R[:%>];241HVC<_1A)+]JHU&ZIHW^&J:>O666X;A
M5583T@[?N%.DZB-RUPYLZ^F>L@3IVX+4Y):75948T&1)O;"U!7P8PT;'>Z>9
MT=8[4(9R":KBKJBO5J)ZJJZ=#YV8.WXE[)ODICHA+F"Q`$FH@D_``3KR6$R\
MNS8QSSO.P""8EB8`F1/^'CHF9@MFJXC"L5E2+&NJK@-RV-[=Y_?DRJ_]X-'-
M:\2EV[45RL<CD35-4T7H'M>3E,,B_CSZ+W$*`B#Q]&WQY`BGP!@BDB=%9^-A
MVQCV;YAPC<N).XN.#%:D'J*:',P2OF1!]IQ"*CTD-.T;R@V%>U&/:)BN&Y6-
M3<BHBN<BK\]$>6C=NLOK>:*3O'C(`$F=`Q8QFE2JJT[Q!^1)'R.O,,+)69X\
M!L?_`!FVE.,[1O>T>KYR(_N]MC!#56HKE5^FB>BKZ:]>16MC@X+D$"@/\>H\
M=;W+M@3<5D13)'TCY16#O3QZZ6^:8%:'E;/QBLA10AR6R]N%K6O#VVD3VR#V
M.[2(9'_4J/5J(BJBJBITI[EW'N&-EE+>.UVS3S"?QZ=(\),_#5B[9VWM6?BF
M]DYB6,BOE:*@1QVKYOW"*Z%`0R0*-7#5BFU>)T<@T>PB"[B*]VWT:K%7<BJF
MNJ>NJ=38?=,;(O&RC'U5)@`0)$CKO7PT)G]H[AB8JWKJ(,>X`9-1'U;CZ209
MK\M.BJ<VVA6$`@DD'<PT@<MPTWQQ0XDAQ!N<KE1$,5[=/75%9\?7T<'(7T'2
MX"UYB"6C8#Q,=21(II5:[>6(S`P2TH@I/U$D&1/@/A70\D(C7)JBJNQBJUOH
MFKQL>J_W;4]5T_ETM;S`EJ*0?W_CJ1E`8#P'[3I[404DOC0N\`"V&.9'$0AW
MC%'8I*^2HE/(>B-#'[@V[GKZ,3555$ZV7BQAH(80)I!Z&NWX[;Z'N>59W(N+
MU\?VVT321VU_$V/PY\J)('`R.%WY=;+%9`%&;<&(=8\D"JPBC"5?I1==Z:=-
M[60H[8,;>X+O(D5"T$?`S_B(.HU1FS#>6`OID"D$F?VZ_P"1U;)XX^9&5<]\
MNT5ME(+,A..^(<WFYM(*D23C\F[=)I<?QLU$`*#L(E1:5XVK(AD<5GOS$>%B
M:JY<V<N_9N-<L6AZ2(Q*H3N=W`(/&(62#U)VIHP8Z74^RM"X+EP!>27"K`(P
M8,I@D<=MZ+69$Z!GEGR'ALCE&%D-[/BXTV_PG'Y+!CA7=J))D$MG52X\?V-:
M:65&%@_2I&C1&IKN7YVGVQW;`P.U76[D[6_4RKC)`-PP0I`D`5ZGPD">NJO[
MC[;F7N[LN(O(JH#$E0"=Z5CK\?Q-=1<][BV2*TU-<5%B]SE5.U)]O9@<U%<Q
MI8<IL>R;HJ?_`.-PU7X*OS;W[G:^[D?:7;3WSX^5@1MN)H=Q4$2`3I.B=PP3
MQOHZ`=:E3%-Q0_C!UX/-OJ@%C##)?(9-&JE23)G0YIRA$K8SEFP),=-@$]$8
M\2IIZ*NB])<NWEX+G&NF784+4DFDB"/#\!OOHZQFV;A5N*[T,2!/P,_B9&A5
MPIFTKCGD/C/,GP6#/B/)N+9("=V/;3AEJ;^EM/=,GRF.3LH6"N_3:Q/JU5$Z
MJ!R&M6&5T!:I@CS3N(._R`_#>=.NX6!DV;EJV8+(>I$R(@Q-/P)ZP::_HF_]
MPC:Q^7_QU^/G./'UX*=%JN<>+[>OO*-U3>0S5?)N#97B<U/<H21$)%WV`E5X
MWZJK41JZJU4<]QM65P'O.H:2KCS$``&9D>!8?+Y3JL^U+C6LYV5H8VR"(D].
M0`.T].LQKAT!$NX^$1),MEK9-IL:Y*I(U/:^OM6X+<,LH$+WD44I&5PB-<<(
MWIZE3:UR?%*T(&0HMA4N$%6$=##"AC<&FTSUUTRT5.!?%QN0%U&66,D000`)
M,`Q,5\>FI)\/?=FX)GL>VB6E96YV7`+VD-.BSBQY$ZX@G!9Q(4\C-S9$0TSM
MM<]4VJQ$UW(WK&)9([VSVP[*;=P$H!-5!7K.X(2/S$2:U#[CE8M["PV+#G:X
MAA4P`T&@^!^?P$:A3<5\(>7RY+SDDEQ^DC5;)*"D-DO*QNCSR)AGH=Z&6R>K
MG.<YVY5UU3X6)F1.[(!#"WC`\B#)/IR:_C_K\1_2(QW21R9]MJ4,>$$4C:)Z
MZ1&LB5_'=G$DRH\>-<W5$`T5K-\XC6-`67)61W&.:QQ".^+?I1?C\U66+@;M
M-Z[>/U7P)^"R0(&^X^<;:WNVU^\7B#Y4A3T!.XF.L>-(^.DW*&,9B6$PU89K
M4-+.$SWOE%D2(\=7-$D92H]HGD(Y%1O]K4]/GUOW$<>V8M@\AS-QB(F9,"#O
MM%*3!I,:G#4Y&09F1X23\=O\?'?3<R^*:)58]`D%&Q]?6HQ\=S&@>,I(,![@
MOB&49PE&Y7;D<C5:Y?@GKU%WCDF)CV7<RE8(@[*/$[U_#7L9D8,;9K6GPI7X
MS_EI$QYC(_&.7JK1J64L;:3M+W=BR8[=$=\$8JZHK4]53I<_(-;N@CC603N:
M"(V(.\G:)U`I!#)7D8H/F37?X4T%#PR]QS6B?NV)OU8NU=HM455VHC?[-$3H
MEKC`@DCC,Q`_&O[#PUA@OUD5'Q^?QT1>&S.I\VAV]BAPA@1+4P7)!-.4DA*J
MP='8R.,9W/:\[6:ZIHU/J71$5>M`]\GE;DN.LGJ?X1K0)CM;9'"FV17;^-(T
MTW4%S,%W(]=(?(*4A"N0)'.(-Q'.0KGHS5VFOR5>LE')@A@GXS,?M76R^G;#
M<B.,`"FU/V^&I4^)V&W]=RUA]U*I9)RXZ:WR"`G:</\`ZM70&.JG%+(:T3!L
MD/0B[E5-6^J+KU4O>W:[W=O;^1VE6:W]PD,1!;@#4030&(G:#XZN?L+,Q\+W
M5B]P=5:Y9/)`Q('.0%'E!DU,"DGJ--3(^-,]LI%*9U?*%:6,"RMI*B#9&5A;
M*]NI<AC?9">J,WZIHFK45%35$Z9]JQ2F*;!2XUNTRH(61"JH!))B>IZP1I9G
MM<;*-XW5MW&#DDDJ07=B103`)BE)TPKCBW-XI`[:281!H]#K[*R"5A'$<X:N
M[\=7.W[_`)]/[5G(=0;5NX5--@),TB"?WC\:[H;B`N5%Q'<&/*29/7>#,U_&
MNM>HQ#**ZWHYDNDLA>QF1#2%;$DKM:R>0CE>WL;WJP:[D3^'P1=>IQ:R+</<
ME)-#L)!Z[2=#D6VBV0"D'<3XS^P.OWF]R6G*^=6U-%E+2S;V46,YD.3`10[U
M;L+#,*.\#FHB-5CF(YB>FGQZ$N^N?,O(3]53\YWC;?1*V\>V(E6C8P-MZ"L#
MPK30R-&FPB(-C3.$(BHHFHY[=J"0C&JC?_5W=537X_+H&V`\,JA;ZDP8%*D3
M.W31]QB)M778V8^GD8J)I_CIV8O-]G)-%=H,,V-*[FV.BDVEC*QBHJ(QOJJZ
MNT]4T714Z(LY.0,=K-WBRL]8%?V'AJ2]8QRC7;3,(7RSM^(/[M](4G&XSZUL
MI%.TB1'D731S/TF(C6HCT314:B:HFBKULUH\"](+'X&(%?VWTN);DH$&GX'7
MJB`TKZX3D16DK<F!IM1ZHXM%::-<U%>BZJO]4_\`'J($K\1'\.N_AH:ZU6`G
MZE(W\?X?'1'Q>-$F\$+[A'.064%CN<Q[0()'S8VQ[I"A*UC&.D;E5S533T]/
MCU8NWVA=[6X/E'J#:)GY;F)_<-095UK&:.-1QV\?\_P_'1JX5D3?'WDL$TTF
M;?XUG%):X;>1:(89!K$!X;+@0XP+6/6.9:4%K'B24:HGA(URM:14(JIIDXF3
MA8MQE(=+B%8WY#H05),BA!,$$&0-,^Q9AS>XICV@BW">)+T44E@3TD`B:T)^
M>D3S$RC'\NLL.G426;EJ*P]+8.LH4>(KC>_DS8Z1UAV-G$D@'$EL:A!F5JJG
MRZ`%FW9[8<=3<YI?@\NDJ(KUGYF/$Z)[UC7K'=5NNJ+;NV94JW*@@5E5((KN
M-0U&]P#C.)[Q'CE:<1AJYA1'`1',*-Z;7,()Z(J*FBHJ:]"!RK<@88&AF*^.
M@()7C$J?A-/CIX5.?96,P`'NI-@`\B.TP;3;8KN.5C"$&63OE"(Y':_01$55
MU5%Z/L]RS.:67NE[(((#5$DP8.XGK6#X:!O=NP^+7!;0-!V\O[P/]-QI;GU.
M265XM$T-C*D'F2XM;#E+)(KR-::6P47N;U"Z4%$5B:;2*J=9RC<MW'5@86X=
MQ^XD]?+_``B-;V[5K@MP<1<9020-YVGQCQU*7#O)CROXPX)N_&N1F5[9^/\`
MG9*?,*_C:]R";:4&+W]#>BFP<NQ6""<6+BMJ*;"4<F,1&@,-^X@%?VRIKC]X
M=L.[V^S%S&,\N23!'125D@]`)4[[C4_],M6;JYY"I<)B01+!AN0#0@":P13Q
MULX=9Y129!;!@WEK'I)V02JK*JZSE&K*`CK*JD6%?<./%4*"=.DQ54H!"43V
MZ=Q[-4=T.UZ[Z(MW*&5"D5(,&`36(D^6E:BHT9:Q%NW;ES$AF"%WV'D!`D-U
MF>G2!MH^<,V&.<AY)1X_?NK+M;?!+^SE`=,MW$K,LHCK('7-0\XZC82M&C]C
M%<F]7.15:B(FO;VN6;R+=M^F6>"JG8<P/4WJHGD>L334W<K-H]FNYF)=Y7K=
MP+`\&4D4VY2""=CM.A3;8Y(L+.V='GEFV&275E"951HLQTF&![',:8YC@`"9
M8*V$CF`C=Q';D<YZ?!+E_2+UW,?(<P;JE4H13>2*".(CC4?+2Y7`4D@!&ZDP
M`=Q2I"QX_*-.5>)9T:+%C2H,FGJ!2&6(I62/C1GRR]DH5&]9RU`S"C!>JO"-
MCWA=Z*KE1'=9O=HQ,7MZXMZ\@M^H6/*!-.'2(V@&((DZ&.7ZB+Q()YM2V"8K
M^,>`)%?JIIIS+[!:!HHZV;K*U&T$>O%5,L9`(\:8YA488PA0ZQ&->Q%1PS$W
M_'5WJO6@R.UV%4+RN^FI`KTW,1&_61-/C654O70B%)L]>9$TJ(WWZSUU''.&
MVDHYYIVU8V%?.48QMF$>U#'+O8TSFHCRI[9J*JII\/FO5$SV+%78#U"TT^,G
M]T$TCI.F5FTZVS)W!^,08_R^'AK9KPI#P,4DK%(BV"M:UK2:2&]MCE5=JM15
M&@E5$=K_`$Z88[\K@LL`RE=@#RW,?`]!N*?+0'$A_44@($)/^9\1X?/3`E74
M`+R&:!-SD=HB.9JFC515(B(XC-J^FBIIU+<Y"ZUJW;*NH(-`-OE,ZC:_;;C<
M125(@'X[5%?XZ?'%685,+)B6,V(Z9%B5&0,:QI$(JS9=-,CC?H]HF;&O+JNU
M?1%71%].C.WX>3W$E;'$>GYCRZP.D#?0F?W2WVRR'O(X9B`.,1),"0>GCUTD
M5O)$B")LEM;`=O<02*H9R#U`JM4;'[FL>K$;HY$55Z7I_.R/1#PR;]?F?D=M
M%-ZF.@N@<K;1$T-:Q.U/X:/7$?E=;\;91$R@>,4MLZ/$L8K(JBL&,5TL"`0B
MI[K:YJ-UW:MUUT5$Z$[Q[<L=Y[2V"<A4+7@Q8JQH.@`K&T?^)U8_9?O1?:'>
MU[I>Q[MZVEMP$1E!9F$`L6!H*[5J#HD9%Y+7...HW0ZS$9)['$\?LY2!I<AB
MQXYK,<B4>"U[Y\:060%2HCR(CF.?KM5WQZG[/V_[FWD*A*\,E@#O,`#EM\/'
M;P&J_P!U[M=LW+5QK8=KEH-]7TEC/&3N.O\`CIER_)VVE2C+(HL6"TL@9S.]
MAD97)VNR-.TA+?3T8+54]$5WS]>K%:P,BPH*$\@#3YGIY9\3^,:0W,VW?N@W
M<=AR(\Q>HV!H.E-AIOS.>:N::+'C5=7+D65F!)I61[JO,"L>0:&2.R2?M.(K
MF*C4>JHU57551$Z&&1F]PROMK;JECB!6LL9\P@4@;[;;5K:+N?V_![/-VVUW
M-]25;D:(M?&LQQ$B:U,SID\G\EU4K-<K6+!B-#/N)EBD8I)(I@5F%4Z#=MC/
MC*H7OT3:JMT1.@VLWL/).!<*F];)D[`@==C0[@:"&79R[*]RL6RMFXJD*=P?
MBOB(\-#.-DM=)G@%(C*C%D?J*I0KO8C-K6JKF"3Y+\=/3TZ]>8"V2UM3O6=C
MU)GQ_P`IUE<AGM^BP8.1"L1UW/R^'A_#2@$59:3XD.,(H72#(Q7HJ.>C.X0A
M'-<-VB(P3-5]$1-OQZ5E[5QO4M"&7>D2=Z?QKMIG;-ST&]0CB?X?/X:27*B5
MXXB-52O;*`S:C6INUVN4FY6HUJ)ZJJKZ?^'6S,'L>D/JYT_AUZ#_`!^(T&UV
MQ:47;K1;'7QK3;>=+&*X)+BA9=6$B$6-`C2&H*'+T-(DS8R@0(WD@*+;[603
MXOT5R?'X=-6['EH@N,UOTH68/^X`C<1M0CH=_BA;O^)F7&Q;,B^'(/(113O(
M.TQ'PG3=CYW4T.(3,"AU=D6$2T-./)MYD/W0SHZ.QP6`@QVHUNZ*U?4OS7T]
M=>HK6:,*R,54\PO<B9FL1%```(WBNQT[]!KG\]^/.-UF"O2`3'^NM>-G(2RJ
M<DD]AMI=!06.FG*R*/:Y.U&0CSJQ$>FNN[X:)\-$2?([FF38>Q:4JY6)!-/E
M)G]Q^&VINV<<#.MY=SSVT:2`*L(@CPJ#I[666T.3`(.<V,;U[@O?(YKQIJJ$
M43@^R:-Y%7=]*(U7_)433K?`F^ET9MZT1<98$PP(GX1O^^3,:+]P]QLYSV&P
M$N*+893RBO(@@@RQ@5!&P_'3+7&ZHS"D$CWB*CV,8C]3-16N<WMA:0C45$35
M%54U]/FO1P[1CW/*"',;@@P?&GAX:KK7;Z0%(#?Y"AG;7JEP`<B<)IIRQ0QN
MR9BJ-4WJ(C'(+N:$'N=I\TT7_3H5.R@7!S8A0>D4BH!DS!Z[[ZQ>SF`9`%DB
MA)W&WX?C&I8>.V58Q3>0W%W^YMA`B<=U_+F,?O2?;`MY]948W8'+CMI;3@4J
M_=C`IJ*P(4;HBND,[2/%H1$3H+.N9%RW=L\5:YQ?B.O+CY=@)^!GH)T381#;
MLWFB0J\B8%`P)KX3OX;:?N,\:V$"USUN.U\Z2E-;\IXY-D#]U:0(Z0Z@D_&)
MSUM(XWFBW):<6KGM:5[7HQ4WIZ5H7,S(=1<\JI(D`#=0:[U!F@I21JW6?L+>
M%DVA!=V0J)),AF4QM3C!G8U!VUFPZAR;D:>:R5)V24POV%DN/'O$=4P3,!;A
MA94ON9S(D$AO9,,G;5FJB&UC4T1&J0BW3:]&ZX(_ENW$THQGP^?CX3MH:QD8
MN+F%VF'M7+>TU*4Y$'H8$;#2_P`,XO:8?R%BUSDMA3T<>MY-S:"PES,9$+98
MI>5[`05KH\&`4JQG%`5&N5C=I#M=Z-55Z9=OQ[CWA<2'-N?+/FXDBOF@,961
M42!32Z]G8UG!OV[JNGK&T00%(#*VYBH$?52!UU'[+O(2SR&?,RJ%"(UF&RI\
M&M"V/6XTYBW4I@"CKQ8]#&P0M@$5^_4CDT37X]8NYG<LNPS9-YV(8`02``8F
M(BIC^'SGS6<-+TVDA2*R2Q/6O(D_MX2-">?SIG4\C4K**FKS/(Q4DOCS+*6C
ME(50INDD&!%:IW(GZ:[DZ#LN46!Q9^0))$EB"2)/4\B3X3.O.`2&`Z$#_/P_
MQT-S2,XO9C7RY<QKY!(P"^W$&`WL([4(FCCM&C$&)-6HGR3HM1?>$5B&^4;_
M`!@;CK6FM0>*4CTX/Q_#_3PC1BRN)$6A.0,+51.<QA2*U'L[AGM=HSN[U5&/
M;IIJB*O0W<"PN(KA1``I6H@&O_CK?%YO99E,&LUK!^8WGH(ZZ2,@L8D#":"O
M5CFND2)$@SP(UYO<CB,&`":O:,32;VO5ZZKIIIJOHI-NVK<+UQBH$1`KX]3T
M^74Z$N.H5D4`L09GIT_RG0;:\;WE*4;7_41J[E155$?]3%7^W1=WP3TZ=<K+
MAKI,LI(CQ\(^?[;Z271>M%;:DQ`(VW\=.C&MR,N#@BM/[:LG%(@6;61P*B#0
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M9*QCRYN06<-TPYFG[6C`.TT:Y?3TZCP[RXEQULV'NV<IF8-R5%6%(/$-)XT$
M$4$T!@C1UK#QLVT][N66;>1CVD2VOI/=-T%S,-*!"BD-YOJAE!!@E=-X2<71
MSU7[ZYIK*V/[:<MV-.0</BS!2"G5]?6URRJL\5=X&,<4SEW#55:@UT:Y2>S7
M<JP]D]Q2PEBXCEB<@.RE3"\?(`PCZI*B12A@-<[LO9;Z76Q<_N%]TNH,9KF-
M:1'M1_,N75^X9[3AHX6U-Q&%3<4B"MX1X">*V9VLF1B_(6:WS**UA`DDQK/<
M!R:(8LUY)S02SQ<6"*')?&7=V#()SE8_1VFG3-_;O:DMI?P<KU[A!9^!7F@#
M<1Y1(8%J2#L5%*G4^9V^^@MW</(LWEXGFKVY*D0OGXL24)V*\H!!J=/0_P"-
MGQKRX1;E_.7+^#3)KN])Q:^QGCRWMZJ2-7Q1,GOA&@`:]S1[T8TO]FB[O7T4
MXZ]DRF.2S^E=8&5=D+*TU#+)C:F_PG;2K,Q._P"/?.(KXV1C6E`%RVQ47"`M
M4Y%3"K((=5Y$4/CA'^(S@*8*,=OE%FH3B?N:MAQ)C08Y7_4YS'CAY.1[Q(J(
MF]'E79_IU@]O[3=NO<MY/.PTB!!.PH(8#D*[K^'76@R,];D>D!:59!Y_"#,2
M*F(!(,36:::$;\1>/X[>0K.I\M<7FC$>0^1%M.(LMA?IRA/5&BD5V0V['-8J
MHBHY&*J_!%U]5I[)C7&-O'S;!<#9H!\#(#$]=XTRL=TS1R5\8M;XB"KHI)IL
M&($"LRT_"--L_P"(C)94@:1/*'A-0P)\N0Y9-/R-6&,)HE.T3'?MJP`(C]S4
MWKW&(NOHNFBQM[=O(`EK+Q#E$R`2PD$P($$]),@1(Z:)M]SP0P3N6)EK;*_^
MSZ=QHB0-X5R2*5Z@<B(TX4_&+RZ.@N8=5RSP+9M=(&\(DSG*8I9":)&WD/-P
M.-'U*UBJNJ"75/DGIU;[^`@"XK745@ML`F>+,JPV\$3(`!D"G@#JBW;'=;&3
MZ0QV6P]YR2ZPRJ=B54^8@[E2362HU';)OQ(^2PK";+K0\/6++,T@G>B\NU$<
M(VG<AG-:.YBUZINU3:NGHGQZK]_VQ>OMZEDIR9_,`]17]V_QDCIOI]B]ZNV[
M`M/:O/<1!4)/*!TXG>D=*T$G3##^,#RAJIAA6&-8$ZC;$?+E6X>1N*+*&!L9
MA'D1GN,KC2MK&J[<0:(B;=5^&J+,SV;W%;7JLC0"=K@3BLU+R0!0<JS3YU<8
M/N%E)4XUPLS@<6Q[CL3L.("EMR)C?<2!.E6;^-KGZ*\8J'B%;B.ZKA,)82,M
MP4PRV*M:0D^L]AG8%)$E!?N:JB7UV(B*BJ[I-F>VO<2FW=P<;+NXK$EBMRS]
M$4*S(,G:HI)\-7?VY?\`:>9C92>X^X8.!D@JF.+MC)/*X6)?GZ9FTJ(&EBK3
M<"K``8Z'.;^!7E%B\6KEU_CQEUX>-)5L]M"R1>.DL5I3;+%E9D$YH&HPK='@
M4/H/XKJJKMA]D]S7[=ZZ<7NE@J%CU4LP9/$^FUJ2\$&:$":QMJ7W;B>TNS)C
M-VSO/9>Y"^2?^T.:&4*LGU!D6E51+`#BQ)8&`5\Q'TGQO\IJ"?O-X\\WTT>0
MQ'Q8(L1RNS8)B,3>T,@M7)26U2[G:*KE:BZ:KIJK3$Q^_P!BT$R$RV(D%C;8
M3&_E*E:")BAWBM*'D7>V9-QO3NV3;I/%PT4_W;[5K7QVT7L%X.L)F&\A6W(=
M+S;QCRO21F6W&<(W%>6E@Y8:-72C&@2#!Q\?M)IK&#%$*0^1'&$;WD=W.VK%
M<86!AY%J^V5Z]G.](M:!MDHP7<$<9ZJ`1M68WT`+Q:/L'Q[N`A'.;@E:SO7I
M)`.\4H=.WF)]9&F<<YMD/-N7V>,Y'BL_[Z"CPR^K\VP;DDZ5DR6+-J2WLW/#
M$N3FF(&V81'R6!)L$K53JM=Z]O7.W6+&1V=Q>N7JO;;E;](@B1!0@I%4(HU*
MC3SM/=;N1<?'[E:MH$;B&+!BPCZ@`00P-"I``G?2OP%6-S''\PK;%J3X5$QQ
MJF3L.>&5LN&<`>Q)F"(UGMSQFN[3'L<U':^B+US[$[LN9E6\?*M%+WJ<2&\I
M(!B@``BM20=_EKJ7Z@>SL'VI>L-VCN-G/P<BQSFRZW.-%E7*DB9,;+L1$@Z8
MV"VUQ*S2@HI5M<VT:3)L8MG4#Q5\6@K20JN=,"Z?<A!'2:=+R&)@]2.9VGZ.
MTTV]7S%LV;=T.H"B(%?D#!WI7KKDE^Z\%5(]4N%FDF3_``Z1L?PT)+7$I7:+
M`>L-[R7=G*,P$90*\(RG6*HQQJ]Z.0/;V[&-:Q4T<OJBN4$Y_;K3,AS,<H2*
M%PK!MJC_`&^$U%9W&FR)S2V7L7N:R"09#"D1Y:$5+&8CP(G3GI^".0<OKA7^
M+P:>?5$D-.TJ7M>V6B`/+[;7P3G%-&]!L;N$]J/:KV_V^O2_O'OCVG[=SD[9
MWON6'BYS6U<!F8@JTD>904!IM((.XU-B]A[ME8QR<3&R;V,G)6;BH@^&XGYQ
M7<&"#I+LN!.7JB]KGGPNWEPE^WR$GTD);&(K&QQ*5-X5,53Q=ZC)JU&[M=NO
MIK&GZB^R'NLEOO/:VX@T]:V-A0>9A$FGQU'_`$?N]JUZ7VN2');\C&1XKQ!!
M%=P9TV,\K+&EJV0K!EA73-T5Q85@$L4^AD$FKP&BB(-ZJGSUU^":+TPO9>/G
MI8S<-TN8MQ059&#(P$B4=95A(BA^=1J'&%RVMX7@/41N)!F0=X(-08TW<ZJ:
M$.%X-.AYC'N\DNQV)[;$8=46$?$P5SG0(CIET=I8-C)M1#81&"8CAH_ZEU]$
M>O9LC$M71=]2ZXDVP(*>'F_,#OTC:HG0YX-<9/1*\5J_1IK`$]*=!H7%H"C!
M'DMF-<V7)01P(U6EC$*]Q-5>0"!<B-'N]%UT<GI\D'X,EH/LI('A_P`>M-0^
M1W$033\.@G]HT6<.PK'K&GMF,NI0+&/37\ZQC-4+!BA1'4?V^0*8S<)L>3+F
MO$=CV+IL16N5':(2]FTAGG/E)(%=O\*"=M;7U:VP-OBRDU'7_4^/\>FFI=8K
M1U(8AQVIS.*XXMT<PYBAVB>1C%CQV(3:9^K$>OHU537^/0&4+EM.=M%+GQ:(
M!&\QK>W#N5O$"W_B?GT_SU.^J<SC+\=TG.(C91;+*N9HL>.<%C)K)$NOA34$
M6`60(#9*5I"5*H<2:L,FK571>FEL&UVA;]X5#D%1/%ECZ2(KTF-MMM*KBD]W
M-M2L`".O3I/6:_QV&JQIV:VUE(-(FBBR'E(0BMFGN+`3>XJ.[;63K20UH1K\
M&?!J+HGHB=+'S[CGH#L!YC`_$FDS3XG3?TR`.,D#QI^WSTAU5U/I[,-K!'&6
M:!3)'))CCEB"XXWB4K`'8\:D&TB[%5'(U?DO6EK*OVGYI'/XU_&/V&M6M6V!
M#U0[C^.K[OQ1V<N7@?-.5W;&22W&;TL:9+9&B#:V0"B&4TAD=@!QHR"`=VQ4
M43!N1$3T7J]^VV;(2_?O,?5;C,4,B:4(,,>(*A6VGIH6;5G(6S;Y+00!(!!.
MT@R9/&0%:G01J0G->`W)\'L;W$:['(X(F%\GVF1D"&I%.;8CKKR;7V;8\B.L
MT]A',Q3=P:J]%1%U]$ZK+8G<,=?O\$*^`0U>/+@.?1@-PD*88`Q3J"0UHFW<
MOL']#U#P,'B1(7S-$?`#>?GKG+6SS4,($B1R#D(G%C(8<9F37^[<0.X;B/+/
M1B(JHFJHFB*J>FO2QC>=0P<%I,#8B#O^PVT0$7CR,%2-M*^)<H\HXY=59XN>
M9407>-&=&DY);6-<YTV*:([NPSS#QR/1AM[%5NYA$:Y-%1.AU_EWP/+ZA%:#
MIM)%3\->*GA02D[?&G^6L=?RCRVPHAP^5.00%<1HF/'E>1.<N]-'=M&SG+IN
MT^&BKK\.I?N<Q+<(7-9B8GPKHA;>.UR;CHEO8L5)CXD"I_\`'4F>'>8N98]+
MGJ3^0,@OW-Q.NRFACY#EV2G'7OJ\QHZFT44N)9P9L)\FLNB(YK2[';&N<U=$
M7J9TMW5)OH+G-I\P,SU,T/0'?PB#.E#V;1*K;4*)(D"NT[`5^/P.I@^,/(.9
M9ES)285D^5Y5.H*V%`MR%)F^6S)-R^T.:NDQK4$JYD1UC@)(8\+@A"YC@MW.
M557ICC`#*LXWF6TA6""9DGP)(F=R/W]=09=M%Q6NJ(++*F!`@C:!(!Z`UU%C
MG/G;RAX_Y1Y,I:WF+-8M/1YQDL"'6AM`R8]=3BO+&'6QNQ(BG,(7M8K6Z$<Y
M51R*KEW^H^9>O"[QONS\0P'PJ05(%*Q4&0:SHC%Q[=U`P13R2=_"IZ[_``W^
M&@_*\R/)Q*FM&/E_)!CCOEC<1K:UQ93B."<*2$?!>-%C"+M9M:WZ/CJJ:]1/
MFY5I%M*_\JM"`1\H(((J8^%-3)C8XEN"[14'KTTI`\R?)D=<\*\JVQ#+("1T
MTL.A=*<`P'L6*Y_VI6/&I!-?_;W$<FF[1=.O>I)YGZF7C(!$@P8XB!N!6)^.
MO/9M<22M!T!-/&`#2?'6\SS>\G(L=ZMY,G&*CAO[SJBA"0;-'(H-050D<-S]
MNJIH]-%T7H@Y>18_F*PEH!I6!M`CIN!XZ@&!BW)1D5444BA'Q/AN=*7)/D'R
MUR)CDV%;\DW^15]?-9<AASJV)7C:R*>+7)*2PKI2S!R(IK=[Q-3:QP-=_KZ=
M3Y.7D-;)M-+*09VV\N^TUEA&T:QBICV[J\@`K@_/RUF!N:=/CH38QFN>SK&!
MBL*^M[";D>1D>\TV0XZEN6C92#D5-])>DYX2P'(%PWG4';5J;%33JOY+WLO.
MM9+7;ZY5E@TK<,D5\K+,%34;;4&KAVGN=OLW;LT+9Q<G&SL:Y8=;UDL$5BK<
MT:*75*J01034==6NYED*8A45HK.!<2CICC?MC&9."5O%`K0&CA.E?'"JN($(
MVJP[D^INUR)IJE=M=Y[4,M\3GQN)=K*$0Q/0\8^,C8=-+[?:LZ[@C.LK_P!L
M\CD8$\0T2.LPT4DFHWU'G#.8J5P+FHG5-Q(LC918@K!6!#"@4LWW@8H(]E2M
ML1C9(`8;UD,W/W+KHGJG5@O]W2VR6\?U%N$0"5F:F3RD4ZB#22/AH+$[+=?E
M>NM:"*G(@-4@;A5CZX`@$B0`9I.HP%F99"GVY;*,%C1K=E$8$@3WH]ZF9'4;
MT<CW;SNUT1NNB+JB>FO(<W%]FYM^Q9]OW,@=R?*M)Q8L1QY>8F4'2/S?@=7F
MQE]\L%V[B+7H)8N$<0H,D$2*FGU&`.G2FCO1U6'RG8UCDS.[ZAMBUBOA@Q.:
M`S2H%%60.TC1HCS$G3!A1C0:]Y&M<J)JY7+7O>-CWEWGWOFV/:O:<7.QTNV;
M"C(4VPS"VH_DL[*G$/R)?9V-3TU>>SYGMSLGLO"O=X[E>Q;K+=OW!:(HG,@&
MYNQ)'$"2L+M$'6>YJ<<P@$*5<>0W)&+MG$**N-D6+VM?"G$:QS2B%(ETD6,0
MG:(BIM71NC=R:(NJC/\`;'ZH8EM3W?V-@K8)@'FE2#NLLP:#O4G?8ZVPO?7L
M[N=XV</W-?N7`IY1;1@`)@L!!$]#Q$G>>L<.6<OJ;S)+"MI;%]Q$:V!*CVYY
M19;98=JZ(P[E7NJUJ(K]-K6[DT_EVWV=@YW;_;&!B=PLBQG):/JVE46U1RS,
M5"B!29$4.\FIURGW'GX?<>^YM_"N(^&U_P#EL*AE"JH;QDP9F"#O!IH=#86X
ML8`Z9TRS)!AVD^5&A[S>T9%&SO'0;%(-1*)&O5_QVZ(O]OI>[%B[ZYO(@>Z!
M)XB3Q44)^%>FU=5V[D?D>YQL@[&>,F-J[F!\X&F%-ENEL'&81SHW=]PC4(F\
MAR/<G<?^FCE1&O5-/333K2X[%.`)X<ICX_Z'PT,0X'(\0XI,?NK.G[QXG9Q7
ME"0CG,1,(F1&Z.W;_=W%$UW]R*FB]I/[4^6GIUE)(<$PQ!_A%*?,[]-;NRK`
M%79A)_>?'X?QZZ'$5[`5ROV=S;]*N:]-5?N>]JZJUZZHCO37TUZ&Y.'67IX1
M/_&>NMKBEV!7ZO&?VIXZN$Y.X])9>#GB=QA&,2FG9K?K?2#R&1CB&V32Y)E9
MBM#(L:D1G*.>Q-7G9HJ)HG\;;<Q3D=NQ<6V]FWZG)BS^-!6*B8IQ!!D37287
MVMWGOF+A23"@\J>6#0QUV$1_"GS/,>#A>76V-1;>)=@J#"`EN!([P'(^,(I$
M:V!86D;<%Y%8J(9WU-^K1?1*SEXR85]K"LESC'F6>)FM)K`^-=.<5QD6A<(9
M.0F&!!%?E/32)%=%<!YBF!W!_P!HEW-(1V]/J1=SD:UJ*NJ::^OPZT3A0,%"
MFI\T1X`"9KK)!+4_;_4ZO]_$ZBQ^&<\F(H'`+R"4Z#.]'#3VU!!:YZ#<CD*X
M3D1R-<US7(WU14ZNOMUK0QGB?6K`'7H)-(W*S,]?#2C(/+NB)Q9F"`4\6,`3
M3C-1,B":&=6+3JY+S`<FA.KQ./88]E$`*.8CB=V3`L8PVC>S0JM5Y=--=5U^
M"^B]`X;W<?M#6T=O2"O(#&(,D@3MQF!(D1K=\B^+A5686F-4GRGQIL)C>-<>
M4U\H;G0IA!OD0"R*PL0K%&<!HSU$6.9&JQ_Z;Q:*CDW(YNGQZJA\](E9WC^/
MAIL`LBX.HGYTTJ8Q76<^ZJ8<&`61(-9UXHPX\>44A#OE"8$(QC81SGF>]&IK
MJW^*IZKU(+8!YL(1=R20(%=_P^6O-=7B56!\OC_AIV6.$<ATUY8UI>/\M%+I
M[B5">T>.7Q%;)@3.THT<&O*)Z*HO1S7.16JBHJHOKM+7$#*)!J(K3<?.GA\]
M1M<3@267C\_#Y^&C9Q;QUS!>.R.CC\:Y-6GGX+G$:+,M:F72P)$B7#@3*B`R
M;<@@P_=2;:O"P+%?J][M$]$],,@R56S3U"P"U@D@[#QI/7K6!H;U$1PRL"P8
M$@2:`'PZ":_*NI7^/6%9W@G,]?G^7,HJ'%,2QZ=B6<V-GE6.0"U>4UTR#:AK
M705MON$E$?.'M)'82.[=JCOCTPQ[=T9@1+9-P6@`M8Y;J.41+4B3,?+6F1=2
M_8](SX@UB"#4DT%=]XT`O+=`YWS[R=><<2&93CN5RZBX#.JG*...06M@#M8\
MD<Y89PDCVD8S7*K-CMR*BKNZ9CL/>.\=UOXO;+0NW[7_`%+:.C,AG\ZAI7S&
M"2`)IJ5[-_M';,?N7<[5['P;X_EW'MLJ7*;VW*\6I_M)IUU'6-Q'G\FK-_TM
MH3QYL1L>N,8:GD`DQY##2`."I@+[<@Q,5KGM<_>BM1VCM#K_`.G/O&WCMDY&
M*MI$)GDZ"%`GD9)``ZZ#M=_[1ZH2W>YLU``"23L`!%9UXM..;[&6!;EKH5$(
M\F%`$KY$@I"23%`YJ&]L&0^.&/%[CWN&PCFJBIM55Z797M/OV!@V\W*]);-Y
MPEOS`DO.T"#\36(BL'1O]4PKCFW:)]15Y-0Q`W_T/@9&G))Q+&1]T3+>#4F'
M$CD!*&N27H[`Y21S@89)-36"C1GB7<KVH[31&Z?4[2%?:W=2K)EW;9D&(H1\
M:5(\#H9NZXUIAQ5RY(-8@CIL/EHB8[`PBJ4[;"\@WH)V'RAO@LL`T;KPME2C
M5*\'ZQ[JCL'7\4(!)[4SM"N*NUB->LK=L%@MCW";C*((!`Y2*\2:@"/"3\(T
M/]UDJXR;?&T1+!@)*UI0B#XGH=JZW,DR3C)\3&'UW$5CQ-E5-";)H+?%<UR3
M((0LEB2PRXMC?5.=KD<.\;/]NU#,A2:U6M^M-^Q!.SGX'952W<L8[6L^XA)A
MRRF#"@R#)B33CUI31.+E]XN6&QLB^;V&K?2P4?5!9D"A2FQWY30$Z9M1RKR$
MMP-^2V;3PGQ)?9?'I\?K4;8RH9AA+%G)!:V4.!-[148]7C>P:HJ>JZIQB8V,
MY<6K))@L?22LGD1+"=P9*G<>&F7)W067N7/3"`<?4<P*J!`?RF#`V/CIR8I1
MYKS%GD"FQ"ZC'OLGDVF23#63H=$.YCUO:)?6$FR/[:-'/V&(K7-3<]ZZZ>NO
M1]CMEGN^2F-B*@?@2>1"*%`D^9C`C^/XZ#.6_;[+7KA`8L%@'E'0%MJ;U;3H
MGQ(EE='KVV!$`2V,LD2F*TPQ,G=U[T!)1#>@A*B_VHFJ?S7KB/M^QWQ.]V;V
M?;L7<)"6-P+9<B%,>9?.OF(K\QTU?>YG!^S=;1=;FW$FXH,FE#Y2L3(Z4-:G
M2%C>*XU6Y]57\&\44I;R1)A13S(SA&E&D%(T$04Z.KRGCC:A%17N551=/I3U
MAR/U#]T]ER?ZIBX*7;>+=YJ65ME)/G*M0'8&*4TQL>S.Q]TMMV_(R'M+D6&1
MCR$RP`\L@3`J1)W\!.I2<^Y?,B<+8*:=;'L,?YEC9'84D"\K,&BV:XIBMI(Q
MBTGFKZD]I>TK9%\!PX:S(]=(EL$I@[@:/=></]9/?WNBS<[+W?'[=9[99(\U
MD^H[$U%IR6<+Q!EXAN4<2!05"S^C_M7VYG#N(?(NNUG^4;G.V02?^JBD*&J(
M%66O6FHWXGP;@?)F/64;CK.K&?R1BN`WO(^08C9TK(K*W%L/KTM;]X[@LF%#
M/%C5[6O$T+RR"(K6M"1^K>JR/>/NZUWI,'-[/8'9&R!;3*3(@D-0$I<.ZU!4
M1MY=,C[5P+%B\^'F&YD!/4N6RM5$"6\J_F)W\T;F*P`FXA9U,R4M"RT<]0VT
M>0H'/BR!C;)"!^C$[94B.&1$1RM1KT=K\%ZZG9QKXM&XG(W*T4&:4)IM,[=?
MCJGW<NT2!0VR1#2"#^`\(_?I!9@MMWQ#;'/'DE4;`>^$<,<9'(14<<C!L:OH
MU5]%]=$ZF?$86@Y=><24(80)ZF(\2:UC\-:8^5]WEC&LJ>)I((;;_E$M_#?3
MPB0I5)32ZB)3K'%FN-LC2)$NT?*>)\2QC%DS0M;7PTB`L)4+4`7]U6#7^]WQ
MZE^T2X+?I<0+JDSRF@H#`%`Q!B9D?+6^4US'+<U=F5Y`"D'P/U0#`()B"*#3
M='B:#BNBOF#U1C6E7<NU>XYK$3>@4$YK%^I?J1=?Z=8N]BI6Z@>)`'*?#_8!
M-3^:L[:'L9UY[RHV/=528)/&-IZ/-=A34Q!`\J.=,*J,&?Q]_NI@W&[H\*A&
M_#Z,T:`Z#4BA0R#GE^VV$MR52MT>KRM<QR+KJO5E[3>[7W?";$SK=X?;.5'(
M1(`K<7J$8]8C0G>6R.TW+:V;MMDOH+@],EBG(R5I]+?[UU#^7*F0AL8_#./Q
MRG.<-8+L#U*P@B(-X4)[ES".&OHKO[55/CU2LNUW7!#Y&5VWAV\56XW'B5)@
M,/-])-!IT@[,ZJY[BOJ\999N^0]0:1(_X4UAI;PUN68`>*<<!G"-71(58W`Z
MIY[.9-L!P!0HZ&?HAM[_`(NUU7T7K;`M6<Z[_-%M+(4$%0?,Q90$@&98$GET
MX_$:!R[KV;MM,=;EQ&)E^9A5"DAR.O(P`-^NK9O''@SS$#C'*<&JS+$/%#'N
M.\$R#DZIJ,WQ^EQ@/+&4`[<)./\`!VUU5./<9S>M&UD8)GN8NC&M8J:[:Q^N
M/ZJX'Z.M[:P\+VSWOOUCW%WVWVPGMBEEP!=`)S,L@@K90$%FV@,>0-#8O8?M
M9_>ZY>5D9>+C/AVN2FXHFX0"8J5\H`\QJ02(!G0?J#?D%N(0"0X^<B!./(EC
M=*CX=7HZ65Y$.;9)[*C5'HY5^EK4<GHG77T?VC:9[>0Z&]90<UEV(Y>52%4?
MG%)`J*=*46^<];I]-27!B0(VUG#P+YO7Y_>S#0*DLD_==+L<@P*ND$DE:Y[Y
M!GU44YB%(_5=^KGJJ_QZ#?O?L1+R\4YY88(B@/)8_E"EE60)FFP(),5C1.ZM
M:**?Y)$FJ[>-:[[:=`/$/RWL'(EARU6U)">BA3/<I-)1=B*US!5M>@%&B)\&
MD;I_#J"Q[J]FG+6QC887+<A0K(BLX`Y*P!+2O%202096")KK`PNX@23MO#"D
MGX?&/]=,;.O'"XXTBP)',GEE1XL.S<58<,MAG5U/EJ-4'(D`KTEMD%C`=_>7
MMHQ'*B:Z^G3-_<>"A%[$Q++VV,<BR">,BD(T@5`_=KR8.=>$AF)ZU\?Q%=/V
MD\&L1R_%#9C3<\SLWKS0"RZNPHZN.:'920C<X8TDSK>41GZS4&]KD:03]4<B
M+Z=*L3WEGYF6<0=O2Q94CEN6()6&4\47A)\S`OQ((8`@Z,N=HN8S6CD7E_G"
M?*P)6I4\U!E30D*0"0010B<6'>"F$7-GED2\O\VDMH+#'C2'1_L-<8(;K#ZK
M(A-F(6%/<JMLTD1=6*WZ1-=JFJZ27?<V3B9'!K2(MRXAV8CDQ"\05)`CB/J"
MB:S)`T.]FR[!+=WU$"L)`,$#E6M8CITK-1HI8L#!IO)$C"276,QJ/"L<R%`1
M)D6)'M\;EP;R*RY2S,R&L616VL@XS@>PIC.554B,5$19NS^X<%.]9&3=N+9R
MB'9RH:V1<EB/4XF?J8,0">3"#10-6;W)[7]P+[3PLKN+Y38U]D:T2Z.CHMO@
MGIH>10VQ*M*+%(TEYC1W%/QERFZ<^N?D<*MF6F#Q:Q(966D>(,-DSM/J%>II
M9$&I1*1&*]FG\DZD.=E-VC)Q;]RX;QDVSZA,6[GE/+D6+$D`@T)!`F3Q"Z_@
M^V<7O/;\KVLF4+5E%:^MTR#?!)8B9(&XCZ:P`>D'JFVS?([3BBQNL+BS$Q$U
ML+*!YW$A-K[6+87H/?'BAMSB>4S:!K8S>XFH3.7MHC514$'N#):WAI>_F'%0
MKY_,!S,%P!4&%(!J09.O9&!CW?N'M@AK]P,0A*B>BR3`!,DBG*M-$KR+Y<3C
M<..T7$!,3G6TB5>9#:9+#P2D50TD6S(VFQ_MS*9`NBUT0G:*4;516"8B/3UU
M`[CW/,5UNXMY^$&5BA\U&,CD#`C>"/CHC'Q<*Y;:T]FWRYT8&6"Q]-#QB8-1
M/QC4>[K-@9GG^*Y\.LKZ-F1U^(%LX<6&R%%CST)-QFX="&WZ"15LA/4;O7=M
M^KU1>AONFS,E;Y\I<09W_P!I(^%8V/6AU"N,V-8:U;!9T/)12#61-!$B*:(;
ML!AV]=3Q[BQN+F)3PUBUH9>2SY=;'&)J]SV$2(Z$",!!JY58)?1%714^5DM]
MG[AG(EJ]_P!-``H+NP5>D"@_=0'8>`%S,R.3&P&66G9>IK)()^1.\`?#3K@\
M84Z161P4BBBQB.E1O;M*5D>40>ULX!"O.=YG)IN7<I%1JZJOQZ:V>P8]NVHR
M77T`T\5(6NW@6\VTDUGI.HCFDL0UQ1!$U%12A,'J)Z5_=HBX]QL.+,I%C"&`
M4.4(44$-DC_``]XW.%'0\<(XX7D?N5!(C'.77UU]7F+VWMV*%%JW!BG(21$G
MQ(!J?C^Z@5WNE@$T+$D?45B1\N1GY^::4Z#S./'#D#'J:UR+CG)P<@UMCD>0
M`A54;)#+<0:?WJ"C+5VC),RCOO;MU:1@T')8USG.9_:J<2N=GP[-\MBV4^[<
M$2!$!O!P0"#'6/"NKBW>LI+*V,Q[BVU`+`B1/B008K202/PKJ+&2XAR2`.MQ
MQWD<.9`:K($B.PLOL2B2PE*8KH@AJA&QV(-J*J.^M')_#H5.T'$5@F.W%A60
M66!7:(/CU^6CG[VN;P=KX++M!"]!L!M3_#3/^Z9Q,37)9.0R25E2Z!2LOW6)
MR1XD%2E#5USI[WG!%B[B/:$2HQB;M$1->E7]'PL%",#%MX_K7N=PV[:IS8T+
MOQ`Y,1NQJ8$F@T[/?\_N0#=SR[F0UBSQ3U+A<JLT`+,2%Z``Q%(C3OX7%;.Y
M2P2^OK'*<.H`7=1<R\XQZF/*L85?5O;($^H0<FM%-.=8R!:B':B(Y7*CD16K
M8,+`Q7:TF9:G"5@\E`Q\IY*0&(!/*(/3<;:1W>[9F/<N9.+?]++*,A(<K*LO
M%DE03Q920:$$3((UUF8?Y<^)&<AK;:U/@SSQ(LE\JCR7#:MF4V,U!QF"FP[F
MYKEJ`D<9KGO9+T8K#JT;O3<G:[=SMF:3<Q+J"\WF'(\0(!$$$`SL`%,RLD;Z
MY2W8NXV[\6[5N]C*%",C*A@@<_*2H(!D@`#X+41"GG_@;P\RT.6S<(N38!9'
MC_N"@+]WBY'52[(3GF6O^SQLGGU$.OLC&<A%&Z.\**U!C8P2H^O=V[?V>_A,
M+CFQF-SGB'O@CBU.">H/-N-FIM)`TS[3W#N'9LVQE%5RK2754I=\D`-!9@5M
MF5W`$B:UD1$SC_QEX=P4%_-Y-Y/ON1GV+7LK0<51*B3:T)5C'(QD^)D5@L.S
MBMFO1J#C/1S!L1_Q<]O27M'M[MG;F895\77N6;2VRJ-""VL$-R'$S/D`(@[T
M!A_W_P!P7^Z6[?`+9XWKMQC<\P<7&Y45/,L4!,="`NQT#)V#54VZFBQF@OCT
MBF$V%^Y*6.VY<YXTU0K:YCXZ%W+Z(/5':ZIIZIT7=[0JWB,=+BXY%2Q4P8_W
M#8"N\"O72ILA;(G)N6^;DT5NE87]VPWF328$Y/'VS_V+XZRS))V)9GD;+/)H
M]0^AQ3VN972&!6QA/,RKIFODTPHJL<.0&2U9`EV(Y4T3H7L79;F'GW5Q'-VS
M>+M#7E9A+*259G`6V/RVXD0:F1JR>[?<N1[D7MZ]QLX6&N)VY+-LVK`L>JB3
MP>[Q!]2]<GS76CD1)C0V_P#Q_P#!Z7@UGRCE?"G*^,0Q90VHGUT^VRO]P/LK
M1CYZSV5++X+D@N5SMZHC%&[5-O4V1VKMN.L7[3L2_$0Y:M2?#:L@`UVG2"WD
MYK71:LWT=N,TXD=/`'QZZ)^*>&?AI;5$;/,5P#/6,K8]3E$$;[[,8LR0P98]
MI6N2#.G]B9J8;7.$KE]6JBI_&$X79\=#EI;NA;1#4Y$@!HD"D@&O78^!&L6L
M_.O7?M1>4,S%26X@+TJ2(@Z.7D7BN1\FX#@-YCF.7$]M7R)B=U/@E]A36./5
M*&GI<7,\4U\A!'C@5BA4:(4:*Y6JJKIUK[A[?A=][7A9CME6K6/FB\2C.D@A
M57U0!/IT\P)@R-M=`]C>_P#,]A8W<<#"M=NR;W<L6]AW6OV%R@ENX$!NXI8`
MVKRE2/56H#"@B=0<\T\\S3`^$>.;[`,JL\2EWF:W8+>76V*Q),V"`%H;L'%)
M<5J+[@.YK!-:NK5U_AU3>"_<Y(86BSNKBAY@+*@-/4"BE:&#JN8ZM?O%B.5G
M:OC/7IX_YZA;XK<T<BWO/F#IF&?9OE5$P>32I]3+MK*VARDC8M;R0[:WN/CG
M.D@37"9L5>XB;?7H["O76RE4DE23-(H/,":=(_=HG(2V,=B`J-R$;3,C\:C5
MNS?(RNE.:W&N.>3\C?*&QPT%B:U,9X_J^KW%S,KPM3ONVN5/C\M>C!:P;>4+
M]MKD@,`H7R`5F`10,6)Y".1`DTC2PXET$ABD-$T)-*C;]U:135#'.N=9#SAR
MYE-_;[HJI92*FMJI\IO9I*ZO.^#7TK7(YPU=#:+1RMU:I5(15]57I1D/;4K;
MM`)BBB@``1T@=-.[2,@X+]4?C^Q/AJ7/X\+[D&)D/)O$D*XA4]5#B1,PEQ+R
M!(LGQ)4.>&HLH=:-MG7@KC3QR![RNWM_3:[:J_%MV3)\YQW8<6/E'4GP'X23
MU_CH+N"("EXH29X]:?&!O'QIT\-6=UUHE9RQR[6F.*$"VP+C2]"R2481$DBD
MYU1G1JF*QA#[8(E1=5]=$1/AU[N&+<!MX^-*6`X=E-5,.K;30U8I05^0A*K!
M4ME?,#<(!K/2?`==(6-<7\9/'9VT.XLYK'3)0[60*X-7PFV;6+(G@DOK@UFL
MB.AM'NWJUVJHY7+KTR_IQ>V[I:M_<N6@D,=S'F'*"8@D4$[14ZWO9>9</H!I
M15B/*3$[;2*Q(^`,>(YRJ^\=L0]RR_N.-1"=-$(;;N^JYUB.(&,T!1RX\RQG
MRY+W2%>U%:Q%:-?7Y];VQCX+7;F3>M,K&@\H%M8$J/S$<ARJ2>1.CVMY-\6P
M+5P.B#D9<ASR)GS'B#'$4@4!B221;>^7WB]B+E#1VU78G096,_8^(.,HTT:J
M1W3F1*\!&O=JO_.<U-/5=>HKO=NVV5XVJQX#KMUC_/15S`O7`("@TF2)FOP.
M]-J[Z@!S/Y"47)5_%E8W4Y)15RX/9898/LGQ%-9QSY)#R*$1D8!9+F16K#:Q
MPNXU=53ZE8FBHKV6N1<*6QQ3AYI\29/[2?EJ:QCKCIQ)-6)D2(I%/']VMG`I
ME-48[15K<HC$/"',<(X\=&ZQ@CMDLBR:T$^3$D%;"$>T(]J*BZ24:4:L<B=6
M;`P.R?:IZ^;<#\9A;8!!->/,JWTU`(&]1OI7D79O/<:T><@U8QY32E*_A44(
M.VC+33*6KKH\&&USXT42!"*2A`C<QB(C5(28[<18XU1/5$=IZK\M+E:[C@V\
M46\5F^WLJ%DT("[CDT;S),03MI3<9KMR03QWD#YTFE"=Z?`#?3@C90=B.^VL
MW-1C'M[<?N^W8)&N?MWG&!=ZZZF>K4>C?CU+8[IC9-V;:L6()D*6!H?A`!W6
MOQ&VH6Q4O,&OQP:9EH#$@QL*#P437;2E`R:]EVP)#4F=D4R*..\:QPMDJXP]
MC6M$`HR/:ID5S'+K_%/3T)]>_=5E9&10>I!#0#)$$P*=2#K;^GV[(-OC;"F"
M0:Q6*5!`I$[_`+ZZWB;RG;RWR>$HXS2IE,?(+_'#L;'DGC0/?^_MZW0OZ2.`
MXZO$_P!?I<J:?2WKFW;<7MN0PL0YO\8-7:1N!"$U7Q@GC(--V'>;6:W_`'5A
M?YH99`%2!N0*[BA$?'IJ=T[CJXREZSK5MU#DG<,_NE*RG(5':/:1HH@MTK<B
MHJ;FO1&-^*(B=-+MH]O7ACX^1<,,\+!)`H[MS*A8_C\SI+8]6Z_J0.<0RLM(
MF32"``>I(K3KH8Y3XXU%I*@3+BK#;SX8"QJ^0Z1,9(BQI$9HYA`LK1@]ZLV+
M)<$AB"*[:BM:]--.IVPLB^ULW+%QW](W!M**=RRJQ@F#6#29IHP#NBH5QH*$
MAF@`^4&*"#216(\3&D:)PM%QU(U7`@FK'QA?]/K7$>E8."%STBHQ+$0F,4B.
M7<B*US%331W6!<Q\1/MRZK;'(P9\H$2*CD`.G0:`OW,US%P<K@EJ"")%""(+
M1U!^4:P2L.'Z%+&@$<'>\RFCQ7I+C)&$CW,*R,-6-(I&M:W7ZFHW1>B%9&0,
MI$$]":UH>O\`&LUT"US+5#]:6QX,P$@]!)I'CL37IIH%HJF8X[8R1$/&>0):
M^'<$KCJ7MHY/\)H0N=O8K$5&O=\/BJZZ;S9>`K_3$S(CKO,DUIK=LK,"CCZI
M4P"2`\@;5:8!\?G(UJ2\6;!E=TUM>X_W&#-%$LH91C(08G,`X<PCFNC:.7U<
M]ZL7TUU37J4A!YV((BOPD>`BO^)\-2V\QG-Q;F/8NL``"5I$;R`.FQ`V'S&D
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M/A-/`?,:RL\@?).C<%XLVY?JVA1>S'CY%F8H@V,<T6U(;GEAM&-ZHU45B;5T
M3^'7FS,JT0AM7%(/+>Z.@^-1%8VZ^)U*+.)<$(;4QT"4D?NB.G^FM2Y\IO(&
M>^"E[R;R&XM;,^YUWW._G-'"L6AD1@RF1Y,5C'JT,E[=I$<UVY=4UT5![_<[
MMT&W>+BAH78"OB*2-Z'1>/;^U!&,51&6&XJM1O!CQW.K#>#N6/'VXX?Q%_+V
M<\=3\U:`DB[#F1H$VT^XQ9EH*')E,FL<P$EL67JUS&[U8[:JJB^F;;X5RVAO
MNA916=Z>/X4),@[ZCNV,RZX4<OMN1@$B!.\#H#`^6B<O._B_C<1ZU>=<<B:-
MFY@:0T,QE1F]408X`U(=4<OHBZJB:Z)\>IGR\*8MLA!G:G2/`=-$+BA(94B)
MC_B:_P`=-U/,KQNQ*+%>N9.M948#.U54])93S(QJ=Y@.X""*$!KC/5=7/W)Z
M:IKKU&N=A6UAV/J1T!FM8_'6?0N/;(!`D'J/':E8\-50<9SL&O>8ID_-[L.,
MXC9760V4BSLXLT[(L2Q).,!RA@AE2?="'*:YC=FCR-1BJFNO5>*B^CVS0'XU
MWV&_[]$`&V0T>;PF!^WX:W;/G:1B/,_(W(7&-1$9&R"990L<)<QY2NJZQ7+'
M@68XD*9"$ELZ,SN:%4HA/?KL5[6N26UDG"O%K07EQ(!(-/B/C%)UBXJW?->.
MY&Q@-M3QBFW7KH/W.=\AY(7W-SD-_8')$9#.>?:3SGD16$<]@I13G>60UI"+
MHCU5$5RZ::KKH][)>6+-)$4G;PU,H4;P!\?VIK).R;D?(P`@W6:Y78PA"'$#
M"L,AMYD=@!,:QD<4)TMT?MA$UJ(BHC6HB)UK<?*?ZF=@!U8T_C^T:T'I6VY(
MH5O$``U^5=8H^%0AM:2QD6`MSV-(X%>XFNYNJ[2,[BO>CE3^/HNO4PPF%+YX
MJ9V$@_,^/RUHU\%?Y<%OB?V^>C7C/&^*`0![))`Q%1-II<*R*35/J^H;0`8-
MCFKZ.^*_)/FC#&P<)[G&YS_'PB13>OQ_?2J[(RKY!-IK:J/$[]-_$?.-%V@Q
M3$B6$:LB1!'E'74)IL4482C$S:J--)D(J'<U-4:@G.>OHF[Y-\+!Q;MST;4"
MIK$]*4F3/3;XZ7W,J^J-<N%BBB@D4WK`4""!U-#J<>"^--'8P16-E>.IF,BL
M,5JP8((\1R$[+81Y(IQU<8PWIHNS1=R)JU45%>8*8_W;VD%E+Z"`6+00:!F`
M4D>:8$,U!O324]SNW7'HHJDR"8+"3&_6AJ:$T(@Z-])XR\91D`UI+V>]S3R&
M[FP9"F(L<BD9&(L5Y)*/")ZL8(;7*B:JB:JJ60=BLN1QR+2.U%/ILK=2PAP"
M2P,@CH#(((F6_C9^8G)\FV)-1!0"#X"8!)!J3/XQI_@X-PWO2'^P/([(A=L=
MK#8(4@7:]J`,<,<922#,;L[K]7]A-JZ+Z)U/9]OYEU3?&4PL$%AQ1"W$\I5N
M7TM%%()@T!(T/8[1">I>O'D`2.$^7B*\AR6A'T@U)'05+IQ[C+"H1P@=B^/B
M*V3&''C]J,5@SGD*KVFDJQS4.(@]SOI:YJKKIHOI/:]J95NQ=0W[MU2A*02H
M^$EN33`6&$`2P`V!DN=J>[DKZ;M<8B2P!6@`,P>FPD2)!&X$\^W"^:Y1QSS9
M4Y+BKF3[>5-O:$`)#.\A&7H3P>X0;51I`,/M*C45-JL3543U3C?8,W)P>XK<
MPGXY+RHZ3R!!!H=Q2(GP.KUE/;L6FO/(LJLDP0`N]?\`"AKJS&QYCYZN(T-%
MGTN-LBH2.Z)`B1POE`,5R%&8\Y3O&R8FJJP>QBZ)HOHB]7Y']Q&_ZN1E$#X0
M.D_5Q$<3$0)$1,UU6#WGMZW'NHY:\QW"\JF@(V)*[`BHB:299=CE7*EX(T7(
M<^+&<I""K60R.$V*-S&"D`:RN#%(]#M5R.*\BD3?HNY=.@CC9N4XNY%SU7I4
MRQ2),JS$_'K!!:/'0]SN-JX5OV4N%E$$F@B3$$S\>A&^F@>)9J8DVRS')BO5
M6%()"S2(YXQDCM$0$F:<*]M53:CT?HQ/7^/4I[1ZCFX['FP%5\L"-A5OQ@5V
M,ZR<TBWZ5FW;(9JDD1N&D4$G\!7KI+GO.17H>3<O>@MBNE3T8YS^WJU6MCHU
MB(C'HJ-9Z(JJJHBIITXM]MQQ;XGS+(,\FY=!O(/\*TWUBRR69=!:`:IXC>O6
MIGXR/"-(#X*^X"C7ABJ(1GN'*.V8A4>PS.VYTISV:D:FK531V]=-VFO63VK$
M5%N%6*J9W,&>I,%C$[S,4VIK)R3;M&[<0<"T4$#P!Z$$$UWUC4\*$4DA@W[V
M.D(TK)$EA$2203SJ)$DL<-'KJYVQ6(B^J)_$:Y@]JL%WN/P+"M28WH#N-"G-
MLO:%MW$&#P!!%)C<'\/Q!CIC)?A8!4='D3')LWR)$!DE'*YG;1!N<P).VFY'
M(YSWJCFZZ_-%S7^VV#ZEI;CH6B0I%)%68@!@#UG_``UG^H6[CES:=%CH8^1(
MG>@$`1INVV6'8ND6MF6/;:[12-$P^YK@D57N(26][7.#_5$737T1>ACWJT+9
MMXZ`VY()8^!J*@@_$T(GIOHZUDR?36$)(CD3X&D1\?A.A;>YW?HC5#B;&O:R
M0P7<(NK%.CF&5@6(QK&O<FJMT715_ATIR>]Y%U5"8Z&&J8F8D4W('S\*Z,&*
MMQH>[;A6^,@4BI/X`]=">VY#Y)<T@@./4BWOW,@QQ1GIZN3:]ZM0I51-$5R^
MBJO22[W/NEL!5+H3X;[UVB?'31,7'!#,98"!7;]OVC0NLCY/9$>:P).D/(][
MWNDN,7>YSWJJJO\`:Y=W\?37I6Q=V\_)G_CHI%MHO%0*#^'B/]-)@<=LY+]6
MPC+KN55[+]$317.57*B?+5?^'6JI=:B@GPI_GK<-;I4'_72Y#PBU8HB."P:N
M7</<1C7+]'JB,:KG*[8J*B?%>B/L\HMQ5"#&Q@>%=8Y(03X?Q$_X?/1(J.);
M&S4/;*QL@J*C5W(YBZH[:A'O1W;:OQW*BHG\NC;?;KEQED_S2P4`5).TB:#X
M]!70-W+1"0@DQT-!_E^&C%B_C5:32/$^(AWD$UC98R.(-IOH<YA'(K!*JL3:
MW3X]6"Q[8OHY#KYNI8_Q`6?'X"1H#*[F+2`W"$831C6.A`$F.NW^FE#*>$(=
M*/V92+W8[E1QQ@$!C][6/U&5^T:HU7*UVOHBZ?%43H?N':AA60[J#:!J1,B=
M@?`[BNH,;-O7AZBD%")V@#>>O\/GIFDXFI3#$QQKL"_2I5"&-.:TB-^*.:U5
M8)VNFWYJOP3X]*F2P?/+!`LS4]8'+RTW_P`>FC1E9`@EE8QU$>$=>NG?CN`8
MS219.AUG2Y"-&T]A'4!(;.XCE1@A.8SN-1JKOW*FJ?#IECX^+Z5QA#LP,5*D
M`;S(`,4B&@`[$[#/?N.X#MQI/E^1^/7YTT]5KJMC8C&!,]([!H9S)#A]TCMJ
MC5$&?M*Y45-=$:FWT_FA!3#1E;T'\HDE3)FF\$[^'Q^.L<45&6W=\T"`2O\`
MF-YI(.E/;`*Q`$KWD8C-&>\:Q=W<U4:"<,Q"(K7IHU-'K\O77IW9':[X5;5A
MENC>:#X`Q+&?``0#.VH6YA23!(Z;C<"2TB9ZTI$QIT4K3P"1VU%D^G>K#RGR
MX,83B-43"*D=@Y@C25*\GS314555.G"86+:M"U!0^`B3-88L)($].E)&HWQ0
MR^H]M?4!`(D`&8DS'AMM/73PA\@\DTB-<ZWF6.JL<[[TBG8\;T(B+W@D8KCG
M=HY%5=%VJNB:]!WU6W990ELB2"S0E&^I@%)(I^XCJ3.AFQ<=V)B(ZABI\9*R
M1'S`^,Z,=3Y29<D"+%]K"F2&$2,.2-HUWME(,1-BED;@M<STW;=K7HU%54]%
M.Q+5]KJ96'>N$"880:'H"RR%%2`9B!L!&@VQ;5EP2Z4$BAFDQ])@@?A23&G'
M$\GL@C3X\^S&,)8R-@2WC4D]!$1W:&J5X%C>WE-"]&N>W09%8BHU-[G=%\>^
MAKOIY+>N]?!2`(4$,"L@U+""Q`D0!,BF]>5ABDFRX$S`Y&29$T/0CS?\L;:.
M.&>0\:]N8$2\K;.-$+)[\<TB$PPA%*6.UIVLB!8U$>QRJJF4I6.5$WZ(FI&-
MWGO5M>-[^<Q'$E($$#\H,T!W'4?'<6[W&YC796[;MV@`#6I68%:E9_,5I2#-
M(HHX>CTMAR]##8P4E1H4FXLMAB*(K9=>][X4MSA%#)0(I"M78YRL?\%:Y/1>
M1>W;%FYW5$O@OY6($M4@2"(ZSXZO/>WN-VYTL^20`30GY5G]T#YZL2??5ROT
MAP#V)%1$E;@O8USR.>U!L<V-ZL$FKFN>YBZ*J*FO71C:N!B;@`MRT3OOX`P?
M#;>OCJ@K@,BKZK<#QWF1^XL3\"!(TBS,K0(QJ.C`SLHT:?YL5SW(NBOW(^01
MKD:YZ:_#^FGKU[T;1;DK<1.\&9V_>?E/0&3HBSV][O(FZP/4\3QWWB)!,0`-
M-0MHLHQC!L7;Q(_TB0!-(K'*\IAMD&(P05#M;JNU':>C55=.F!L\%`@!0PW/
MX"FYF=J_$1HP8E_@H95XG?F2?@#`J=Z23XD;Z;]A+'*5RC)8G&]F]N\K0*BL
M$)%5'L:P:,<Y4;M1C7.?HO\`%>L!9`2YRYJ>DJ-R*F`9\*D0#J<=O4_]1AS#
M">,CK^_XU)'&=)"L8W]38(!3"8UK7*U2*[:7_D*YSVLW*[<CE:[5?37J)_1,
M7"H#`F)EB5G<FGRH8UL<:UNZC<^+?FW;]VOUST&$)6JU517#5XFZ*C=$>]-=
M4'NU?M<KU3U5$33H2XZHYY2OS%)%=Z1M0_,2=:V\9PQ1%@5IL)DU&QZ;"?X:
M]H`TA5.L9S6L5C'2.PUXVN12,1I")J!""_M<]5V[U75?31%;M9]1KBHO)E!F
M0>AGXB/"E8$^.CXK\`4'G/B=NM/'KO6*:2302R.V1G=*U&.D:B1Q".81.XPO
MU(5B-5B(KM%U33X>O2*_BO>8)]1X\IF6DS%)@#KTJ`3310Q&1^5ZX()WH1(Z
M<:G\1X;ZU9%&YR!1:UQGO<X33%`9\=A-'L4*-"V2_N?HJJ*UCFZ?-/BF;?;<
MA0+\CFTBM(&V^_\`Y:5%=M$"S8*EG>WP^HU!@>)\*]?E32O`XUM;@AHM1A=C
M>'&U'JE;!GRAM&[>52,0$-&N>Y@E<B/5KG::-3Y]&6>VY!?TK`:Y<:09?:!(
M/E!_+X4WVB=1AL0*C,X(KO.PWD"H@==@),ZUY7$MZI"PRX-:1)(/<(^*F-6B
M/:1KB(_W+GQ7=AZ.^K8JM1J>GSZC/:G6\!<>+AH*UY$QLP),;1-=]JZD3+QC
MY?4\QV'(`CH"0:Q6/GIHV?&DFL1/N-//A(UK7*R3"DA>,;QJJJ^.9@]6M<J:
MHFJHU=?CJG6ESM^?94O?539@$@4(W$T(/@3$]:G6OJLK>2X#XDD5CJ($_/36
M#6U)ROBP$?8.:YS9!8<"4P`WAW;V.+(`@6;W.]/71Z?'1.EUW.M*Z@.LJ#(F
M.FXD`^%!_#6>.62`&8`[5F1OT-)\=]/FAQJMC3F2IE@6KBC8)[2,=NWN:5C7
MC4`7.&B($CM-=JNT_AZH=VLX^<_IW[R6N/$@M0L?A)I!ZP)IY2-X[J9"L`PD
MMML/D),S/\-2MJLQQNDJ9$6KN&RE*`C(KIKQ]Z(1D9A'2(L=!L5S&N3:C%T5
MKE73X=="7(L+9:Y;=&7<GD!7J21N>I^$:J^1VS)S\A+^3;5718,;5-5,G<@4
M(!,?&-"K.LS!?4RQ(4R$*U:I6I&*,;26%?)5#$<Y6N,)3L*!&M_Y;E9JBM3Z
M>D7>[]A^W/9LW$+Q5IJ0-P)$$G:L]8KIMAX38^0YQQY745K]8)CB(%""9WBD
M$:!S72`L4:)'=J-'(G>$US'"1HF+M(BE='W)ZHU47UT541=%H@,GTT`!)'F(
MDTF/-)$0-OXC;30O=0P*D#8>'_@?^)TH1K]['"8^(91HQPY#"H1S5:-^K""?
MO<-RKW?J^'_'X],K.<+3#RJR;\@28KN%,_"D?$2-#+=Y,4MDE?A&Y\09/S/P
MUMLF`<[<R((C%&T3A+'01D.K$5Y1F9VT03Q+ZM<NB::^GKI/<S+=Z&9`5!V@
M6R3ORD1O6A@".FL%B\>FG[H,?,5^=*^'AI78\;=Z--("(;^WHSO-?N01%&Y=
M7/#^DFOP31R:::+T\MY=E.5M5NV^)Z,3N)@`DR9^,>%#J4-(/^X[2?`CH0#)
M^-3_`(?I#[A,<,@G.CM:0398H[WL>A"*C'J-SY!%<U/[?_2[71/7HD=P=6Y+
M=9KG&"+J#K042'+4C:((,^&SWG5_+YG;X<9$;S(\(CY_+6\2PM).Q=D:&[<K
M"DKE5K)"LT>FXDULAZH]QD5%T8K=$T7TUZEQCEY)A?3X;>3^6>G6X"9/_+$>
M.AUY!B&):WQJ":]`8%.D[$]1UUD#)G$8(22)RU[G/:L>*1",,]4;])&A<,DA
M==K>XKMJD?JJZ:=,<?U0Y=A>].)`5E*B!L1()J)B37\3J(6<=&+LLW0)4T!`
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M6@0G8D2&@GO,SL)82W0WJG:57H1B+JNC6JNNBO?O4MW/,ZQ`%.31`F9Z&>GR
MZC6EI!8@VOYC^42)WI6-A!@5,14Q$AMV-%:4Z.9)C'CJX16B#$>.8PBN>QZN
M),B.*`I2()[FZ*B:)\]NG1]K/QKR2-IFJD'X$"*?XSN*SI@&6X#RXR'!EH^F
MM`!_'<]:3.E"FP3-<BE#KZ[';L\N2X81F+!=&&1IQM:)9!9#6-!N>\>USE:U
M=4=KZ>@MWN&%;94-QF)(`4,14?$E1)J*&D10D:TX@7OY;E@"1Q66CKN*5$TY
M=/GIQ5W$F439AZB?"FP[%@_\F&^/,8>.U^V*"2=S0H-:[N&5'&$\S/I<Y%1K
M57H7)[V+)9E4^4?[B2`?S`?57H9VVDD3H,BWS*.K\AM,[R*D5(G<4!Z03HS4
MWBU93H3[(\ZVFMVB:EC5PP#"09A*H11W3IWW2P:]6(K49'?VT15=Z;=8[=_N
MN=9^[P,=EM%9#$`AEFE1L9CRR()Z&0<J&%[TK:);$,P5@301+2`%4$D=:F($
MR-.:'XL0I<9\6VM(L5Z311I(2BMH8X:`(,I_=/#66O>[C-J_JC1^UVK43UT%
M6UF9MZ[;<HC6E87%97(!CD`Q*\3(@5(D$UF%,/HWL@1;<->0;$Q6H($@`$TZ
MK.Y&XT8:3QNX\F3VXY2Y)21)5>QIY9RU\EB-C"AG(L&3'EQQ3;%KY3G%8Y7A
M&3L.>Q&*Q44G'[$7M-_W8]0#BY"FVR[LK"@E8!"Q&PW(T-?QLC'L'*>V[7_5
MV#!CYB5%28@J#444&*&FGXGCAQ2\C8[+<]I)"-'NF4-74IW7*X*EB-B19DN9
M):&1(<-W=:)'[6]I%1JJK7#[1AY>.UI;[7[O&?41JT)!DP?-(,`B"=ZAM*\6
M_?\`MS>?$:QPYJ&>X;8`Y'BYY`+6('`D4EJ3!.IN+O'^":-*)3UP+`9R+"-:
M`)*N+83%.K*UY!QI90RV/`B#')[)E<)5VZ*B]-E[;VVUQ552YRY<2PY5BL!C
M!`J*@@;#;4'<KW=<?#4KA%KY"B4*N%9J3RD!R/S$!T4&2T4TOT]+2`L+=:6U
MF5\,DL#8U1)@L!+@;98YHU-(G->:U:$QF;4&]5VN1')_>C2[0=L95LVB]TJ"
M"WE9/JY=1`I!MK/"J@A8ACG=SRCB):.,+F6B!7NKR<1Q@@6T@A".4,5I$"@J
MYO=5)%^WV.5`D!G'?,LV&(`$)L^(=S-[BP`L&^3.,5%<)Y7'D-U<UNC7*W`1
M%N$,_JW$<LI;B1;B*479)&_FF8/@EQO6QF;*LX-X9RT5[0)+($($\[A57113
MD%17@;[,PM/1V9RPEQT:Z";,JY3P"-%D0SJXQO;0[`=?/=)DM>K'QPNU?O$J
MM:U'(HUF]AD(MNVO.&8$H'0JU6((6#RD$A5)#&2Q-=/K%[+LA1?N"Y9APP>"
MW.):7\Z%8DD^:"C`-!&AKE_CEQ/<.(29B=0RQEACQU#7MF5,F-,-&*Z"5WVV
MK#!BQT>)BG:\I3-0A%<W1$7I8WM[LF9ZN7?M6V%RV`.4R"!4A2%`:(`Y#@67
MQF=\;N'%H6RZV"3Q=>,>6NPN!C(FK*%\L"3N#LU\&L6]O'D8G<74(<R))>JO
ME@NX,>:)@V]MCY,>'-`&0]Z/8J(KV:.U14:CE%N>U\"Y8!QUMFVO*0Z@@@R(
MD3/P`!C84B9K&=?OAXN6S>MTAE-0P+`$J34?28#3(B""!%F]\&LN>&7,K31;
M!Z]Q6E":;6.:U''8<A0H(A):L.'16#1Z(W15735W2S.]O&S9'IV+I<,*(ZW.
M/T[B9@AI!$DU"]1HNYD9%F%N6U90\$)<#@4$$@@1((@D[_&@$TKQ'Y#Q>?+F
M$JK*7(A.*R1'%9UA0C>8S(NQ@#.`>2?17-1J-16O:OKZ=)7[5;MW?29[RWN)
M/&XK"@K(:"@`$?4VQ$FM"1EL_D(949>0`$B`)FDTB@(W^$Z8=QAMS3G5]S36
M]*2.I(W_`%*FDC1R!:W8K7M;L]4*WZD716^J^FBK$N"!;'H7A<4-(\P:9`)!
MXM7>@Z"I&H[BV\A0UFY;!;<"FTF0#61$^-/W:01,C$:`(PH[5B'(DPL1_<3N
MC>JBD*YI%7;JNQ%33T3U73J55?$=[5@6RH"LQY,AF23"MO.QX@D":0:0W,1X
M-PAF3\")(%0/@3'03\M9$4;D_7;WV+M<C7HU&"8K&ZJCBL(12.T<B:)N1$1%
M3YH8;]BZ0ET*;+<OJXD@$01,2?A$5-!OJ$XK6_+!6"9I7QJ1`,&`*?'6VHH:
MN5"BF`'O8/>AR=EOTN1CT2.<HG-5BHU'Z(BM]%_AT>,?M)4&X'M(`/,)B(H2
M1(%*$MT@;#4;>KR`Y%@?&8(/2"/VW\=8`PP$7:.T(8CG:HXSHBZD<56[G.)V
MS.56HBJK'._CJGJG7D[;@9!#XV8&E3Q!XLW[R`Q^$Q4`K\=Q:)8$+6*"8\28
MZ4\3!_QUZ2KFB'L8U%1C4T2(X@6.:Y5?H]B,.YFQWU+HNB(BZ^G4USMO>+-L
MOB\&"J>/%R":B(GD/@"3T%>HP``94G>DD&9^,R/VB=?(R<`:O.AW-)WMHA.C
MF54>Y!/4+&N17N1WU:HQ=6>GJO0MO([WC.3=MW.6ZCRD_($2(!F1&U)G>4RA
M\SU!`VC]_4R?^.O?W8T:4Q'+V4<UZ(KA)'&H5<]H6N(5KV]T8T<CU]-=?3X:
M]%KWZ_9!2^AXR)8^29)I!)VK0"D0-:^FMS<-29K!-:TFH_TWTM4N2F%.A$#V
M7M,>,/:$0S.:SW`A@(TJN8\S&.$U=4;IZ*CODJ3'W#C\!Q\K<.4E08J:GZ>5
M?#:-YG6&Q[%T#DH^O>(GKL*5.W44U8S)Q"SBFE=V0N709,NSG):8ZZ+3'@Q(
MR#CM&&''B1W$>AS*CHOTO1&(USU75.J_=]=+`OVG2Y"<@`QN0W&A)-5<@D&!
MR)!VK.6P"BCU$5':.7'B3-#4_P#-)GKO`$3I$J>-*V=9U$X%`>WO(3$`=+JP
M=+CPR->IXIY5:<T.8>9%A"W;'%>HG%1=^B+N"6X?4-J"STXC?U`S$&5BAF/-
MR%/,0%6-:JJ6K<.3ZI(@#Z:F*[$@BD1-=_%Z5L&#&#;5;I<>5<SAR/:,RZH=
M'BG2,1Y4%H1DTCH`6/\`;Q3%^IZLT1NW723'Q[1XG"O^E:AJ@<%D&67F3&X,
M\HV'ST2MLW;4IZ9N@Q"RBF#4ES'S`ZUZ`Z5I&#VME:>W^X5*)81:VNL+6`><
MPI)D4QS-K@1WL35(P6HKE4JO>]-CF(U%ZG7L_K6W07!>MAE0W!Q:&()X@E@K
M&(4FVQ*A5)`(.I+8<6O5"PPD;\XBE3M'A&W&9\')1S!86\M82O*M8$(X\655
MTK;4TZ.P#@-&XQ)LCVL9#E_4>56:*5/1R)TSQC_2[H>Y:+9!@2@5D*\OKJW'
MH\P1S))B9B1K:61ZE]'2_P`@"9)7<0TB98P1`-1UJ3K:6UKV-'844B2R0$Q_
M<LJ31V&I[IL8J'@Q&]L#:OM(FYR,?^D1^QVW75N_'":VSXEZ_:O.>2FV/H(!
ME"6*KZ<58PRORY<1`CRVYL-;MFXR,9V)++U5S(!I3S@@D?3(HITS;D)0UYI0
M''M32;"4DE)<24>P.Q-;.*Z/*0>_N#5CI+RO)]"JJHC41Q?;\:ZR`WL@"^UQ
M7<7%))K!X\2BL&Y<7"L3Q`DD@C6++6FX/<90ZD\AQF@_=S'1E`(B.M`ZK$ES
M&2U:=EX\$4(G3ID!DPSHXI0I*D(-X#B&(151Q$-+.[0+W,W+M1KF60JF,4K=
M11`/`LY6V0>((#`JP)H&=B/,VY`&K/C^2WY.;D4!%0I'$T!((`B!)I6-9:./
M72(LX=A.O99$4SX3II`0@U*D&,3_`+<:.%37%N-8R.$FY$9]2J3U=U/AV+(O
M+:9<N;9(YWB".9@^1A`<`$<6/,D"(W&M,Q&%Y+EECN!)4.&@S'$^46^)\WU,
M9B*+IYU=57QFOCUL_,YDFR1T2;4&<ZN$&SD21SPE*Y(K0SY".WD>Y)+&;1JY
MVBZ(K>Q<4(5YFX+7F'*%9@Q^J`!+343)`)!WTKR.X93@W,UL);6,/46Z%GC;
M(*A@)5BQ/$<>).U"#(6S60F*:)&L"1G/D-D>U)[6$5BPY`72!+(BR%!72A@A
MJ[5(VTA.XYKVN5-V<6V6M-;QD!"$*9Y0LT\H@58\MIJ)*D:TLX27"KV[/-P"
M"5D@!U\I,K+#S[32%4K`!";)/1A5GLHYXR"L9$EU6-T62V:<K6H:68@O:S8B
M]F6JO8-1HU-N]KE=N2:U8O\`&;3L'99@B.L3TK*PI6%Y$DD[:/MX62ZM9NQZ
MERV%Y!64!5(@"95O,H`:IY$D$0`5>6)(#`-4TR%7$LB(<=T3[JKY,J$(K7/6
M"YC7_P"0QK'-5QQ[U5[7Z-<WH'%P[ZW;C<G:Y5U\Y@SO`/$DJ3,&228)KH+$
ML&^["XJ7,E03::TO$E9((7G/&A\Q,,2O`J9$Y;.0M&(RA&^>&1:B?%)$0`I4
MRQ=`,V-(K8L&6.P2,,BF(_N(C`BWINV_VD7;C6;9+<UN%:5+1R:.-9%)GH%H
M2.,Z$3!&395+[-95;4<7'*!S!/-KB@<C`((,EB"0.(.FBW+:5)-+?3*2_C9.
MULB,T[K*Q%6Q9-DXXD,%A7DL"QWHKU51[OK<[1Z(BN<-<O+=NA\BU=#(P"P"
M55Z*%,0M01+<(`$G=29&[1EIZF$&M?9,09198L`(YNO$`@`#=Q`!->(#B!<D
MBVQ(?O#`B(]&K5NBRZJ(63("PQ9$:Z95#C2AO))<@D/HJ$57;MR$1)(2U??R
MW(#+'(#B*3`(^H17B30CY`AW^TW[J&XD-EJL<RO,&%!"E!<)M\N*FXR26\RD
M"@.A=0'S:V<IF5FVQ2=LFRJP=G$M(48J*5LJ,R"9Y[(RPW#[C]K4]6H_ZD=U
MJ;0RK;"X+;`L1!AQP!A92*F0"T214`R-3XUG*#I:>ZC(JP4#7.8+,#`=GCTI
M,E15@?I\I&AF_$\.FQ!LE5!Q+VNU'"!LNOKI)@JR..$V!6Q7BA5XOTU84+GN
M[C49\55$0W^U]G6X+^=C>AQNE8DJ'D`$PRK`):`2Q"CBI,SIG?#E[=TJ!9)*
ML%8<AY3)4O\`62T`@Q`J:)#-7+>#N,Y:5<+)<92N<>25(U[LW..PRN<)Z$>#
M[B4,1K%VN23)1B_2[T7;T1D=IP>?&PERRO$$NIYH'.RE6)DE0)X@57<3&H['
M#(8W\:Z)5I"@LI7C$I]?`F=^2J#$`+(F.$[PLQ^VE`GX'D"6=3+"Y]@`$Q'Z
MR4[3C%+%EPP/APQH]S$,TW;5VWT3<O2N]V=KUT+AO9N8KJ9!(0C<`%3RZS)E
M6'*@,5+.3?M+5RMX+)-P*14F`&7<F`2(Y*>0J=P3EWB'R'C!!!89I`S5GI%5
M!>U)&9%WC8";8$L!5\E7,1K&/9OT5WJU%:J](\GLM_":<EWL62`$D[@#Z8#"
M3%9"L.(!D2=93N/W%@Y%NR'1"I)5QY8,3Q(!#"I`(GRGXZ$UGP[R74*Q9>'V
MYXK6N1TL,8<X0QC1)#1J9A-61W-"16O;W-%8NJ)\5EMW+RVP\6FM3#.X$`"O
M'S!2-I^H#RDUK&2V+R)8D-RBH(K\P(D_"-B1IDR`3QL(4T.TB-VD&;V\>6!(
MP!E<Q$,5K7M&)&#5=Y$1'-<C=4UTZV.6+3K<]%[2P/H=E:D><&JD0""/COK8
M+:9O3M$>4U\PK0>,5F-MO`Z3WV(VHH22G,4#W[F2(S^Q]>UZM`A'#1B/$J_6
MF[Z531%3335._"W<97RKBEF/$/;%T,*4#;QTH#OO2DQLW>'-P2"?S5D"=]_`
M?CUUNDL0*-6E4;!HC55C%5CM[@N<-JI]+AN1$T:U4W.]?3X=&#N]W*\A%FZH
M$\02"6V$<B#(/_+0]>N@%4D?22Q7:M9H`*D?ZQ.O4%PY%A6IV(<=&V$6&9A@
MJDA`ME-*KG*UL9KVM*Y%5'*K5]4V_#J#[BQ<17OVD0$\''"9@09<%2H6)KY3
M6DQK='*.")"1)V-:`1X'QC;5O,_%8(YC:'%<IBXH6'-L@!AI609MC8MC'<<T
MLHRRE%$CR4=O>11L(YVY58CM%0A^T]KR\I$]86+Y(0)"NK,`6^JWYRQB@,2S
M`"2`"8UKE</$*%$>1I@4K#!BS'X;00`3K>C5E\''GU^15->:621(?5V$2&^"
MTC4>)T"6XJ%@BEF)%3<<+B/3^T>Y473J$X/<NWV6[>UNTG(B'50IYQ'-6`0G
M<CSP9X\JQK5[MZW=*K;5;A-50S2?*>D3-12#OU.F6ME0QY(ZW(61XDV9(;'A
M294*P&XCW&:*2,#XR30"E*PC=NJHOT]SU:W50,1[F!<`>W.(A8P&=+AG=@#,
MT_,``RKQ'F@C:UD,+/*ZO\I*`&A'7E+`T)H(\QVF:Z<]",[_`'LY\51P*BV<
M&7`F&BKNKW39!`3$.&.!R26#5WH01G(UZ*GZC=7'X^#C+BWKV.+)%EE!#W."
MEF^EN;A65D!XJ&!/F:(-->MXMNO!QZG0>IQ!*@U,A>A@3Q)DUF=.,&45AY`9
M%1'CU\B/`,R,JS%G&D,B-&]13W)7V`#PU$K&.>C>\OJB::=;VL^W;>T;`]&Z
M$$'GSYJH^AJ'G22`D72#(\LZA#7!]/(VU,D,03$P?S3N3],$S(!UBI79':-+
M8T"53F6L8Z2HL2O(A*^QD0W2)4B9)DGB..%@`LWJP3WZ>B/1=O3IKW>KN"+T
M"ZPA&MK;?R000Q5ZA)8#@9\H`#2"=39>1&.+V6&X#C`K!_F0OT@^0EHAP/&:
M'6Q49!F8QVJ3P6#["OC.$V/%CQ)-<QJ:LF"<VV<0<&J$PKGM5['N02HFC_EI
M@9>=RN_?V;]VX+U%`HH<%O-^5!Q4$,0P$0"29UA;R75XWK<Q<40)!@U\K`@R
M>*D%B#0G<G1#N3>SB07GA&(Z5&BV]F211C<,@(X#,!(GDB&&2U<R,K'B:WU1
MY%^E$U3IJ&OC$5[J7'%T_P`P0@#D\1Q8(6!)($;R`2`8UK8M`NRL2RLQ4*&$
M`T,0>14L1Q,22!,F9UL8[;#!-O9M.^N*LN..,]SR/)!:\(8Q7I$'+',E05.K
M6B:/8YPUU55:FU.B$LJUP7D=S>N$0K@\4<EH$%4K$U0E01'_`"ZS?P_6%E,D
M.&!V8<2"6(EHX+<H)Y`\?RB:KK(EHI9!5:Z3)'&)L?&EUI;@J1T8Q75J.A2Q
M]IW=&B`5CF>A==K4U8NV0N7B72<1P]_FH,*6\\2U94J2AH:6QNU3.O/;.*L#
MSH"!*T'(20T$3]),T""))F&THUEU$[,MMG5UO<`P,N[E/EO6RG37QA]DDF0X
MFPP@21HCW"(Y6$5OTNVZI/\`=7S<2XA9<=@0%Y(P&W($K*KQ/E$?'HP.@\Q+
MHNV[UFX?MI;TED<$F`TA96!/%94&)K#$EG@S>EGBF1N\6.<$^0^82$R$\QXS
MPDCQC-D,>Y#149*7]+6*0A$^H:KJ]5UGN&/EN%]9K-U+I+!;B,"H/$@,"PCD
MHD(%84,@B#)9O*+ALW[A#V^)J_E((!A7!($E0:<H%0P$`?,Y"Q`4VU?65M(>
M$D=B5'VZ*:9.G&C"[IBR03KJ>XA/=*N]([&&$1K4T<BN1);=ZTKL$N*W&78+
M_P!1E,FDGJ0?,5XR)*QYA!8%N]<-TY%RY=EBWFA^,56VP6W,1OQXF>7$;Z=%
MARA5CIX$W]MV;22(DH=G8K!."F!+C0Y)RBM)\>5)MA$FLD/02/'JYWQ1_P#;
MU+:R+8YY*F]Z5L%@(DK0$!A%#(%0I6"((&H;'VWJL6+C%#<E$<F!8?G!7TP=
MIIU_*=#B#RM3V5-=.AT99<:0)TW)12"TDDD9HBO1`I&9(A6!1@=W&N:7=N8B
MN;HJMTB3NUB[;-U$<60`TAE!`<<2Q1RI:%@#B#NH@DE=2/E6W"MQ<VK*D`AQ
M0058D%CT$@!5'PFA(N+W^.LI*^RKH<Z3`DBFI)JH38<F.E2D5T=C*N#"CRV-
M=)E2$^DB-<U';G,:FKE*2XK8;9*,6MAE`\KL48M`E4)V"R>(,S(@T&ZV4?$9
MS<4V#Q`=O4,,7#><%RQA5V$S7C7RA\-R64.6$KNRR'-?'DP(=K7Q61FA",CT
MBQR+##)BO*T9FD([:C55&IMU15)>TP0(I5KHF:'D*"@*D]>)(,FII-`O_H%D
MV$.%>OJ]MR6-LR2"P*J02PXEBL`">,U)VRU^4P16=M)I#5U:HZT>ZG?.8EK"
MLH@_\D;??"9"CPVE16$&/1[F(A%VZMZ@>UCJW"\88GP\L&:CQ80:D=!0B=8_
MI1%A,7/+W<JY=`]8(1;=?RR$/+D*E:!08!8@,-(-WDUM?3O;_:8\ZOB2*1P)
M4N1613"!'5K;2(*2V$R&R1*V,(C=1M<U%5/CTMM91=CP]-<9&HQ8#DT5$#G4
MJ2J[;U-1$_;\%\.QZ[7+=J\&N29N.K20%\O.1.TP1L)BNO1,9KI#+!TW*Q8X
M]9@Z2VKFT-/'$\DF.TME"29%'(FP4CQCM:TB-%JCTWD<J*]-K>.+=YQAO",2
M.*0&#,`?K*[DPQ(`,TD0L>7)N6[MJWBV#D6V+'D&;DI!A6KQ4RYY&K$10``:
M9Z5HZBUNRT%?3W?TQHLTMB6YOXYH<891O4A$%(K@2/55>(49!O=N_6>BHBR6
M[#WPY:";K*I!#<V*^6>;-2`(6?B6-)#94MY:J<FY_-=A$A480:AJ\@!^4DSO
MR58Y:;X04-[D=SV\*+,)908H4KG/8C[*%#_P"&/5,CS0@B1I#B,0`R.14T1R
MHJ*G0UEK62K,UM5O7`H*LT.1(2XK`%@H3B@#"`TF!`)&$MBSA!4N!5J'K!$F
M2H+$5Y0><`5,TV9=IQ5A<TZ@M*&GK22`G',*2(-CGR(ZE#*JTLH#D&<E:U!Q
M"C1IFJK_`*7J_<WK%SLG;L:V;H-I,=FXN`S<DF89>1/*6(A3"]>(E1K/V&'=
M*W%175&@U9768XMQ!Z@$R2(`JH#"0#=^*^$R$M"T4>RAI-9[B&X@1681`8U1
MR$+!E*VT`Q5*]6#$5I6['JK-NNU'<[;9!NW67(.`UYN)*(2;8M@@IQ8'D6YT
MC:/*)$^OX@4"[8N7%1'/U`$$;B(B3,D_EB*`S(7E^(YIH#PZ[((!+)$+I"9$
MGCE-*\"-AE#'FE8XBET5Q45Q'L1%42$3U14O;\')#V<:PY957B08<SMY7"U(
M@CD!4U(ZP)=SK;IR5+BL)\:#J20L"?II0[SH-.X.R&BOQ5;%O9$RL-V9L"-0
MV!FQI#2H<8560$+70SM33OL85B-=ZJBHG0USM/V5HW,>^]FXX`(?BE#Y27`8
M14P=]H6=:C.XE6RE4*S&!4P?&.)J(/PZ]8U8_.+D$^Y@RJN7<!J9>0'A'I:V
MHI),5\E49(*VSM'>K(XD,YC'D43'J'<U5T:KIGLYF0R-AK<5'R&%M"%8<B1L
M`?*0*JY6"H\IK0BV[F6##BPFW*EMVXQ()`K_`,H,#I).BM99-D3V$AVJ@+60
M(KP!AQTCV$R(Z.Y5*^LL/\05?)0@D1J(A4,-?[=$<_JQ/D=V9WM9R`O])0.H
MDJ.99G8!/J&P9BL&5)'EU/KWKYM\%2ZYEB8'J$"C-7B5%20:@@R)@AL64NOH
M(P\BBTC4*\(DC;(XI"ME'5\<Y8@(G<.YS7&:YR.1&F9KJY41503UL>W97)O6
MEMK]OQ0PO#U9\\E`S4*!0K.$*L2(!U"V4Y4V<EU&.*`B=R0:D!BP,$0**23*
M[Z0H-#?JYEA6UP*UYMS1`D6#V1YJ&(AB+]LG1#$[DA5]N]NYST:J:/5=RH/B
M=IS\N_\`?8?!0+?*+A(%PQ2+;\@JM/E)+1(J`!&;=F\Y'I,#8$EBYD'8\^)$
M@2:20)FHH=."CQ6P!-;.EX[`I+AS$#/+4K&?6-86+&&VN#-EAC,@HI$0KD"C
M7.^K>[U<G1^!V*U;R6N9;_;WV8%&4C@#Q\XJ]8*E1Q`@$@FIGUG%Q"5:Y<N6
MRYY(""P4@&M&EH(B=J"ITZ!65M[Q_:'+8)QI:UT4-A[Z.=XA.^XE*HX@BC57
MHB!<-BJ_=I]3575E_4^XY&8#<%M5"\0"0+3**,74(7HOTCS<F4\9`T=Z^1ZA
M:\450H5I`"P6BH'F:!6H@G;IKU(B6=;%FR(<2R?,9(')51S2D#']S($RS+.%
M-!I)A"?JBL$CG(+Z51VY40W+MW,>VUJRS/8XHS$4+S,@`H\@&'('G:@A0.1G
M=[5FKW%>T8#E54<N,@`#<TACYN3?E`XR7*(^49%6U\5'Y'%##J9`XOVVL#8#
M@%EA.R5)$B2M60)(E;MCD(PZL:[:JMTTTQE[CF67MV[@Q&Z%U#.Y#2IJS<=_
M**D0"V\:5!L&U<O7[=],>X[6V<W>0#%(""6@`U@D%A0$[DZ;EM>5>#B`.TE0
MJ:&LYD,]C<%BPK"1<.AL+**$$I$EG='`Q6N:)$9';L5'?!W4`[C]CC<%2[>/
M)%-YC,\=V],S<<``\*020)XUU(,VUSYWSZN45'"#*LBL()EJU(X&?,)I$Z%V
M=9_6,9"-B\ZOM+6)/(X<;<6,)0F86P+*DQ(AH[;A2Q]O:%JYC".;\=%<L?>.
MZ7+=];^+>=0OGX"@$!6#$\A+2.+!D?;CT((.9W?)MW&-ES0@Q]2U`W8UI'F,
M`R(TQ8^:SK&Q$%"4D:80`YK1"=V*:7+G[)$F+-D@M8SVV482J1[!:*S5'%9N
M5-J2UW/NEG'O-D!`JW/443"N=P;H@"WO'E,L0#6(TN^[O8P;'X_RKC<VMB1)
MK!+#I6@$`]=9(MU955;.-'J:N)9(H9$N74W"15AF[[G2'V,'(8PJ](1(I&*U
MQ7R"JC2,WJKG+TQM9^#CW&M9"FU=+LP*<S+$>H5(%LIZ;B:%8)F2334MC*QS
MRY6@F0Y+.0>5:!4-LP"L"@-!.TT&;`LUQO-#7L6Z-56-2TT*OCNH\3G$L*\-
MH%9`P$<Z$E='D1K#NC0@G-8QB*Y1KNW=3Y%S'NVU'=A:6R)B+<L:1R%`;4#8
MK-1*`2#J539NCA>7'LVQ_M5O4K`D\`0@WI-0*0!HI`JX>*0+"9QX^\A:LEQI
M\(UD;_K<A0M>-+DUF"2X@M9"(PX&L:/5R(-6ZHAV-Z%S$/\`3ENB\7"*K+P,
M@PY@U)BM:_,T$BFV+7I6N3MS`6A)W(9A(('&.5`-_,Q@0,*JB^^2C3G9.!QH
M0T;(JJ?[!=G`,ATCBK[!\.E@%$"4L1W><X@0-]/TW*BITMM6VLY1O]PO+>L`
M$K=MDEFD$23<4,H$\6!4<NC$:AOBY:N!+[H]FY)YIP/(;;!9W)%1!DCQ.G%;
M0;6YEU=9&QBZLW/4112K+.(.'7)93JX:1R4]]B\>,254BEF3;$5KD5$7=M;\
M#REXY;6GQD^V``MS>MAC"D@*%,$<8"@R"3RD-J9,4)?<H+J6@H'$<%X@5W#`
M$<9DB229!F"=6RKN;*ZO(>FMZ6#6P$;)-"LAR[6?*4*@?(I''B/GBD/1`/"T
MXQ,WC1%4>BH_J9<?,L,X2[?M_;^<\6]0$F"0>*LSQ('`JI(,*#!(G1<I`;J-
MPO6@"RR3!,0Q^H$P:5BHZ@PLU/-H(-74_O:!34MN4TJP%,K9$$]9-C/E*0,2
M!*+(20R='4`V$<X82B8YJ(UB:M31.^6N+GN">H_`"A4""(52"Q(+,:J2.A:D
M'1.'G8MU[OW(8$VX'F`@!9F2TM)#`@$B?JF=$.%E^'YP!D&1;PQAD2E(R-8S
MJ616LD(YCV?=(AS.B23O<,F@5(PB.:J(1R/3KR96#GK;M7F6V+8Y\7XEF7I7
MJ8W*\O*!R@;[VGMLC-9=5B)H&8K,!`9D$4!9000)($:(B2V19,-XHE2CB0-+
M*?&;$EV$F9&:!H"J5\4T4*C@(-FY'.:]J-8W5S57IPMFPRL6!3-NBDCC,BH9
MARHL4Y2"8K0#4RXN,K7$>1D&.(;E;!$S%&\T&=Q\#0!=*T>ZQQ]1&E2ITJLG
M0BG44AE8Z5("ZOG&6,5QGQ4!,@(=HFM]NK#[%1&(B:)U%Z&0P^S_`.M<55F0
M##0(H(!XQ)(`%"21H=<'N'K/C6@M\%0?3=@!400.-4,$GS`@$<C!U@BLBS!7
M,TIX,NYL:KWDDDMC*DLNM4!T/$0Q"NDBD38R%(Y&N(5@VHCFJY&J_5DPVNNL
M<']+TWI.Q)!@0>*DGCM!,@ZDNW$%];#(4QD#(8FXH*U#,H`D*:#8;MS`)`$D
MFKKHK7!DT18?W%42!'B9`.`<CFP@O0/L21SG)!G!,PRJC'(3Z?K<[UZK>?C8
M^)G)"ATN4<FXR*K"".*0SR3#&=J$"`HU*RVK5^W<MW"P#0:$IO6.3;TB?A,`
M1K%(6%;2DL0XB2?/@1FH>++WD?'+$B%C&GGFSYH(PXL03GM&1$CN+O73T8JN
M]>RQE(GJ8S-%PR"H4JM5+EV*,;<56VX"O78D1-=OV7QUL9+L;"W2:(`U3N&"
M@[1`)*S(.\!$&6MBR*R7"JX)KF3"9&B6$A:HE<W_`!)0`-BVHYEA8Q.PV0@%
MVJ9RE>UB-<U%1H-W*3&SDM8B*KW9"%[:^B;@8+S!1F84IY6!!J3Q4:@N"R+G
MK7%/`F@BD@T(@GP'+B1!)K%-;M-%O37`95].?7GFC;(]E&2)-'6N.8(^W&R8
M];KNG!W*W:+M(U^QPVN1KNM?Z=D^2W?R%N9#<N04>14)(X,ZBX"WFC<$B3'F
M!UJMLM#L52XK$!:$M0B90GJ`(;YZ=<W]G>WD_;/>=KW%E]K]I[7W_:[B=O\`
M^K^GW'M]==/I[&[;Z=2/_1OL[?\`UO6]1/4X?]3C)B.=>?&-O-$]9T$GV?.U
MP];GR$_*3]/+KMM7:=.YONOVM$]G[/[-]R#]]]_['O\`N?;FV=CVWZO8]KNU
MV_1KNV?1OZLG=?OHL<OMY]/^9ZOU1'FGEY?]W_-RCI.C^X_;>M;^XCU?2\LS
MSX]9FG+G/U>:8Y=-:!?V?[.\][[SVFTGN=G:_M_PM?M_;_2[G9VZ[?U=FW;_
M`.;J+NO]*C_N./VW$\Y]3ZJ3/I_GCPZ1TU%<^WYV_2X[GZO&O+Z:<^41TF.F
MF8+[7W97V'[WO]\3V7O]_P!M^Y_5W/MOO?U.]M^._P#3_N[?ZFO2CNGW'J__
M`(>/4CS<>/#E*[Q_[T1RY>>9X==>[C]8]#_J>EYXCET_V]8WCK/'KI?N/V[N
M-W/??=/9V7VSN^]]O[KL)[GW?L?^G[.UKKO_`$]=-/KZ]W3^C_;I_P#XO]=C
MIRX_],<HXTGA$<Z<N7QUL/1XC[;T^4CEZ?+AL?IG\-^O_JUCQS7[34^R^^^W
M]V3O:>Y[GW;VY.U[?[K_`)._W&[VO8]?_5Z]0X_W?I7/MIY>C7ER^OC^7E_,
MVF>'GB>DZ#N?F]+U.,"?4GGQ@<HX^:)F>G"8I.G-=>]]PW[W]Q]Q[:!K]XV?
M=/:[G_'7_)[G;W[_`/Y/<T^737S?:V?5G[F!RWGG3?TO-&WPG15K[3T?+RYQ
M3APX\I,3QK]41/FB?CH<W/WO]HRO9?NK[;[B'[W['[W]R_9O?#]MVOV[_G]_
MW_\`?VO3L?'UV])\C[_T/S>AZJ_5]?&DSQI//GRGIQG\NE61SX+]S'V_(1SC
M>#$=.?&=NFU-1%S7]@>^Q[]Y_OOM=@GW/V?[C]YN[C__`*C]S?\`2_M_:]MV
MMWZNGQ^GJ+M?/UD]3U?1\T?3SXP)X33G_P#U.L[^?0Y]3F>?K?8\J3QCE_RS
MY>41]-=2>XK_`/PUW3/N/[A]M]L3[7]Y[_OON_M5[?8_<'_3_<=[N=OV/U[-
M^[Z>C[_"'CC]M-(X?[OYG/K,[=-YTO\`^^].W]MZ7W')^7/?AQ\O*:<9X\^/
M3Z*QJ/7-'_XZ_<7?[>_N?WGWZK^Y?MCM_8_=]AF[V6S_``O<Z:;OMWZF[7Y;
MNI<CCPN?:<>/(<^<;2/VMSY?#6V/S]?^9RY5^G_I_#ARK/&9BFTZ)K?V7_MM
M;_[8??.Q[L7W/]X>Q]YW.XOW#[?^\/\`#]S[??V]WU[]NWZMG4?<./VEW[3T
M?2AO4Y_]2:<.,>?C]$<*_P#W:8V_M_MWY^GRY?S/4GU(D1'7CMQBD<OCH547
M[;VD[GWS[)]\@=O['O\`N78V$]O[+;_]G:ZZZ;O\SM;]OIMZ6_\`:_:KZGH^
MIZ@]3U9^N:3-)Y3QY^;G/'RSI<./VH^G[GE3C,^G`C_EVVC\-&Z;]N_:T7WG
MM_LGW$F_;V-_N-TO[9]G^U_Y/W'_`)O=[?T[M=W0V5_4OMLKUN'I\?Y?#CRW
M/^S^9_MF*;_\VBL?CZ2\O5Y^:/\`?,B8Z?L>--,>L^^[+OV7[R]E[:#[/[!N
M^Y;MQNQV^]]'V_3_`)O=_2_M[WIIU.?ZOZ5O[7_J2?4XS'&!Z?X?^7K]-)U!
MC>EZ9]"/2XKPGAQW,?53E/*.LSUG3)S;=VJW?^^/N&X_LO9?;_WAKW']K[?W
M/^C?:=G_`#>S]&[33J%/5Y7.?I>K`CU.?'8<IY>;GQ^CCU^JFMSZGJ6_2CU/
MQX[&?I_-X<ZS]/36UCG[K^_P/W=_N+^T/NDOW'LON_[@]M]O73N_MS_)]O\`
M<=N_7]/?IIZ:]%6?L83CZO+TZ\.4\/4/*.5>7/\`]7&9Z:D,^7T^?J\O-QG;
MBT_\NVW6?QUK6W[&W.]WW_LWNK7]G]WW_O=N\7MNY[+_`#/O?O=?==__`"-N
MG=]-.A5]/U\C[+U.7%^7.?JXK''E2?IXS29X]=##TX7CRXR-Y\3SY<?A^/C2
M-/JK_P!J/_MG[M[#[EV:_P!G]C^X>[[7N6>[W;_^C=_OZ;MO^3_=K_\`,Z./
M+T;/J^A$'EOSG\O/\W&8XSY9CX:.M?T_T#Z_I\.!X1,^I'DY\?Q^KX\M.@?W
M']Y67W;]Q;]J_MS?[C[;]O[:[/=?8?\`(V_;NUK]P_\`]C_D_7NZT;^H_<7^
M4>K-OGS]6.$?^W'DF8Y1Y?&NBSZO)?N?I]-8]/EZGXS2-I^,:,4?N_X_M^Q[
MCM4WW;W'L.WM[,GW/VWO?J]_=MV;O\CMZ;O7?T\L?UK[[*^SGU?42?5Y1Z7$
M<8X^3_S37;GIG9^]]2[Z7.9_]S_;/EY<*?\`FGR>%=;\_P"P?_\`5^X?_4M[
M^WN>YW=UV[M=S]7N=O3=V?33^WTUZG/]*^T7[WA]W/ECU/K@_3QK/&8FFT_E
MT+;C@8]3[K@T1]'2)X^6?]O_`*9I&OOJ[0?:?N3M>T%W/9>W]MKL?L]SK^OL
M]OL[FO\`Y=?Y=*\;EZJ_TWG]OR7CQ_Z?J0.,SY./#ERZS\-18OK<CRCU/4$<
M^/*>(\:1'+X3^.M.3]A_1^_Z_=_<I[GV?8]U]M[$KM^_]E^E['N]W=__`"_E
MKUOV[^I<F_J$??\`-/7]&?5].O#GZ?GX<XCCTX\J1IO:^^Y-Z?J>I(]2)Y<9
M$<8\V_&(IM\-8(O[/W3>W]PW]EGL/MO<[OM.\SL^TV?J:>^_OW?J_'9Z;^MN
MS_9??7?HY^J.''GZ7'TUGE-8C>/-'+_FUMC3]P?7Y>GR$3]$\?-SGR[1$>:9
MBNM2@]MN%V?NNW[J/[;]Q[OONY[@7W'9[WZ?;=W7^[ZNSMW_`$=)<#[KCD_T
LN/M/N1Z?'UN?*1/+IPCERX].$TC40X_S/Z?SX\OR3/\`RSTXQMQK/X:__]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>v014148_psivida-sig.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 v014148_psivida-sig.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`6@#+`P$1``(1`0,1`?_$`'H``0`"`@,!`0$`````
M```````("0<*!`4&`0(#`0$!`````````````````````1````8#``$#`P(#
M!0D!`````0(#!`4&``<("1$2$R$4%3$6(D(C0207&`I1P3)3-64V-S@9$0$!
M`0```````````````````2'_V@`,`P$``A$#$0`_`-_C`8#`8&-=N;@UMHFA
M3>S-LVZ)I5*@$TS/YF65$I3N%S?&SC8]JD55Y*R\@MZ)MFC=-5PNH/H0@C@5
M7K/>PO(T(OX6RWKAGBQV3Y6,K&HH0O4N\X@2A\KHKUPHJ73U,?MA,)5$0%\=
M,?<*BA#"5,(&>)+6T.GY,^OKSRW/;#<<=4FE$UB_E[E=+)>6NS]C(2$"FA8P
MG+$[=+24DYEH>:D4%_4#),')?:":;HI1#:-P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&!C+<.X->:&UY8=I;2L;.KTVLMTE7\B[$3*+N72Z;2.BXYL0#+/Y65
M?+)H-T$P$ZBAP_0/40"M;4&@;IVAL:%Z][#KTG&4J%7+(<O\H61-$\%0HI1L
M@*&Q]E1?J=O8K_.G]5D2N"`1JW$A?8!0*F`8^[ZZ'V=OG9*7C9XWD"_XG7>/
M,WZ-VRQ47+"Z*UJ];E-)PRTDR3$&]EFHQ7VNB)F!=LV63:I`#ET!D`LPY:YF
MUKR/I:IZ2U='_;P==;BO)RRZ21)6V65X5,TW:9LZ0>U21E7)/7VAZD;HE313
M]$TR``2'P&`P&`P&`P'ZX#`8#`8#_=@=<QF(B36>MXV4CI!>-6*WD4&+YL[6
MCW!@$Q4'J:"JAVJQBE$0*H!3"`?I@=C@,!@,!@,!@=;,S$77HF3G9R0:1,-#
M,'<I+2D@L1LQCXYB@HY>/7;A4Q4T6[9!(QSF$?0"@.!4=JV'G_(=N5+HS94<
MZCN2]165PWYIUK("Y;DVK88T$2/]OWR)5(5%]'MI)(0BFYA.@4I`*('$%CJ!
MW7<_:5Y@+9$\;<>,1N_8&S3,H]Y(1J";^#YYJ4P0H+;!NZYR&C64HE&B99BU
M7,4J!`!RL'I\"+@)+\1\7TGC762U=C7REQV?<G1+'N':\F112?V#<7`'6>O7
M#EVJY?$BV[EPJ+=)14YA$YU5!%50XX$TL!@,!@,!@,#&VWXK:4YK2Y1.D[C5
MJ!M=[#+)46X7>I.[S4X*=]R9T'4Y5&,]67<RQ,F4Y#$3>HF()P/Z']GQG#"7
M&LIV6\U:\B^Y*KJ*&W%7+(^AF]HTC.2$C1-D59%NU4B[FWA)A).8ITH\6.LF
MZCEC*%*9,%$Q`I_C($ML!@,"J'R;=K6[04+3]*Z`L]<A^D-HN4G[*5GFT5(1
M6MM>LCNC3%ZL:4T(PL:Q4^P7*FY?%.V;-6KQRH02M_00C:6_=4^0ZIP@P&W5
M^?>)Z#5V:NYND:O'OJ;L;I:8K<2W4NDKK:-?)&<Z^U-+*(.%VXF]KM5N<IU_
MH8&(!W7A2TH:#B.A.BH=O,1.JMRWE2`T3'2[]^[D9W5U(F["6-N\XN^2;KRD
MC+KRGVQ':A"J*"T6,4`34)@7K8#`8#`8#`8%2O5L_(]E;TC^%->RTY'ZXHLA
M5[_UU>*T\0;HMX-JN>9KVG2OC?(1P]M#MBC^0;I@=1,JB8*`4I%BB'D^K^VI
M77EIKO!?`M0C-@=42D2QKB;.%:I/->\OT]%NW8I6B_.$B*QJ$Q$,%2*MHU81
M*U#VN7H>TR3=R$I^&>&JAQ[2W[V0EG6Q]_;$'\SN[=,ZY?2,]=[.\<*2,B1J
MZDU%7;.!2D%S&22_A,L8`44`!]A$PG?@,!@,!@,!@,!@,!@?D2^IBF]3>I?<
M``!C`4?<`>ON*`^TXAZ?3U_3`P1TQT1K[E;2MVW?LQ^1I7*@P(9NR*L1)]8K
M`_5(RKU8B0/Z_+*3TJLF@F`%-[`,90P>PAA`-9OBOF#=WDGZ#V+T_P!*O)N*
MU[8K$T?R;4K<&A9"K,O<I6M0P;@Z"S48!I'E:E?IHF$OHD"BHBL8OR!:KOFR
M(=6[$1\<?,LDTK>KM;-H3_-I>ZJ\49LZ10D"'0C-.U!TQ;NFKNYV!9L"3Q(Z
MJ9FB93&4$YDUR8%M-6K$#2:U`4^KQC6%K=8B(^!@HEDF"36/BHMJFS8M$"!_
M*BW1*'J/J)A^HB(B(X'?X#`8#`8#`B7VWU'!\A<[7?;\@FWD;$W03KVNZTLN
M1!2U;!G04;5V(2$X#[FZ*I3O'8_RLVRH^OJ`8&NOH#I#<FRXFQ\;>.&:8[/Z
M?V9-CL#NOO8"_/JW4=GM20?EX"C60K1RTL]IJ[$YHYL]2^X31<)JF9`Z<'%9
MN&P%Q%PKJ7B'7:M<IH/+7L.TG&6VKM^SG._NNQ;,[6.]DG\C(NE'#EO&GD%S
MG1:@H;ZC[UCK+B=4P>PZ@[1YYY"@64IN:[I,I^>'X:7K6MM5;/M*_/C&,DBP
MIM%BQ4F94ZRY!3%P8J+)(_T573P(8>-;RCSOD3V3T-",>;K/J+6VFPK3:OW>
M?M#.?=V*9EWLTW?0,\QCXMK'0$^@TCDW0,T'3X44Q,"JGU3$X6U2DI&0<9(3
M4U(L(>'B63F2E9:4>-X^,C(YDB=R\?R#]VHBU9LFC=,RBJJARD3(43&$``1P
M*RM9>:/Q@;GZ<BN0-4]@ZRV!O:><2,?7X&K_`)^5J]AF8M!PZ>5^O;*;PIM<
M3LZ#9HJ=)LTE5E%_C,5(#G#VX%HF`P/GJ&!]P&`P&`P/PHH1(AU5#D333(91
M110P$(0A`$QCG.80*4A2AZB(_0`P-:O>=JD_+'URAIVB6)W"\@<\??2]SV$B
M=!.!G9B-55++6Y)XJHK'K-5?@^SAA7!,2HI+NP,5)81P,I[%ZW?[GFZ]XZ_%
M@\@H@@5]Y&WSH;[I9A!Z\I\>JBPLLA2%CI(/['/$3=?(K+MP4.LX6(5E[C'.
M\:!;#R)R3JSC/3\5J;6+5=T;YCS5VNTOZ+6G8ES>E*:8MEE>"=555R\6]000
M]YDF;<"I$]?:)C!*/`8'Y.<B9#**'*1,A3'.H<P%(0A0$QCF,80*4I2AZB(_
M0`P.!'3$3,)JK1$I'2J2"QFZZL:];/DT7!0`QD%3M552IK%*(")1]#``_I@=
MC@,!@4)='ZMHGE)\@4KRKLZ()<^3^/:$:7W!74)^=@R6K<NR8URV@X8'];?Q
M<FD>NL/8H806)\:C-PGZB"H@(6N\\\V\X</Z4CM4:*H]3TUJ&DLW4DZ(FY^V
M0]4TQ6E;/<+3-NEI&8DU$D_>YD)%TJI\9``3@F0I2A!2X=Q[IZPGYO4'C6J;
M6;C8]\G"WCM38,>JVT?0A.J5*2#648[;&<;>MC%N<3H?&0(P#`!O[PD/O`*\
M]S:)95/<(\=<FV*P[Z\@^Z8CW]1]M[9>K6:QZ%U3))@,Z,1(E*\9:XFK'%//
MMVK*+^)TQ8+)$(8RSAK[`LYFKKP[X-.'6<ALNY,*#K.F)J'<OU$$7FQ]W[3D
MV@*O$*Y7&ZA9"V7JT+M0*@U2$4F+)(GRJHM&YUB!J*>5;R#[%WGKZ&WIY/75
MSY^Y4O#)>S<?>&[65T=5#HKJ:*`5?VMN/N:\1`H2^J=*N7"9%A8@0C]T7U1B
MFI'"1I-8+A/].SXI5M<U%[Y%.P.==)T?IK=ZL78>=J-5Z*K72<LZ&<5\C2N5
MBMU5=^Z@Z?/61@O]R9<6ZUG29+"61DEW3MZD0))^77_4,<^^.:39:!TG`M.N
M.X[+/Q%9B.?J7+NUF-+D)EV@S9!LJ<K\=-NFEC?N'":4?6F22LV^65)\A6B)
MR+F#A][^<"]<R:ZYWYWU!SR3;7E^Z;H>OY*,XFKTF:]1NBK1;(..E+`XW%.5
MQ[&G0AX!55T#-N#EFJ\1;&>.%FD>FH[P(*^1#I3_`%&7C[XX==T;JZ0X'9-=
M?V#6+.T<[ZCT38K"VF"7BQ1L(YC;#?+U)%?)JQ+Q^5%T$(X2!8GR&;.0]"',
M&U[H'93C<^B-*;A=Q(0+O;&I-<;+=08"L8(5Q>Z=#6A:)`S@"KB$<I*"CZG`
M#_P?7ZX&6\#X`@(`("`@/U`0^H"']GH/]N!]P&!2SY->H;]8Y^!X`Y<,K*;P
MW0FE%;%EHM<Q%*'19EL8ZL2=VBFM^,>V.)%1:2=&]OXR"`Z@?UG+<2A/ODSD
M[7W*FAX'2\#'QDL)HT1V!-N(UH(WF?D&XIS+N30.@!5XH2JG;-6JA1(BR*5/
MT_XA$*YK7K;7'-WECXNKNKJ)7-8T?86EMXQRC*KQ[6)C9RTBO/S<@DZ2;D!5
MTY3/(M#$^01*DG\*2($(F!,">W<_8$'QII9:_J0O[PO=DEF]/U?1DW!D1LEN
MD2'%%60.@"CY*N0J)1</E&Z:BYB^Q!(HKKI`(5M\RZQW/'7,GD9\D^YGVN65
M9C)F1UOJNS3[FN1M=2EXYZP"1F:8W=DB(4R$0\4)$P+=!U+K++?,\.+C^B8,
MTZ_ZT[X[+A%+-RWH?6NCM1RCR4CZ]N??]CD+!)S+=BJ=!.?K5!KC)LLZ;*J$
M_@%<%6@G]2@N82'``]4S\9$WM1Q^=[1ZWW_T3)N#E<*T2LV9QI+2\:JHD8CA
MI&TR@KM)1TT]#B4IG$A[C`)O4H`;T`.PX_Y.N?(_6W2,)2Z,A$<E[/I]!L6K
MY2.M)I?]N6RKMTHN=J%@BIZ5>6P9%RK*/'3>0.9XFX;@4IU2*%!,`M*<+H-4
M%G3I9%LV;)*+N'#A0B*""")#**K++*&*FDDDF43&,80`I0$1P,%?YJ>8/A^Y
M_P`Q^A?M_N_L/G_Q?U[\/WWY#\3]E\O[A]GW7Y3^[?'Z^_[C^GZ>_P"F!GK]
M,#76T7/]C<);I[D8O^#=X]*V#H+HR9VAKK:.LINBMZ#9*R_062@&-KL$W.!(
M5`(LKDQC@JS5%+Y5"`7U(`G"3T7QIU5V=+,;5Y';[!UG4C1^PFH#B?1$M)MJ
M,NX9N"NFA-X;`!<DELE5N=(OO9-S%CC'_B3%+^(A@R[V)T23E.BT7FCDJAUM
MUTAMA`U4T3K&O1$>QK-$CU3F:O-C62'8E:LF5<KQA4513.!2O729Q/ZH(NCD
M#`DY-<V^"GA[:G3O0=MDK]L.77+/[*NCI1%QL??NZ[(+QU`ZXIQGIC+G"1FE
MERM2J&,1LW!R_="5)-3XPU1#[[Z9ZPZZI>Y;[K>.[0\P&QF!Y3CWA5N(3/'G
MB5T]8/M7,%N+I@KHYH)YNUI%O6\G^)DE$W$8L9L[FS$D31T8W"(<+RSSM2_/
MG,USRD=GPVP&/)M4@.CNT]Y[NFP@X+=^^6<-4+K$Z@U?7'Y0FIJBPTE=82-:
M0S1H=Y(Q4.^*@S;H*(M&X;.<WVCY(/-W(/\`6WC#@[7PMX_7#M6%O?D9VS77
MD-MW:D00WQR4;RYKU=9E*QC5Z@)B)S`*)N2>H"=]$N""U5"D.&\#/E`X5\FE
M]OG#',-9VK!/6#ZN<K=>]`[=U_:X334]8(&'C[ATULBL.GA)V5VZU!Q,JQ;5
M:$7:,9)^#ANRD#-T"B&VYXK_``\ZG\=+&U[9N-NF.E.Y=V`M+=#]:;$.ZD[?
M:IJ7<$DIJ`IHRSA^]K-*_)@!C%%4[Z3,DFJ\5,";=!L$#?\`59:@Z6WIPAJ2
MAZ-T_L[<6N6/1]6V!TQ#:CAR6*YL=2TBNV)T9RRKR"Z<Q*E_+/R*D*U35]CA
MND=3V$#W@'@M#\P>6;RIQB.V>A-\;X\0?'\)6FD/R/R3S5.%J'0@Q,(S1:T2
M_P#0EL?,$I8$6;=HW4/`N$F1GI2>PK*,(!5W82[U=XS_`"A7Z<IM2[^\K4GN
MGFW7DHS=+:MT/J1EH.Y]`,HE0/Q<;OS;%3DHJVG@%R()FDXJ,5%&6$QR.%C%
M$1,%^L=',8B/9148U291T:T;L6+-`OL0:M&J146[=(G\J:21`*`?[`P.9@87
MZ'LFVZEIC8$]HFC)[&VTS@7`4>JK2,7&-G4RN)4$WSE:7>,&CE"'34,[%J"I
M5'@H@@00,H!@"!WC0XML&E:].=!=!,UI;JO="[^:MDI8%4I2?I<),NDWQZT=
M\55RBG.S#E(KN6,@?XP."34G])L'N"UG`H#\MVYXJN=*<-QFFI2HW+J[6.R9
M&S0NK'TDHD*\+=T8B`KS6WNVBS=*!BK+:6K9`H++HKF;&57('QD$^!G&N^*]
M?<45,;0[AW'=-G]3VQ!@XCKGKR=D*=3N?R1\F,Y$U?25>)[V23"+D/8+EX_0
M54D3HD.)$E"@H(9>I/BYT:C9(R\=`7':W7=TAE2JPS[H:XO+;6X@Z1_<B9E2
M0^&`=&#U'W??E>E,/U]H"`8%D;)DSC6;6.CFC9A'L6Z+-BQ9()-6;-HV3*BW
M:M&J!$T&[9!$@%(0A2E*4````,#E8#`X,G&1TU&R$/,,&<K$2S)W&2D7(MD7
ML=)1S]NHU?1[]DY(JW>,GC94R:J2A3$4(82F`0$0P*D/_P`%?$I^(_"?Y,-:
M_8?N7]Q>GSV+[C[;][_X@_L[[O\`-?<_X>_N3Z_@_=^/^U_NWQ_!_3P+?<!@
M1.[&ZQJ/(NIG%VEHYY;[U8785;46K8)-1W:=F7]\4$XF`B(]L51V+)%=4BC]
MT4@D:MQ_M5.BFH&$.$>5KG1"V'IKI9T>T=:[T3;3MV=R)6ZY-80[A$QHW6%4
M!%19M'1=>9K`V]J/I\2100`QP*HJL&"/++X7]3^7%321=N=!=`:CC-%O+#*U
MBO:CE:DVK\A/V):'%:TRL?9:Q-G-:(MG$`V8NTE2"U265`I1]YO<$K."_'#R
M?XW]8.-:<R:]+!N)Y=*3V+LNRNS67;&V+$0#F4L.Q+P\3)(3+LZZRBB35(&\
M<T,JI]LV1`Y_<'M]K<$\1;UV)';<W1R-SCM3:,6X8.FFP;]IJ@6JWBO%()M8
MLSR>F(%W(R18QLB0C<KE14B!2%`@%`H>@2J8L&,6R9QL:S:QT='M4&3!@Q;I
M-&3%DU2(@V:,VK<B:#9JW13*1-,A2D(4H````8'*P&`P&`P&`P&`P*O.W^M]
MO0VP:7QGQA$QEDZOVNT5DY2VS"#>2I'.FN41;_DMCWML94"+2AVSD#1<>H4W
MS")5#$4][=%P$'=P\<ZRYEMO$&IJQ.S&S>B=Y=>5C:.WMPWMP:Q;1V.K3#EF
MK3.OI5]]V[@*5""_4%G&MU2H-T0]/550JBI@V)<!@,!@,!@,!@8TW#MV@Z&U
MI<-N;/G4*Y1J/$+3$Y)K^AC@F0Q$&K%DB)B&>2DJ^62;-$"C[EW"I"!]38%<
MG'&L+QTOM-QY!>CZXVBW\S'&C.4M9N9%U*)ZGU4Z.91*P.4!3:Q9K=<2`1TL
MZ*DH<QCB=,X(E:@F%LV`P&`P&`P&`P&`P&`P&!U4\]?1L',R,9&JS,DPBI%[
M'Q"!R)K2KYJS67:1J*B@@1-5\NF5(IC"``)O4<)<C7J\?G4NLM74G9VP=B5W
M9^T?(5T#L6P3FRM+5/5]H?;4CG23Q=M4:"HX<1C>N5&DP;1(#&?OGK./0((@
M83?;$+A5@O,G-&V[%NZ>[3Z^2@D=W2D(>H:@U57I`TS6N>-:+F<JK0:<N4XL
MI^]S8/5/R<@@4J7]54B8F(IZ)A9+@,!@,!@,!@<9Z]9QK-W(R+MLPCV#9=Z^
M?/5TFK-DS:I'7=.W;I<Z:#9JV03,=10Y@*0H"(B``(X%,%(DIORC[\<WM<ZZ
M?C[T1/OHJCPCR,<-F_2FSXXQFKR\K*.13%S28`_RH,TS)^OPF]Y?:JZ4^V"Z
M-!!%LBBW;HI-V[=)-%!!`A4D4$4B`FDBBD0"D323(4"E*4```#T`,#^N`P&`
MP&`P&`P&`P&`P&`P.,FS:).5WB35LF[=%3*Y=)H)$<N"(A[42KKE*"JQ4BCZ
M%`PC[0_3`Y.`P&`P&`P&`P*4NTMJV[M/>ROC+YUL+F)@FK-E.]L;@K[E-0==
MZ_7.DLEJN,<$$Z8VNX)B";M/^4IR-C_P"]!,+=];Z[J&I*'4]:T&'0@:=2H1
MC`0$4W^I6S!@B5(AE5!_C<.W!@%5=8_J=98YCF$3&$<#VV`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P->OP3?^5^1G_P`?_P#J!3_J?_O/]+)_[D_[G_R_
D^X_D,#84P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/_9
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
